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Abstract  
Skeletal muscle is a highly compliant organ system that is composed of muscle fibres, 
nerves, sensory cells, blood vessels and connective tissue. A central concept of skeletal 
muscle biology is the existence of an inverse relationship between muscle fibre size and its 
oxidative capacity which has been used to explain why small fibres are oxidative and large 
fibres glycolytic. However, sturdiness of this relationship is unknown. In order to investigate 
the rigour of this relationship we made use of a genetic model that enhances oxidative 
metabolism, mediated by estrogen-related receptor gamma (Errγ) (a constitutively active 
orphan nuclear receptor belongs to the ERR subfamily), and the hypertrophic background of 
Myostatin (a member of the Transforming Growth Factor beta (TGF-β) superfamily that is 
negatively regulating skeletal muscle mass development) null (Mtn‐/‐) mice. We show that 
superimposition of Errγ on the Mtn‐/‐ background results in hypertrophic muscle that 
displays a high oxidative capacity (Mtn‐/‐/ErrγTg/+), thus violating the inverse relationship 
between muscle fibre cross-sectional area and its oxidative capacity. Thereafter, we 
examined the canonical view that there is a high number of satellite cells (skeletal muscle 
resident stem cells) in oxidative muscles. Surprisingly, I found that hypertrophic oxidative 
muscle fibres from Mtn‐/‐/ErrγTg/+ mice showed a deficit in the number of satellite cells. 
Unexpectedly, the lower population of satellite cells in the hypertrophic oxidative model is 
not associated with a lower regenerative capacity. We also examined the relationship 
between muscle fibre phenotype (size and metabolism) and components of its force 
transducer apparatus that consists of both extracellular matrix (ECM) and dystrophin-
glycoprotein complex (DGC). Interestingly, I showed that levels of ECM and DGC entities can 
be influenced by muscle fibre phenotype.   
Observations of this work firstly, challenge the notion of a constraint between skeletal 
muscle fiber size and oxidative capacity, secondly, indicate the important role of the 
microcirculation in the regenerative capacity of a muscle even with low population of 
satellite cells, and thirdly, show that the metabolic properties of a muscle fibre are a critical 
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1.1. Muscle tissue   
Muscle tissue is one of the four primary types of body tissues, together with epithelial, 
connective and nervous tissues. Muscle cells are highly specialized for contraction; it 
produces movement within certain organs and the body as a whole. There are three types 
of muscle tissues can be uniquely identified by functional characteristics and the basis 
morphological features. The structure of each type is adapted to its physiological role. These 
muscle types are, cardiac muscle, smooth muscle and skeletal muscle (Mesher, 2010).  
Cardiac muscle cells develop from splanchnic mesoderm surrounding the endocardial heart 
tube, and myoblast cells adhere one to another by a special attachment that later develops 
into an intercalated disc (Sadler, 2012). The cells are relatively small, although a few cardiac 
cells may have two or more nuclei; a typical cardiac muscle cell has a single centrally located 
nucleus. The cardiac muscle is striated not voluntary that found specifically in the heart to 
provide the force required for circulating blood around the body. It contracts at a steady 
rate set by the heart’s pacemaker (Marieb, 2008). The intercalated discs are responsible to 
stabilize the relative positions of adjacent cells and maintain the three-dimensional 
structure of the tissue (Figure 1.1). Furthermore, the more longitudinal portions of each disc 
have multiple gap junctions, which provide ionic continuity between adjacent cells. Building 
on this, tightly knit bundles of cardiac cells and its interwoven organisation provides for a 
characteristic wave of contraction that leads to wringing out of heart ventricles (Martini, 
2006).  
Smooth muscles are constituents of internal organs and blood vessels. Smooth muscles for 
dorsal aorta and large arteries are derived from lateral plate mesoderm and neural crest 
cells, in the coronary arteries, smooth muscles originated from proepicardial cells and 
neural crest cells. Moreover, smooth muscles in the wall of the gut and gut derivatives are 
derived from a splanchnic layer of lateral plate mesoderm. Only sphincter and dilator 
muscles of the eye pupil and muscle tissue in the mammary and sweat glands are derived 
from ectoderm (Sadler, 2012). Smooth muscle cells are relatively long and slender with a 
single centrally located nucleus. They are nonstriated and involuntary cells, and their 
contraction mechanism is performed by calcium interacting with calmodulin, a calcium-
binding protein (Mesher, 2010). Both intermediate and thin filaments of smooth muscles 
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insert into dense bodies, this attachment is essential to transmit contractile force to 
adjacent cells. Smooth muscle cells control the distribution of blood and regulate the blood 
pressure. Extensive layers of smooth muscle cells in the walls of digestive tract play an 
essential role in moving materials along the tract. Furthermore, contraction and relaxation 
of smooth muscle in respiratory system can alter the diameter of respiratory passageways. 
In addition, layers of smooth muscles in the walls of urinary and reproductive systems’ 
organs, enable these organs to move their contents from one part to other (Martini, 2006). 
Skeletal muscle is the most abundant tissue in the human body constituting 40-50% of the 
total body mass. It is essential for voluntary movement through its attachment points to the 
skeleton. In addition, skeletal muscle is involved in a number of involuntary actions such as 
breathing and swallowing (Bannister, 1995). Skeletal muscles vary in their size, shape, 
attachments and relative myosin isoform proportion. They range from extremely tiny 
strands like the stapedius muscle in the middle ear, to the gluteus maximus being the 
largest muscle is an example of the range of different sized muscles in the body. They are 
capable of producing various motions, such as the extra ocular muscle of the eye which 
performs fine contracting motion, as well as gross movement in large muscles like 
quadriceps muscle of the thigh (Williams, 1999). There is also a huge disparity in skeletal 
muscles shape, the Oblicularia oculi are circular, whereas the sartorious that stretches along 
the thigh length is very long. As a result of these variations exhibited by skeletal muscle, it 
has been documented to have many important functions within the body: (1) Maintain 
posture and body position, skeletal muscles responsible for balancing the body above the 
feet during walk as a result of skeletal muscles tension. (2) Support soft tissues, the floor of 
the pelvic cavity and an abdominal wall formed from layers of skeletal muscle. (3) Produce 
skeletal movement, contractions of skeletal muscle moves the bones of the skeleton by 
pulling the tendons. (4) Guard entrances and exits of the mammalian orifices. (5) Maintain 
body temperature via heat production (Martini, 2006). Muscle fibres have a dynamic 
structure capable of changing their phenotypes in term of size and composition in response 
to environmental and physiological challenges such as mechanical loading or unloading, 
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1.2. Skeletal muscle  
1.2.1. Structure of skeletal muscle 
1.2.1.1. Macroscopic anatomy of skeletal muscle  
Skeletal muscle is made up of parallel bundles of long, cylindrical, and multinucleated cells 
that show cross-striations, each cell contains hundreds of oval nuclei just internal to the 
basement membrane (Figure 1.1). Multinucleation of skeletal muscle results from the fusion 
of multiple myoblast cells during myogenesis. The peripheral location of nuclei in skeletal 
muscle cells is an important feature to distinguish these cells from cardiac and smooth 
muscles, both of which have central location nucleus. Moreover, contractile proteins within 
the individual muscle fibre allow for powerful contractions and also give the striated 
appearance of the muscle. The contraction in skeletal muscle is voluntary and controlled by 
somatic motor innervation (Williams, 1999).   
Skeletal muscle is comprised of different tissues such as blood vessels, nerve fibres and a 
substantial amount of connective tissue. Each muscle is served by one artery, one or more 
vein and one nerve, usually all of these components enter and exit near to the central part 
and branch profusely through its connective tissue sheath (Marieb, 2008, Gumerson and 
Michele, 2011). The whole mass of each muscle that formed from regular bundles 
surrounded by a dense layer of collagen called the epimysium. The epimysium separates the 
muscle from surrounding tissues and organs and is connected to the deep fascia. From the 
epimysium, there are thin septa of connective tissue extended and surrounding the bundles 
of fibres within a muscle, this connective tissue around each bundle or fascicle called 
perimysium. Within fascicles there is a delicate connective tissue layer termed the 
endomysium, surrounds the individual muscle fibre and interconnect adjacent muscle fibres 
(Figure 1.2). The epimysium, perimysium and endomysium come together at both ends of 
muscle to form a bundle known as a tendon or a broad sheet called an aponeurosis. 
Tendons usually attach skeletal muscle fibres to the bone. Force generated by skeletal 
muscle contraction transmitted via tendon to cause bone movement. The blood vessels and 
the nerve supply generally enter the muscle together and follow the same branching 









1.2.1.2. Microscopic appearance of skeletal muscle 
Skeletal muscle fibre is a highly specialised structure filled with predominantly filament 
proteins that comprise myofibrils, the contractile apparatus of the tissue. The myofibrils 
align longitudinally and form series of contractile units called sarcomeres (Aidley, 1998).   
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Each sarcomere consists of (1) thick filaments, (2) thin filaments, (3) proteins that stabilize 
the positions of thick and thin filaments, and (4) proteins that regulate the interaction 
between thick and thin filaments (Martini, 2006). The interaction between thick and thin 
filaments of sarcomere is responsible for muscle contraction. It has been shown that the 
sarcomeres within the myofibrils are demarcated by a dense line called Z- line. The region 
between the Z- line can be divided into light area consisting of the thin actin protein 
filaments which called (I-band), and the dark area which mainly comprises the thick myosin 
protein filaments (A-band) which has a central lighter area called H-Zone. This central area is 
bisected vertically by a dark line called M-line (Figure 1.3). In addition, there are cross 
bridges projected from myosin filaments to establish the contraction with the actin 
filaments. During muscle contraction, the filaments slide over each other pulling the Z- discs 
together and shortening the length of the muscle (Sciote and Morris, 2000). Each myosin 
molecule consisted of two rod-like tails woven around each other and terminates into two 
globular heads. These heads contain ATPase enzyme that hydrolyses ATP molecules to 
generate energy require for contraction, as well as contain actin binding sites to link 
together and forming cross bridges. On the other hand, thin filaments are formed by two 
twisted strands of actin polymer, as well as regulatory proteins such as tropomyosin and 
troponin. Troponin composed of three polypeptides, Tn-I which act as myosin binding 
inhibitory, Tn-T which helps the binding of tropomyosin to actin, and Tn-C which bind to 
calcium ions (Marieb, 2008).  
    
1.2.1.2.1. Transverse tubule system and sarcoplasmic reticulum 
In large muscle cells, the signal causes a contraction of peripheral myofibrils before those 
more centrally positioned. In order to get a simultaneous contraction of all muscle cell 
regions, the signal has to be distributed rapidly throughout the cell interior. The sarcolemma 
has a transverse tubule (T-tubule) system that through invaginations penetrates throughout 
the myofibre to form a complex network of narrow tubes extending to the sarcoplasm, and 
encircles every myofibril near the sarcomere (Mescher, 2010). As the T-tubule have same 
properties of muscle sarcolemma, so electrical impulses conducted by the sarcolemma 
travel along the T-tubules into the cell interior, which in turn provide a uniform muscle 
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contraction. In the same line of thought, the T-tubules are short and broad in a cardiac 




















 Figure 1.3. Sarcomere structure (Mescher, 2010) 
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Wherever transverse tubules encircle myofibrils, the tubules are linked to the membrane of 
sarcoplasmic reticulum (SR), which a specialised endoplasmic reticulum of skeletal muscles 
that consist of a network of membrane passages. Adjacent to opposite sides of each T-
tubule, there are expanded terminal cisternae of sarcoplasmic reticulum, a pair of small 
cisternae of sarcoplasmic reticulum plus T-tubule is known as a triad. In spite of a tight 
binding of the two cisternae, their fluid contents are completely separate and distinct. In the 
cardiac muscle cell, the sarcoplasmic reticulum lacks terminal cisternae, whereas it forms a 
loose network throughout the sarcoplasm of smooth muscle cells (Martini, 2006). 
 
1.2.2. Skeletal muscle physiology  
1.2.2.1. Mechanism of contraction 
Resting sarcomeres show partial overlap of thick and thin filaments. Increase in amount of 
overlap between the filaments triggered by sliding of thin and thick filaments on each other, 
which lead to muscle contraction. Muscle contraction occurs following the discharge of a 
motor neuron at the neuromuscular junction (Mescher, 2010). 
A neuron stimulates a muscle fibre through orderly steps:  
1- Arrival of an action potential. When the neuronal signal arrives to nerve presynaptic 
terminal at the neuromuscular junction, an action potential propagates leading to calcium 
ion flow in the extracellular fluid which in turn causes release of acetylcholine (ACh) into the 
synaptic cleft as a result of permeability of the synaptic terminal membrane that induced by 
the action potential (Marieb, 2008).    
2- ACh binds at the motor end plate. The released ACh molecules bind to their sarcolemma 
nicotinic receptors. This binding induces the permeability of motor end plate to sodium ions 
that present in a high concentration in the extracellular fluid, whereas its concentration is 
very low inside the cell. The Na+ ions influx into the sarcoplasm lasts until 
acetylcholinesterase (AChE) enzyme eliminates ACh from its receptors (Martini, 2006).  
3- Development of the action potential in the sarcolemma. Inrushing of Na+ ions depolarize 
the sarcolemma. The action potential then spreads throughout the myofibrils via  
depolarization of sarcolemma T-tubules system which pass transversely into the muscle cells 
and surround each myofibril forming a membranous network with the sarcoplasmic 
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reticulum and end at flattened terminal cisternae which released the Ca2+ at the junction 
between the A and I bands of each sarcomere (Burkitt, 1993) (Figure 1.4). 
 
1.2.2.2. Contraction cycle 
In the resting sarcomere, myosin head charged with energy that is going to be used to 
power contraction. At the beginning of the contraction cycle, myosin head split ATP 
molecule and store the energy released in the process. ADP and phosphate which are 
products of ATP molecules breakdown, remain bound to the myosin head. During muscle 
contraction, membrane depolarization activates voltage-sensing Ca2+ channels in the T-
tubules that in turn activates ryanodine receptor 1 (RyR1) on SR membrane to release Ca2+. 
Subsequently, rise level of Ca2+ in muscle cytoplasm which is essential for contraction 
process (Andersson and Marks, 2010). The Ca2+ ions then bind to troponin-C. This binding 
weakens interrelate of troponin, tropomyosin and actin complex, that causes tropomyosin 
to be displaced, so exposing of myosin binding sites on the actin filaments. This permits the 
formation of cross-linkages between actin and myosin through sliding of thin on thick 
filaments producing contraction. Following contraction, Ca2+ ions are releasing from 
troponin and actively pumped back into the sarcoplasmic reticulum. Then the active sites of 
actin are re-covered by tropomyosin, resulting in the release of myosin-actin binding hence 
causing muscular relaxation (Ganong, 2005) (Figure 1.4).          
It has established that Ca2+ storage, release and re-uptake require feedback control through 
the sarcoplasmic reticulum (SR). In fact, there are three Ca2+ proteins regulate these tasks. 
Firstly, luminal calcium-binding protein that is required for calcium storage. Secondly, sarco 
(endo) plasmic reticulum calcium release channels for calcium release. Finally, sarco (endo) 
plasmic reticulum Ca2+ ATPase pump (SERCA) for calcium re-uptake. The proper calcium 
storage, release and re-uptake are important for efficient skeletal muscle contraction and 
relaxation (Rossi and Dirksen, 2006). A single stimulus-contraction-relaxation sequence in a 
muscle is called Twitch. Twitch varies in its duration depending on the muscle type, location, 
internal and external environmental conditions. A single twitch can be divided into three 
phases: (1) The latent period. During this period, the action potential sweeps across the 
sarcolemma and the sarcoplasmic reticulum release Ca2+ions. (2) The contraction phase. As 
the tension rise, calcium ions are binding to troponin, active sites on thin filaments are being 
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exposed, and cross-bridge interactions are occurring. (3) The relaxation phase. During this 
phase, calcium levels fall, active sites are covered by tropomyosin, and the number of active 
cross-bridges is decreased. Thereby tension falls to resting levels (Martini, 2006). When 
stimuli are delivered slowly enough, the tension in the muscle will relax between successive 
twitches. On the contrary, the high frequency delivered stimuli, the sarcoplasmic reticulum 
does not have time to reclaim the Ca2+ ions, which eliminates the relaxation phase and 
resulting in tetanic contraction due to twitches overlap. Such case, the contracting tension 
in the muscle remains constant in a steady state, and this is the maximal possible 
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1.2.3. Skeletal muscle metabolism and energy production  
Skeletal muscle is a large contributor to total body mass, thus offers an important role in 
maintaining whole body metabolism and energy homeostasis at normal levels. It recognises 
as one of the key regulators of metabolism and energy by away of metabolic crosstalk 
between body organs (Meyer et al., 2002). Glucose and Fatty acid metabolism largely 
regulated by skeletal muscle.  At both muscle fibres and body organs, glucose regulation is 
the centre of energy balance. Interestingly, skeletal muscle is able to store glucose in the 
form of glycogen that imparts rapid energy production for muscle contraction when glucose 
is not available from diet. Skeletal muscle stores amino acid in order to support energy 
production when other sources are depleted in elsewhere in the body (Wolfe, 2006). In 
support of this view, proteolysis in skeletal muscle is a critical process that can provide 
amino acid substrates like glutamine and alanine to augment glycogen synthesis by 
regulating gluconeogenesis (Perriello et al., 1997).  
Skeletal muscle fibres exhibit remarkable diversity in energy metabolism initiation. Oxidative 
muscles using lipids as a main source for energy production, with glycolytic phenotypes 
depending on glucose (Demontis et al., 2013). Energy turnover in skeletal muscle increase in 
response to exercise and contraction. Production of ATP molecules by skeletal muscle to 
provide sufficient level of energy that maintain muscle contraction is dependent on the 
contents and activities of organelles required for a particular process (Richter et al., 2001, 
Kiens, 2006). Indeed, muscle cells generate ATP molecules through (1) Aerobic metabolism 
in mitochondria and (2) Anaerobic metabolism in the cytoplasm. During aerobic metabolism, 
mitochondria absorb oxygen, ADP, phosphate ions, and organic substrates such as pyruvic 
acid from the surrounding cytoplasm, and through Tricarboxylic Acid cycle, an enzymatic 
pathway that breaks down these molecules and then generates a large amount of energy 
which is used to make ATP. This metabolism process relies on the glucose and fatty acid 
which is absorbed from the circulation, as well as oxygen necessary for aerobic metabolism 
acquired from blood stream and so it is known as oxidative metabolism. On the other hand, 
when the muscle start to contract, the mitochondria begin breaking down molecules of 
pyruvic acid, which is providing by the enzymatic pathway of glycolysis, which breaks down 
glucose in the cytoplasm.  
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This shift from fatty acid metabolism (aerobic oxidative metabolism) to glucose metabolism 
enables the muscle fibres to contract for an extended period with limited availability of 
oxygen (Martini, 2006).  
It has been documented that production and utilization of energy lead to constant 
metabolic rate and effective functional performance at a broad range of environmental 
conditions. Conversely, extend disturbance in energy homeostasis might contribute to the 
aetiology of many diseases. Complex pathways have evolved to adequately respond to 
constantly changing metabolic needs in particular for long-term adaptation that requires 
transcriptional regulation of metabolic genes. Moreover, nuclear receptors have been 
implicated in the regulation of a network of genes that involved in metabolic processes such 
as thermogenesis, lipogenesis and fatty acid oxidation (Desvergne et al., 2006). 
      
1.2.4. Skeletal muscle plasticity  
1.2.4.1. Muscle fibre types and distribution   
In mammalian skeletal muscle, there are different types of muscle fibres that contribute to a 
variety of functional capabilities. The fibre types differ according to their metabolic, 
structural, contractile and molecular properties. During the last decades, the classification of 
muscle fibres based on the isoforms of myosin heavy chain (MHC), become most prevalent 
(Schiaffino and Reggiani, 1996, Pette and Staron, 1990, Pette and Staron, 2001). MHC 
encoded by a multigene family and it is the major component of the contractile apparatus 
combining with actin to form the actomyosin complex, which is responsible for muscle 
elastic and contractile properties (Kammoun et al., 2014). Classification of muscle fibres as 
slow or fast has traditionally been related to the type of myosin expressed which is a 
structural and functional protein in the muscle sarcomere, and specifically myosin heavy 
chain, an integral component of native myosin (Smerdu et al., 1994). Based on the myosin 
heavy chain content, the mammalian skeletal muscle fibres can be classified into Iβ, α, 
extra-ocular, neonatal, embryonic, IIA, IIX, IIB and IIM (masticatory) which are expressed 
from a large genes family (Weiss and Leinwand, 1996). The major fast isoforms present in 
limb muscles of small mammals are MHC IIB, MHC IID/X and MHC IIA. Other fast MHC 
isoforms exist, but limited distribution to specific muscles, e.g. extra ocular and masticatory 
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muscles. The abundant MHC isoform in slow-twitch muscle is the slow MHC Iβ (Pette and 
Staron, 2000).  
Immunohistochemistry analysis of muscle tissue has revealed the existence of pure and 
hybrid fibre types. Pure fibre types with single MHC isoform, whereas hybrid fibres contain 
two or more MHC isoforms. Pair of major MHC isoforms coexists in hybrid fibres, which are 
classified according to their predominant isoform. Thus, the following hybrid fibres can be 
distinguished, type I/IIA, also termed IC, type IIA/I, also termed IIC, type IIAD, type IIDA, type 
IIDB and type IIBD. Collectively, the pure and hybrid fibres form a continuum from slow to 
fast (Pette et al., 1999). Unlike to myofibrillar proteins, C-protein, myosin-binding protein at 
the A-bands of the myofibril that stabilizing thick filaments of striated muscles during 
sarcomere assembly (Winegrad, 1999), does not show a strict correlation with the fibre type 
distribution in adult skeletal muscle. For instance, type II muscle fibres contain both slow 
and fast isoforms of the C-protein (Dhoot et al., 1985).  
There are also differences in fibre types between mammalian skeletal muscles. A number of 
investigators have reported that the fibre type profile in rodents is different to that in 
human muscles. Although the presence of corresponding gene in the human genome, the 
type MHCIIB protein is not detectable (Smerdu et al., 1994, Schiaffino and Mammucari, 
2011).  
Quantitative differences in metabolic enzyme levels in particularly of aerobic and anaerobic 
pathways of energy metabolism, have been also exploited to delineate muscle fibres. 
Aerobic (oxidative) fibres have small fibres cross-sectional area (CSA), high content of 
myoglobin and mitochondria. In contrast, anaerobic (glycolytic) muscle fibres display large 
cross-sectional area, less myoglobin, few mitochondria and rich in glycogen (Burkitt, 1993) 
(Table 1.1). Although classification based on MHC content does not necessarily correlate 
with oxidative capacity of muscle fibres, type I and IIA fibres tend to be oxidative, with type 
IIX and IIB muscle fibres being more glycolytic (Smerdu et al., 1994, Ciciliot et al., 2013).  
As myofibre types robustly correlate to functional demands placed on the muscles. A 
number of studies have investigated pathways and mechanisms underpinning muscle fibre 
development. It was well established that the development of the slow muscle fibre 
phenotype is largely controlled by Protein Kinase C, Calcineurin/nuclear factor of activated T 
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cell (Calcineurin/NFAT), AMP Activated Protein kinase (AMPK), peroxisome proliferator-
activated receptor gamma co-activator 1-alpha (PGC-1a) and Sex determining region Y-box 6 
(Sox6) (Gundersen, 2011, von Hofsten et al., 2008).  
 
 
Type IIB Type IIX Type IIA Type I Fiber type 
Very fast Fast Fast Slow Contraction 
time 
Low Intermediate Fairly high High Fatigue 
resistance 
Anaerobic Anaerobic Moderate Aerobic Activity 
Very high High Medium Low Force 
Low Medium High High Mitochondrial 
density 
Glycolytic Medium Oxidative Oxidative Oxidative 
capacity 
Large intermediate intermediate Small Cross-sectional 
area 
Low Low Low High Myoglobin 
content 
low low High High Satellite cells 
Thin Thin Thick Thick Connective 
tissue 
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Fast glycolytic muscle development on the other hand seems to involve the activation of the 
Akt signalling pathway through the transcriptional regulation by molecules including Baf60c 
(also called Smarcd3) and T-box 15 (Tbx15) (Meng et al., 2014, Lee et al., 2015).  
The majority of studies in relation to muscle fibres distribution have unveiled that myofibres 
arranged in a way that slow-twitch and oxidative fast-twitch fibres increase toward the deep 
regions in muscles, with fast-twitch glycolytic myofibres accumulating at the superficial 
areas (Pullen, 1977, Gunn, 1978). Consistently, a number of investigators have reported that 
the deepest extensor muscles from rats, cats and pigs have a high proportion of muscle fibre 
type I, with less percentage of type IIB fibres. In contrast, the superficial muscles contain 
few number of type I fibres, and the majority is type IIB muscle fibres (Armstrong and Phelps, 
1984). 
   
1.2.4.2. Muscle fibres transition  
Muscle fibres are dynamic structures with remarkable adaptive potential. Their phenotypic 
profiles are influenced by innervation, altered neuromuscular activity, exercise training, 
mechanical loading/unloading, hormonal profile and ageing. The changes in MHC isoforms 
tend to follow a general scheme of sequential transition from fast to slow and from slow to 
fast: MHCIβ  MHCIIA  MHCIID  MHCIIB (Pette and Staron, 2001). Remodelling of 
muscle fibres takes place by means of signal transduction where an extracellular stimulus 
interacts with cell receptors that result in activation of signalling pathways, which in turn 
remodel the fibres by eliciting changes in gene expression (Pette and Staron, 2001). In order 
to inspect genetic alteration and transition of muscle fibres in response to functional 
demands, numerous studies have been performed using exercise, electrical stimulation, 
transgenic animal models, and disease status (Bassel-Duby and Olson, 2006).  
The impact of innervation on the establishment of specific muscle fibre phenotypes during 
development stages and the subsequence maintenance of their phenotypic properties has 
been demonstrated in numerous studies (Buller et al., 1960). Fast muscles turn slow when 
reinnervated by slow nerve, and slow muscles turn fast when reinnervated by fast nerve, 
most probably due to specific neural impulse patterns delivered to the muscle fibres. Similar 
to cross-reinnervation, chronic electrical stimulation with slow or fast motoneuron-specific 
impulse patterns provokes profound changes in muscle phenotype (Pette and Staron, 2001). 
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MHC composition of skeletal muscle is readily altered by physical exercise. It has been 
demonstrated that endurance exercise causes an increase in MHCIIA concomitant with a 
reduction in MHCIIB/X in human muscles (Scott et al., 2001). Moreover, exercise training 
induces muscle adaptation in order to improve the physical performance which 
characterized by an increase of mitochondrial biogenesis, angiogenesis and fibre type 
transformation  (Yan et al., 2011). In the line of thought, it was revealed that the metabolic 
enzymes activity are largely unchanged following resistance exercise in human (Tesch et al., 
1990), but a reduction in the citrate synthase activity and glycolytic capacity has been 
reported (Baldwin et al., 1976). Recently, it has been shown that the estrogen-related 
receptor gamma (Errγ) is robustly expressed in slow muscle and can promote the formation 
of oxidative fibres (Narkar et al., 2011).  In addition, previous work has shown that lifting the 
inhibition of Akt signalling mediated by Myostatin is also a potent means of inducing the 
formation of glycolytic muscle fibres (Trendelenburg et al., 2009). 
  
1.2.5. Skeletal muscle supporting tissues  
1.2.5.1. Skeletal muscle capillarization  
A number of physiological processes in skeletal muscle are regulated by muscle 
capillarization, as the density of blood vessels that serve muscle fibres can be a limiting 
factor to the delivery of oxygen, substrates, and hormones (Gudbjornsdottir et al., 2003). 
Consequently, a lower level of muscle fibre blood supply may be an important determinant 
of a wide range of muscle or whole-body functions.  
Arteries that originated from large conduit arteries are positioned to control the total blood 
entering the muscle where they branching into networks of arterioles (Segal, 2005). The 
terminal arterioles of these networks control perfusion through blood distribution along the 
full length and depth of the muscle. Ultimately, the capillaries organized into microvascular 
units that represent the smallest volume of muscle to which blood flows and, therefore, 
oxygen, glucose and fatty acids delivery can be controlled (Lund et al., 1987). 
The microvasculature of skeletal muscles is subject to a large number of mechanisms that 
responsible for blood flow regulation. Such point of view might ensure that blood supply 
matches the metabolic demands of the muscle fibres under resting conditions and during 
exercise (Mortensen and Saltin, 2014). In line with this thought, previous studies have 
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demonstrated that oxidative myofibres are densely vascularized due to their high 
expression levels of angiogenic factors, which is not the case in glycolytic phenotypes 
(Annex et al., 1998, Hudlicka et al., 1992, Cherwek et al., 2000).  
In fact, numerous factors affect skeletal muscle capillarization. Regular exercise that boosts 
oxidative myofibre phenotypes can profoundly influence muscle blood supply. Such positive 
impact of exercise on muscle capillary density might be linked to the ability of oxidative 
fibres to induce a high angiogenic response (Yang et al., 2008, Cherwek et al., 2000). Recent 
studies have revealed a number of transcriptional regulators of oxidative myofibres can 
stimulate neoangiogenesis. For instance, nuclear receptor PPARgamma-coactivator-1α 
(PGC-1α) an important regulator of oxidative fibre type (Arany et al., 2008a), and 
peroxisomal proliferator activator receptor (PPARδ) are known to be able to promote 
angiogenic genes expression in skeletal muscle (Narkar et al., 2008, Gaudel et al., 2008). 
Further study that investigated treating ischaemic disease in skeletal muscle has reported 
ameliorative effect of Errγ on ischaemia, which might link to this nuclear receptor ability to 
remodel fibres types, thereby inducing angiogenic factors expression, as well as basal blood 
flow in the transgenic skeletal muscles (Matsakas et al., 2012b). 
             
1.2.5.2. Skeletal muscle connective tissue  
Skeletal muscle is an organ system composed not only of myofibres but also of nerves, 
sensory cells, blood vessels and connective tissue (Gumerson and Michele, 2011, Gillies and 
Lieber, 2011). Almost all connective tissue components are produced by fibroblast cells, 
primary cells in muscles and tendons that majorly responsible of connective tissue maintain 
and repair (Kuhl et al., 1984, Gatchalian et al., 1989). Although skeletal muscle myoblast 
cells have also been shown to contribute to collagen production, presence of fibroblast is 
indispensable for proper assembly of collagens into the functional extracellular matrix (ECM) 
(Lipton, 1977). The ECM in skeletal muscle is formed of a dynamic network of collagens and 
non-collagenous components like glycoproteins, proteoglycans and elastin. Fibrillar 
collagens (collagen I and collagen III) of ECM bear great stress within muscle and provide 
ECM capacity to transmit muscle contraction force to the bone via the tendons, thereby 
produce the movement. Non-fibrillar collagen (collagen IV) is concentrated in the basement 
membrane (Kjaer, 2004). Collagen IV with other components such as laminin are unique 
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molecules that bind to skeletal muscle complex named dystrophin-glycoprotein complex 
(DGC). DGC is a multicomponent complex that linking muscle fibre cytoskeleton, the 
sarcolemma, and the ECM into a functional unit that maintains muscle integrity (Ohlendieck 
et al., 1991). It is composed of three sub-complexes: (1) the sarcoglycans (α, β, γ, and δ); (2) 
syntrophin, nNOS, and dystrobrevin; and (3) α and β dystroglycan (Matsumura et al., 1993) 
(Figure 1.5). In addition to the mechanical properties of ECM compositions, they have a 
critical role in regulating skeletal muscle stem cells (satellite cells) activity and self-renewal, 
thereby muscle regeneration process (Calve et al., 2010). Moreover, there is a body of 
evidence that ECM components profoundly contribute and play a dynamic role in different 
cell signalling, facilitating cell proliferation and migration (Gillies and Lieber, 2011).  
The skeletal muscle connective tissue is functionally organised into three distinct layers 
(Gillies and Lieber, 2011). Individual muscle fibres are surrounded by the innermost layer of 
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connective tissue, the endomysium. The endomysial ECM is a highly ordered layer of 
collagen I and collagen III. It functions to transfer tension between overlapping muscle fibres 
and a load bearing structure upon myofibre contraction. The endomysium connecting to the 
sarcolemma via basement membrane that formed from two layers, internal basal lamina 
directly connect to the sarcolemma, and the external reticular lamina (Sanes, 2003, 
Campbell and Stull, 2003, Trotter and Purslow, 1992). 
A number of muscle fibres are bundled together in what is termed a fascicle. Each fascicle 
enclosed by the second type of skeletal muscle connective tissue, the perimysium. The 
perimysium layer is composed of mainly collagen I and the proteoglycan decorin, and it is 
continuous with the tendon, so it is responsible to transmit force from muscle to bone to 
create movement. Blood vessels and nerves are contained within the perimysium tissue 
(Passerieux et al., 2007, Gillies and Lieber, 2011).   
The third and outermost layer of skeletal muscle connective tissue that surrounds the entire 
muscle is epimysium (Gillies et al., 2014). The components of the epimysium layer are more 
similar to the endomysium than the perimysium, however, the collagen structure has a 
particular 'crimp' patterning more similar to the perimysium and tendon than the 'mesh' 
patterning in the endomysium (Gillies and Lieber, 2011). 
A number of studies have illustrated that the amount of ECM is not constant in all muscle 
types. The concentration of ECM components is much lower in fast muscles compared to 
the slow ones (Kovanen et al., 1980). The correlation extends to the level of individual 
muscle fibres. The endomysium and perimysium connective tissue are greater between slow 
type I than the fast type II myofibres, indicating that the differences in function would be 
reflected on the muscle connective tissue components (Kovanen et al., 1984a).  
Nevertheless, connective tissue is a part of a muscular organ, a number of studies have 
reported diverse impacts of molecules that regulate muscle development on muscle fibres 
and connective tissue compositions. Study by McPherron et al. has shown that muscle 
connective tissue entities fail to develop to their normal levels in mice and cattle that had 
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1.2.5.3. Skeletal muscle innervation  
Proper motor control of nervous system where muscle performance can be adapted in a 
short term is a critical factor that enables accurate muscle functionality. Such interaction 
might indicate an essential role of the neural system in regulating muscle properties and 
determination of muscle phenotype (Buller et al., 1960). Nevertheless, skeletal muscles are 
often under voluntary control, a number of skeletal muscles may also be controlled at a 
subconscious level, such as skeletal muscles involved in breathing, like diaphragm usually 
works outside conscious awareness (Martini, 2006). Like that in skeletal muscle connective 
tissue arrangement, each nerve consists of groups of nerve axons surrounded by three 
connective tissue layers. The epineurium is a sheath of longitudinal collagen fibres that 
enclosed the entire nerve. The perineurium which is formed of connective tissue layer of 
concentrically laminated structure wrapped a group of nerve axons. Third layer is the 
endoneurium, a longitudinal collagen fibres layer condensed around each individual nerve 
axon (Thomas, 1963). Myelinated motor nerve gives rise to several terminal twigs within 
perimysium connective tissue layer. The axon loses its myelinated sheath at the site of 
innervation where it forms a dilated termination situated within a trough on the muscle cell 
surface, a structure called motor end-plate or the neuromuscular junction. There are 
numerous mitochondria and synaptic vesicles within the axon terminal, and other 
containing neurotransmitter acetylcholine (ACh). The space between axon and muscle is 
called synaptic cleft (Mesher, 2010).  
The motor unit, consisting of a motor neuron and the myofibres it innervates. A 
coordination between groups of motor units is required for a single muscle contraction 
(Gutmann and Hanzlikova, 1966). Study on human muscles has reported positive correlation 
between muscle size and the number of motor units. Large muscles of the limb contain a 
greater number of motor units compared to small ones. For instance, Extensor digitorum 
brevis muscle has about 200 motor units, whereas the intrinsic muscle of the hand contains 
100 motor units (McComas, 1991).  
A number of studies have demonstrated that muscle fibres are regulated by the innervation 
pattern. Expression of myosin heavy chain (MHC) type I (slow fibre) depends on activity of 
slow nerve fibre. In contrast, fast MHCs (IIA, IIX and IIB) are regulated by fast innervation 
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pattern (Ohira et al., 2006, Patterson et al., 2006).  In this line of thought, previous work has 
demonstrated that loss of neuronal influence may cause a slow-to-fast shift in fibre type and 
MHC isoform profile (Herbison et al., 1979). Moreover, muscle fibre conversion from slow- 
to-fast phenotypes due to denervation usually but not always accompanied by muscle 
atrophy that is characterized by a decrease in muscle fibre cross-sectional area (CSA) and 
protein content (Herbison et al., 1979). Same muscle fibre may respond differently to the 
denervation according to muscle type. Muscle fibres type I and type IIA from rat’s soleus 
muscles undergo dramatic atrophy following denervation, whereas same fibre types from 
the extensor digitorum longus (EDL) muscles of same animal maintain essentially same size 
(Aravamudan et al., 2006). In addition, an increase of neuromuscular activity through 
endurance exercise and chronic electrical stimulation causes an increase of fast-to-slow 
fibre type transition evidenced by an increase in MHC type I and MHC type IIA (Pette and 
Vrbova, 1992). Conversely, reduction of neuromuscular activity through complete spinal 
cord transaction appeared to induce slow-to-fast muscle fibre type conversion in soleus 
muscle of the cat (Roy et al., 1992). According to Buller’s group (Buller et al., 1960), cross-
reinnervation pattern was able to induce muscle fibre transition according to the new motor 
connection.  
 
1.2.6. Skeletal muscle development    
1.2.6.1. Embryonic origin of skeletal muscles  
Skeletal myogenesis is an important field for studying the restriction of cell fate during 
embryonic, fetal and post-natal development. Skeletal muscle develops in sequential but 
overlapping stages (Ordhal, 2000). Muscles of the body arise from somites, segmented 
structures that form from paraxial mesoderm in an anterior to posterior manner. Somites 
receive signals from the neighbouring tissues that induce primordial muscle precursor cells 
to be committed in a myogenic fate  (Borycki and Emerson, 2000). The somite then divides 
into ventromedial and dorsolateral portions. The ventromedial portion disperses into 
mesenchymal sclerotome where it forms the cartilages of the vertebrae and ribs. The 
dorsolateral portion of the somite that facing the surface ectoderm called dermomyotome 
epithelial that gives rise to muscle progenitor cells. The dermomyotome also gives rise to 
cells of the endothelial, vascular smooth muscles, dermal and brown fat lineages.  
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Diaphragm and tongue muscles also originated from dermomyotome via long-range 
migration of muscle progenitor cells (MPCs) (Tajbakhsh and Buckingham, 2000, Biressi et al., 
2007). Moreover, unsegmented head mesoderm and prechordal mesoderm give rise to 
ocular, mandibular and superficial facial muscles (Brand-Saberi and Christ, 2000). The 
dermomyotome is further subdivided into two cell populations, medial and lateral that 
giving rise to the epaxial and hypaxial muscles (Ordhal, 2000).  
In response to signals from adjacent tissues, the dermomyotomal progenitor cells become 
committed to the skeletal muscle lineage and form the myotome, a population of 
differentiated muscle cells (Tajbakhsh and Buckingham, 2000). The differentiated cells 
(committed muscle cell precursors) align and fuse to form the mature multinucleated 
myotubes. Whereas a population of undifferentiated cells remain quiescent, but are 
activated upon injury or degeneration of mature fibres, these are termed satellite cells and 
defining as stem cells (Seale and Rudnicki, 2000). Cells differentiation is accompanied by the 
transcriptional activation of muscle-specific genes encoding for metabolic enzymes, ion 
channels, neurotransmitter receptors and contractile proteins (Hastings and Emerson, 
1982). 
Delamination of cells from lips dermomyotome gives the start step of myogenesis process. 
The delaminating cells that already expressed myogenic determination factors Myf5 and 
Mrf4, move below the dermomyotome and rapidly differentiate into the skeletal muscle 
cells. In the absence of the determination factors, the early myotome does not form and 
instead the delaminated cells are dislocated (Bajanca et al., 2006). Study by Manceau et al. 
on chick and mouse embryos has shown that the epithelial cells in the central part of 
mature dermomyotome express Paired box3 (Pax3) and its paralogue Paired box7 (Pax7) 
during disintegration (Manceau et al., 2005). These cells proliferate and do not express 
myogenic regulatory factors or muscle proteins, however, they can give rise to skeletal 
muscle cells, as a result of activation of myogenic determination factor (Myf5) and myogenic 
differentiation (MyoD) leading to subsequent skeletal muscle differentiation. Mutation of 
Pax3 and Pax7 genes lacked fetal muscle development, Pax3 is transcribed in satellite cells 
in many, but not all skeletal muscles (Zammit et al., 2006). In fact, the majority of body 
muscles are derived from a highly proliferative Pax3+/Pax7+ cells that derived from the 
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central dermomyotome (Relaix et al., 2005, Gros et al., 2005, Kassar-Duchossoy et al., 2005). 
The emergence time of this cell population is mainly regulated by myotome-derived 
Fibroblast Growth Factor (FGF8) that stimulates expression of transcriptional factor Snail1 in 
dermomyotomal cells, which in turn induce epithelial-to-mesenchymal transition (Delfini et 
al., 2009). Importantly, the Pax3+/ Pax7+ progenitor cells are able of both proliferation/self-
renewal and differentiation along the skeletal muscle lineage (Kang and Krauss, 2010).  
 
1.2.6.2. Satellite cells and muscle regeneration  
Stem cells of skeletal muscles named satellite cells (SCs) that located beneath basal lamina 
were first discovered by electron microscopic study of skeletal muscle fibres (MAURO, 1961). 
Reznik was the first who showed that satellite cells function as myoblast and he labelled 
them as stem cells (Reznik, 1969). These cells were firstly identified in the muscle of the frog, 
but then immediately confirmed to reside in rat muscle and later found to occupy a 
common anatomical position in a majority of vertebrates (Grounds and Yablonka-Reuveni, 
1993). In normal muscle cell (non-injured), satellite cells are quiescent and it has few 
organelles with high nuclear-to-cytoplasm ratio, and small size nuclear compared to the 
adjacent nucleus of myotubes. However, it appears as swelling on the myofibres with 
cytoplasmic processes after activation (Schultz and McCormick, 1994).  
Almost all quiescent satellite cells are expressing CD34 and Myf5, thus it was believed that 
these markers playing a role in maintenance satellite cells quiescence (Beauchamp et al., 
2000). However, Bjornson et al. demonstrated that Notch signalling is crucial for 
maintenance satellite cells quiescence. Same study reported that deletion of satellite cell 
specific recombining binding protein-Jĸ (RBP-Jĸ) led to spontaneous activation of the cells, 
which terminated by cell differentiation and fusing with muscle fibre. Thus, depletion of 
satellite cells pool, hence the skeletal muscle lost the capacity of regeneration following 
injury (Bjornson et al., 2012).  
It was well established that satellite cells on isolated muscle fibre were stimulated to 
activate and divide by a mitogen originated from crushed skeletal muscle, indicating an 
external factor act upon the quiescent satellite cells (Bischoff, 1986). Consistently, Allen and 
Boxhorn have shown that the inhibitory effect of Transforming Growth Factor beta (TGF-β) 
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on satellite cells differentiation is probably mediating by the mitogen lineage (Allen and 
Boxhorn, 1987). The mitogenic response of satellite cells in contact with cultured myofibres 
is reduced compared to the isolated cells, indicating a vital role of myofibre to initiate 
satellite cells activation response, which provides evidence of the critical role of niche 
environment in regulating satellite cells behaviour (Bischoff, 1990).  
For a better understanding of satellite cells functions, describing of molecular mechanisms 
that control their behaviour is required. A number of studies have demonstrated that Pax3 
and Pax7 are members of Paired Box family of transcriptional factors play a vital role during 
muscle myogenesis (Bopp et al., 1986, Goulding et al., 1991). Although their structural 
homology, Pax3 and Pax7 have different functions during embryological development. Pax3 
is expressed in the developing presomitic mesoderm, however, it becomes localized into the 
dermomyotome following somite differentiation (Goulding et al., 1991). It is necessary for 
myoblast migration, thus its absence results in the loss muscle precursor migration from the 
hypaxial dermomyotome into the limps and tongue (Goulding et al., 1994, Epstein et al., 
1996). Moreover, it was well established that Pax3 is involving in regulating precursor cells 
entry to the myogenic lineage through acting upstream of the myogenic regulating factor 
MyoD in mouse embryo (Tajbakhsh et al., 1997). Further investigation has revealed a high 
affinity of Pax3 to Myf5 promoter enables it to bind 145-base pair elements, which is 
essential for Myf5 transcription (Bajard et al., 2006). Pax7 is expressed in the developing 
dermomyotome, indicating its role during muscle myogenesis (Jostes et al., 1990). Previous 
studies have demonstrated that Pax7 is essential for satellite cells lineage specification, as 
well as renewal and propagation of satellite cells population throughout embryogenesis and 
adulthood (Seale et al., 2000, Oustanina et al., 2004). Furthermore, Pax7 has been shown to 
have a critical role as a cell survival signal for satellite cells mediating by the prevention of 
the expression of the myogenic regulating factors MyoD and myogenin (Olguin and Olwin, 
2004). In support of this view, myogenin has been shown to downregulate Pax7 expression 
in order to allow muscle cells differentiation to proceed (Olguin et al., 2007). Additionally, 
Pax7-null mice, progressive loss of satellite cells during adulthood with or without 
expressing of Pax3, indicating that Pax3 cannot compensate Pax7 anti-apoptotic role (Relaix 
et al., 2005).  
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Using Pax3 and Pax7 as satellite cell markers has provided evidence that these cells remain 
as progenitors throughout late foetal development, then developed beneath basal lamina 
where they take up the position of quiescent satellite cells (Gros et al., 2005, Relaix et al., 
2005). Indeed, embryonic and foetal muscle develops through two stages, primary and 
secondary myogenesis, and these processes are carried out by primary and secondary 
myoblasts, respectively (Feldman and Stockdale, 1992). Nevertheless, it was thought that 
satellite cells are a final population of myoblasts during late foetal development, Gros and 
Relaix have demonstrated that satellite cells emerge from an undifferentiated population of 
stem cells that originated from embryonic dermomyotome (Gros et al., 2005, Relaix et al., 
2005).  
Satellite cell numbers per single myofibres vary in different muscles depending on the 
muscle fibre composition (i.e. slow oxidative, fast oxidative or fast glycolytic fibres). It has 
been illustrated that soleus muscle, which is mainly made up of slow oxidative fibres, 
contains a higher number of satellite cells compared to the Extensor digitorum longus (EDL) 
muscle that shows fast glycolytic fibres predominant. Moreover, despite the reduction in 
satellite cell populations in both soleus and EDL muscle with age advance, it has been shown 
that soleus muscle shows an increase in satellite cell numbers between 1-12 months of mice 
age, which is not the case in EDL muscle (Gibson and Schultz, 1983).  
Muscle development and regeneration share common features because the molecular 
mechanisms underpinning the development are reactivated for tissue reconstruction after 
injury (Charge and Rudnicki, 2004, Hawke and Garry, 2001). Satellite cells characterised by 
its ability to regenerate damaged skeletal muscle fibres (Moss and Leblond, 1971). Further 
work has reported that the satellite cells pool not only responsible for replenishing of 
damaged muscles, but also repopulate its own cell pool that is essential for tissue repairing 
following further injuries (Collins et al., 2005). It seems that the satellite cells carry out dual 
functions: it provides differentiating progeny that will fuse with both new and damaged 
myofibre, meanwhile repopulate the stem cells pool through a self-renewal mechanism. 
Two possible mechanisms by which satellite cells maintain their pool. A subpopulation of 
satellite cells stop progression down the myogenic lineage and revert to the quiescent state, 
alternatively, a subpopulation of satellite cells must divide into differentiating and stem cell 
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progeny (Zammit et al., 2004, Kuang et al., 2008). Following muscle injury, satellite cells 
activate, then the majority of the activated cells switch on the expression of the myogenic 
regulating factor MyoD, and thereafter differentiate (Cornelison and Wold, 1997, Zammit et 
al., 2004). Zammit then showed that a subset of the activated satellite cells (MyoD+) switch 
off this marker, simultaneously retaining Pax7 expression, thereby these cells retain to a 
quiescent state and replenish the satellite cell pool (Zammit et al., 2004) (Figure 1.6). Others 
demonstrated that satellite cells have also been shown to divide a symmetrically giving 
differential daughter (Shinin et al., 2006, Kuang et al., 2007).  
It was well documented that satellite cell in contact with basal lamina of the muscle fibre 
retains its stem cell state, whereas cell that loses its contact initiates Myf5 expression and 
subsequently differentiate. Such scenarios indicate the crucial role of the niche environment 
in controlling satellite cells proliferation and differentiation (Bischoff, 1990).  
Previous work has reported that canonical Wnt plays a role in regulating satellite cells 
proliferation in response to muscle damage (Otto et al., 2008). Moreover, canonical Wnt 
regulates MyoD during muscle development and regeneration (Munsterberg et al., 1995). In 
addition, study by Wei and Pterson (Wei and Paterson, 2001) has demonstrated that cyclin 
D1 (a Wnt β-catenin target gene) induces expression of cyclin dependent kinase (Cdk) Cdk4. 
The later directly bind to MyoD and inactivate it, allowing cell cycle progression until 
mitogenic signal is depleted. Following mitogen depletion, cyclin D1 level drops, and 
thereby Cdk4 repression of MyoD activity is disappear, ultimately allowed MyoD to induce 









         




1.7. Myostatin  
Myostatin is a member of the Transforming Growth Factor-β (TGF-β) superfamily, is 
predominantly secreted by skeletal muscle to negatively regulate its growth and 
development. It is an autocrine/paracrine inhibitor of muscle growth that expressed in cells 
of the skeletal muscle lineage from embryonic myotome to striated muscle in adult 
(McPherron et al., 1997). Consistent with this view, localize ectopic expression of Myostatin 
was attained by vector modulate gene electro transfer to tibialis anterior (TA) muscle of 
adult rat results in a decrease in muscle fibre cross-sectional area (CSA) and subsequently 
muscle mass diminish. Moreover, noticeable reduction in the expression of muscle 
structural genes (MHC IIB, troponin I and desmin), as well as expression of myogenic 
Figure 1.6.  Satellite cells self-renewal  
Quiescent satellite cells (green) activate, co-express Pax7 and MyoD (green and red tartan), 
and then most proliferate, down-regulate Pax7, maintain MyoD (red), and differentiate (red 
pathway) to produce myonuclei. A subpopulation of activated (green and red tartan) satellite 
cells down-regulate MyoD expression and cycle while maintaining only Pax7 (green). Thus 
renewing the satellite cell pool (green pathway), adapted from (Musaro, 2014). 
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transcription factors MyoD and myogenin, was also reported (Durieux et al., 2007). Genetic 
evidence demonstrates that Myostatin has a pivotal role in regulating skeletal muscle mass 
and function, since deletion of the gene produces mice with a phenotypes exhibiting a 
dramatic increase in skeletal muscle mass due to hyperplasia, an increase in absolute 
number of muscle fibres, and hypertrophy, an increase in the cross-sectional area of 
individual muscle fibre (McPherron et al., 1997, Mendias et al., 2006). Beside mouse model, 
the double-muscling phenotype due to Myostatin mutation has been observed in cattle, 
sheep, dogs and human (McPherron and Lee, 1997, Kambadur et al., 1997, Clop et al., 2006). 
A sequence designated Myostatin was obtained by using oligonucleotide corresponding to 
highly conserved regions among the TGF-β superfamily members as primers for polymerase 
chain reaction (PCR) on mouse genomic DNA. The obtained Myostatin protein sequence had 
all the features of TGF-β superfamily members, including secretion single sequence, a 
proteolytic processing site and a carboxylic terminal region containing the conserved 
pattern of nine cysteine residues (McPherron et al., 1997).  
In fact, the biological function of Myostatin is not only restricted to suppress skeletal muscle 
growth. It regulates muscle stem cells proliferation and differentiation, as well as fibre type 
switch (McCroskery et al., 2003, Thomas et al., 2000). In vitro study by Taylor et al. has 
revealed an inhibitory effect of Myostatin on protein synthesis in both myoblast and 
myotubes (Taylor et al., 2001). Although it is expressed in lower level in adipose tissue 
compared to muscle tissue, it has been demonstrated that Myostatin is profoundly involved 
in adipogenesis (Feldman et al., 2006). Moreover, previous work has reported that 
Myostatin induces proliferation of muscle fibroblast therefore it increases the deposition of 
ECM components (Li et al., 2008). 
Despite the enormous muscle develops in the absence of Myostatin, loss of this gene 
expression in young mice is associated with specific metabolism features in skeletal muscles. 
Early studies provided evidence that absence of Myostatin leads, despite the enlarged 
muscle mass, to loss of oxidative properties, with impaired in oxidative enzymes activity, 
and a reduction in muscle capillary density (Amthor et al., 2007, Lipina et al., 2010, Savage 
and McPherron, 2010). Further evidence regarding a metabolic deregulation due to 
Myostatin deficient was shown by Ploquin et al. reported perturbations in the inter-
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myofibrillar mitochondrial respiration of young Myostatin knockout (Mtn-/-) glycolytic 
muscles, that was associated with an increase in muscle fatigability during contractility tests 
(Ploquin et al., 2012). Furthermore, there was a decline in muscle force generation, as well 
as specific tetanic tension in Mtn-/- muscles, suggesting that muscle mass increase in 
Myostatin mutant animals confers no strength advantage more than the control animals 
(Amthor et al., 2007). Other findings by Amthor et al. illustrated predominantly of muscle 
fibre type IIB, with a marked reduction in type IIA and IIX fibres in the extensor digitorium 
longus (EDL) muscle from Myostatin null mice, as well as in tibialis anterior (TA) and 
gastrocnemius muscles of the same genotype (Amthor et al., 2007). These data were 
supported by findings of Girgenrath’s work (Girgenrath et al., 2005). In addition, a reduction 
of oxidative enzymes activity in Mtn-/- muscle was associated with high proportion of fast 
glycolytic myofibres that contains fewer mitochondria compared to oxidative phenotypes. 
Consistently, Mitochondrial density, and the mtDNA copies number per myonucleus in 
muscle with Myostatin mutation was lower than that seen even in glycolytic fibres of wild 
type muscle (Amthor et al., 2007, Girgenrath et al., 2005). 
 
1.7.1. Effects of Myostatin on muscle cells proliferation and differentiation  
Myostatin is a negative regulator of skeletal muscle growth, an effect attributed to 
inhibition of both myoblast proliferation and differentiation. It arrests myoblast cell cycle at 
the G1-phase. Several studies have demonstrated that Myostatin induces satellite cells 
quiescence is associated with the up-regulation of the cyclin-dependent kinase (Cdk) 
inhibitor p21, the decrease in Cdk2 activity, and decrease phosphorylation of 
retinoblastoma (Rb) protein (Thomas et al., 2000, Joulia et al., 2003). Moreover, it has been 
shown that Myostatin increases cyclin D1 protein degradation that in turn causes G1 cell 
cycle arrest through PI3K/Akt/ (Glycogen synthase kinase-3 beta) GSK-3β signalling pathway 
(Yang et al., 2007). Importantly, Myostatin inhibits myoblast differentiation by 
downregulating the expression of myogenic regulating factors, MyoD, myogenin and Myf5, 
as well as the activity of their downstream target creatine kinase (Huang et al., 2007, Joulia 
et al., 2003, Langley et al., 2002).  
Satellite cell promotes post-natal muscle growth and repair. McCroskery reported that 
Myostatin has also been able to maintain satellite cells quiescence at this stage (McCroskery 
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et al., 2003). Analysis of cell cycle has confirmed Myostatin potential to up-regulate p21, 
simultaneously reduces Cdk2 level and activity, indicating Myostatin potential to prevent 
transition from G1 to S-phase of the cell cycle, thereby maintains satellite cells at quiescent 
status (McCroskery et al., 2003). 
 
1.7.2. Structure and proteolytic processing of Myostatin  
Similar to other members of TGF-β superfamily, Myostatin is synthesized as a precursor 
protein composed of a signal sequence, an N-terminal propeptide domain, and a C-terminal 
considered as the active molecule. Myostatin is expressed in mouse muscles at about 9.5 
days post-coitum, and it can be detected in the developing skeletal muscle throughout the 
myogenic embryogenesis (Lee, 2004, McPherron and Lee, 1997).  The full length Myostatin 
protein is proteolytically processed to form an amino terminal propeptide and a disulfide-
linked dimer of carboxy-terminal fragments. The Myostatin protein can be detected in 
skeletal muscle and in circulation in an inactive latent complex (Myostatin propeptide 
bound to the mature region) (Lee, 2004, Patel and Amthor, 2005, Walsh and Celeste, 2005). 
Indeed, two proteolytic cleavages are required to liberate the mature region and allow 
Myostatin signalling. The first cleavage by furin family enzymes that removes the 24 amino 
acid signal peptide, and the second cleavage by Bone morphogenetic protein 1  
BMP1/Tolloid matrix metalloproteinase (Lee, 2004). Mature Myostatin dimer can be found 
bound to a number of proteins that are able to moderate its secretion, activation, or 
receptor binding (Lee and McPherron, 2001). 
 
1.7.3. Myostatin signalling pathway  
Mechanism of Myostatin signal is similar to that of TGF-β. It initiates an intracellular 
signalling cascade by firstly binding to the activin type II receptor (ActRIIB), which leads to 
the recruitment and activation of the activin receptor-like kinase 4 and 5 (ALK4 and ALK5) to 
form a heterotetrameric receptor complex (Shi and Massague, 2003). Two intracellular 
signalling cascades have been described that are activated through phosphorylation 
mediated by the receptor complex. Phosphorylation of Smad2 and Smad3 enabling an 
interaction and form a complex with Smad4 that translocates into the nucleus, where it is 
involved in regulating the transcription of target genes (Shi and Massague, 2003, Feldman et 
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al., 2006). Myostatin initiates another signalling pathway without the involvement of Smad2 
and Smad3 phosphorylation, by preventing phosphorylation and thereby inhibition of AKt, 
which in turn results in activation of FoxO that leads to protein degradation, and hence 
muscle atrophy through either proteasome or autophagy mechanisms (Trendelenburg et al., 
2009) (Figure 1.7).  
It has been shown that there is another group of Smads, Inhibitory Smads (I-Smads) that are 
responsible to terminate TGF-β signalling (Shi and Massague, 2003), include Smad6 and 
Smad7 (Attisano and Wrana, 2000). There is evidence that Smad7 provides a negative 
feedback loop mechanism to inhibit Myostatin signal pathway (Zhu et al., 2004). 
Another molecule can interact and influence Myostatin signalling pathway is FoxO1. FoxO1 
is a member of the Fork head box O (Fox O) transcription factor family (Murray et al., 2013). 
It is known to be expressed in skeletal muscle and to be involved in regulating of genes 
expression during muscle atrophy, particularly in the activation of ubiquitin ligase 
expression, which leads to protein degradation. FoxO1 has recently been associated with 
Myostatin pathway. Several FoxO boxes have been characterized in the mouse Myostatin 
promoter, and activity of this promoter can be profoundly induced by FoxO1. This suggests 
that FoxO1 could enhance muscle atrophy through two paths, inducing protein degradation, 
as well as through inhibition of myogenesis and protein synthesis mediating by promoting 










1.7.4. Post-developmental blocking of Myostatin   
Skeletal muscle wasting occurs in a variety of pathological settings. A majority of studies into 
the relationship between Myostatin and muscle mass have revealed an increase in 
Myostatin expression in disease states causing muscle wasting.  Previous studies have found 
an increase in Myostatin level in ageing subjects (Yarasheski et al., 2002), as well as due to 
immobilization or prolonged bed rest (Reardon et al., 2001, Zachwieja et al., 1999).  
Consistently, it has been shown that patients with acquired immune deficiency syndrome 


























Muscle protein              Protein degradation 
ALK5ALK4
ActRIIB
Figure 1.7. Myostatin signalling pathway 
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1998, Sun et al., 2006, Breitbart et al., 2011). Following Myostatin discovery (McPherron et 
al., 1997), extensive studies have unveiled a remarkable increase in muscle mass of a range 
of species due to Myostatin ablation (McPherron and Lee, 1997, Schuelke et al., 2004, 
Mosher et al., 2007). Therefore, a number of strategies to inhibit Myostatin signalling have 
been proposed, given the therapeutic potential of stimulating muscle growth or preventing 
muscle loss in settings of diseases that induce muscle wasting. A modified Myostatin 
propeptide which blocks Myostatin signalling has been applied to enhance muscle growth in 
normal mice, as well as to ameliorate the dystrophic characteristics of the mdx mice, a 
model of Duchenne muscular dystrophy (DMD) (Matsakas et al., 2009, Bogdanovich et al., 
2005). Similarly, administration of follistatin, a secreted glycoprotein that can bind 
Myostatin and inhibit its interaction with ActRIIB, has been reported to induce muscle mass 
(Haidet et al., 2008, Nakatani et al., 2008). Moreover, neutralizing Myostatin antibody was 
described as a potential method to block Myostatin pathway in adult mice, hence motivate 
muscle growth (Krivickas et al., 2009, Wagner et al., 2008). Furthermore, administration of 
soluble ActRIIB causes an increase in muscle mass of wild type and Myostatin null mice, 
indicating that in addition to Myostatin, there are other ligands contribute to limit muscle 
development (Lee et al., 2005). Indeed, these investigations indicate that the regulatory role 
of Myostatin is not limited to muscle developmental stage.  
Unlike Myostatin genetic deletion, hypertrophy without hyperplasia was found in mice with 
Myostatin inhibition at post-natal stage (Girgenrath et al., 2005, Lee et al., 2005, 
Whittemore et al., 2003, Zhu et al., 2000). The changes in muscle fibre number and 
distribution seen in Myostatin null mice, do not occur following Myostatin inhibition in adult 
animals (Girgenrath et al., 2005, Matsakas et al., 2009, Welle et al., 2007). In this line of 
thought, it has been shown that treatment with anti-Myostatin antibody did not rescue the 
decrease in force output in mdx mice, however, administration of Myostatin propeptide 
results in an increase of specific force output of these animals, implies different implications 
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1.8. Mechanisms regulate skeletal muscle mass   
Skeletal muscle mass increases during post-natal development through hypertrophy process. 
In adult muscle, a similar process can be induced in response to contractile activity such as 
strength exercise and specific hormones (Bottinelli et al., 1991). Muscle mass is tightly 
regulated by a dynamic control of the processes of protein synthesis and degradation 
(Conlon and Raff, 1999). In fact, multiple processes operate according to highly 
interconnected signalling networks that coordinate quality control mechanisms to maintain 
protein homeostasis (Morimoto and Cuervo, 2014). Insulin-like growth factor-1 (IGF-1) has 
long been implicated in controlling skeletal muscle growth. It is able to increase protein 
synthesis within cells (Russell-Jones et al., 1994). Previous work has demonstrated that 
transgenic mice overexpression of IGF-1 show muscle hypertrophy (Coleman et al., 1995), 
whereas IGF-1 null mice are smaller than wild type (Miyake et al., 2007). Insulin-like growth 
factor 1- phosphoinositide- 3-kinase - Akt/protein kinase B - mammalian target of rapamycin 
(IGF1-PI3K-Akt/PKB-mTOR) pathway has been positively implicated in muscle growth (Glass, 
2010, Sandri, 2008). IGF-1 signalling acts through IGF-1 receptor at the cell membrane, 
binding of IGF-1 to its receptor leads to generate docking sites for insulin receptor substrate 
(IRS), which is also phosphorylated by the IGF1 receptor. Phosphorylated IRS then acts as 
docking site to recruit and activate phosphatidylinositol-3-kinase (PI3K) which 
phosphorylates membrane phospholipids, generating phosphoinositide-3,4,5-trisphosphate 
(PIP3) from phosphoinositide-4,5-bisphosphate (PIP2). Then PIP3 acts as a docking site for 
two kinases, phosphoinositide dependent kinase 1 (PDK1) and Akt. PDK1 in turn 
phosphorylates and activates Akt. The phosphorylated Akt stimulates protein synthesis via 
the mammalian target of rapamycin (mTOR) and glycogen synthase kinase 3β (GSK3β), 
meanwhile, inhibits protein degradation by phosphorylating and thus repressing the 
transcription factors of the FoxO family (Manning and Cantley, 2007). Akt activates mTOR in 
an indirect way; it inhibits the tuberous sclerosis complex (TSC) proteins 1 and 2 in order to 
activate mTOR signalling. mTOR forms two complexes, mTORC1 when bound to Raptor,  and 
mTORC2 when bound to Rictor that is required for Akt phosphorylation and activation 
(Zoncu et al., 2011). mTORC1 stimulates protein synthesis by phosphorylating S6 kinase (S6K) 
to activate ribosomal protein S6 and other factors involved in translation initiation and 
elongation. Simultaneously, mTORC1 phosphorylates the inhibitory eIF4Ebinding proteins 
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(4EBPs) in order to activate eukaryotic translation initiation factor 4E (eIF4E) (Guertin et al., 
2006). S6K can negatively affect this pathway by phosphorylating and inhibiting IRS, thus 
inducing its degradation and alters cell localization (Harrington et al., 2004). On the other 
hand, FoxO factors that were phosphorylated and inactivated by Akt, are required for the 
transcriptional regulation of the ubiquitin ligases Atrogin-1, and muscle ring finger 1 
(MuRF1), leading to the ubiquitylation and degradation of myosin and other muscle proteins 
via the proteasome. FoxO factors are also required for the transcriptional regulation of the 
microtubule-associated protein 1 light chain 3 (LC3), which together with BCL2/adenovirus 
E1B interacting protein 3 (BNIP3) are essential for the autophagy-lysosome pathway 
activation (Sandri et al., 2004, Stitt et al., 2004, Li et al., 2007a). In feed-forward mechanism, 
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Figure 1.8. Muscle mass balance, adapted from (Schiaffino and Mammucari, 2011) 
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Alternatively, it has been mentioned that Myostatin acts via its receptor (ActRIIB) on Smad2 
and Smad3, inhibitors of Akt, thereby downregulating IGF1-PI3K-Akt/PKB-mTOR 
hypertrophy pathway (Trendelenburg et al., 2009, Sartori et al., 2009). Myostatin also 
increases the level of the active form of FoxO, enabling increased expression of atrophy and 
autophagy-related genes, ultimately induces protein degradation (Greer et al., 2007). A 
number of studies have provided evidence that Myostatin acts as a negative regulator of 
Akt/mTOR signalling pathway consistent with its inhibitory effects on protein synthesis 
(Lipina et al., 2010, Sartori et al., 2009, Trendelenburg et al., 2009). By contrast, Myostatin 
deletion or post-natal inhibition that causes inhibition of Smad3 activity, is critical for 
activation of Akt/mTOR signalling, which drives muscle growth by stimulating protein 
synthesis. Therefore, a direct interaction between Smad3 and Akt, may be involved in cross-
talk between the Myostatin and IGF1 pathway in skeletal muscle (Conery et al., 2004). 
Autophagy, a dynamically regulated process that is responsible for degradation of long lived 
proteins and other organelles (Eisenberg-Lerner et al., 2009, Klionsky, 2010), begins with the 
formation of double-membrane autophagosomes that is initiated by PI3 kinase (PI3K) type 
III-Atg6/Beclin-1 cascade (Xie and Klionsky, 2007). In the same line of thought, previous 
work has reported that PI3K /Akt/mTOR pathway is a negative regulator for the formation 
of autophagosomes, thereby prevents autophagy process (Geng and Klionsky, 2008). On the 
other hand, a number of investigators have demonstrated that AMPK induces autophagy. It 
phosphorylates and activates TSC1, which in turn results in inhibiting of mTORC1, and hence 
suppresses protein synthesis (Meley et al., 2006, Inoki et al., 2003). These studies suggest 
that the interaction between the mentioned anabolic and catabolic pathways is crucial for 
proper skeletal muscle growth.   
 
1.9. Estrogen-related receptor gamma (Errγ) 
1.9.1. Errγ is orphan nuclear receptor 
Nuclear receptors (NRs) are members of a large family of transcription factors that 
coordinate and regulate gene expression in cellular processes. The NRs comprised of two 
groups, ligand-regulated receptors, or receptors for which no endogenous ligands have 
been yet identified, thus they are defined as orphan nuclear receptors (Mangelsdorf et al., 
1995, Gronemeyer and Laudet, 1995, Giguere, 2008). Mitochondria perform functions 
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related to several biochemical processes. A number of nuclear receptors have implicated in 
controlling a network of genes that regulate mitochondrial function. Peroxisome 
proliferator-activated receptors (PPARs) α, δ and γ have been associated with control of 
expression of genes related to fatty acid oxidation (FAO) and oxidative phosphorylation 
(OXPHOS) pathways, but not expression of genes that make up the respiratory chain (Gulick 
et al., 1994, Alaynick, 2008). The nuclear receptors known nuclear respiratory factor 1 and 2 
(NRF-1 and NRF-2) have also been associated with regulation of a number of nuclear-
encoded mitochondrial proteins (Scarpulla, 2008). 
A large body of recent work has established that the estrogen-related receptors (Errs), a 
specific class of orphan nuclear receptors, act as comprehensive regulators of nuclear 
mitochondrial gene expression (Giguere, 2008). Although the name reflects their molecular 
origin, the ERRs do not bind natural estrogens and they do not have roles in classic estrogen 
signalling pathway. Previous work has reported that there is a marked preference for the 
recognition of the sequence TCAAGGTAA for the ERRs that named estrogen-related respons 
element (ERRE). The important functional characteristic of ERRs is their ability to bind close 
to the promoters, which provides profound advantages to these receptors in term of 
identification and characterization of their target genes (Deblois et al., 2009). Notably, the 
ERRs are expressed in lipid metabolism and highly energy demands tissues, and their 
transcriptional activity is largely associated with presence of co-regulators that implicated in 
controlling complex metabolic programs. Along the same lines, ERRs control the expression 
of a wide range of genes, in particular those genes involved in mitochondrial biogenesis and 
functions (Giguere, 2008).  
ERRs subfamily consisting of three members, estrogen-related receptor alpha (Errα), 
estrogen-related receptor beta (Errβ) and estrogen-related receptor gamma (Errγ). Errα and 
Errβ were identified as the first orphan nuclear receptors, whereas Errγ has been recognized 
ten years later as the third member of ERRs subfamily (Eudy et al., 1998, Heard et al., 2000). 
Like other nuclear receptors, Errγ comprises of N-terminal activation function (AF)-1 domain 
that is involved in the transcriptional regulation of the receptor, centrally located DNA-
binding domain (DBD), a ligand-binding domain (LBD), and C-terminal (AF)-2 domain that 
interacts with coactivators and co-repressors (Huss et al., 2015). Eudy et al. first identified 
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Errγ through its connection with a critical region of Usher syndrome type IIa (Eudy et al., 
1998), then it was described by Hong et al. as a protein that interacts with nuclear receptor 
co-activator glucocorticoid receptor-interacting protein (GRIP)-1 (Hong et al., 1999). Despite 
excessive functional overlap between Errγ and other members of ERRs due to the high 
similarity in their DBDs (Alaynick et al., 2007, Wang et al., 2015), it controls a various 
metabolic processes that do not involve both Errα and Errβ (Kim et al., 2011, Zhang et al., 
2015). The ligand-independent orphan nuclear receptor Errγ is highly expressed in 
metabolically active and densely vascularised fetal and adult tissues, including the placenta, 
brain, skeletal muscle, kidney, heart, and liver (Giguere, 2008). These findings might indicate 
a crucial role of Errγ in differentiation and maintenance of these tissues. Subsequently, Errγ 
null mice die shortly after birth due to a reduction in mitochondrial activity, abnormal heart 
and spinal cord functions. There is also evidence that phenotypic characterized of Errγ 
knockout mice displayed a clear reduction in expression and activity of enzymes that 
regulate tricarboxylic acid cycle (TCA) and electron transport chain (ETC) (Alaynick et al., 
2007).     
 
1.9.2. Errγ is an inducible transcriptional factor  
Several studies have demonstrated that a number of orphan receptors are directly 
implicated in the control of specific cell mechanisms and metabolic pathways, even with the 
absence of natural ligands that could link these receptors to their functions (Desvergne et 
al., 2006, Rangwala et al., 2010). Indeed, the transcriptional activity of nuclear receptors is 
dependent on the presence of co-regulatory proteins. Approximately 200 nuclear receptor 
co-activator and co-repressor proteins have been identified to date, with a specificity of 
each protein to interact with the members of nuclear receptor superfamily (Lonard and 
O'Malley B, 2007). Importantly, the co-regulator proteins are able to impart specific 
transcriptional properties to the nuclear receptors that they interacting with, thereby 
inducing the biological functions of these receptors (Feige and Auwerx, 2007).  
Like other orphan nuclear receptors, the transcriptional activity of Errγ depends on tissue-
specific co-regulators that can be stimulated by different cell signalling. In particular, Errγ 
transcriptional activity has extensively linked to the members of peroxisome proliferator-
activated receptor gamma co-activator 1 (PGC-1) family that integrate nutrient and 
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energetic signals in diverse metabolic pathways (Giguere, 2008, Huss et al., 2015). More 
specifically, it has been shown that PGC-1α, a member of PGC-1 family, binds to the AF-2 
domain of the Errγ, resulting in a profound modulating of the later transcriptional complex 
(Devarakonda et al., 2011). Interestingly, study by Wang et al. has provided evidence of Errγ 
potential to transactivate the PGC-1α promoter (Wang et al., 2005), indicating the presence 
of a feed-forward loop in which Errγ activates PGC-1α, and the later then co-activates Errγ. 
Furthermore, previous studies have established that signalling factors such as Transforming 
Growth Factor-β1 (TGFβ1), Platelet-Derived Growth Factor, Fibroblast Growth Factor (FGF) 1 
and 2, and Vascular Endothelial Growth Factor (VEGF) are known to stimulate angiogenesis. 
One possible explanation for these factors orchestration potential is by co-activator PGC-1α 
that is induced by exercise and during hypoxia (Arany et al., 2007). Several other studies, 
however, reported that genetic deletion of PGC-1α has no impact on muscle vasculature, as 
PGC-1α knockout mice are viable, show normal capillary density with oxidative muscles 
(Arany et al., 2007, Li et al., 2004). Errγ is abundantly expressed in muscle fibre type I, and 
its forced expression in fast-twitch anaerobic type II muscles triggers aerobic transformation, 
mitochondrial biogenesis, and robust myofibrillar vascularization in the absence of exercise 
(Narkar et al., 2011). Although the co-regulator PGC-1α along with nuclear receptors 
controls diverse aspect of aerobic respiration (Wang et al., 2004, Arany et al., 2007), there is 
a considerable controversy on this role with Errγ. Previous work has reported that the 
intrinsic effects of Errγ are not dependent on PGC-1α, but rather are linked to activation of 
aerobic master regulator named AMP-activated protein kinase (AMPK) (Narkar et al., 2008). 
Further study has illustrated that AMPK is naturally activated during exercise (Fujii et al., 
2000), and it is a remarkable contributor in muscle metabolic and vascular adaptation (Fujii 
et al., 2007). Consistently, oxidative muscles from wild type mice show a high level of AMPK 
than the predominantly glycolytic fast muscle phenotypes (Narkar et al., 2011). Same study 
surprisingly found that AMPK was constitutively activated in Errγ transgenic mice, which 
suggests a convergence between Errγ and AMPK pathways to direct intrinsic vascularization 
and oxidative metabolism in type I muscle fibres (Narkar et al., 2011) (Figure 1.9).  
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A number of genetic studies in mice have shown that steroid receptor co-activator (SRC)-1, -
2, and -3 play a crucial role in regulating of hepatic metabolism, fat storage, and energy 
balance (Jeong et al., 2006, Louet et al., 2006). Importantly, these co-regulator proteins 
directly interact with the members of ERRs. The three classes interact with ERRs in 
mammalian cells (Xie et al., 1999), whereas SRC-2 has been shown to be specifically 
interacted with LBD of Errγ and stimulate its transcriptional activity (Hong et al., 1999).  
The activity of Errγ is also modulated by receptor-interacted protein 140 (RIP140). RIP 140 
has been known as ERRs co-repressor that critically implicated in the regulation of 
important metabolic pathways such as OXPHOS (Augereau et al., 2006, Castet et al., 2006, 
Seth et al., 2007). Interestingly, RIP140 can function as both a co-repressor and co-activator 
of Errγ, its dual effects on Errγ transcriptional activity can be determined depending on the 
target gene. For instance, RIP140 inhibits Errγ activity on estrogen response element (ERE) 
constructs, whereas it activates Errγ activity on several promoters containing Sp1 response 
elements (Castet et al., 2006). It is worth noting that the co-repressors inhibit Errγ 
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transactivation by directly competing with the binding of the coactivators to the AF-2 
domain of Errγ (Misra et al., 2017). 
Growing evidence also suggests that Errγ gene expression is tightly controlled by membrane 
receptors. In response to glucose concentration decrease during fasting, both glucagon and 
insulin receptors can modulate Errγ activity. Glucagon induces hepatic Errγ expression, 
whereas insulin suppresses Errγ activity in response to fasting (Kim et al., 2012a, Misra et al., 
2016). Moreover, expression of Errγ can also be induced by cytokine interleukin (IL)-6 
receptor during bacterial infection. Binding of the cytokine to its receptor promotes the 
binding of signal transducer and activator of transcription (STAT)-3 to Errγ promoter, which 
in turn upregulates Errγ expression (Kim et al., 2014).   
In the line of thought, it was well established that activity of Errγ can be influenced in 
response to various stresses. Hypoxia regulates the transcriptional activity of Errγ in a tissue-
specific manner. Hypoxia-inducible factor (HIF)-1α positively regulates Errγ expression in 
hepatocyte (Lee et al., 2012a). Additionally, intrinsic metabolic requests can induce Errγ 
expression. Kida et al. has revealed a high level of Errγ during somatic cell programming in 
order to match the metabolic demands through enhanced mitochondrial aerobic OXPHOS 
(Kida et al., 2015). There is ample evidence of interaction between Errγ and miRNAs. 
Although Errγ induces expression of miR-208b and miR-499 that are known to contribute in 
muscle fibre types formation (Gan et al., 2013), Errγ itself is regulated by miRNA. Previous 
work has documented that miR-378 robustly inhibits Errγ expression in breast cancer, which 
leads to a metabolic shift from oxidative to a glycolytic pathway that was associated with an 
increase in cells proliferation (WARBURG, 1956, Eichner et al., 2010). 
Structural studies have provided evidence that the LBD of Errγ contains a flexible small 
ligand-binding pocket (Greschik et al., 2002), however it is able to be re-arranged in order to 
accommodate large volume synthesized molecules (Wang et al., 2006). Although Errγ shows 
constitutive transcriptional activity, previous investigators have demonstrated that 
structurally related phenolic acyl hydrazone compound, GSK4716, and Bisphenol A, a 
ubiquitous environmental endocrine disruptor, both able to bind it and positively regulate 
its transcriptional activity (Yu and Forman, 2005, Tohme et al., 2014). By contrast, GSK5182, 
a derivative of 4-hydroxytamoxifen, has been identified as an inverse agonist selectivity for 
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Errγ (Chao et al., 2006). These studies indicate that the transcriptional activity of Errγ can be 
upregulated or inhibited by pharmacological agents.  
 
1.9.3. Roles of Errγ and transgenic approach  
Like other members of ERRs superfamily, estrogen-related receptor gamma (Errγ), is 
constitutively active orphan nuclear receptor that is selectively expressed in metabolically 
active and highly vascularized tissues such as heart, kidney, brain and skeletal muscle 
(Giguere, 2008, Heard et al., 2000, Hong et al., 1999). The Errγ activity might attribute to the 
active conformation of its ligand binding domain (LBD) even in the absence of a ligand 
(Greschik et al., 2002).  
Recent findings have established that Errγ is directly or indirectly regulates the expression of 
numerous target genes related to different metabolic pathways in various tissues. One of 
the most important and well-described role of Errγ is its actively contribution in 
mitochondrial bioenergetics pathways, TCA cycle, fatty acid oxidation, OXPHOS, and 
electron transport chain (ETC). Furthermore, it has a pivotal role in regulating multiple genes 
that linked to mitochondrial biogenesis and fatty acid oxidation in cardiac muscles (Alaynick 
et al., 2007, Dufour et al., 2007). In addition to its critical role to activate FAO in neonatal 
heart (Kubo et al., 2009), Errγ upregulates expression of a network of genes that are crucial 
for normal heart function including fatty acid oxidation, such as fatty acid-binding protein 3 
(Fabp3), mitochondrial creatine kinase (Ckmt2) and ATP/ADP translocator genes (Alaynick et 
al., 2007). Errγ is also involved in lipid metabolism in the liver. It induces the formation of 
diacylglycerol (DAG), which are the precursors of triglycerides and phospholipids (Kim et al., 
2011). Moreover, Errγ contributes to maintain body temperature. It has been shown that 
increased expression of Errγ leads to induce oxidative metabolism and heat generation 
(Dixen et al., 2013). Errγ has emerged as a promising target in the treatment of certain 
metabolic disorders and cancers. It is a negative regulator of anaerobic glycolysis in breast 
cancer cells, thus its inhibition results in an increase in lactase production and a decrease in 
aerobic respiration (Kumar and Mendelson, 2011). Furthermore, it has been shown by a 
number of investigators that Errγ plays a critical role in gluconeogenesis regulation that can 
be drug target in order to reverse hyperglycaemia and hepatic fat accumulation in the 
milieu of insulin resistance (Heard et al., 2000, Kim et al., 2011).         
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In skeletal muscles, gene array analysis has found that Errγ regulates a total of 1123 genes, 
the up-regulated genes were mainly belonge mitochondrial biology (90) or oxidative 
metabolism (43) that encoding numerous components of fatty acid oxidation pathway as 
well as the oxidative respiratory chain reflective of aerobic adaptation. (Narkar et al., 2011). 
Consistently, Errγ has been known as a transcriptional factor that is highly expressed in slow 
muscles and other tissues with high oxidative metabolism levels where it promotes 
mitochondrial biogenesis and activity. Moreover, a gene set analysis identified an increase 
in the expression of the contractile genes, particularly the ones that associated with slow 
muscle due to Errγ overexpression. Additionally, introducing of Errγ into WT muscles causes 
a subsequent coordinate increase in mitochondria function via increased in TCA cycle 
activity, induced mitochondrial size, and enhanced muscle oxidative capacity  (Narkar et al., 
2011, Rangwala et al., 2010). In fact, Errγ is not only contributing to controlling of 
mitochondrial programs such as FAO, TCA cycle and OXPHOS pathways, it also implicated in 
regulation of a wide range of genes that involved in ATP transport across the membrane, 
uptake and modifying energy substrates, Ca2+ handling, as well as intracellular fuel sensing 
(Dufour et al., 2007, Alaynick et al., 2007). Study by Luo et al. (Luo et al., 2013) has revealed 
critical roles of ERRγ during human pregnancy, it is necessary to promote hormone secretion 
and angiogenesis, as well as it required for the transcription of several voltage-gated K+ 
channels. Consistent with these observations, Errγ transgenic mice displayed an activated 
angiogenic response that consisted of the secretion of pro-angiogenic factors and robust 
fibre vascularization (Narkar et al., 2008). Interestingly, the increased oxidative capacity and 
mitochondrial size in transgenic Errγ mice were associated with an increase in exercise 
capacity, suggesting that Errγ may control the metabolic response of the muscle during 
exercise (Narkar et al., 2011, Rangwala et al., 2010, Badin et al., 2016). Conversely, Errγ 
heterozygous mice (Errγ+/-) show a reduction in expression of genes that related to fatty acid 
uptake and fatty acid oxidation, indicating that the utilization of fatty acids as fuels is 
compromised (Rangwala et al., 2010). Errγ is an indispensable part of mitochondrial 
oxidative phosphorylation, which is essential for normal muscle differentiation and growth. 
In muscle-specific Errγ-null mice, there was a reduction in mitochondrial content and 
alteration in their distribution, an increase of medium chain FAO, and a decrease of glucose 
oxidation. Thus, myotubes maturation in these animals (Errγ-/-) is hampered mainly due to 
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an increase in Reactive Oxygen Species (ROS) generation that induces muscle atrophy by 
upregulating components of the ubiquitin proteasome system during differentiation 
(Murray and Huss, 2011, Li et al., 2003b).   
These studies indicate that Errγ acts as a central transcriptional factor that controls 
mitochondrial functions and metabolism together with angiogenesis that anatomically 
synchronizes vascular arborisation to oxidative metabolism. Several recent reports 
suggested that transcriptional regulators that induce muscle oxidative metabolic properties, 
can promote angiogenic gene expression in skeletal muscle (Gaudel et al., 2008, Narkar et 
al., 2008). Such combination of factors is profoundly required for better physiological 
performance and normal pace of regeneration and repair processes. Given these 
considerations, muscle-specific overexpression of Errγ using specific promoter has been 
widely performed (Narkar et al., 2011, Rangwala et al., 2010). Two skeletal muscle 
promoters have been extensively utilised. Muscle creatine kinase (MCK) promoter that is 
expressed at high levels in skeletal and cardiac muscle tissues was applied. Jaynes et al. has 
reported that several regions of the mouse MCK are responsible for tissue-specific 
expression in transgenic mice (Jaynes et al., 1988). Thus, MCK has been exploited as a 
specific promoter in order to overexpress Errγ on a C57Bl/6 background mice, and the 
transgenic construct consists of the 4.8kb fragment from the mouse genome to drive 
hemagglutinin-tagged Errγ gene construct (Rangwala et al., 2010). Alternatively, a number 
of studies have demonstrated that human α-skeletal actin (HSA) gene promoter is complex 
and spanning at least 1,300 bp, and that three segments of this region when adjacent to 
simian virus 40 (SV40) promoter act as regulatory domains which respond to muscle-specific 
factors to regulate transcription. Muscat and Kedes have dissected the promoter and found 
that the proximal domain (positions -153 to -87) of the HSA gene promoter is crucial for 
muscle-specific expression in two different myogenic cell lines (L8 and C2C12). They also 
established that the distal domain (positions -1300 to -626) of the promoter is only 
positively modulating transcription in C2C12 but not in L8 cells. It seems that the tissue-
specific transcription of the HSA gene promoter resulted from the interaction of the 
upstream regions with trans-acting positive regulatory factors in muscle cells (Muscat and 
Kedes, 1987). Consequently, a number of investigators have used a large portion of the 
promoter (2.2kb) to express Errγ in a mouse skeletal muscle (Matsakas et al., 2012b, Narkar 
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et al., 2011). Importantly, we have used the same 2.2kb human actin skeletal muscle 
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Hypothesis, aims and objectives 
First hypothesis 
The main hypothesis of this study is that muscle-specific manner overexpression of Errγ into 
Mtn-/- background muscles using specific promoter (HSA) would overcome the deficits in 
hypertrophic muscle fibres developed in the absence of Myostatin at different levels.  
Aims and objectives 1 
1- To determine whether the constraint between muscle fibre size and its oxidative 
capacity can be broken, thereby produce large oxidative myofibre 
A fundamental concept of skeletal muscle biology is the existence of the inverse relationship 
between the oxidative capacity of a fibre and its cross-sectional area (CSA) (van Wessel et 
al., 2010, Degens, 2012). Previous studies have reported that genetic deletion of Myostatin 
results in hypermuscular phenotypes called (Muscle Doubling) due to both hyperplasia and 
hypertrophy (McPherron et al., 1997, McPherron and Lee, 1997). Errγ is a master regulator 
of oxidative phenotypes that is highly expressed in tissues with high oxidative metabolic 
demands where it has been demonstrated to trigger mitochondrial biogenesis (Giguere, 
2008, Narkar et al., 2011). 
Therefore, we postulated three possible outcomes of the introducing of Errγ into Mtn-/- 
muscles: 
a- Mtn-/- phenotype is fixed, so it maintains hypertrophic and glycolytic state. 
b- Oxidative features imparted by Errγ programme would follow the inverse relationship 
and results in small mitochondrial-rich fibres.  
c- The constraint is broken in this strain and results in the development of hypertrophic 
yet oxidative fibres.   
I aim to utilise a panel of in vitro assays to investigate muscle mass, muscle fibre size, muscle 
fibre number and oxidative properties, these experiments will indicate which possibility is 
the truth.  
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2- To determine if overexpression of Errγ can influence specific muscle force generation 
capacity and physical performance of the animals 
Although Mtn-/- enlarged muscles appear normal at histological level, their ability to 
generate force is impaired in particular for long time of work (Amthor et al., 2007, Mendias 
et al., 2006). Amthor also suggests that the high fatigability of Mtn-/- mice might attribute to 
the low content of mitochondria that results from Myostatin ablation (Amthor et al., 2007). 
On the other hand, Errγ forced expression in fast-twitch anaerobic muscles causes aerobic 
transformation, mitochondrial biogenesis, and induces muscle fibres capillarization in the 
absence of exercise (Narkar et al., 2011).  To accomplish this aim, mice will be subjected to a 
series of tests in order to detect the physiological activities. Thereafter, a number of 
histological protocols and metabolic assays will be performed to identify skeletal muscle 
fibre profiling, mitochondrial quality and quantity, and metabolic status. 
3- To determine the identity of the metabolic programme that is imparted by introducing 
of Errγ into Mtn-/- muscles at molecular level 
Following the investigations into the previous aims, further investigation will be performed 
to identify whether the differences in oxidative metabolism in muscles from the three 
genotypes of this study (WT, Mtn-/- and Mtn-/-/ErrγTg/+) would be mirrored at transcriptional 
level. Using quantitative polymer chain reaction (qPCR) technique, the expression levels of 
key genes that associated with transcriptional regulators, different metabolic aspects and 
angiogenesis programme will be examined.   
4- To determine if overexpression of Errγ can influence skeletal muscle stem cells (satellite 
cells) population and behaviour 
There was a controversy regarding the effect of Myostatin deletion on satellite cells 
population. Although McCroskery referred to an increase in satellite cell number following 
Myostatin ablation (McCroskery et al., 2003), his findings were robustly contradicted by 
others who demonstrated that muscle hypertrophy resulted from genetic alteration of 
Myostatin was not due to increase in satellite cells number and activity (Amthor et al., 2009, 
Matsakas et al., 2009). It was well established that muscle metabolic properties can 
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influence satellite cells population; satellite cells number increases as a muscle become 
progressively oxidative (Peuker et al., 1999, Christov et al., 2007). 
To accomplish this aim, isolated and cultured single myofibres from EDL muscles of the 
three animal cohorts will be processed for immunocytochemistry against satellite cells and 
activated/proliferated myoblast cells markers including Pax7 and MyoD. This will enable 
detailed investigation of effects of the metabolic programme on satellite ells number and 
activity.  
5- To determine whether muscle metabolic properties affect not only muscle fibres but 
other tissues 
I sought to establish whether supporting tissues such as entities of extracellular matrix 
(ECM) and dystrophin-glycoprotein complex (DGC) would be changed in response to 
metabolic reprogramming. ECM and DGC of skeletal muscle are essential structures for 
myofibres force transmission and protection against injury (Gumerson and Michele, 2011, 
Alameddine, 2012). Myostatin induces fibroblast proliferation, hence connective tissue 
depositions (Li et al., 2008). Subsequently, genetic deletion of this gene results in a 
remarkable reduction of ECM components compared to counterpart wild type mice (Elashry 
et al., 2012).   
Therefore, investigation of ECM and DGC compositions at transcriptional and protein levels 
would give insights into the relationship between muscle fibre phenotype (size and 
metabolism) and its force transduction apparatus.  
 
Second hypothesis   
The microenvironment plays a crucial role in regulation and function of skeletal muscle stem 
cells (satellite cells), helping to maintain tissue homeostasis and regeneration capacity 
(Carlson and Faulkner, 1989). Muscle regeneration rate could be severely hindered due to a 
fall in satellite cells population (Schuster-Gossler et al., 2007, Vasyutina et al., 2007). 
Additionally, published studies unveiled a positive correlation between muscle oxidative 
metabolism and regeneration capacity (Lowrie et al., 1982, Matsakas et al., 2013). 
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Consistently, muscle blood supply and ECM components are critical contributors in skeletal 
muscle regeneration (Bencze et al., 2012, Calve et al., 2010). 
Errγ transgenic mice displayed an increase in oxidative capacity and activated angiogenic 
program that consisted of the secretion of pro-angiogenic factors and robust fibre 
vascularization (Narkar et al., 2011, Badin et al., 2016).  
The second hypothesis emanated from the findings of the primary investigations.  
I hypothesise that the oxidative environment imparted by overexpressing of Errγ into Mtn-/- 
muscle would enhance the process of muscle regeneration in response to acute muscle 
injury.    
Aims and objectives 2 
1- To determine if high levels of muscle oxidative capacity and capillarization are sufficient 
to influence muscle regeneration even with lower population of satellite cells  
I aimed to find whether muscle-specific expression of Errγ into Mtn-/- muscles can drive 
normal regeneration process in response to skeletal muscle injury through the use of an 
established skeletal muscle injury model – cardiotoxin (CTX) injection. The number of 
necrotic fibres, density of macrophages, amount of cell death in damaged areas were 
followed through immunohistochemistry using endogenous immunoglobulin, F4.80 and 
cleaved-caspase-3 antibodies respectively, along with satellite cell marker (Pax7) and 
proliferative myoblast marker (MyoD). Antibody against formed embryonic myosin heavy 
chain (eMHC) will also be applied to quantify regenerated fibres. Similar experiment carried 
out to advanced stage of regeneration (14 days) after injury in order to identify whether 
prematurely regeneration can affect size of newly formed muscle fibres. 
 
Third hypothesis 
Post-natal inhibition of Myostatin signalling has been extensively applied as promising 
therapeutic against muscle wasting (Collins-Hooper et al., 2014, Matsakas et al., 2009). 
Unlike genetic alteration of Myostatin gene, hypertrophic phenotypes result from Myostatin 
blocking is due to muscle fibre hypertrophy, but not hyperplasia (Whittemore et al., 2003, 
Lee et al., 2005). Beside fibre hypertrophy resulted from Myostatin inhibition, there is a 
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remarkable decrease in expression of genes related to muscle mitochondrial functions and 
oxidative phosphorylation pathways (Rahimov et al., 2011). Moreover, mdx mice injected 
with sActRIIB that antagonizes Myostatin signalling, show low levels of muscle 
capillarization, force generation capacity and high fatigability (Relizani et al., 2014).  
The third hypothesis of my study stems from attractive observations of previous 
investigations.  
I hypothesis that inhibition of Myostatin signalling at post-natal stages in ErrγTg/+ mice that 
display high oxidative capacity, would enable the generation of hyper-trophic / hyper-
oxidative phenotypes. 
Aims and objectives 3  
1- To determine if oxidative metabolic programme established by overexpressing of Errγ 
would be appropriate to complement the increased muscle mass  
There is uncertainty over whether induction robust oxidative metabolic programme would 
be enough to provide a protective effect against the decrease in oxidative capacity and 
physical activity following post developmental blocking of Myostatin. The investigations into 
the muscle morphological, histological and metabolic properties that have been utilised in 
our laboratory may help to answer this question. The adequate level of skeletal muscle 
function and size is paramount importance for health. Thus, this work will present possible 
therapeutic targets when looking to improve muscle function and size, ultimately improve 
life quality of human.  
2- To investigate whether it is possible to induce muscle fibre size while maintaining high 
oxidative metabolic level 
Previous studies have reported that ActRIIB signalling is a key regulator of oxidative 
metabolism (Relizani et al., 2014), thus treatment with a soluble form of ActRIIB leads to 
downregulation of genes involved in oxidative phosphorylation and mitochondrial functions 
(Rahimov et al., 2011). There is ample of evidence regarding Errγ potential to induce muscle 
oxidative capacity in parallel to promote a network of genes that involved in muscle energy 
production, metabolism and vasculature pathways (Narkar et al., 2011, Alaynick et al., 
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2007). Thus, I set out a series of investigations in adult WT and ErrγTg/+ mice treated with 
sActRIIB to determine how post-natal blocking of Myostatin using this ligand trap might 
affect oxidative metabolism features imparted by Errγ overexpression.   
3- To determine whether overexpression of Errγ would attenuate complications of post-
natal blocking of Myostatin on muscle fibre only, or exceed to the supporting tissues 
Although widespread beneficial effects have been observed with post-natal inhibition of 
Myostatin, there is evidence of muscle blood supply and physiological activities compromise 
(Relizani et al., 2014). I aimed to utilize immunohistochemistry technique using a panel of 
specific antibodies to discover whether the metabolic reprogramming can affect muscle 
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2. Genetic In vivo experimentation 
2.1. Animal maintenance 
Three lines of mice were used in this study: 
 Wild type (strain-C57BL/6JOIa/Hsd), from Harlan laboratories, UK. 
 Myostatin null mice (Mtn-/-), were a gift of Se‐Jin Lee (John’s Hopkins USA) 
(McPherron and Lee, 1997). 
 Errγ transgenic mice were a gift of Ronald Evans (Salk Institute for Biological 
Studies, La Jolla, USA).  
Errγ was overexpressed on Myostatin null background mice (Mtn-/-/ErrγTg/+). 
Mouse Errγ cDNA was placed downstream on the human α-skeletal actin promoter and 
upstream of the simian virus 40 (SV 40) intron/poly (A) sequence. The purified transgene 
was injected into C57BL/6J x CBA F1 zygotes. Two transgenic founders (TG 425 and 421) 
were obtained that were backcrossed with C57BL/6J (Narkar et al., 2011). 
The Errγ transgenic mice were bred to Myostatin null (Mtn-/-) mice, which resulted in 50% 
Myostatin heterozygous with WT Errγ alleles (Mtn-/+/Errγ+/+), and 50% Myostatin 
heterozygous with Errγ transgenic (Mtn-/+/ErrγTg/+). Males Mtn-/+/ErrγTg/+ were then 
backcrossed with females Myostatin null (Mtn-/-) mice which produced (Mtn-/-/Errγ+/+) and 
(Mtn-/-/ ErrγTg/+), males offspring were genotyped and categorized into Mtn-/- and Mtn-/-
/ErrγTg/+. 
Mice were bred and maintained in accordance to the Animals (Scientific Procedures) Act 
1986 (UK) and approved by the University of Reading in the Biological Resource Unit of 
Reading University. They were housed under standard environmental conditions (20–22°C, 
12h–12h light–dark cycle) and provided food and water ad libitum.  
Three months old mice were used for the study, and each experimental group consisted of 
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2.2. Genotyping 
Genotyping was performed to determine differences in the genetic make-up (genotype) of 
the individual mouse line.  
DNA Isolation   
Samples (ear clips) were collected in Biological Resource Unit and placed in Eppendorf 
tubes, then were transferred to the laboratory on ice. Samples were submerged in 100 µl of 
50 mM NaOH, left in rocking machine (PLATFORM SHAKER STR6) for 1 hr at 95°C. 10 µl 
Neutralizing solution (Tris 1.5 M pH: 7.4) was then added and samples were left at room 
temperature for 10 minutes. This method produces solubilised DNA which was used for 
genotyping by PCR. 
Primers Concentrations Calculation and Master Mix preparation 
For Errγ PCR genotyping reaction, primers using are: 
mErrG-F    5’-TTGGTGGTTATCATTGGATGGG-3’ (Eurofins Genomics) 
mErrG-R   5’-TAGAAGTGCTGGACTGCCTTGG-3’ (Eurofins Genomics) 
Primers were dissolved in water to produce concentrated stocks (0.1 mM). A (0.1 mM) 
concentration stock was diluted 1:10 in water to make the working solution which is (10 
µM) concentration. The final concentration of primer in the PCR genotyping reaction is (250 
nM). Master Mix for each reaction was prepared in sterile Eppendorf tube by mixing 20 µl 
Taq 2x Master Mix, 1 µl of each primer (Forward and Reverse), and volume was then made 
to 35 µl with nucleic acid free water. Finally, 5 µl of DNA was added to make the final 
volume reaction 40 µl. 
 
PCR Cycling  
Small PCR tubes of total volume reaction (40 µl) were centrifuged quickly, and moved into 
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The cycler was set up with following conditions for Errγ PCR reaction: 
1- 94°C 1min  
2- 94°C 20secs 
3- 52°C 30secs                  x35 
4- 72°C 1min 30secs 
5- 72°C 3min 
6- 4°C Indefinitely 
Errγ+ band runs at 482 bp. 
 
For Myostatin PCR genotyping reaction, primers using are: 
mMyo  13      5’-AGAAGTCAAGGTGACAGACACAC-3’ (Eurofins Genomics) 
mMyo 168    5’-GGTGCACAAGATGAGTATGCGG-3’     (Eurofins Genomics) 
mMyo 169     5’-GGATCGGCCATTGAACAAGATG-3’    (Eurofins Genomics) 
mMyo 170     5’-GAGCAAGGTGAGATGACAGGAG-3’   (Eurofins Genomics) 
Same conditions of Errγ PCR reaction have been used, with different annealing temperature 
(57°C), a heterozygous sample produces a 350 bp Knockout specific band and a 225 bp WT 
band, 35 cycles. 
Agarose gel electrophoresis preparation 
To prepare 1.5% gel, 0.75 g agarose was dissolved in 50 ml 1 x Tris acetate EDTA (TAE) buffer 
(pH 7.8) by boiling, then allowed to cool to RT and SYBER Safe DNA gel stain was added (0.5 
µl /10 ml TAE buffer). The gel was cast and allowed to set before being submerged in the 
(TAE) buffer with SYBER Safe DNA gel stain (0.5 µl /10 ml TAE buffer) (to increase the 
visualisation) in the gel tanking. A 100 bp DNA Ladder (Promega) was loaded as a molecular 
weight marker, then 15 µl of PCR reaction were loaded in the gel wells after mixing with 1 µl 
orange G stain. The gel was run at 70 V, and DNA bands were visualized using UV light 
illuminator (Syngene/ U:Genius). 
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2.3. Assessment of mice fatigue resistance 
Mice were acclimatised to run on a treadmill in three sessions (10 m∙min‐1 for 15 minutes 
followed by a 1 m∙min‐1 increase per minute to a maximum of 12 m∙min‐1) (Columbus 
Instruments Model Exer 3/6 Treadmill, Serial S/N 120416). Exhaustion was determined by 
exercising the mice at 12 m∙min‐1 for 5 minutes, followed by 1 m∙min‐1 increases to a 
maximum of 20 m∙min‐1 until the mouse was unable to stay at front of the treadmill and 
repeatedly falling back to the treadmill brushes ~5 times over 30 seconds. 
 
2.4. Assessment of forelimb muscle strength using grip strength meter 
For all tests, mice were moved to the experimental room 5-20 minutes before testing to 
ensure they are properly awake. The grip strength meter (Chatillon DFM-2) was tested 
before the experiment to ensure it was functioning. The grip strength meter was fixed on 
the bench and positioned horizontally, and it was set to zero or reset before each 
measurement was made, to allow proper values to be detected. Maximal force was 
measured in grams. The mouse was held by the tail base and lowered towards the bar (the 
front paws were at the same height as the bar) and moved until the bar was within reach. 
The mouse was allowed to grab triangular pull bar and was then pulled backwards in the 
horizontal plane. The force applied to the bar just before it loses grip was recorded as the 
peak tension. Measurements were discarded if the animal used only one paw or if is used its 
hind paws, turned backwards during the pull, or leaves the bar without resistance. The test 
was repeated for two days with three measurements per day to achieve the best 
performance. To avoid habit formation and to allow recovery, one minute time was 
between trails, then the single best recorded value was used for analyzing. 
The mice were weighed just before measuring grip strength, so the maximal force values 
were normalized to animals’ body weights.  
  
2.5. Behavioral and Locomotor measurements using Open Field Animal Activity 
Monitoring system 
Open field activity monitoring was used to offer a comprehensive assessment of behavioral 
and locomotor activities of mice, without require to special training. These assessments are 
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done with multiple photocell receptors and emitters. Animal activity is measured via a grid 
of invisible infrared light beams. 
Mice were acclimatised to the test chamber environment for two days. This was attained by 
placing each mouse alone in one chamber, then mice were left uninterrupted for 60 
minutes every day to reduce variation in data. 
All data collection performed in an undisturbed environment, in the mornings at the same 
time for 3 days to reduce variability in the behavioral measurements. 
The primary data collection duration (Bine time 10 minutes, n Bine 9 for total duration of 
1hr and a half) was set in advance. The buttons that designate the individual cages should 
turn green, indicating that there is no block between the sensors. When all cages are ready, 
note the ID of the mouse insert into the test chamber, making sure that the mouse ID 
matches the one entered into the software. A 5 minutes extra time was set to allow the 
mice to acclimatize into the test chamber before starting data collection. While the animals 
are in the test chamber, external noise was minimized. When the experiment time elapsed, 
the data were saved and exported to Excel sheet. Mice were replaced in their cages, and all 
chambers were cleaned.  
  
 2.6. Mice euthanasia 
Animals of all experiments were humanely sacrificed via Schedule 1 killing by carbon dioxide 
asphyxiation followed by cervical dislocation. 
 
2.7. Muscle tension measurements 
Dissection of the hind limb muscles was carried out under oxygenated Krebs solution (95% 
O2 and 5% CO2). Under circulating oxygenated Krebs solution one end of a silk suture was 
attached to the distal tendon of Extensor Digitorum Longus (EDL) muscle and the other to a 
Grass Telefactor force transducer (FT03). The proximal tendon of EDL tied to a fixed 
immovable hook using a silk suture.  
The leg was pinned to a Sylgard‐coated experimental chamber. Two silver electrodes were 
positioned longitudinally on either side of the EDL. A constant voltage stimulator (S48, Grass 
Telefactor) was used to directly stimulate the EDL which was stretched to attain the optimal 
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muscle length to produce maximum twitch tension (Pt). Tetanic contractions were provoked 
by stimulus trains of 500 ms duration at 10, 20, 50, 100 and 200 Hz. The maximum tetanic 
tension (Po) was determined from the plateau of the frequency‐tension curve. Specific force 
was estimated by normalising tetanic force to EDL muscle mass (g). 
 
2.8. Skeletal muscles dissection 
2.8.1. Hind limb muscles dissection 
Tibialis anterior (TA), Extensor Digitorum Longus (EDL) and Soleus muscles were chose to 
identify the morphological and cellular features of hind limb muscles, due to their ideal 
anatomical location permitting ready isolation without damages muscle’s mid-belly region, 
and because they show the major types of contractile properties.  
Gastrocnemius muscle was used for the molecular work, as its anatomical shape makes it 
impossible to obtain the same mid-belly sections for histological analysis, and its large size 
imparts us with sufficient amount of RNA to use for genes expression assessment.   
Once death had been ascertained the animals were weighed. The hind limbs of the mice 
were sprayed with 70% ethanol in order to make the fur damp to avoid hair contamination. 
Circular incision was made through the skin around the proximal end of thigh using a sterile 
surgical scalpel blade (ensuring no damage to the muscles). The isolated skin of the limb was 
then pulled distally to a point beneath the ankle joint, so exposing the (TA) which lies over 
the EDL muscle. Skin covering foot and ankle joint was removed by carefully slicing down 
the footplate and pulling the skin distally free by hand. The muscles were dissected within 
10 minutes post mortem.  
 
2.8.1.1. Tibialis Anterior (TA) muscle dissection 
Tibialis anterior muscle lies on the anterior-medial surface of the leg region of the hind limb. 
The fascia layer (connective tissue) surrounding the TA muscle was removed by inserting 
grad 4 forceps (Dumostar, A. Dumont & Fils, Switzerland) between distal tendons of the TA 
and EDL and pulling the fascia toward the knee joint. Using curved Vanna’s microscissors 
(Agar Scientific T5220), the distal tendon was cut from the insertion point at the dorsal 
surface of the tarsal and metatarsal bones (about 1 cm below the TA muscle). The muscle 
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was pulled from the insertion tendon until the proximal attachment to the tibial tuberosity 
using the tendon. The TA muscle was carefully disabused by cutting it at its origin. Free TA 
muscle was transferred immediately into Phosphate buffer saline (1 x PBS). 
  
2.8.1.2. Extensor Digitorum Longus (EDL) muscle dissection 
Extensor digitorum longus muscle (EDL) lies on the lateral part of the anterior of the hind 
leg. The EDL has two tendons at its origin, which have attachment points to lateral condyle 
of the tibia and the head and anterior surface of the fibula. Both tendons of EDL muscle 
appear as one white structure lateral to the knee joint. The EDL muscle runs distally from 
the knee joint, lateral and beneath the TA muscle to the ankle joint. The distal tendon splits 
into four tendons, which then run under the retinaculum, cross the dorsal footplate and 
inserting separately on the dorsal surface of the middle and end phalanges of the four outer 
digits. 
The fascia layer covering the TA and EDL muscles was removed, and to locate the proximal 
tendon of EDL, the fascia and muscles covering this tendon were removed using Grade 4 
forceps. The distal tendon of TA muscle was cut using curved Vanna’s microscissors, and the 
muscle was pulled proximally to the knee using the tendon. The four distal EDL tendons 
were raised from the footplate and all cut using microscissors, (ensuring all tendons were 
cut to avoid muscle tearing). Tendons were then pulled free of the cartilage around the 
ankle by pulling the tendon from just below the muscle. The EDL muscle was pulled 
proximally to the knee using the tendons and while the muscle was kept taut, the two 
proximal tendons of the EDL were cut as far from the muscle as possible using microscissors. 
The free EDL muscle was then pulled away from the limb and placed immediately either in 
the prepared 2% type 1 collagenase solution or Phosphate buffer saline (1 x PBS), depending 
on requirements.  
 
2.8.1.3. Gastrocnemius and Soleus muscles dissection 
The gastrocnemius and the soleus muscles are situated at the posterior of the hind leg. The 
lateral head of gastrocnemius muscle originates from the lateral condyle of the femur, and 
its medial head originates from the medial condyle of the femur. Soleus muscle arises at the 
head of the fibula and the medial border of tibial shaft.  
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Both muscles run distally along the leg and inserts via the calcaneal tendon into the tuber 
calcanei. 
The skin was removed around the thigh to avoid muscle damage. The fascia layer covering 
gastrocnemius muscle was removed using Grade 4 forceps thus expose it, and then Biceps 
femoris muscle which covers a part of the gastrocnemius muscle was cut using 
microscissors. The mouse was turned on the belly and the foot pinned to cork board. The 
calcaneal tendon (s) was cut at the calcaneus and the gastrocnemius and the soleus were 
pulled proximally to the knee. The posterior muscles were pulled with forceps while cutting 
gently with scissors on both sides. The distal tendon of the soleus muscle was then cut and 
muscle free from the leg. The gastrocnemius muscle was a way from the thigh by cutting as 
close as possible to the femur. 
Both muscles were weighed prior to move soleus muscle into pre-cooled iso-pentane for 
snap freezing, and gastrocnemius muscle into liquid nitrogen, then storage on dry ice. 
    
2.8.2. Forelimb muscles dissection 
Biceps brachii (BB) and Extensor carpi radialis longus (ECRL) muscles were chose for 
investigating ultra-structures of skeletal muscle using transmission electron microscopy 
(TEM) technique. 
Forelimbs were completely separated from animal body and transferred immediately into 1 
x PBS, the facial layers covering BB and ECRL muscles were removed, and both muscles were 
fixed in-situ prior to their dissection.  
The muscles were dissected within 10 minutes post mortem.  
 
2.8.2.1. Biceps brachii (BB) muscle dissection 
The whole forelimb was fixed by pins on a cork board. Biceps brachii muscle lies in front of 
the arm. The fascia layer covering Pectoral and Biceps Brachii muscles was removed, and in 
order to locate tendon of origin, part of the pectoral muscle was removed. The tendon was 
severed from the supraglenoid tuberosity of the scapula, then the whole muscle pulled 
away to the radial tuberosity of the radial bone where the muscle been inserted. The Biceps 
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Brachii muscle was carefully freed by cutting its insertion tendon, and free muscle was 
transferred immediately into fixative solution (2.5% Glut in 0.1 M Na-Cacodylate pH 7.4).  
 
2.8.2.2. Extensor Carpi Radialis Longus (ECRL) muscle dissection  
Extensor Carpi Radialis Longus muscle lies on the ulnar (medial) side of the forearm. After 
BB muscle disabusing, the fascia layer covering ECRL muscle was removed gently. Whole 
muscle was detached from all surrounding muscles; and origin tendon severed from the 
lateral condyle of the humorous. ECRL muscle was then pulled away using its tendon toward 
the insertion site in the lateral dorsal surface of the base of the third metacarpal bone 
where the muscle was removed completely, and transferred immediately into the fixative 
solution. 
 
2.9. Ex vivo skeletal myofibre experimentation   
2.9.1. Isolation of intact single myofibres of EDL muscle 
The EDL muscle was placed in 1ml of 2% type 1 collagenase (2mg/ml) after dissection. 1ml 
collagenase was sufficient to digest both EDL muscles from one mouse. The bijous that 
contain the EDL muscles were incubated at 37°C, 5%CO2. The tubes of EDL muscles were 
agitated gently every 15 minutes to augment the digest speed. After approximately 30 
minutes, individual myofibres began to peel away from the muscle. By 1.5 - 2 hours, the 
bulk of the myofibres had separated from the muscle mass. Prior to transfer the myofibres 
into a sterile washing dish, the dish was coated with horse serum to prevent myofibres 
attach on plastic.  
A stereomicroscope (Nikon SMZ1500) with under stage light source was used to visualise 
the myofibres. Bundles of myofibres were gently aspirated using the sterile glass pipette 
until single isolated myofibres were seen. To remove residual collagenase, the myofibres 
were washed twice in Dulbecco's Modified Eagle Medium (DMEM), and twice with Single 
Fibre Culture Medium (SFCM). Care was taken during the washing to ensure that not all 
media was removed which can lead to myofibres contracting and so rendering the tissue 
useless for analysis. At this point, myofibres were either fixed at time-zero (T0) or cultured 
for desire time point (maximum 72 hours). Fixed myofibres were stored in 1.5 ml clear 
microtubes (Axygen MCT-175-C-S) at 4°C. 
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2.9.2. Single myofibre fixation and culture 
Cells (single myofibres) were fixed using 4% PFA/PBS at a volume ratio of 1:1 (final 
concentration 2% PFA/PBS) in 1.5 ml clear microtubes. To remove the fixative solution after 
15 minutes of incubation at room temperature, 1 x PBS was used for three washes each 
wash lasting 5 minutes before being stored at 4°C.  
For culturing, single myofibres were transferred carefully using a sterile glass pipette into 
12-well plate (approximately 20 fibres per well), then 1 ml of SFCM was subsequently added 
to each well. All wells were checked to contain intact myofibres and any myofibre bundles 
liberated. Plates were transferred to a humid incubator at 37°C, 5% CO2 and incubated for 
the required time period. Once myofibres had been cultured for the desired time period 
they were fixed as above, and stored in 1.5 ml clear microtubes at 4°C for 
immunocytochemistry.   
   
2.9.3. Immunocytochemistry staining 
After samples (EDL muscle fibres) fixation in 2% PFA, they were washed three times in 1 x 
PBS, with each wash lasting 5 minutes using Pasteur pipet. The myofibres then treated with 
permeabilisation buffer at room temperature for 15 minutes. Another two five minutes 
washes in 1 x PBS were performed prior to pre-blocked the myofibres in wash buffer for 30 
minutes at room temperature. Primary antibodies (Pax7 and MyoD) (Appendix I) were pre-
blocked in wash buffer for 30 minutes prior to incubate with the myofibres overnight at 4°C. 
In order to remove primary antibodies, samples were washed in fresh wash buffer three 
times 10 minutes each. Secondary antibodies were used to identify the primary antibodies, 
they pre-blocked in wash buffer for 30 minutes before incubating with myofibres for 1hr in 
the dark at room temperature. Samples were then washed three times in fresh wash buffer 
with each wash lasting 10 minutes. Myofibres were then transferred onto poly L-lysine 
slides. Once the myofibres were evenly distributed around the slides they were mounted 
with fluorescent mounting media (Dako S3023) which had been supplemented with 7.5 µl of 
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2.9.4. Myonuclear organization  
This work has been done by Jo C Bruusgaard, University of Oslo, Norway. 
For visualizing myonuclei, fibres were mounted with ProLong Diamons Antifade Mountant 
with DAPI (Molecular Probes, P36962), and a confocal microscope (Olympus FluoView 1000, 
BX61W1, Olym-pus, Japan) was used to observe single muscle fibres. Pictures were taken in 
confocal planes, separated by z-axis steps varying between 0.4 and 2 µm according to the 
optical thickness and the desired Nyquist sampling frequency. Confocal microscope images 
used for mapping of Euclidean positions of myonuclei were processed and analysed using 
Imaris (Bitplane) and ImageJ (NIH, Bethesda, MD, USA). For each muscle fibre, an idealized 
circular cylinder segment with constant radius was constructed, and the distance from each 
nucleus to its nearest neighbour was calculated. In order to measure how ordered the nuclei 
distribution for a particular fibre is, the mean nearest neighbour distance was calculated for 
the experimental data, as well as for the random and optimal distribution using parameters 
from the experiment. We denote the experimental, random and optimal means by ME, MR 
and MO. An ’orderness-score’, g(ME), was then calculated as: 
                                  
 
2.10. Tissue freezing and preparing for cryosectioning 
Following dissection, the muscles were immediately washed in 1 x PBS, dabbed onto tissue, 
weighed and placed on a strip of foil to snap freeze on the isopentane was frozen solid by 
liquid nitrogen (LN2). Once the muscles were completely frozen, they were removed from 
the foil and placed in labelled Eppendorf tubes that had been precooled in dry ice, and 
placed in dry ice for short term before transferring to -80°C.  
Prior to transfer the tissue from -80°C, a metal block was placed onto dry ice, and a dry ice 
alcohol bath was set up, both allowed to cool down for 15 minutes. The frozen tissue was 
placed on the cooled metal surface and drop by drop coated in cryo-embeding medium 
(Optimal Cutting Temperature compound (OCT) (TAAB O023)) until completely enclosed. 
The coated tissue was placed quickly into aluminium foil holder and filled with (OCT), before 
being froze in the dry ice alcohol path. Therefore a moderately quick freezing technique was 
ME  - MR 
MO  - MR 
g (ME, MR, MO) = 
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used in order to obtain fast freezing (within 10-15 seconds). The frozen muscle blocks were 
stored at -80°C prior to cryo-sectioning.  
The frozen blocks were transferred into the cryostat chamber (-20°C) (Bright 5040 Cryostat), 
and OCT medium was used to mount the tissue onto the chuck. The temperature of the 
tissue was allowed to equilibrate with the cryostat. 10 µm transvers mid-belly cryo-sections 
for each muscle were obtained and transferred to poly-L-Lysine coated slides. The sections 
were dried at room temperature for 1 hr, and either directly processed or stored at -80°C 
for further immunohistochemistry or histological staining. 
 
2.11. Haematoxylin and Eosin staining protocol (H&E)  
Sectioned slides were dried for 20 minutes and then washed in 1 x PBS for 2 minutes 
followed by a 18 minutes incubation in the haematoxylin stain to stain the nucleic materials. 
The haematoxylin stain was removed by a 2 minutes wash in distilled water followed by two 
immersions in acidic alcohol in 0.1%HCl in order to control the staining intensity. The slides 
were submerged in running water for 5 minutes before being placed in the Eosin stain for 2 
minutes to stain the protein materials. The sections were then washed in ascending gradient 
of ethanol concentrations (70% for 1 minute, 90% for 2 minutes, 100% three times for 2 
minutes) to remove unbound eosin stain before a final 2 washes in xylene for 3 minutes 
each.  
 
2.12. Immunohistochemical staining 
Prior to stain, slides were left 20 minutes at room temperature for drying. Muscle sections 
were then washed three times in 1 x PBS with each wash lasting 5 minutes to remove the 
embedding media. Following PBS washing, muscle sections were incubated in 
permeabilisation buffer solution for 15 minutes at room temperature. To remove excess 
permeabilisation buffer, another three five minutes washes in 1 x PBS were performed 
before being pre-blocked in wash buffer for 30 minutes at room temperature. Primary 
antibodies (Appendix I) were pre-blocked in wash buffer 30 minutes prior to their addition 
onto the muscle sections and incubate overnight at 4°C. In order to remove the primary 
antibodies, muscle sections were washed three times in wash buffer with each wash lasting 
10 minutes. Primary antibodies were identified using Alexa Fluor 488, 594 and 633 
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secondary antibodies (Appendix I). Pre-blocked in wash buffer was performed for all 
secondary antibodies (in dark) for minimum of 30 minutes prior to their addition onto the 
slides. Sections were then incubated for 1 hr in the dark at room temperature. Following the 
secondary antibodies incubation, the sections were then washed for a further three times in 
wash buffer with each wash lasting 10 minutes. Finally, slides were mounted in fluorescent 
mounting medium, and myonuclei were visualised using (2.5µg/ml) 4, 6-diamidino-2-
phenylindole (DAPI). 
 
2.13. Antigen Retrieval Immunostaining protocol  
In order to improve the presentation of our target antigens and enhance immunoreactivity 
by breaking down the protein cross-links formed, pre-treatment with the antigen retrieval 
reagents was performed. Briefly, Sectioned slides were dried for 20 minutes at RT and then 
washed three times in 1 x PBS with each wash lasting 5 minutes before being fixed in 4% 
PFA for 20 minutes at RT. Following fixation, slides were again washed 3 times in 1 x PBS, 
before being incubated in 100% methanol for 5 minutes. The antigen retrieval solution 
(Appendix 2) was prepared and heated to 90-95°C by placing the staining jar filled with 
retrieval solution into a water bath. The sectioned slides were then washed in 1 x PBS three 
times with 5 minutes each before being immersed into the preheated retrieval solution for 
2-10 minutes. After the incubation is finished, the staining jar with retrieval solution and 
slides were removed from the water bath and left to cool to room temperature. To remove 
excess retrieval solution from the slides, further three five minutes washes in 1 x PBS were 
performed before sections being pre-blocked in wash buffer for 30 minutes at room 
temperature. Primary antibodies (Appendix I) were pre-blocked in wash buffer for 30 
minutes prior to their addition onto the muscle sections and incubated overnight at 4°C. 
Primary antibodies were identified using Alexa flour 488, 594 and 633 secondary antibodies 
(Appendix I). Steps of day 2 of immunostaining protocol were followed before slides being 
mounted in fluorescent mounting medium and coverslip was placed over the top. Details of 





S. S. Omairi, PhD 2018 
 
2.14. Macrophage immunocytochemistry  
For macrophages identification, the Vector Laboratories ImmPRESSTM Excel Staining kit 
Peroxidase was used and the protocol with the kit being followed. 
Muscle sections were transferred from -80 freezer to room temperature and left for 20 
minutes for drying. Prior to fix with acetone, the sections were washed in 1 x PBS three 
times with each wash lasting 5 minutes. For quenching of endogenous peroxidase activity, 
the sections were incubated with BLOXALL blocking solution for 10 minutes. Another two 
three minutes washes in 1 x PBS were performed before the slides being incubated with 
2.5% of Horse Serum for 20 minutes. Primary antibody F4.80 (rat anti-mouse, BioRad 
MCA497R) was diluted in washing buffer prior to incubate on the muscle sections overnight. 
The slides washed twice in 1 x PBS each wash lasting three minutes before being incubated 
with Amplifier antibody for 15 minutes, washed a further twice in 1 x PBS three minutes 
each, and incubated for 30 minutes with ImmPRES Excel reagent. The sections were again 
washed twice with 1 x PBS for 5 minutes each prior to incubate with ImmPACT DAP EqV for 
2-10 minutes and keep monitoring the stain develop till get the desire intensity. Another 
two washes in 1 x PBS each wash lasting 5 minutes were performed before slides being 
rinsed in tab water for 2 minutes. The sections were dehydrated in series concentrations of 
ethanol (70%, 90%, 100% and 100%) 30 seconds each before two washes in xylene for 30 
seconds each. The slides were then mounted using DPX mounting media and covered with 
cover slip. 
  
2.15. Succinate Dehydrogenase Stain (SDH) 
Slides were left for 20 minutes at room temperature for drying purpose. Nitro blue 
tetrazolium (NBT) and Sodium Succinate stocks were prepared and stored as aliquots of 2 ml 
in -20°C freezer, the stocks were thawed on ice before mixing. Incubation medium (SDH 
stain) (NBT Stock 2 ml, Succinate stock 0.2 ml and Phenazine methosulphate 0.7 mg) was 
prepared shortly just before using and stored in dark. Muscle sections were incubated in the 
incubation medium (SDH stain) for about 2-5 minutes (2-3 minutes for soleus muscle, and 3-
4 minutes for TA and EDL muscles). Care was taken during the staining to determine the 
optimal time of incubation for each muscle. Slides were washed in distilled water for 1 
minute to stop enzymatic reaction. Then samples were fixed in 10% formal‐calcium for 15 
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minutes. Finally, slides were mounted in aqueous mounting media (Hydro mounting media) 
and coverslip was placed over the top. Details of reagents are given in (Appendix 2). 
 
2.16. Periodic Acid-Schiff (PAS) Stains 
Slides were moved from -80°C freezer and left 20 minutes at room temperature for drying. 
Muscle sections were hydrated in distilled water. The slides were then incubated with 
Periodic Acid Solution for 5 minutes at room temperature. Sections were rinsed well in tap 
water, prior to incubate in Schiff Reagent for 15 minutes to achieve desired contrast. 
Samples were washed in tap water for 10 minutes to produce a bright magenta colour. The 
muscle sections were stained with Haematoxylin stain for 1 minute to achieve desired 
contrast, followed by 30 seconds washing in tap water. The slides were placed in Bluing 
Reagent for 1 minute; then rinsed in deionized water for 30 seconds. The sections were 
dehydrated in two changes of anhydrous alcohol for 1 minute each, then cleared in three 
changes of clearing reagent for 1 minute each. Finally, slides were mounted in DPX media 
and coverslip was placed over the top. Details of reagents are given in (Appendix 2). 
 
2.17. Dihydroethidium (DHE) stain   
Muscle sections were transferred from -80 freezer to room temperature and left for 20 
minutes. The sections were rehydrated in 1 x PBS for 5 minutes before being incubated with 
10 µM of DHE stain for 30 minutes at 37°C.  The slides were then washed in 1 x PBS three 
times with each wash lasting 5 minutes. Finally, slides were mounted in fluorescent 
mounting medium, and myonuclei were visualised using (2.5µg/ml) 4, 6-diamidino-2-
phenylindole (DAPI). Details of reagents are given in (Appendix 2). 
 
2.18. Acid Phosphatase essay  
Prior to incubate muscle sections with acid phosphatase incubating solution at 37°C for 1:30 
hr, slides were left for 20 minutes at room temperature. Stain progression was monitored 
every 30 minutes at low magnification of a light microscope. When incubation time finished, 
the slides were washed with ddH2O three times with each wash lasting 30 seconds to 
remove residues of the incubation solution. The sections were counterstained using Harris 
Haematoxylin was diluted 1:30 for 1 minute. The slides were then rinsed with tap water 
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before being washed in running tap water for 5 minutes and then rinsed twice in ddH2O. 
The slides were mounted in aqueous mounting media (Hydro mounting media) and 
coverslip was placed over the top. Details of reagents are given in (Appendix 2). 
 
2.19. Transmission electron microscopy (TEM) 
This work has been done by Oliver Kretz, University of Freiburg, Germany. 
To identify size and distribution of the mitochondria in the muscle fibres, Biceps Brachii and 
Extensor Carpi Radialis Longus muscles were removed and cut in pieces of 1 mm3. Small 
slices of muscles were immersed in fixative solution (2.5% glutaraldehyde in 0.1 M Na-
cacodylate buffer pH 7.4), samples were then stored at 4°C. Tissue blocks were contrasted 
using 0.5% OsO4 for 1.:30 hr in RT, and 1% uranyl acetate in 70% ethanol for 1 hr in RT. After 
dehydration tissue blocks were embedded in epoxy resin and ultrathin sections of 40 nm 
thickness were cut using a Leica UC6 ultramicrotome (Leica, Wetzlar, Ger- many). Sections 
were imaged using a Zeiss 906 TEM (Zeiss, Oberkochen, Germany) and analysed using ITEM 
software (Olympus, Germany). 
 
2.20. 1H NMR spectroscopy-based metabonomic analysis 
This work has been done by Natasa Giallourou, University of Reading, Uk.  
Gastrocnemius muscles were pulverised, 40–50 mg of muscle tissue was snap frozen in 
liquid nitrogen and finely ground in 300 µL of chloroform : methanol (2:1) using a tissue 
lyzer. The homogenate was combined with 300 µL of water, vortexed and spun (13,000 g for 
10 min) to separate the aqueous (upper) and organic (lower) phases. A vacuum 
concentrator (SpeedVac) was used to remove the water and methanol from the aqueous 
phase before reconstitution in 550 µL of phosphate buffer (pH 7.4) in 100% D2O containing 
1 mM of the internal standard, 3-(trimethylsilyl)-(2,2,3,3,-2H4)-pro- pionic acid (TSP). For 
each sample, a standard one-dimensional NMR spectrum was acquired with water peak 
suppression using a standard pulse sequence (recycle delay (RD)-90°-t1-90°-tm-90°- acquire 
free induction decay (FID)). RD was set as 2 s, the 90° pulse length was 16.98 ms, and the 
mixing time (tm) was 10 ms. For each spectrum, 8 dummy scans were followed by 128 scans 
with an acquisition time per scan of 3.8 s and collected in 64 K data points with a spectral 
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width of 12.001ppm. 1H nuclear magnetic resonance (NMR) spectra were manually 
corrected for phase and baseline distortions and referenced to the TSP singlet at δ 0.0. 
Spectra were digitized using an in-house MAT- LAB (version R2009b, The Mathworks, Inc.; 
Natwick, MA) script. To minimize baseline distortions arising from imperfect water 
saturation, the region containing the water resonance was excised from the spectra. 
Principal components analysis (PCA) was performed with Pareto scaling in MATLAB using 
scripts provided by Korrigan Sciences Ltd, UK. Details of reagents are given in (Appendix 2). 
 
2.21. Western blotting 
Frozen muscles were pulverized in order to obtain fine powder from the muscles.  Muscles' 
powder was then homogenized in lysis solution (4M Urea, 125mM Tris pH6.8, 4% (w/v) SDS, 
protease inhibitors). Protein amounts were quantified with the Bradford Protein assay. 
Proteins (20µg/lane) were separated on 4–12% gradient SDS-PAGE mini-gels (Invitrogen), 
transferred to nitrocellulose membranes (Whatman), and blocked with 5% skim milk in 0.1% 
(w/v) Tween-20/Tris buffered saline. Membranes were cut at appropriate molecular weights 
in order to allow for simultaneous probing of the exact same samples for dystrophin and 
multiple DGC proteins, as well as alpha-actinin that was used as an internal control for 
protein loading. Membrane strips were incubated with appropriate primary antibodies 
overnight at 4°C, followed by a 1 hour incubation at room temperature with the appropriate 
horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch). 
Protein bands were visualized using enhanced chemiluminescence reagents (BioRad). Signal 
was detected on a ChemiDoc MP Imaging System (BioRad) at an automated range of 
exposures ranging from 1 second to 1 minute. For densitometric analysis, protein band 
intensities were quantified using ImageJ (NIH). Values in the linear range of pixel intensities 
were selected for quantifications. Signal intensities were normalized to alpha-actinin. Details 
of primary and secondary antibodies are given in (Appendix I). 
 
2.22. RT-qPCR 
Gastrocnemius muscles were dissected, weighed and placed on a strip of foil to snap freeze 
in liquid nitrogen (LN2). Once the muscles were completely frozen, they were placed in dry 
ice for short term before being transferred to -80°C.  
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Frozen Gastrocnemius muscles were chopped into three thirds, and (40 – 50 mg) pieces of 
each muscle were pulverised and solubilised in TRIzol® (Fisher) using a tissue homogenizer 
(QIAGEN). Total RNA was isolated and purified using a sequence of chloroform and 
isopropanol, following the protocol included in the RNesay Mini Kit from Qiagen (74104). 
RNA concentrations were measured using the Nanodrop 2000 (Thermo Scientific). 
5 µg of total RNA was revers-transcribed to cDNA with SuperScript II Reverse Transcriptase 
and analyse by quantitative real-time RT-PCR on a StepOnePlusTM Real-Time PCR system, 
using the applied Biosystems SYBRGreen PCR Master Mix and StepOne software v.2.1. 
Primers were designed using the software Primer Express 3.0 (Applied Biosystems). Relative 
expression was calculated using the ΔΔCt method with normalization to the housekeeping 
genes cyclophilin‐B and Hypoxanthine‐guanine Phosphoribosyltransferase (hprt). Details of 
reagents are given in (Appendix 2), and specific primer sequences are given in (Appendix 3). 
 
2.23. In vivo assessment of regeneration capacity following Cardiotoxin injection 
2.23.1. Anesthetising mice  
Induction of anesthesia was carried out with 3.5% isofluorane in oxygen before being 
maintained at a lower than 2% isofluorane concentration during the procedure using face 
mask. 
 
2.23.2. Intramuscular (IM) injection of Cardiotoxin into TA muscle  
Prior to anesthetising, the solution to be injected was prepared in 30G, 8 mm long 1 mL 
insulin needles (Insumed 3079264). Animals were anesthetised and the fur at anterior side 
of the hind leg, around the TA was shaved to allow more accurate orientation. The first 
injection was carried out with an insertion point parallel to the muscle, at the distal end of 
the anterior part of the TA. The needle was inserted approximately 7 mm into the muscle 
and 10 µL of solution was injected. The following two injections were carried out with 
insertion points vertical to the leg, lateral to the left and right of the proximal end of the TA, 
with 10 µL solution injected in both sites. In total, 30 µL of 50 µM Cardiotoxin from Naja 
mossambica mossambica was injected into the right TA, and 30 µL of sterile 1 x PBS was 
injected into the left TA muscles of all mice. Following injection, the animals were returned 
to their cages and allowed to recover from the anesthesia. The mice were closely monitored 
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for at least 30 minutes to ensure full recovery.  The animals were allowed to convalesce 
before being culled at three time pointes (day 3, 6 and 14), then TA muscles were dissected 
and snap frozen for analysis. Details of reagents are given in (Appendix 2).  
 
2.24. In vivo Post-natal blocking of Myostatin 
2.24.1. Intraperitoneal injection of soluble activin receptor IIB (sActrIIB-Fc) 
One month-old males WT (C57BL/6JOIa/Hsd) and ErrγTg/+ mice were injected 
intraperitoneally twice weekly with 10 mg/kg of the soluble activin receptor IIB (sActRIIB-Fc) 
for a total period of two months before culling. Prior to inject the animals, they were 
weighed, and doses of (sActRIIB-Fc) to be injected were calculated for all animals 
considering their weights. Animals were held by the tail base, then grabbed at the scruff 
over the shoulder, turned upside down, and the soluble activin receptor IIB was 
administrated intraperitoneally using 30G, 8 mm long 1 mL insulin needles (Insumed 
3079264). Following each injection, the animals were returned to their cages, and they were 
monitoring for at least 20 minutes at the day of injection, and day after to ensure they are 
fine and no bleeding followed the injection. 
  
2.25. Semi-quantitative measurement of Collagens and dystrophin-glycoprotein complex 
(DGC) proteins expression by immunofluorescence 
Membrane signal intensities of approximately 30 muscle fibres of MHC phenotype (IIB-/IIB- 
and IIB+/IIB+) in muscle sections (EDL, Soleus and TA) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ 
mice, and approximately 50 muscle fibres of MHC phenotype (IIB-/IIB-, IIB+/IIB+ and I+/I+) in 
EDL and Soleus muscle sections from WT.PBS, ErrγTg/+.PBS, WT.sActRIIB and ErrγTg/+.sActRIIB 
were measured. 10 random fibres of a specific phenotype from a central region of each 
muscle section were counted from three mice of each cohort. Fiji software was used to 
measure signal intensity from an area of interest after images have been corrected for 
background to avoid regions of signal saturation. As well as internal controls, all images 
were taken at the same exposure time based on a non-saturation level in WT tissue. To 
calculate relative signal intensity levels, individual measurements from fibres of all cohorts 
were taken as a percentage of mean of MHCIIB- and MHCI of WT muscles. 
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2.26. Sarcolemma thickness measurement  
Connective tissue thickness between 30 -50 chosen fibres of MHC phenotypes (IIB-/IIB-, 
IIB+/IIB+ and I+/I+) of (EDL, Soleus and TA) muscle sections was measured using Fiji software. 
10 random fibres of a specific phenotype from a central region of each muscle section were 
counted from three mice of each cohort. One measurement on the constant connective 
tissue thickness, with multi measurements on the fluctuating connective tissue thickness 
areas between each two myofibres that expressed same MHC isoform were taken on all 
muscle sections of WT, Mtn-/- and Mtn-/-/ErrγTg/+ as well as muscle sections of WT.PBS, 
ErrγTg/+.PBS, WT.sActRIIB and ErrγTg/+.sActRIIB mice. Importantly, all analysed images were 
taken at the same light intensity (exposure time). 
 
2.27. Imaging and analysis 
Haematoxylin and Eosin (H&E), Succinate Dehydrogenase (SDH) and Periodic Acid-Schiff 
(PAS) stained sections were examined using Ziess Axioskope2 microscope, and images were 
captured using an Axiocam digital camera with Ziess Axiovision computer software version 
4.8. Fluorescence microscope (Ziess AxioImegar A1) was used to examine 
immunofluorescent stained sections, and images were captured using an Axiocam digital 
camera with Ziess Axiovision computer software version 4.8. To examine entire muscle, the 
images at mid-belly were reconstructed using Adobe Photoshop CS3. ImageJ software was 
used for counting analysis. For the detection of differences in myofibres cross-sectional area 
(CSA), Ziess Axiovison software version 4.8 was used. 
 
2.28. Statistical analysis  
Data were presented as mean ± SE. Significant differences between two groups were 
performed by Student’s t-test for independent variables. Differences among groups were 
analysed by one-way analysis of variance (ANOVA) followed by Bonferroni’s multiple 
comparison tests as appropriate, and Twa-way ANOVA followed by Bonferroni post-tests to 
compare replicate means by row. Statistical analysis was performed on GraphPad Prisim 
software. Differences were considered statistically significant at p < 0.05 (one asterisk), p < 
0.01 (two asterisks) or p < 0.001 (three asterisks). 
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3.1. Introduction  
The maintenance of muscle mass and function has important health implications and loss of 
muscle mass in particular is associated with increased morbidity and mortality and a 
reduced quality of life (Huss et al., 2002, Wang and McPherron, 2012).  
Skeletal muscle plasticity concept was applied by John Eccles and colleagues to describe the 
effect of cross-innervation on the size and fibre characteristics of skeletal muscle of cats 
(Buller et al., 1960). It was well established that skeletal muscle is a highly compliant tissue 
that undergoes both qualitative and quantitative changes as a part of its adaptation to 
physiological and environmental stimuli. Most skeletal muscles are composed of a 
heterogeneous population of muscle fibres that differ in their metabolic and molecular 
properties as well as contractile speeds, a feature imparted by the expression of the type of 
myosin heavy chain (MHC) being expressed. Moreover, muscle fibres are affected by 
different factors, for instance innervation, genetic background, neuromuscular activity, 
exercise training, mechanical loading/unloading, and ageing (Pette and Staron, 2001). 
Further studies have described skeletal muscle as a dynamic tissue that displays varied 
responses to internal and external stimuli by changing its phenotypic profile in terms of size 
as well as its composition through changing genes expression and metabolic properties 
(Matsakas and Patel, 2009b).  
One of the main factors that induce muscles mass and imparts high quality of life is 
mechanical loading. Conversely, loss of skeletal muscle mass as a result of genetic disorders, 
ageing and energy shortage has a major effect on public health (Thomas, 2007, Matsakas 
and Patel, 2009b). Modification in muscle mass following mechanical loading or resistance 
exercise requires a high level of oxygen consumption that is realized by an increase in 
capillary density to maintain maximal mass specific blood flow (Armstrong et al., 1986).       
Skeletal muscle mass depends chiefly on the fibre number (hyperplasia) and fibre size 
(hypertrophy). However genetic background and animal breed are major factors that 
determine muscle mass (Martyn et al., 2004). The skeletal muscles constitute ~ 40% of the 
animal body mass, therefore whole body weight can be affected as a result of muscle fibre 
number and size changes. The number of myofibres is fixed at the prenatal stage. At the 
post-natal stage, muscle growth is accompanied by fusion of myogenic precursor cells to the 
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existing myofibres (Sandri, 2008). Nader (Nader, 2005) has shown that muscle mass 
maintenance or loss is fundamentally the consequences of a balance between two 
important processes, skeletal muscle protein synthesis and protein degradation. This 
balance is regulated by two important pathways, AKT/mammalian target of rapamycin 
(mTOR) that control protein synthesis, and AKT/fork head box O (FOXO) pathway that 
controls protein breakdown (Glass, 2005). Further work has described Myostatin as a key 
regulator of muscle mass, since its absence leads to muscle hypertrophy, whereas its 
overexpression causes muscle atrophy (Elliott et al., 2012).      
Numerous studies have demonstrated that skeletal muscle fibres are generally classified as 
slow or fast fibres, where slow fibres express the myosin heavy chain (MHC) isoform I, 
whereas fast fibres express MHC IIA, IIX and/or IIB. They display noticeable differences in 
term of their metabolism, contractile properties and susceptibility to fatigue. Slow fibres 
generally show a small cross-sectional area (CSA), contain more mitochondria which sustain 
a high oxidative capacity, and a denser microvascular network than fast fibres that rely 
predominantly on glycolysis for ATP production, with low mitochondrial content and 
oxidative enzymes, and they are fatigue susceptible. Muscle fibres can change their 
phenotype, such as the expression of MHC, mitochondrial content and capillary supply in 
response to external stimuli (Pette and Staron, 1997, Pette and Staron, 2001, Olson and 
Williams, 2000). 
Previous works have established that during the development of skeletal muscle fibres in 
response to endurance exercise, there is also increase in the proportion of type IIA and type 
IIX fibres at the expense of IIB fibres (Hather et al., 1991, Erskine et al., 2010). Other studies 
have reported that exercise training induces fast to slow transition in fibre type and myosin 
isoforms within the fast fibres population shift from type IIB toward type IIA (Andersen and 
Henriksson, 1977, Jansson and Kaijser, 1977). There is also evidence of myofibres adaptation 
in order to improve the physical performance which characterized by an increase of 
mitochondrial biogenesis, angiogenesis and fibre type transformation, in response to 
endurance exercise (Yan et al., 2011). In the line with these investigations, findings by 
(Amthor et al., 2007, Girgenrath et al., 2005) have revealed a shift of myofibres toward type 
IIB, with a noticeable reduction in type IIA and IIX myofibre types of the extensor digitorum 
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longus (EDL) and tibialis anterior (TA) muscles from Myostatin null mice. Conversely, 
increase in the proportion of slow myofibres, with simultaneously decrease of fast-twitch 
myofibres has been reported following Errγ overexpression (Matsakas et al., 2012b).  
Until recently it has been shown that mitochondria need a high level of oxygen that diffuses 
from capillaries to generate ATP for muscle contractile and aerobic metabolism. Therefore, 
there might be a trade-off between muscle fibre size and aerobic metabolism determined 
by diffusion limitation (van Wessel et al., 2010). In fact, an inverse relationship between 
muscle fibre size and maximal oxygen uptake has been reported (Van der Laarse WJ, 1998). 
This relationship, in theory, ultimately imparts a constraint on the size that mitochondria-
rich and therefore high O2 -dependent oxidative fibres can attain before they become anoxic 
or adapt to a glycolytic phenotype less reliant on O2 (Desplanches et al., 1996, Deveci et al., 
2001). 
Here we investigated whether inverse relationship between muscle fibre size and aerobic 
metabolism mediated by mitochondrial density can be broken, and sought to develop large 
fibres without compromising function, such as fatigue resistance and exercise capacity.  
Previous studies have shown that Myostatin is a potent inhibitor of skeletal muscle growth 
and its deletion results in a hypermuscular phenotype called "Muscle Doubling" as a result 
of generalized hyperplasia and hypertrophy which seen in mice, cattle and even in humans 
(McPherron et al., 1997, McPherron and Lee, 1997, Schuelke et al., 2004). Although such 
enlarged muscles appear essentially normal at the histological level, their ability to generate 
tension is impaired, particularly during prolonged periods of work (Amthor et al., 2007, 
Mendias et al., 2006, Relizani et al., 2014). In this section we determined whether altering 
the metabolic profile of skeletal muscles through Errγ overexpression would influence these 
features of Myostatin null muscles. To that end, we developed a novel mouse line by 
introducing an Errγ overexpression allele driven by a skeletal muscle fibre promoter (Human 
α -Skeletal Muscle Actin) (Muscat and Kedes, 1987) that enhances the oxidative capacity 
(Narkar et al., 2011) into a hypertrophic Mtn-/- background. Based on the concept of a 
constraint between the CSA and aerobic metabolism of a fibre, there are three possible 
consequences of the cross: Firstly, absence of Myostatin resulted in de-represses and 
prevails of Akt pathway that leads to hypertrophic, but glycolytic fibres. Secondly,  oxidative 
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features would be imparted by the Errγ programme that would follow the inverse size 
relationship and lead to mitochondria-rich fibres which would be smaller than wild type 
(Rangwala et al., 2010). And finally, the constraint is broken resulting in the development of 
hypertrophic hyper-oxidative fibres. 
Three genotypes of male mice (WT, Mtn-/- and Mtn-/-/ErrγTg/+) (n=5) were bred, housed 
under standard environmental conditions and provided food and water ad libitum in the 
Biological Resource Unit, University of Reading, to an adult age (3 months). 
Animals’ physiological properties like fatigue test, muscle strength and locomotor activities 
were examined using exhaustion running protocol on treadmill, grip strength meter, and 
open field activity monitoring respectively.   
The hind limb muscles (Soleus, Extensor digitorum longus (EDL), Tibialis Anterior (TA) and 
Gastrocnemius) were isolated and weighed. These muscles have been selected because 
they represent a sufficient variety of myofibre composition. One side EDL muscles were 
used to measure force generating capacity. Then muscles were frozen, cryosectioned and 
immunostained using antibodies for myosin heavy chains (MHC) (types I, IIA and IIB) to 
determine total muscle fibre number, types and size (CSA), and CD31 antibody to identify 
capillary density per muscle fibre. Gastrocnemius muscles were pulverised, divided into 
three thirds, one third was homogenized and RNA samples were extracted to determine 
expressions of Errγ and MHC genes using qPCR technique. Another third was powdered and 
lysed, then protein samples were extracted and used to determine the expression of 
molecules responsible for protein synthesis and degradation. Biceps brachii (BB) and 
Extensor carpi radialis longus (RECL) muscles were isolated, fixed and used for transmission 
electron microscopy (TEM) work.  
The main observations of this chapter are, firstly, muscles from Mtn-/-/ErrγTg/+ mice maintain 
the same muscle fibre number and size exhibited by Myostatin null mice. Secondly, Mtn-/-
/ErrγTg/+ mice show fatigue resistance characteristics not only more than Mtn-/- mice, but 
even outperform wild type mice during an incremental exercise test. Thirdly, we show that 
Errγ overexpression into Mtn-/- background drives a partial reversal transition of MHCs 
profiling toward WT muscle condition. Finally, forelimb muscles from Mtn-/-/ErrγTg/+ mice 
show absence of ultrastructure abnormalities seen in Mtn-/- muscles, with a remarkable 
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increase of mitochondrial numbers in particular at the sub sarcolemma location, that exceed 
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3.2. Muscle-specific expression of Errγ into Mtn-/- background mice using human α-
skeletal actin promoter 
Previous studies have demonstrated that estrogen-related receptor-γ (Errγ) is exclusively 
expressed in metabolically active and densely vascularised tissues like skeletal muscles 
(Giguere, 2008, Hong et al., 1999). Further investigations have reported that Errγ has a 
potential role to regulate not only mitochondrial programs involved in Fatty Acid Oxidation 
(FAO), Tricarboxylic Acid Cycle  (TCA), and Oxidative phosphorylation (OXPHOS), but also the 
expression of genes network that controls angiogenesis programme, and calcium handling 
pathways in skeletal muscle that are required for longer term adaptation to exercise (Stein 
and McDonnell, 2006, Alaynick et al., 2007). Moreover, evidence has been provided that 
Errγ overexpression in skeletal muscle is sufficient to enable anaerobic muscles to attain 
enhanced oxidative capacity, and increase treadmill endurance (Rangwala et al., 2010). 
Therefore, transgenic overexpression of Errγ in skeletal muscles using specific promoters 
have been broadly applied to enhance muscle mitochondrial functions, induce expression of 
fuel uptake genes, and restoration of blood perfusion in different cases of muscle disorders 
(Rangwala et al., 2010, Narkar et al., 2011).  
Outcomes of previous transfection studies have shown that sequences upstream of the 
transcription start site of the rat and chicken skeletal actin gene were sufficient for both 
stage- and tissue-specific expression (Melloul et al., 1984, Grichnik et al., 1986, Bergsma et 
al., 1986). Further study has demonstrated that the human α-skeletal actin (HSA) gene 
promoter is complex and large, spanning 1,300 bp. Three segments of this region when 
adjacent to simian virus 40 (SV40) promoter act as regulatory domains that respond to 
specific factors produces by muscle itself to regulate positive modulation of transcription 
(Muscat and Kedes, 1987). The proximal domain (positions -153 to -87) of the HSA gene 
promoter is crucial for muscle-specific expression in two different myogenic cell lines (L8 
and C2C12), and the distal domain (positions -1300 to -626) of the promoter is only 
necessary in C2C12 cells for tissue-specific expression (Wang et al., 2004). Moreover, it has 
been reported that the tissue-specific transcription of the human α-skeletal actin gene 
promoter resulted from the interaction of the upstream regions with trans-acting positive 
regulatory factors in muscle cells (Muscat and Kedes, 1987).  
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In the present study, we found that introduction of Errγ in a skeletal muscle-specific manner 
into the Mtn-/- background to generate double transgenic Mtn-/-/ErrγTg/+ resulted in viable, 
fertile offspring that were born at the normal Mendelian ratios. 
Next we examined the expression of Errγ gene in gastrocnemius muscle (n=5) from all three 
cohorts (WT, Mtn-/- and Mtn-/-/ErrγTg/+) mice. Our results showed that using HSA promoter 
induced robust overexpression of Errγ in the Mtn-/- background mice, indicating by a 
significant increase of Errγ gene expression (~ 250 folds) in muscle samples of Mtn-/-/ErrγTg/+ 

















































Figure 3.1. Errγ expression induced by using human α-skeletal actin promoter 
Displaying Errγ mRNA level in Gastrocnemius muscles of wild type (WT), Myostatin null 
(Mtn) and Errγ transgenic mice on the Myostatin null background (Mtn:Eγ) mice.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, ***=p<0.001.
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3.3. Body weight and skeletal muscle mass following Myostatin deletion and Errγ 
overexpression on Myostatin null background mice 
Myostatin has been known as a member of the Transforming Growth Factor beta (TGF-β) 
superfamily that its gene is highly conserved among vertebrate species, and functions as a 
negative regulator of skeletal muscle mass development (McPherron et al., 1997, 
McPherron and Lee, 1997). Thereafter, number of studies have shown that lack of 
Myostatin results in a dramatic and widespread increase in skeletal muscle mass, 
demonstrating the existence of a powerful mechanism to control muscle growth (Amthor et 
al., 2007, McPherron and Lee, 1997). 
Once death had been ascertained, we first examined the consequences of Errγ 
overexpression in a muscle-specific manner on whole body weight of mice lacking Myostatin 
(n=5). Our results showed that body mass of WT, Mtn-/- and Mtn-/-/ErrγTg/+ animals were 















Figure 3.2. Myostatin deletion and Errγ introducing into Myostatin null background mice 
doesn’t affect body weight 
Body weights of wild type (WT), Myostatin null (Mtn) and Errγ transgenic mice on the 
Myostatin null background (Mtn:Eγ) mice.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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Then we examined the weight of hind limb muscles (EDL, Gastrocnemius, Soleus and TA,) of 
the three genotypic groups.  
In agreement with previous study by McPherron and Lee (McPherron and Lee, 1997), we 
found that all the examined hind limb muscles (n=10) of Myostatin null animals were 
heavier than the wild type. The EDL, gastrocnemius, soleus and TA muscles were in both 
Mtn-/- and Mtn-/-/ErrγTg/+ approximately 43%, 44%, 47% and 70% larger than their WT 
counterpart respectively (Figure 3.3 and Table 3.1). 
Importantly, the increase in muscle weight in Myostatin knockout mice was maintained 
following Errγ overexpression. Of particular note there was no significant difference in mass 
for any of the muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice. These data show that in the 
absence of Myostatin, the skeletal muscles become bigger, and Errγ transgenic mice 





















Figure 3.3. Hind limb muscle mass of WT, Mtn and Mtn:Eγ  mice 
Displaying clear disparate of hind limb muscles size of (WT), Myostatin null (Mtn) and Errγ 
transgenic mice on the Myostatin null background (Mtn:Eγ) mice.  
Male twelve-week old mice. 
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Muscle / Weight (mg) WT Mtn Mtn:Eγ 
Extensor Digitorum Longus 14.91 21.40.8 21.20.9 
Gastrocnemius 195.35.5 284.515.8 27610 
Soleus  12.61 18.51 17.20.5 






















































































































Figure 3.4. Muscle-specific expression of Errγ maintains hypertrophy features of 
Myostatin null background muscles  
Quantification of skeletal muscle (EDL, gastrocnemius, soleus and TA) mass of wild type 
(WT), Myostatin null (Mtn) and Errγ transgenic mice on the Myostatin null background 
(Mtn:Eγ).  
(n = 10) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, ** = P<0.01 and ***= P<0.001. 
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3.4. Errγ overexpression into Myostatin null background mice induces fatigue resistance   
We showed that Myostatin deletion resulted in a dramatic increase in muscle mass 
compared to wild type without change of whole body weights. Previous study by Savage’s 
group has shown that the exercise intolerance is not related to body weight, as they 
demonstrated a reduction of exercise capacity in young Myostatin knockout compared to 
wild type mice while body weights were similar (Savage and McPherron, 2010). Other 
studies have illustrated that cattle with muscular hypertrophy as a result of Myostatin gene 
mutation, are prone to muscle damage after mild exercise (Holmes et al., 1973, Marchitelli 
et al., 2003). 
On the other hand, Rangwala and his team provided evidence that induce Errγ expression is 
sufficient to increase treadmill endurance and exercise tolerance (Rangwala et al., 2010). 
Therefore, to determine whether the increase of Errγ expression into hypertrophic 
Myostatin null mice would enhance the exercise capacity of these animals, we subjected 
mice (n=5) of three cohorts WT, Mtn-/- and Mtn-/-/ErrγTg/+ to the exhaustion treadmill 
running protocol. In accord with previous observations, we found that Mtn-/- mice reached 
exhaustion significantly earlier than WT control and had shorter total running time. 
However, the Mtn-/-/ErrγTg/+ mice ran for approximately 80% longer than the Mtn-/- and 25% 
longer than the WT mice.  
These results show that Errγ overexpression in a muscle lacking Myostatin improved the 

































































Figure 3.5. Exercise tolerance test for WT, Mtn and Mtn:Eγ animals, using mouse 
treadmill protocol 
Quantification of running distance of WT, Mtn and Mtn:Eγ mice on treadmill showing a 
remarkable exercise capacity for the Mtn:Eγ mice, with worse performed of Mtn mice  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, ** = P<0.01 and ***= P<0.001.  
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3.5. Increased muscle force generation capacity following muscle-specific manner Errγ 
overexpression into the Myostatin null background mice   
We demonstrated above that overexpression of Errγ using specific promoter is efficacious to 
induce exercise capacity and attenuate muscle fatigability of Myostatin null mice. Thereafter, 
we performed a series of tests for muscle force generation aptitude.  
In this regard, conflicting results have been reported. Previously it was well established that 
treatment of mdx mice with stabilized Myostatin propeptide resulted in an increase of 
muscle-specific force output (Wagner et al., 2002, Bogdanovich et al., 2002). Several other 
studies have reported, despite a remarkable increase of skeletal muscle mass following 
Myostatin deletion (McPherron and Lee, 1997, McPherron et al., 1997), this increase was 
not accompanied by propionate increase of muscle force generation (Amthor et al., 2007). 
Here we examined the potential of a muscle-specific manner Errγ overexpression to 
promote force generation in the muscles lacking Myostatin.  
We found that the maximal isometric tetanic force generated by the EDL muscles of 12 
weeks age Mtn-/- mice was not significantly different to that of age-matched WT mice, 
despite the larger muscle mass (Figure 3.6A). The tetanic force generated by Mtn-/-/ Errγ Tg/+ 
EDL muscles was, however, greater than that of the EDL from both WT and Mtn-/- mice (n=5) 
(Figure 3.6A). We next calculated the Specific Force (sPo), the tetanic force per muscle mass. 
The (sPo) of the EDL of Mtn-/- mice was lower that of the other groups, with that of the Mtn-
/-/ErrγTg/+ mice being significantly greater than Mtn-/- mice, but not normalized to WT levels 
(Figure 3.6B).  
We also examined the force generating capacity of the soleus muscles from all three cohorts. 
The tetanic force of Mtn-/- soleus muscle was significantly lower than those of WT. There 
was no difference in this parameter between the soleus muscles of WT and Mtn-/-/ ErrγTg/- 
(Figure 3.6C). The specific force of the soleus muscles showed the same overall profile as 
that of the EDL but did not reach statistical significance, possibly due to low sample size 
(Figure 3.6D). 
Altogether, these data show that lack of Myostatin compromises muscle force production 
even with a marked increase of muscle mass. However the muscle-specific expression of 
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Errγ in Mtn-/- mice not only induces muscles maximum tetanic force generation, but also 


















































































Figure 3.6. Errγ overexpression into Mtn
 
mice is required to improve muscle force 
generation capacity 
Contractile properties of EDL and Soleus muscles from WT, Mtn and Mtn:Eγ mice. Specific 
force denotes tetanic force normalized to wet muscle mass 
(A) Quantification of maximal isometric tetanic force generated by EDL muscles 
(B) Quantification of specific force generated by EDL muscles  
(C) Quantification of maximal isometric tetanic force generated by soleus muscles 
(D) Quantification of specific force generated by soleus muscles  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests. *=P<0.05 and and ** = P<0.01. 
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3.6. Errγ overexpression induces forelimb muscles grip strength that was compromised 
due to Myostatin deletion   
 
We demonstrated that the increase in muscle mass following Myostatin deletion was not 
accompanied by a proportionate increase of exercise capacity and muscle force generation. 
However, muscle-specific manner overexpression of Errγ was sufficient to improve these 
features. Previous work has shown that normalised gripping strength of forelimb muscles to 
body weights of Mtn-/- and WT mice, was not significantly different (Guo et al., 2016). Here 
we examined whether 12 weeks old of age Myostatin knockout mice show a difference of 
muscle grip strength compared to matched age WT mice (n=5), and to what extent that Errγ 
overexpression in a muscle lacking Myostatin would affected this parameter.  
Using a grip meter to assess muscle strength, our observations showed that Myostatin null 
mice had reduced strength compared to controls. However, muscle strength was 
significantly improved following Errγ overexpression into Myostatin null background 
muscles (Figure 3.7). These data suggest that introduction of Errγ into a muscle lacking 






























































































Figure 3.7. Muscle-specific manner overexpression of Errγ attenuate Mtn muscle strength 
decreasing 
Forelimb muscles contraction measurement through assessment of grip strength for WT, 
Mtn and Mtn:Eγ mice, using grip strength meter. Grip strength was normalised to the 
weight of the mice. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05 and ***= P<0.001.  
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3.7. Locomotor activity of Myostatin null and Errγ overexpression into Mtn-/- background 
mice  
To further solidify of our results at a functional level, behavioural and locomotor activity of 
mice from our three cohorts (WT, Mtn-/- and Mtn-/-/ ErrγTg/+) (n=5) were measured using 
open field activity monitoring. Previous work has illustrated a reduction of muscle 
physiological function following Myostatin deletion (Matsakas et al., 2012a). Conversely, 
Study by Rangwala’s group has reported a significant increase of travelled distance and work 
performed of Errγ transgenic into WT background mice compared to controls (Rangwala et 
al., 2010). Therefore, in this section we determined whether Errγ overexpression into 
Myostatin null background mice would induce locomotor activity of these animals.   
We found that Myostatin null mice were the least active indicated by spending longer 
periods of immobility compared to other genotypic groups (Figure 3.8A, B and C). However, 
Mtn-/-/ ErrγTg/+ mice showed higher activity than both Myostatin null and control mice with 
less static time (Figure 3.8A, B and C). Moreover, muscle-specific expression of Errγ into 
Myostatin null mice enables these animals to travel longer distances than WT and Mtn-/- 
mice without arriving at significant differences (Figure 3.8D).  
Taking together, these data suggest that introducing of Errγ into a muscle lacking Myostatin 

























































































Figure 3.8. Errγ over expression promotes behavioral and locomotor features of 
Myostatin null mice 
Organismal activity measurements through activity cages for WT, Mtn and Mtn:Eγ mice. 
(A)  Quantification of total activity of each animal from the three genotypes 
(B)  Static time of each animal from the three cohorts 
(C)  Quantification of the inactivity time 
(D)  Quantification of the distances were travelled by each mouse 
 (n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, and **=P<0.01.  
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3.8. Errγ overexpression sustains myofibres hyperplasia exhibited by Myostatin null 
muscles 
We showed that Myostatin null mice exhibit a dramatic increase in muscle mass compared 
to controls. However this increase was concomitant with reduction of exercise capacity, and 
was not accompanied with a proportionate increase of muscle force generation. Strikingly, 
Errγ overexpression into Mtn-/- mice maintained the increase of muscle mass, improved 
muscle force generation, and not only normalised muscle function-fatigability but also 
exceeds the WT values.  
Pervious work has reported that a large part of the increase of muscle mass of growth-
differentiation factor 8 (GDF-8) mutant mice resulted from muscle cell hyperplasia 
(McPherron et al., 1997). Other studies have illustrated that the increase in muscle mass 
following germline deletion of Myostatin gene is due to an increase in muscle fibres size and 
number (Elashry et al., 2009, McPherron et al., 2009).   
In present study, we determined whether the increase in muscle mass of Mtn-/- and Mtn-/-/ 
ErrγTg/+ mice resulted from an increase in muscle fibre numbers or sizes, or both of them. 
Therefore, Immunohistochemistry protocol using antibodies against myosin heavy chain 
(MHC) isoforms (type I, IIA and IIB) was performed to determine total fibre number in both 
EDL and soleus muscles (n=5) of each genotype (WT, Mtn-/- and Mtn-/-/ ErrγTg/+) (Figure 3.9A 
and B). Total fibre number of TA muscles was not included in this analysis, as its anatomical 
shape makes it impossible to obtain the same mid-belly section.    
Here we examined the effect of a muscle-specific manner Errγ expression into hypertrophic 
Myostatin null EDL and soleus muscles fibre numbers. 
Our data showed a significant increase in total fibres number of EDL and soleus muscles 
from both Mtn-/- and Mtn-/-/ ErrγTg/+ compared to their counterpart muscles of wild type 
mice (Table 3.2, and Figure 3.9 C and D). Interestingly, we found that the introduction of Errγ 
into Mtn-/- muscles did not significantly changed the number of fibres seen in Mtn-/- EDL 
(Figure 3.9 A and C) or soleus muscles (Figure 3.9 B and D). These data reveal that loss of 
Myostatin induces an increase muscles hyperplasia. Most importantly, overexpression of 
Errγ into Mtn-/- mice conserved the increase of total fibres number of these muscles.  
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Muscle  Genotype  Average total fibre number 
Extensor digitorum longus 
(EDL)  
WT 88232 




Mtn  89028 
Mtn:Eγ 89647 
Table 3.2. Myofibre number of Soleus and EDL muscles from WT, Mtn
 
and Mtn:Eγ mice. 














































































Figure 3.9. Myostatin deletion increased muscle fibres number and Errγ overexpression 
maintained this increase.  
Muscle-specific expression of Errγ didn’t affect the hyperplasia of Myostatin null 
background muscles  
(A) Immunohistochemical images of EDL muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCIIB appearing as red.  
(B) Immunohistochemical images of soleus muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCI appearing as red. 
(C) Quantification of total fibres number in EDL muscles. 
(D) Quantification of total fibres number in soleus muscles.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, and **=P<0.01.  
Chapter 3 
118 
S. S. Omairi, PhD 2018 
 
3.9. Muscle fibres hypertrophy following Myostatin deletion was not affected by Errγ 
overexpression into Mtn-/- mice 
We demonstrated that overexpression of Errγ conserved myofibres hyperplasia induced by 
germline deletion of Myostatin. Previous work has shown that hind limb muscles of Mtn-/- 
mice undergo large and show remarked levels of size increase (McPherron and Lee, 1997). 
Further study has reported that the large size of muscles lacking Myostatin is attributed 
mainly to individual muscle fibre hypertrophy (Amthor et al., 2007). Moreover, it has been 
established that Myostatin plays a fundamental role in regulating of muscle mass and size, 
since its inactivation induces a marked increase of muscle fibre cross-sectional areas  
(Rodriguez et al., 2014). Here we investigated whether metabolic reprograming imparted by 
Errγ introducing into Mtn-/- mice affected the increase of myofibres size promoted by 
Myostatin ablation. Therefore, muscle sections were immunostained using antibodies 
against MHC isoforms (type I, IIA and IIB). Then measurement of cross-sectional area (CSA) 
for myofibres (type I, IIA, IIX and IIB) of hind limb muscles (EDL, soleus and TA) from three 
cohorts of mice (WT, Mtn-/- and Mtn-/-/ErrγTg/+) was performed. A minimum of 150-200 
measurements per myofibre type were taken in each muscle section (n=5) (Figure 3.10A-C). 
We found that the fibre sizes were equivalent in the EDL muscles of Mtn-/- and Mtn-/-
/ErrγTg/+ mice (Table 3.3). Of particular note was that the MHCIIA in EDL muscles of Mtn-/- 
mice displayed a significant increase in fibre size compared to controls. MHCIIA of the EDL 
muscles of Mtn-/-/ErrγTg/+ mice were smaller than Mtn-/-, but they were still larger than those 
in the WT mice. Consistently, CSA of MHCIIX and MHCIIB of EDL muscles from both Mtn-/- 
and Mtn-/-/ErrγTg/+ mice were significantly larger than the corresponding fibres in the EDL 
muscles of WT mice. Interestingly, there was no significant difference in the fibre sizes of 
MHCIIX and MHCIIB in the EDL muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice (Figure 3.11 A). 
Next we examined myofibre sizes in the soleus muscles. We found that there was no 
significant difference in CSA of myofibres type I (which were measured only in soleus muscle 
sections as there was insufficient numbers in other muscles (EDL and TA)) in the soleus 
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Further, fibre size of MHCIIX in the soleus muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice was 
greater than those fibres in the soleus muscles from wild type animals. Of particular 
observations, fibre size of MHCIIB from Mtn-/-/ErrγTg/+ mice was significantly smaller than 
this isoform of fibres in the soleus muscles of Mtn-/- mice (Table 3.3 and Figure 3.11 B)  
Finally, myofibres sizes in the TA muscles (deep and superficial regions) from WT, Mtn-/- and 
Mtn-/-/ErrγTg/+ mice were measured. We found that the size of MHCIIA in the deep region of 
TA muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice was significantly larger than those of WT 
mice. Importantly, the fibre sizes of MHCIIA in this region of TA muscles from Mtn-/- and 
Mtn-/-/ErrγTgl+ showed no significant difference. On the other hand, MHCIIA were completely 
absent in superficial regions of TA muscles from WT and Mtn-/- mice. Along the same lines, 
we found that the CSA of MHCIIX in the deep region of TA muscles from Mtn-/- were slightly 
larger than these myofibres in the same region of TA muscles from WT mice, with a 
significant increase in CSA of MHCIIX in the deep region of TA muscles from Mtn-/-/ErrγTgl+ 
compared to other two cohorts. Superficial area of TA muscle sections from Myostatin null 
mice displayed a significant increase in CSA of myofibres type IIX. Remarkably, this increase 
of MHCIIX size was preserved in the same region of TA muscles from Mtn-/-/ErrγTgl+ mice. 
Moreover, our data highlighted that glycolytic type IIB myofibres in both deep and 
superficial regions of TA muscles are most prone to undergo hypertrophy following 
Myostatin deletion. Most importantly, fibre sizes of MHCIIB in the deep and superficial 
regions of TA muscles from both Mtn-/-and Mtn-/-/ErrγTgl+ were significantly larger than the 
size of MHCIIB in both regions of TA muscles from WT mice (Table 3.3 and Figure 3.11 C-D).  
Altogether, these data show that germline deletion of Myostatin induces muscle fibres 
hypertrophy. Importantly muscle-specific overexpression of Errγ into Mtn-/- mice had no 





































































Genotype WT Mtn Mtn:Eγ 
Muscle I IIA IIX IIB I IIA IIX IIB I IIA IIX IIB 
EDL n/a 553.72 883.821 1345208 n/a 802.325 153519 3634249 n/a 714.571 161187 367891 
Soleus  230046 164024 212769 n/a 269456 182027 284258 507373 273856 206924 290948 381670 
Deep TA n/a 108720 120216 305042 n/a 133475 127423 362247 n/a 124629 151631 377457 
Sup. TA n/a n/a 118426 283440 n/a n/a 151151 368137 n/a 111573 150952 400661 
Table 3.3. Cross sectional area for type I, IIA, IIX and IIB myofibres of (EDL, soleus, and TA) 
muscles from WT, Mtn and Mtn:Eγ mice. Size in (µm
2
) with SEM of 5 muscle sections 




Muscle-specific expression of Errγ maintains muscle fibres hypertrophy exhibited by 
Myostatin null muscles.  
(A) Immunohistochemical images of EDL muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCIIB appearing as red. Non green and red 
fibres represent MHCIIX.   
(B) Immunohistochemical images of soleus muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCI appearing as red.   
(C) Immunohistochemical images of TA muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCIIB appearing as red. Non green and red 
fibres represent MHCIIX.     
(n = 5) male twelve-week old mice per group. 
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Figure 3.11. Myofibres of hind limb muscles from Mtn and Mtn:Eγ mice show larger CSA 
than their counterpart myofibres from WT mice   
Myostatin deletion induces muscle fibre size, and Errγ overexpression preserved the 
increase.  
(A) Graph showing measurements of the cross sectional area (CSA, µm2) of MHCIIA, IIX and 
IIB in EDL muscles from WT, Mtn and Mtn:Eγ mice. 
(B) Graph showing measurements of the cross sectional area (CSA, µm2) of MHCI, IIA and 
IIX in soleus muscles from WT, Mtn and Mtn:Eγ mice. 
(C-D) Graphs showing measurements of the cross sectional area (CSA, µm2) of MHCIIA, IIX 
and IIB in Deep and Superficial regions for TA muscles WT, Mtn and Mtn:Eγ mice. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, **=P<0.01 and ***= P<0.001.  
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3.10. Mechanisms underpinning muscle enlargement following Myostatin deletion and 
Errγ overexpression 
In addition to induce exercise capacity and muscle force generation, we showed that Errγ 
introducing into Mtn-/- mice maintained the increase in muscle fibre numbers and sizes 
exhibited by Myostatin deletion. We believe it is necessary to develop the understanding of 
mechanisms underpinning muscle fibres enlargement. Previous work has established that 
skeletal muscle mass is the result of a dynamic balance between two crucial processes, 
protein synthesis, that regulated by AKT/mTOR pathway, and protein degradation, that 
controlled by AKT/FoxO pathway (Sandri, 2008, Glass, 2005). Further investigation has 
revealed a central role of Myostatin in regulating of muscle protein synthesis and 
degradation, indicating by a cross talk between Myostatin and AKT/mTOR signalling 
pathway (Elliott et al., 2012). Here we examined the consequences of Myostatin deletion on 
the key molecules that control protein synthesis and degradation processes. Then, we 
determined whether a muscle-specific manner overexpression of Errγ into Mtn-/- muscles 
would affect expression of these molecules. We found that levels of phosphorylated AKT 
that induce muscle anabolism was significantly higher in muscles from Mtn-/- and Mtn-/-
/ErrγTg/+ mice compared to WT. Interestingly, there was no significant difference in pAKT 
level between muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice (Figure 3.12).  
Next we examined the level of pAKT downstream target (4EBP1) in all cohorts. The same 
relationship of pAKT was discovered in muscle samples of the three genotypic groups. AKT 
not only promotes protein synthesis but also suppresses catabolism partly by 
phosphorylating and thereby inactivating FoxO3. Thus, we next examined expression of 
FoxO, we found that that deletion of Myostatin resulted in an increased ratio of the 
inactive:active (phosphorylated:non-phosphorylated) form of FoxO3. However, in muscles 
of Mtn-/-/ErrγTg/+ mice the levels of inactive FoxO3 was significantly lower than in that of the 
Mtn-/- mice, with no difference in FoxO3 level in muscles from Mtn-/-/ErrγTg/+ and WT mice 
(Figure 3.12). Collectively, these observations suggest that Myostatin could be a key 
regulator molecule that control muscle protein metabolism (synthesis and breaking down) 
that support myofibre enlargement in absence of Myostatin. Importantly, overexpression of 
Errγ into Mtn-/- muscle has not affected this feature.   
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Figure 3.12. Muscle-specific expression of Errγ maintains the hypertrophy in the 
Myostatin null background muscles 
Protein expression of key regulators that control anabolism (pAKT, p4EBP1) and catabolism 
(pFoxO3) in the gastrocnemius muscle.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05 and ***= P<0.001.  
This work has been done by Roberta Sartori, University of Padua, Italy.   
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3.11. MHC profiling in hind limb muscles of Mtn-/- mice reforms by Errγ overexpression 
We showed that overexpression of Errγ into a muscle lacking Myostatin is efficacious to 
improve muscle force generation and general physiological functions, while maintained the 
increase of muscle fibre number and size induced by Myostatin ablation. We speculate that 
it is necessary to identify whether the metabolic re-programing driven by Errγ 
overexpression into Mtn-/- mice would impact muscle fibres profiling. Previous work has 
established the striking feature of skeletal muscle fibres plasticity and ability to undergo 
conversion between different fibre types in response to intrinsic and extrinsic factors. 
Moreover, the transitions between muscle fibre types have primarily limited within the fast 
myosin isoforms (shift from MHCIIA to MHCIIB and from MHCIIB to MHCIIA), as a response 
to environmental and physiological stimuli (Pette and Staron, 2001). Further work using 
animal models has concluded that Myostatin deletion induced fibre types conversion from 
the slow (type I and IIA) into fast (type IIX and IIB) phenotypes (Girgenrath et al., 2005). On 
the other hand, Matsakas and his group have referred to an increase in the proportions of 
myosin heavy chain type IIA and IIX, and a decrease of glycolytic myofibre type IIB following 
Errγ overexpression into WT background mice (Matsakas et al., 2012a). However, the 
potential of muscle-specific overexpression of Errγ into Mtn-/- mice for myofibres re-
patterning remain to be elucidated. Here we examined MHC profiling of hind limb muscles 
(EDL, soleus and TA) (n=5) from three cohorts of mice (WT, Mtn-/- and Mtn-/-/ErrγTg/+), that 
were immunostained using antibodies against MHC isoforms (type I, IIA and IIB) (Figure 
3.13).  
Our observations revealed that each muscle displayed varied levels of transition between 
myofibre types following Myostatin deletion and Errγ introducing into Mtn-/- mice. Muscles 
isolated from Mtn-/- mice exhibited an increase expression of fast fibres and a concomitant 
decrease of slow fibres. In contrast, muscles of Errγ overexpression mice showed an 
increase of slow fibres in expense of fast phenotypes within the MHCII subtypes, but did not 
extend to normalize the proportion of MHCI fibres in the soleus muscles.  
Of particular note, we found that EDL muscles form Mtn-/- mice showed a high percentage 
of MHCIIB (70.8%) compared to counterpart muscle from WT mice (64.2%). Errγ introducing 
into Mtn-/- resulted in a significant decrease of fast (IIB) myofibres percentage (61.6%) 
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compared to Mtn-/- muscles with no significant different compared to WT mice (Figures 
3.13A and 3.14A).  
Next we examined MHC proportions in soleus muscles that made up mainly of MHCI (31.4%) 
and MHCIIA (63.3%) and devoid of MHCIIB myofibres in wild type animals. Contrary, in Mtn-
/- muscles, we found that MHCIIB was (17%), and type MHCIIX myofibres increased 
significantly (18.7%) compared to soleus muscles of wild type mice (5.2%). The proportion of 
MHCIIB fibres of soleus muscles from Mtn-/-/ErrγTg/+ was lower than that in Mtn-/-, while that 
of MHCIIA fibre was higher. Nevertheless, both Mtn-/- and Mtn-/-/ErrγTg/+displayed a lower 
proportion of MHCI fibres in the soleus muscle than WT (Figures 3.12B and 3.13B). 
Then we determined the MHC profiling of TA muscles (n=5) from the three genotypic 
groups. We showed that TA muscles from Mtn-/- mice displayed high percentages of MHCIIB 
(62.9% and 91.7%) compared to WT (36.2% and 72.1) in deep and superficial regions 
respectively. Interestingly, Errγ overexpression into Myostatin null muscles resulted in a 
significant decrease of MHCIIB compared to Mtn-/- mice (38.1% and 77.3%) in deep and 
superficial regions respectively (Figures 3.13C-D and 3.14C-D).  
Together these data show that Myostatin deletion resulted in a significant increase of fast 
muscle fibres compared to WT. However, Introduction of Errγ into Mtn-/- mice was 
efficacious to drive a partial reversal of MHC profile of Mtn-/- towards the WT condition in all 
muscles examined, without rescue deficit of type I myofibre. Such data with above 
observations, raise possibility to challenge the trade-off that is thought to exist between 
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Figure 3.13. Myosin heavy chain profiling of hind limb muscles affects by Myostatin 
ablation and Errγ overexpression into Mtn
-/-
 mice.  
Muscle-specific expression of Errγ in Myostatin null mice induced muscle fibres conversion 
toward WT conditions.    
(A) Immunohistochemical images of EDL muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCIIB appearing as red. Non green and red 
fibres represent MHCIIX.   
(B) Immunohistochemical images of soleus muscles from WT, Mtn and Mtn:Eγ mice. Green 
fibres signify the expression of MHCIIA with MHCI appearing as red. Non green and red 
fibres represent MHCIIX. 
(C-D) Immunohistochemical images of (deep and superficial regions) of TA muscles from 
WT, Mtn and Mtn:Eγ mice. Green fibres match MHCIIA with MHCIIB appearing as red. 
None green and red fibres represent MHCIIX. 
























































































































































Figure 3.14. Muscle-specific expression of Errγ into Myostatin null mice normalizes 
myosin type II phenotype  
Errγ overexpression is sufficient to derive a partial reversal transition of MHC profiling in a 
muscle lacking Myostatin.  
(A) Graph showing fibre type composition in EDL muscles from WT, Mtn and Mtn:Eγ mice 
(B) Graph showing MHC profiling in soleus muscles from the same animals above.  
(C-D) Graphs showing fibre composition in deep and superficial regions of TA muscles from 
same three genotypes.   
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05 and ***= P<0.001.  
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3.12. Errγ introducing into Myostatin null muscles alters MHC profiling at transcriptional 
level 
To further solidify of our results, we examined the expression of MHCs at transcriptional 
level. Gastrocnemius muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice were 
homogenised and total RNA was reverse-transcribed to cDNA and analyzed using 
quantitative real-time RT-PCR. We found that the expression of MHCIIA in Mtn-/- muscles 
was lower than the other two genotypic groups, with that of Mtn-/-/ErrγTg/+ higher than that 
of Mtn-/-, but not normalized to WT level (Figure 3.15A).  The expression level of MHCIIX was 
the lowest in muscles from Mtn-/- mice compared to other two cohorts, however, in muscles 
from Mtn-/-/ErrγTg/+ mice the level of MHCIIX was not only higher than in Mtn-/- but also 
more than the WT condition (Figure 3.15B). Finally, we found that the expression level of 
MHCIIB was the lowest in muscles from Mtn-/-/ErrγTg/+ mice, with no difference of this MHC 
isoform level in muscles from Mtn-/- and WT mice (Figure 3.15C). 
These data adds to grow body of evidences that muscle-specific manner overexpression of 
Errγ into Mtn-/- muscles is sufficient to induce a reverse transition of muscle fibres from fast 
to slow phenotypes within MHCII subsets.  
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Figure 3.15. Gene expression levels of MHCs in hind limb muscles from WT, Mtn and 
Mtn:Eγ mice 
Errγ overexpression in a muscle lacking Myostatin promotes fibre types transition toward 
normal condition indicating by gene expression levels of MHCs.  
(A) Expression level of MHCIIA gene in gastrocnemius muscles from WT, Mtn and Mtn:Eγ 
mice. 
(B) Robust expression of MHCIIX gene in muscles from Mtn:Eγ mice. 
(C) Lower expression level of MHCIIB gene in muscles from Mtn:Eγ mice. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, **=P<0.01 and ***= P<0.001.  
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3.13. Errγ overexpression normalizes ultra-structural abnormalities of Mtn-/- muscles 
We showed that absence of Myostatin resulted in suppressing of FoxO3 expression, 
however, Errγ introducing in Mtn-/- normalised its level to control condition. It was well 
established that the maintenance of muscle structure is largely mediated by mechanisms 
that remove unwanted proteins and organelles through either the proteasome or 
autophagic pathways (Sandri, 2013). Previous study has reported a marked reduction of 
mitochondrial numbers in myofibres from a muscle lacking Myostatin (Amthor et al., 2007). 
In contrast, electron microscopy study by Rangwala;s group (Rangwala et al., 2010) has 
revealed an increase in mitochondrial numbers in muscle fibres of Errγ transgenic on wild 
type background mice compared to the controls. However, to what extent that muscle-
specific manner overexpression of Errγ into Mtn-/- mice would mitigate the reduction of 
mitochondrial density and ultrastructural abnormalities following Myostatin absence, was 
not been explored. Therefore, the ultra-structure of forelimb muscles in the three cohorts 
were examined. Using transmission electron microscopy, we found a number of 
abnormalities in the structure of muscle from Mtn-/- mice, heterogeneously sized 
sarcomeres, misaligned and disrupted Z-Lines, large inter-sarcomeric spaces and altered 
mitochondrial distribution and size. Contrary, the muscle from Mtn-/-/ErrγTg/+ largely lacked 
these abnormalities (Figure 3.16A). 
Thereafter, we examined the numbers of mitochondria in sub-membrane and intrafusal 
regions in muscles from all genotypic groups. We found that the density of mitochondria in 
both sub-membrane and intrafusal locations was decreased significantly following the 
deletion of Myostatin. Interestingly, the expression of Errγ significantly increased the 
mitochondrial density at both locations compared to Mtn-/- and at the major site, the sub-
membrane region, increased it even compared to WT (Figure 3.16B-C).  
Mitochondrial hypertrophy has been postulated to compensate for decreased mitochondrial 
number or function. Hypertrophy is thought to either protect against apoptosis or for 
functional mitochondria to fuse with aberrant ones resulting in the maintenance of cell 
function (Frank et al., 2001, Ono et al., 2001).  
Mitochondrial hypertrophy was evident in both compartments in muscle from Mtn-/- (Figure 
3.16D–E) and was normalized by Errγ in the sub-membrane region (Figure 3.16D).  
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Taken together, these results show that the deletion of Myostatin leads to numerous ultra-





































Figure 3.16. Transmission Electron Microscopy (TEM) investigation of mitochondrial 
numbers, size and distribution in muscles from Mtn and Mtn:Eγ mice 
Muscle-specific expression of Errγ normalizes ultra-structural abnormalities of Myostatin 
null mice.  
(A) Transmission electron microscopy images in longitudinal and transverse sections of WT, 
Mtn and Mtn:Eγ muscle, scale 0.5 mm. Note the large spaces (red arrow) disrupted Z-lines 
(red arrowhead) and non-uniform sarcomere width (yellow arrows).  
(B) Quantification of sub-membrane mitochondrial density.  
(C) Quantification of Intrafusal mitochondrial density.  
(D) Quantification of sub-membrane mitochondrial size.  
(E) Quantification of intrafusal mitochondrial size. 
(n = 3) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=p<0.05 and**= P<0.01.  
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3.14. Discussion  
Classical training experiment has established that skeletal muscles have limited capacity to 
get a commensurate improvement of their mass (hypertrophy) and fatigue resistance 
(Hickson, 1980). Further study has illustrated that skeletal muscle is a highly compliant 
tissue that undergoes both quantitative as well as qualitative changes in response to 
intrinsic and extrinsic stimuli (Matsakas and Patel, 2009b). In consistence, previous work has 
referred to the plasticity nature of skeletal muscle that capable to alter almost all its 
features at metabolic, ultrastructure and molecular levels in response to environmental 
stimuli or gene mutation (Pette and Staron, 2001). A profound example is the phenotype of 
Myostatin mutation in mice. Myostatin is a member of the TGF-β family of secreted protein 
that been defined as a potent inhibitor of muscle development oxidative metabolism, and 
mutation of its gene leads to hypertrophic fast contracting fibres (McPherron and Lee, 1997, 
Amthor et al., 2007). Despite the enlarged muscle mass following Myostatin absence, their 
ability to generate tension is impaired, particularly during long periods of work (Mendias et 
al., 2006). The higher than normal fatigability of the muscle could be attributable to the 
lower number of mitochondria consequent to deletion of Myostatin in the germline 
(Amthor et al., 2007). Alternative efficacious molecule that induces oxidative slow-twitch 
muscle fibre in parallel to promote a network of genes linked to muscle energy, metabolism 
and vasculature pathways is estrogen-related receptor gamma (Errγ) (Narkar et al., 2011, 
Alaynick et al., 2007). Structural studies have established that Errγ is constitutive active in 
the absence of added ligand (Greschik et al., 2002). Since Errγ might potentially contribute in 
regulation of mitochondrial biogenesis and genes encoding pathways for contractile proteins 
for slow muscles (Dufour et al., 2007, Rangwala et al., 2010) we asked whether selective 
induction of Errγ into Mtn-/- muscles via transgenic approach using specific promoter (HSA), 
would affect morphological, physiological and histological features of Myostatin null 
muscles.  
The investigations of Errγ expression, body and muscle mass, physiological features and 
force generation capacity, muscle fibre number and size, mechanism underpinning muscle 
fibres enlargement, myosin heavy chain (MHC) profiling, and mitochondrial content and 
distribution undertaken in the work unveil a number of interesting features regarding 
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genetic deletion of Myostatin and muscle-specific expression of Errγ into a muscle lacking 
Myostatin.   
Firstly, we showed that the human α-skeletal actin promoter (HSA) used in this experiment 
induced a robust over-expression of Errγ in the Mtn-/- background muscles. Secondly, we 
demonstrated that the body mass of all genotypic groups was similar. However, all muscles 
examined from both Mtn-/- and Mtn-/-/ErrγTg/+ were markedly larger than their WT 
counterpart. Importantly, there was no significant difference in mass for any of the muscles 
from Mtn-/- and Mtn-/-/ErrγTg/+ mice. Examining muscle physiological features of animals of 
this study highlighted that the exercise capacity was reduced significantly in Mtn-/- 
compared to WT mice, however, Mtn-/-/ErrγTg/+ mice were running longer than the Mtn-/- 
and even longer than WT mice. Furthermore, the tetanic force generated by Mtn-/-/ErrγTg/+ 
EDL muscles was greater than the other two genotypic groups. Subsequently, specific force 
(sPo) of EDL muscles from Mtn
-/- was lower than the other cohorts, with that of Mtn-/-
/ErrγTg/+ mice being greater than Mtn-/-, but not normalised to WT level. Moreover, we 
showed that muscle-specific expression of Errγ into Mtn-/- was sufficient to attenuate the 
reduction in muscle strength of Mtn-/- mice. Additionally, we found that the Mtn-/-/ErrγTg/+ 
displayed better behavioural and locomotor characteristics than Mtn-/- mice.  
We also provided evidence that the increase of muscle mass followed Mtn-/- resulted from 
both hyperplasia and hypertrophy. Interestingly, the introduction of Errγ into Mtn-/- muscles 
did not significantly change the number and the size of Mtn-/- myofibres. Our work 
examining level of protein molecules offered interesting insights regarding mechanism 
underpinning muscle fibres hypertrophy. We showed that both Mtn-/- and Mtn-/-/ErrγTg/+ 
muscles expressed high level of protein synthesis that induce muscle mass, importantly 
muscle-specific expression of Errγ in the Mtn-/- normalised the level of molecules that induce 
muscle catabolic and maintain the tissue homeostasis. An important finding in present study 
was that the introduction of Errγ into Mtn-/- caused a partial reversal transition of MHC 
profile of Mtn-/- toward WT condition within MHCII subtypes, without induce the transition 
to MHC type I isoform. Finally, an interesting features highlighted by examining muscle 
ultra-structure using TEM in this section was that muscles from Mtn-/- mice displayed 
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number of abnormalities in sarcomeres and mitochondria. In contrast, the muscles from 
Mtn-/-/ErrγTg/+ mice largely lacked almost all these abnormalities.  
We commenced the study by examining the efficiency of HSA promoter to drive Errγ 
overexpression. We found that muscle-specific expression of Errγ using HSA onto Mtn-/- 
background muscles induced Errγ expression significantly. A number of investigators have 
revealed a critical role of Errγ in regulating a network of genes linked to fatty acid oxidation 
and mitochondrial biogenesis (Alaynick et al., 2007, Dufour et al., 2007). Further study has 
described Errγ as a key regulator of nuclear-encoded mitochondrial genes that maintain the 
oxidative metabolic genes (Dufour et al., 2007). On the same line of thought, it has been 
demonstrated that muscle fibre type I maintain high oxidative and vasculature capacity in 
the absence of exercise (Cherwek et al., 2000). Subsequently, it has been shown that Errγ is 
exclusively and abundantly expressed in oxidative type I myofibre of skeletal muscles 
(Narkar et al., 2011), which might indicate the Errγ potential role in regulating the intrinsic 
angiogenic pathway in oxidative slow-twitch muscles. Based on aforementioned reports, 
transgenic overexpression of Errγ in skeletal muscles using specific promoters has been 
widely applied to enhance muscle mitochondrial biogenesis and functions, oxidative 
capacity and restoration of blood perfusion in muscular tissue disorders (Rangwala et al., 
2010, Narkar et al., 2011). Notably, numerous studies have revealed that the transgenic Errγ 
overexpression onto WT background induces aerobic transformation, mitochondrial 
biogenesis and robust myofibrillar vascularization, all in the absence of exercise (Matsakas 
et al., 2012b, Narkar et al., 2011). On the other hand, it has been established that the 
sarcomeric α-skeletal actin is synthesized in large amount during differentiation process of 
muscle tissue, and expressed in adult human skeletal muscle (Bains et al., 1984, Nir et al., 
1986). Further, it was firmly demonstrated that the ability of the HSA regulatory domains to 
positively modulate expression in different cell lines is variable. This mutability suggest that 
the particular combination of domains used is dependent on the availability of trans-acting 
transcription-modulating factors present in each cell type (Miwa and Kedes, 1987). It seems 
that the tissue-specific transcription of the HSA gene promoter construct resulted from the 
interaction between the promoter domains and trans-acting positive-regulatory factors in 
skeletal muscle cells, or with negative regulatory factors in nonmuscle cells (Muscat and 
Kedes, 1987).  
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Despite such combination of Errγ potential roles to enhance muscle oxidative and 
vasculature capacity, and tissue-specific expression criteria of the HSA promoter, it remains 
important to be determined to what extent this mechanism is operative in animal models 
with metabolic disorders.  
In addition, it is not known whether this approach can provide a therapeutic benefit for the 
patients with muscle wasting, a question that we are going to address at different muscle 
aspects. 
In this study, we showed that body mass of all genotypic groups (WT, Mtn-/- and Mtn-/-
/ErrγTg/+) was similar. Previous work has revealed a critical role of Myostatin to enhance 
muscle fibroblast proliferation, thus induces connective tissue deposition in extracellular 
matrix (Li et al., 2008). In support of this view, it has been reported that Myostatin deletion 
resulted in a significant reduction of muscle connective tissue content compared to control 
(Elashry et al., 2012). In the same line of investigation, it has been established that one of 
the intriguing aspects of the Mtn-/- phenotype is the concurrence of a large muscle mass, 
decreased fat deposition and increased resistance to obesity (Lebrasseur, 2012).  
Indeed, number of investigators have illustrated that Myostatin involved in adipogenesis by 
inhibiting brown adipocytes differentiation through the activin receptors IIB (ActRIIB)-
Smad3 pathway (Feldman et al., 2006, Kim et al., 2012b). Further study has shown that 
Myostatin inhibition promotes brown adipose phenotype in mice (Zhang et al., 2012). 
Consistently, it was well established that Myostatin deletion leads to an elevation in 
expression levels of brown adipose tissue BAT signature markers (UcP1 (Uncoupling protein 
1) and PGC-1α (PPARgamma-coactivator 1α) (Kim et al., 2012b). In addition, the newly 
identified myokine Irisin that encode by the gene Fndc5 (Fibronectin type III domain-
containing protein 5), that regulated by PGC-1α, secreted from muscles into blood and 
activates thermogenic in adipose tissue (Bostrom et al., 2012). Notably, it has been 
demonstrated that Mtn-/- increased the expression of Irisin and AMP-activated protein 
kinase in skeletal muscles (Shan et al., 2013). On the same line of thought, AMPK which is 
essential for exercise-mediated to aerobic myofibres, it is activated by Errγ in skeletal 
muscle (Jensen et al., 2007). By a way of explanation, mutation of Myostatin drives 
browning of white adipose tissue WAT in an indirect way by activating (AMPK-PGC1α-Fndc5) 
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pathway in muscles, leads to increase production of a myokine Irisin hence enhances 
adipose tissue thermogenic and reduces fat mass. 
Although the three cohorts of mice in present study showed similar body weights, muscle 
mass of all examined muscles were remarkably larger in Mtn-/- and Mtn-/-/ErrγTg/+ than their 
counterparts from WT mice, with no significant difference in mass for any of the muscles 
from Mtn-/- and Mtn-/-/ErrγTg/+ mice. A number of studies have shown that deletion of 
Myostatin leads to the development of large muscle mass as a result of both hyperplasia 
and hypertrophy, however the increased muscle mass was not accompanied with 
proportional increase of muscle force generation and specific tetanic tension, particularly 
during prolonged periods of work (Amthor et al., 2007, Mendias et al., 2006, Relizani et al., 
2014). To investigate this further, we examined mitochondria density, size and distribution 
in muscles from the three genotypic groups of this study. Our findings with aforementioned 
reports on correlation between muscle mass and force generation capacity strengthen the 
notion that the higher than normal fatigability of Mtn-/- (Figure 3.5) could be attributable to 
the lower number of mitochondria as a result of germline deletion of Myostatin (Amthor et 
al., 2007) (Figure 3.16, the TEM work has been done by Oliver Kretz, University of Freiburg, 
Germany). 
To alleviate this mitochondrial deficit in muscle from Mtn-/- mice, we introduced the 
expression of Errγ into skeletal muscle. Numerous studies have reported that this gene is 
highly expressed in tissues with a high oxidative capacity, such as the heart, kidneys, brain 
and slow oxidative skeletal muscle where it has been demonstrated to trigger mitochondrial 
biogenesis (Hong et al., 1996, Heard et al., 2000, Giguere, 2008, Narkar et al., 2011). We 
hypothesised that muscle-specific overexpression of Errγ that would promote mitochondrial 
density, thereby increase muscle oxidative capacity on a Mtn-/- background that is 
associated with hypertrophy would challenge the exist trade-off between aerobic 
metabolism and muscle fibre size (Van der Laarse WJ, 1998, Degens, 2012).  
One of the main features of Myostatin deletion or loss of its function is the dramatic 
increase of muscle mass in phenomenon called muscle doubling (Kambadur et al., 1997, 
McPherron and Lee, 1997, Hulmi et al., 2013a). In agreement with aforementioned reports, 
we showed that the increase in muscle mass resulted from an increase in muscle fibre 
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number and size (Elashry et al., 2009, McPherron et al., 2009, McPherron et al., 1997, 
Amthor et al., 2007). Therefor a better understanding of mechanisms that drive skeletal 
muscle overgrowth upon Myostatin absence is required.   
Myostatin signalling modulates the expression of target genes that involved in the control of 
myoblast proliferation and terminal differentiation (Thomas et al., 2000, Taylor et al., 2001). 
Further, in vitro study has shown that the proliferation and differentiation rates of satellite 
cells from Mtn-/- mice much faster than those of WT (Magee et al., 2006). Previously it has 
been documented that Myostatin anti-proliferative action is associated by up-regulating of 
p21 (Cyclin-dependent kinase inhibitor) and a Cdk inhibitor, decreases the cyclin-dependent 
kinases (CDK2 and CDK4) and phosphorylation of retinoblastoma protein (RB), thereby 
satellite cells quiescence and interfere with the cell cycle progression from G1 to S-phase 
(Taylor et al., 2001, McCroskery et al., 2003). Consistently, number of investigators have 
reported that Myostatin regulates myoblast differentiation through inhibition of myogenic 
regulating factors (Rios et al., 2002, Amthor et al., 2002). In the line with these 
investigations, previous work has demonstrated that the embryonic program of the primary 
and secondary myogenesis was accelerated by Myostatin ablation, which offers 
developmental origin of the hyper-muscular phenotype (Matsakas et al., 2010). Moreover, It 
was well established that post-natal Myostatin inhibition caused an increase in muscle fibres 
size but no enhance myofibre numbers (Matsakas et al., 2009).  
We suggest that the hyperplasia following genetic deletion of Myostatin imply excess 
proliferation of muscle progenitors during early stage of muscle development. In support of 
this view, previous work has reported that Myostatin limits proliferation rate of myogenesis 
cell through prioritizing their entry into terminal differentiation (Manceau et al., 2008). In 
the same line of thought, it has been illustrated that Errγ implicated in regulating of 
myogenesis process reflects by highly up-regulation of its expression during muscle 
differentiation (Murray et al., 2013). By a way of explanation, Myostatin knockout enhances 
the proliferation pace of the muscle precursors, and Errγ overexpression was sufficient to 
regulate differentiation process. Therefore, the muscles of Mtn-/- and Mtn-/-/ErrγTg/+ animals 
reach the peak and maturation comparatively faster than the wild type muscles.  
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Despite a notable part of muscle mass increase resulted from muscle fibres hyperplasia, 
myofibres cross-sectional area also appeared to contribute significantly to the overall 
increase of muscle mass (McPherron et al., 1997, Amthor et al., 2007). It was well 
documented that the balance between muscle protein synthesis and degradation processes 
is a critical factor in regulating of muscle mass (Sandri, 2008, Ruegg and Glass, 2011).  
Several signalling pathways are known for their role in regulating of muscle fibre size 
through control the rate of muscle protein turnover. A number of studies have defined the 
role of specific signalling pathway, the insulin like growth factor 1- Phosphoinositide 3-
kinase-Akt (IGF1/PI3K/Akt) pathway in muscle mass regulation (Glass, 2005, Sandri, 2008).  
In contrast, FoxO transcriptional factor has been described as a key mediator of muscle 
atrophy that coordinate the activation of two most important cellular proteolytic 
mechanisms, the autophagy-lysosome and ubiquitin proteasome systems (Sandri et al., 
2004, Stitt et al., 2004). Moreover, Myostatin has merged as a key regulator of skeletal 
muscle mass, since its deletion or inhibition induces muscle overgrowth, whereas its 
overexpression causes muscle atrophy (McPherron et al., 1997, Rodriguez et al., 2014).  
Previous studies have established that muscle protein synthesis and muscle mass are 
promoted by (IGF1/PI3K/Akt/mTOR) pathway, as the expression of constitutively active Akt 
robustly enhances muscle hypertrophy (Rommel et al., 2001, Bodine et al., 2001). Further 
studies have shown that Akt mainly acts via mTOR activation, that promote muscle protein 
synthesis by phosphorylating and inhibiting of 4E-binding protein 1 (4E-BP1) and activation 
of the ribosomal protein S6 kinase (S6K) (Wullschleger et al., 2006, Tee and Blenis, 2005). 
Another important role of Akt is compromising the negative regulation of protein 
degradation via inhibiting FoxO3 mediating proteasome activity (Stitt et al., 2004). Others 
have shown that the suppressing of FoxO3 by Akt leads to prevent the expression of two 
critical atrophy-related ubiquitin ligases, MAFbx/Atrogin-1 and MuRF-1 (Sandri et al., 2004, 
Stitt et al., 2004). 
In present study, as the proteasome and autophagy pathways are involved in muscle 
atrophy, it seems intuitive that they should be tuned down in order to support muscle 
growth, as we showed that muscle fibres from Mtn-/- and Mtn-/-/ErrγTg/+ displayed a 
significant increase in their size compared to the control. Indeed, we found that the activity 
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of a key regulator of these processes, FoxO3 is suppressed in the absence of Mtn. However, 
we showed that Errγ expression in muscle leads to a substantial restoration of its level to 
normal condition (Figure 3.12, this work has been done by Roberta Sartori, University of 
Padua, Italy). Giving our explanation, several studies have referred to a cross-talk between 
Myostatin and Akt/mTOR pathway, since Myostatin absence leads to upregulation of 
PI3K/Akt/mTOR pathway in mouse and cattle (Chelh et al., 2011). Consistently, other studies 
have reported a clear elevation in activity of Akt/mTOR signalling components in skeletal 
muscle from Mtn-/- mice (Morissette et al., 2009, Lipina et al., 2010). We suggest that 
Myostatin deletion leads to activate PI3K/Akt/mTOR pathway that support protein synthesis, 
while FoxO3 was blocked, leading to decrease the expression levels of Atrogin-1 and MuRF 
genes, increase protein synthesis, decrease protein degradation rates, increase myofibres 
size hence promote muscle mass. On the same line of thought, it was revealed an important 
role of Errγ in supporting protein synthesis; thereby prevent muscle atrophy. Previous work 
has referred to a marked elevation in the expression level of Atrogin-1 in muscle cells from 
Errγ-/- mice (Brunet et al., 1999). It seems that the increase in muscle fibre cross-sectional 
area exhibited by Mtn-/- was maintained by introducing of Errγ, since the latter regulate 
protein synthesis and prevent muscle atrophy.  
The increase in fibre number and size thereby muscle mass of Mtn-/- mice was associated 
with a larger proportion of type MHCIIB fibres than seen in muscles from WT mice. We also 
showed that even though the muscle mass and fibre size did not differ between Mtn-/- and 
Mtn-/-/ ErrγTg/+ mice, the latter caused partial normalisation of the MHC fibre profile; a 
decrease in the proportion of IIB fibres in all muscles examined. What was conspicuous, 
however, was the absence of normalization of the proportion of MHC I fibres. Our data 
were in agreement with previous findings that revealed the increase of hind limb muscle 
mass following Myostatin deletion was accompanied by fibre type conversion, 
predominantly of MHCIIB with a marked reduction in proportions of MHC types IIA and IIX 
(Girgenrath et al., 2005, Amthor et al., 2007). On the contrary, study by Matsakas’ group 
(Matsakas et al., 2012b) has demonstrated that muscle-specific transgenic overexpression 
of Errγ into WT background muscles robustly induces proportions of IIA and IIX myofibres, 
simultaneously leads to reduce the number of MHCIIB. We also provided evidence of the 
absence normalization of the proportion of MHC I fibres. Such finding was supported by 
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previous work that revealed complete fibre type shift from MHCIIA to MHC I in muscles 
from Errγ transgenic mice did not occur (Matsakas et al., 2012b). We believe that this is 
significant and reveals a key feature of the influence of a metabolic programme on muscle 
physiology. We suggest that the oxidative programme, here driven by Errγ, readily converts 
IIB to IIA fibres but that it is unable to induce the transition to type I MHC isoforms. The 
reversal transition between MHCII subsets following Errγ overexpression without formation 
of type I fibres, adds to a growing body of evidence that the type II programme is plastic and 
adaptable, whereas the type I fibres are more resistant to change (Sutherland et al., 1998), 
and may not be part of the IIB  ↔  IIX  ↔  IIA continuum. Indeed a number of studies have 
questioned whether the ''final step'' (conversion of type IIA to I) is even possible. 
Development of type I fibres has been described in a number of conditions, for example 
following chronic low-frequency stimulation (CLFS) (Peuker et al., 1999, Kwong and Vrbova, 
1981). However, these studies never examined whether type I were formed as a 
consequence of the remodelling of type II fibres or through the formation of new fibres, a 
process that would require satellite cells. Indeed the development of type I fibres following 
extended CLFS can only be induced to significant levels when accompanied by robust 
myofibre regeneration (Pette and Staron, 2001, Maier et al., 1988).  
Taken together, these studies imply that Myostatin signalling acts at an embryonic/foetal 
stage of muscle development to pattern a subpopulation of satellite cells/muscle precursors 
in a muscle-specific manner to form type I fibres. The protocol of overexpressing Errγ used 
in this study is unable to influence this process. 
In this study, we investigated the functional characteristics of enlarged skeletal muscle from 
Mtn-/- and Mtn-/-/ Errγ Tg/+ mice. In accord with previous reports, our findings showed that 
the increased muscle mass following germline deletion of Myostatin (McPherron et al., 1997, 
Whittemore et al., 2003) was not accompanied by a proportional increase in force output 
(Amthor et al., 2007). We also provided evidence that the muscle hypertrophy which 
develops following Myostatin deletion has many ultrastructural abnormalities including 
splitting of sarcomeres, misaligned Z-lines and alteration in mitochondrial density, 
distribution and morphology. A number of studies have reported that the relationship 
between muscle fibre cross-sectional area and mitochondrial density implies that the 
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myofibres can hypertrophy in expense of its endurance capacity (Hickson, 1980, Des Tombe 
et al., 2002). However, the decline in maximum steady state power can be prevented by 
reducing the diffusion distance for oxygen to mitochondria by relocating the mitochondria 
to the sarcolemma (Deveci et al., 2001), and by increasing myoglobin and capillary density 
per muscle fibre (van Beek-Harmsen et al., 2004). Moreover, the maintenance of muscle 
structure is largely mediated by mechanisms that remove unwanted proteins and organelles 
through either the proteasome or autophagy pathways (Sandri, 2013, Bonaldo and Sandri, 
2013). Further investigators have demonstrated that deregulated proteasome activity or 
autophagy leads to muscle wasting in a number of disease conditions (Sandri et al., 2004). 
We have mentioned previously that the expression level of the key regulators (FoxO3) of 
both autophagy and proteasome pathways was suppressed in muscles from Mtn-/- mice to 
support the high level of protein synthesis required for initial muscle hypertrophy and 
maintenance of the large muscle mass. However, we showed that muscle-specific 
expression of Erry into the Mtn-/- muscle leads to elevate FoxO3 level, a substantial 
normalization of almost all the abnormalities in the ultrastructures of Mtn-/- muscles, as well 
as improvement in the exercise capacity, specific force generation, grip strength and animal 
activities. Most importantly, we showed that a physiological measure of muscle function- 
fatigability is not only normalized but exceeds the value of WT mice (Figures 3.5). We 
suggest that the molecular and organelle clearance programmes being mediated by FoxO3 
are generally not anabolic but are rather there to maintain cellular homeostasis. However, 
when its activity is attenuated in muscles from Mtn-/- mice, it leads to an accumulation of 
structural abnormalities that compromises muscle function.    
In summary, we can conclude that the complex physiological properties such as fatigue and 
running capacity can be genetically manipulated. Such alterations might attained by 
supporting protein synthesis rate thereby maintaining the increase of muscle mass followed 
germline deletion of Myostatin, and relocating the mitochondria particularly to the 
sarcolemma region. Interestingly, these adaptations were not associated with the loss of 
muscle force generating capacity and in fact even resulted in improved exercise capacity. 
Furthermore, findings of mitochondrial re-localization that might enhance muscle oxidative 
capacity, indeed raise the possibility of challenging the trade-off between muscle fibre size 
and aerobic metabolism (Van der Laarse WJ, 1998). Determine of Erry potential to activate 
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pathways that would promote muscle oxidative capacity in hypertrophic muscle fibres is 
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4.1. Introduction 
A central notion of skeletal muscle biology is the existence of an inverse relationship 
between the oxidative capacity of a fibre and its size, which might interpret why small fibres 
are oxidative and large fibres glycolytic (van Wessel et al., 2010, Degens, 2012). Small 
oxidative fibres are characterised by high mitochondrial content, high level of blood supply 
that supports a steady and prolonged supply of oxygen and nutrients, and hence are fatigue 
resistance (Annex et al., 1998, Cherwek et al., 2000). Conversely, large glycolytic fibres show 
low mitochondrial content, a reduced capillary density, and are fatigue sensitive (Annex et 
al., 1998, Narkar et al., 2011). Several studies have defined a relationship between muscle 
fibre size, force generation capacity and metabolism. Wherein fibre that relies on oxidative 
phosphorylation (OXPHOS) for ATP generation, tend to have a small size and high capillary 
density in order to facilitate O2 diffusion. These fibres have high fatigue threshold, however 
their small CSA means the individual muscle fibre generate low force level. On the contrary, 
fibres that rely on glycolysis show increased CSA and high force generation capacity, but 
their low fatigue resistance might attribute to the metabolic pathways that produce energy 
rapidly but lead to build up of lactate (Bottinelli et al., 1991, Jones et al., 2008, Krivickas et 
al., 2011). Skeletal muscle fibre ability to transform and remodel in response to various 
physiological and environmental demands has been established as a striking feature of this 
tissue (Matsakas and Patel, 2009b). In some cases the response of muscle fibre takes place 
when signal stimulates extracellular milieu then interact with cell surface receptors and lead 
to activate signalling pathways that ultimately remodel the fibres by eliciting changes in 
gene expression (Pette and Staron, 2001). Moreover, it has been reported that skeletal 
muscles remodelling can be induced by aerobic exercise which results in an increase in 
muscle fibres oxidative capacity and new blood vessels formation per myofibres. Such 
changes are essential for the physiological adaptation to exercise (Bloor, 2005, Egginton et 
al., 1998, Gavin et al., 2007). Consistent with these investigations, previous work has 
reported that skeletal muscle remodels the fibre composition to sustain muscle 
performance by activating distinct pathways that reprogram gene expression (Bassel-Duby 
and Olson, 2006, Olson and Williams, 2000). 
A number of studies have revealed a tight positive correlation between muscle fibre 
oxidative capacity and vascular supply, which is especially evident in skeletal muscles as 
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each enriched in either oxidative slow-twitch or glycolytic fast-twitch (Pette and Staron, 
2000, Fluck and Hoppeler, 2003). Moreover, it has been firmly established that formation of 
new blood vessels is required to reduce the average and maximum diffusion distance from 
the capillaries to the mitochondria in the hypertrophic muscle fibres (Egginton et al., 1998, 
Degens et al., 1992). Further work has reported that oxygen diffusion problem in large fibre 
can be attenuated by facilitating this process. Despite myoglobin molecule has defined to 
facilitate oxygen diffusion from capillaries to mitochondria, it remains uncertain whether 
myoglobin concentration increase in muscle hypertrophy (de Koning et al., 1981).  
Muscle fibre is large single post-mitotic cells that form from the fusion of differentiated 
myoblast (MAURO, 1961). Indeed multinuclear feature of muscle fibres provides more 
transcriptional capacity, as the myonucleus provides a template for the production of all the 
RNA in the cell (Bruusgaard et al., 2003, van der Meer et al., 2011). Further work has defined 
cytoplasm volume that supplied by myonuclei as the myonuclei domain, which is size 
limited by half-life of RNA as well as the diffusion rate of RNA (van der Meer et al., 2011). 
Although the positive correlation between muscle fibre size and number of myonuclei has 
been firmly established (Allen et al., 1999, Bruusgaard et al., 2003), there is a considerable 
debate whether fibre hypertrophy has to accompanied by addition of myonuclei, or marked 
increase in muscle fibre size possible without the addition of myonuclei (McCarthy et al., 
2011, van der Meer et al., 2011). The nuclei are distributed evenly and orderly throughout 
cytosol indicates the challenge of transport distance in these cells (Bruusgaard et al., 2003). 
In addition, myonuclei distribution was observed in both IIA and IIB muscle fibre, but the 
degree of order was much higher in IIB than IIA isoforms (Bruusgaard et al., 2006).  Skeletal 
muscle repair and regeneration is mediated by a pool of stem cells referred to as satellite 
cells which are located beneath the basal lamina (MAURO, 1961, Zammit et al., 2006). In 
normal muscle cell (non-injured), satellite cells are quiescent and have few organelles with 
the high nuclear-to-cytoplasm ratio, and small size nuclear compared to the adjacent 
nucleus of myotubes. However, it appears to swell on the myofibres after activation (Schultz 
and McCormick, 1994). Myoblasts are satellite cells after division and proliferation, which 
then undergo terminal differentiation and incorporate into mature muscle fibre as post-
mitotic myonuclei (Bischoff and Heintz, 1994). Moreover, numerous correlative studies have 
revealed the number of satellite cell increases as a muscle becomes progressively oxidative 
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(Putman et al., 1999, Christov et al., 2007). Another investigation reported that the soleus 
muscle which is mainly made up of slow oxidative fibres, has a higher number of satellite 
cells than the Extensor digitorum longus (EDL) muscle, which predominantly contains fast 
glycolytic fibres (Gibson and Schultz, 1983). 
We can infer from this, the metabolic properties of muscle are believed not only to control 
fibre size but also the number of satellite cells. 
Previous investigation of skeletal muscle features has shown that Errγ expressed exclusively 
in metabolically demanding and highly vascularized aerobic muscles (Narkar et al., 2011). 
Further studies have reported that transgenic overexpression of Errγ into WT background 
muscles is efficacious to enable anaerobic muscles to attain dense capillary density and 
enhanced oxidative capacity (Narkar et al., 2011, Rangwala et al., 2010). Moreover, muscle 
remodelling driven by Errγ overexpression in WT mice functions by regulating a network of 
genes that control oxidative phosphorylation and fatty acid oxidation pathways parallel with 
induction of angiogenic markers that regulate muscle vasculature (Matsakas et al., 2012b, 
Arany et al., 2008b). Additionally, Harper’s study (Harper et al., 2004) revealed that increase 
of intracellular ROS level, which is mainly produced through mitochondrial ETC pathway of 
myocyte, induces a level of oxidative stress capable to inhibit myogenesis. Since Errγ 
regulates the expression of genes that control mitochondrial pathways including ETC and 
TCA cycle, it protects muscle cells and myogenic processes by precluding excessive ROS 
emission (Eichner and Giguere, 2011). 
On the other hand, functional studies of Myostatin knockout animal models have illustrated 
a reduction in oxidative fibres number and a concomitant increase in the fast glycolytic 
phenotypes (Girgenrath et al., 2005, Amthor et al., 2007). Moreover, previous work 
provided evidence of a decrease in muscle capillary density following Myostatin deletion 
(Lipina et al., 2010, Rehfeldt et al., 2005). In addition, muscle hypertrophy generated by 
Myostatin ablation involved no increase in a number of myonuclei as well as a marked 
reduction of satellite cells population on each muscle fibre (Amthor et al., 2007). Here we 
investigated whether muscle-specific expression of Errγ in Mtn-/- muscle that maintained the 
increase of muscle fibre size exhibited by Myostatin deletion, while driving a partial 
transition of muscle fibre from fast to slow phenotypes, as we showed previously, would 
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enhance muscle oxidative capacity, capillary density and molecular features of Mtn-/- 
muscles, thereby break down the constraint between muscle fibre size and oxidative 
capacity.   
We also sought to examine the canonical view that oxidative muscle phenotype positively 
correlates with resident stem cell number. 
In order to investigate the robustness of the inverse relationship between fibre size and 
oxidative capacity, as well as between myofibre phenotype and satellite cells number, we 
made use of a genetic model that enhances oxidative metabolism, mediated by estrogen-
related receptor gamma (Errγ), into the hypertrophic background of Myostatin null (Mtn-/-) 
mice.  
Three genotypes of male mice (WT, Mtn-/- and Mtn-/-/ErrγTg/+) (n=5) were breed, housed 
under standard environmental conditions and provided food and water ad libitum in the 
Biological Resource Unit, University of Reading, to an adult age (3 months).  
The hind limb muscles (Soleus, Extensor digitorum longus (EDL), Tibialis anterior (TA) and 
Gastrocnemius) were isolated and weighed. The sectioned slides were stained for the 
mitochondrion-associate enzyme succinate dehydrogenase (SDH), Periodic acid–Schiff (PAS) 
and Dihydroethidium (DHE) stains to identify oxidative, glycolytic status, and Reactive 
Oxygen Species (ROS) level respectively in muscles from the three genotypic groups. 
Immunostaining for CD31 antibody was performed to identify capillary density per muscle 
fibre. Gastrocnemius muscles were pulverised, divided into three thirds, one third was 
homogenized and RNA samples were extracted to determine the expression level of genes 
that are involved in regulating of angiogenesis, energy metabolism, oxygen handling and 
antioxidants, glucose and fatty acid oxidation, transport and metabolism pathways. Another 
third was powdered, homogenised and used to determine the muscle metabolic profile by 
1H NMR. Finally, single muscle fibres from EDL muscles were cultured and fixed in different 
time points, time zero (T0) and 48 hours culture (T48), thereafter immunostained with two 
myogenic markers (Pax7 and MyoD).  
We show in this section, firstly, muscles of Mtn-/-/ErrγTg/+ mice that resulted from 
superimposition of Erry on the Mtn-/- background have a high oxidative capacity, evidenced 
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by the supernormal activity of succinate dehydrogenase (SDH) thus violating the inverse 
relationship between fibre size and oxidative capacity. Interestingly, the increase of muscle 
oxidative capacity was paralleled with hyper-capillarization of muscle. Secondly, Errγ 
overexpression into Mtn-/- resulted in a remodelling of phenotype to a state that 
differentiates it not only from Mtn-/- but also WT muscles NMR profiles. Thirdly, introducing 
of Errγ reprogramed Myostatin null muscles at molecular level, show the normalization of 
the expression levels of biomarker genes that regulate energy metabolism, glucose 
metabolism, and oxygen handling pathways. In addition, Errγ overexpression increases the 
transcriptional level of antioxidant, fatty acid transport, uptake and oxidation, and 
angiogenesis program genes to that level above even the control. Finally, our observations 
demonstrated that hyper-oxidative hypertrophic muscles from Mtn-/-/ErrγTg/+ mice do not 
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4.2. Errγ introducing into Mtn-/- mice induces robust increase of mitochondrion-associated 
enzyme succinate dehydrogenase (SDH) activity 
We demonstrated that muscle-specific expression of Errγ into a muscle lacking Myostatin 
not only significantly improved exercise and muscle force generation capacity of Mtn-/- mice, 
but also maintained the increase of muscle fibre number and size that followed Myostatin 
deletion, and caused a partial reversal in the MHC profiling of Mtn-/- muscles toward normal 
condition.  
In agreement with previous study (Girgenrath et al., 2005), our findings showed a shifting of 
hind limb muscle fibres toward fast phenotypes following Myostatin deletion. However, 
introducing of Errγ into Mtn-/- mice resulted in restoration of myofibres profiling to WT 
state. We speculate that muscle fibre-types bias toward fast phenotypes as a result of 
Myostatin knockout, and toward slow-twitch phenotypes following Errγ overexpression, 
might attribute to alter of mitochondrial enzymes activity.  
Previously has been reported that lack of Myostatin resulted in a reduction of oxidative 
myofibres with concurrently increase of glycolytic myofibres, indicating by fewer number of 
succinate dehydrogenase (SDH) positive fibres from muscles lacking Myostatin compared to 
WT (Amthor et al., 2007). Further investigation which referred to succinate dehydrogenase 
that is located at the inner membrane of mitochondria as a component of electron 
transport chain (ETC) as well as the tricarboxylic acid cycle (TCA), has reported a robust 
increase of the SDH positive area as well as intensity in muscle sections from Errγ transgenic 
mice compared to the control (Rangwala et al., 2010).  
Therefore, we performed staining for the mitochondrion-associate enzyme succinate 
dehydrogenase (SDH) to investigate whether Errγ overexpression would promote the 
oxidative capacity in hypertrophic-glycolytic myofibres from Myostatin null mice (Figure 
4.1A-D). A minimum of 200-300 myofibres were counted per each muscle section (EDL, 
soleus and TA) (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice. In all muscles examined, we 
found markedly few strongly stained fibres (high SDH activity) (measure oxidative capacity), 
and an increase in proportion of very pale fibres (low SDH activity) in Mtn-/- muscles 
compared to wild type. However, upon over-expression of Errγ, the intensity of SDH staining 
in fibres of Mtn-/- muscle was restored to that of WT level. Indeed, the number of SDH 
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positive fibres was higher than that seen even in the WT muscles albeit not significantly 
(Figure 4.1E-H). Of particular note, soleus muscles from Mtn-/- mice showed lower 
percentage of SDH positive fibres (38%) compared to WT animals (67.6%), counterpart 
muscles from Errγ transgenic mice displayed a significant increase in the proportion of 
oxidative myofibres (76.3%) (Figure 4.1B and F). Same scenario has been seen in all muscle 
examined (Figure 4.1E-H). 
Taken together, these results imply that muscle-specific expression of Errγ into Mtn-/- mice is 
sufficient to break down the suggested constraint between muscle fibres size and oxidative 
capacity (Degens, 2012), indicated by high SDH activity of hypertrophic muscle fibres.   
Chapter 4 
158 

































































































































































Oxidative fibres Oxidative fibres Glycolytic fibresGlycolytic fibres
TT
TT
Figure 4.1. Errγ overexpression into Mtn-/- background muscle restores oxidative capacity 
to WT condition  
Muscle-specific expression of Errγ normalizes the metabolic profile of Myostatin null mice 
(Mtn).  
 (A – D) Succinate dehydrogenase (SDH) staining Images of (EDL, soleus and TA-deep and 
superficial) muscles from WT, Mtn and Mtn:Eγ mice. Black fibres signify the SDH positive 
fibres (Oxidative fibres), and pale (white) fibres signify the SDH negative fibres (Glycolytic 
fibres).    
(E – H) Quantification of SDH activity in EDL, soleus, TA-Deep and TA-Superficial muscles 
respectively.   
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05 and ***= P<0.001.  
Chapter 4 
160 
S. S. Omairi, PhD 2018 
 
4.3. Remodelling muscle glycolytic status following Errγ overexpression into Myostatin 
null mice   
In presented study, we showed a partial reverse in transition of myofibres toward the slow 
phenotypes driven by muscle-specific overexpression of Errγ into Myostatin null mice which 
was accompanied by a remarkable increase of SDH activity that indicated a high oxidative 
status of these muscles. At the same time we maintained the increase in muscle fibre size 
exhibited by Mtn-/- muscles. Such combination of a high oxidative capacity and large fibre 
size is clear evidence for the violating of the trade-off between the oxidative capacity of 
muscle fibre and its size.  
Previous work has illustrated predominantly of glycolytic type IIB fibres in hind limb muscles 
from Myostatin knockout mice, with obvious reduction of type IIA and IIX phenotypes 
(Girgenrath et al., 2005). On the other hand, Errγ has been described as a key regulator of 
fatty acid oxidation, mitochondrial biogenesis and oxidative metabolism pathways (Dufour 
et al., 2007). To further explore of Errγ potential to promote remodelling of muscle 
metabolism status, we applied a specific protocol Periodic acid–Schiff (PAS) stain to identify 
glycolytic status in muscles (EDL, soleus and TA) (n=5) from Mtn-/- and Mtn-/-/ErrγTg/+ mice 
(Figure 4.2A-C). 
Our findings showed higher numbers of positive glycolytic fibres (dark colour) with 
concomitant reduction of the negative (pale-white colour) fibres in all muscles examined 
from Mtn-/- mice. In contrast, muscles from Mtn-/-/ErrγTg/+ mice displayed a considerable 
decrease of dark stain fibres (high PAS activity) and increase in non-glycolytic (low PAS 
activity) fibres (4.2D-F). Of particular note, we found a high percentage (29.1%) of positive 
fibres (Glycolytic fibres) in EDL muscles from Mtn-/- mice, compared to counterpart muscles 
from Mtn-/-/ErrγTg/+ (8.9%). However, Errγ overexpression increased the proportion of PAS 
negative fibres (76.3%) compared to (49.1%) in EDL muscles from Mtn-/- mice (4.2A and D). 
The intermediate fibres from both cohorts showed no significant differences in all muscles 
examined (Figure 4.2D-F). Both soleus and TA muscles from Mtn-/- and Mtn-/-/ErrγTg/+ 
displayed approximately same myofibres distribution (Figure 4.2E-F). These data highlight 
the potential role of Errγ introducing into Mtn-/- mice to normalize muscle glycolytic status.  
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Figure 4.2. Errγ overexpression into Myostatin null muscles reduces number of glycolytic 
myofibres   
Muscle-specific expression of Errγ normalizes the number of PAS positive fibres of 
Myostatin null mice (Mtn). 
(A – C) Periodic acid–Schiff (PAS) staining Images of (EDL, soleus and TA) muscles from Mtn 
and Mtn:Eγ mice. Black fibres signify the PAS positive fibres (Glycolytic fibres), and pale 
(whit) fibres signify the PAS negative fibres (Oxidative fibres).    
(D – F) Quantification of PAS activity in (EDL, soleus and TA) muscles respectively.   
(n = 5) male twelve-week old mice per group; statistical analysis between each two groups 
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4.4. Muscle-specific expression of Errγ is efficacious to promote angiogenesis program in a 
muscle lacking Myostatin  
In agreement with aforementioned studies, we demonstrated a predominantly of fast-
twitch glycolytic fibres profile following genetic ablation of Myostatin (McPherron and Lee, 
1997). In addition, our findings which conform with previous reports, showed that the 
glycolytic muscle phenotypes of Myostatin null mice are associated with marked reduction 
of mitochondrial number, mitochondrial enzymes expression and capillary density (Amthor 
et al., 2007, Lipina et al., 2010). However, introducing of Errγ into Mtn-/- mice restored 
almost all these features in Mtn-/- muscles indicated by high mitochondrial density and a 
high number of SDH positive fibres (oxidative fibres), thereby driven a partial reverse 
conversion of myofibres toward slow-twitch phenotype. A number of studies have 
established that the capillary density per muscle fibres is related to myofibre size, therefore 
an increase in the capillary number that follows a similar time course as the hypertrophy, is 
required (Degens et al., 1992, Plyley et al., 1998). Several other studies have recognised Errγ 
as a key transcriptional regulator that regulates the intrinsic vascular features and oxidative 
metabolism in the skeletal muscle (Rangwala et al., 2010, Narkar et al., 2011). Here we 
sought to determine whether the restoration of muscle oxidative capacity followed Errγ 
introducing into Mtn-/- mice would be accompanied by increasing of factors related to the 
microvascular supply of the muscle that known to regulate angiogenesis program.  
We found that the expression of endothelial mitogenic factors (Vegf-α165 (Vascular 
endothelial growth factor α 165), Vegf-α189 (Vascular endothelial growth factor α 189) and 
Fgf1 (Fibroblast growth factor 1) was lower in the muscles of Mtn-/- than WT mice, but 
similar in Mtn-/-/Errγ Tg/+ and WT mice (Figure 4.3A-B). Of particular note, Fgf1 expression 
was similar in muscles from WT and Mtn-/- mice (Figure 4.3C), however, its level induces 
significantly by Errγ overexpression not only more than Mtn-/- but also WT. The expression 
levels of Vegf-α165 and Vegf-α189 were significantly lower in Mtn-/- than in WT, and Errγ 
overexpression normalized them to the control condition (Figure 4.3A-B) and induced Fgf1 
to be even higher than in WT (Figure 4.3C). These observations suggest that features 
induced by germline deletion of Myostatin are not genetically looked down, but can be 
modified and thereby normalized by muscle-specific expression of Errγ. Therefore, the 
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angiogenesis program imparted by Errγ overexpression was responsive to myofibres size 
























































































Figure 4.3. Molecular reprogramming of Myostatin null muscle by Errγ overexpression. 
Errγ introducing into Mtn mice significantly increases expression levels of biomarker genes 
that regulate angiogenesis program 
(A) Quantification of Vegf-α 165 gene expression. 
(B) Quantification of Vegf-α 189 gene expression. 
(C) Quantification of Fgf1 gene expression.   
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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4.5. Errγ overexpression is required for synchronizing of myofibre size and capillary 
density    
We established that introducing of Errγ into a muscle lacking Myostatin preserves the 
increase of muscle fibre cross-sectional area (CSA) induced by Myostatin ablation, while 
simultaneously promoting muscle oxidative capacity. Several studies have indicated a 
marked decrease of mitochondrial enzymes expression and capillary density in Myostatin-
deficient muscles (Rehfeldt et al., 2005, Amthor et al., 2007, McPherron and Lee, 1997, 
McPherron et al., 1997). Recently, Errγ has been described as an orphan nuclear receptor 
that drives a network of transcriptional programmes would encode highly oxidative 
myofibres (Narkar et al., 2011). We wondered whether muscle-specific Errγ overexpression 
into Mtn-/- mice in addition to its potential to hold the increase of muscle fibre size and 
promote the oxidative capacity, could induce blood vessels formation to match the 
increased size and oxidative demands of the muscles. To test this, we examined TA muscle 
sections (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice for (CD31) expression, an endothelial 
cell marker that is routinely used to identify blood vessels (Figure 4.4A).  
We found that capillary to fibre ratio (C:F) was the lowest in TA muscle sections from Mtn-/- 
mice, and the highest in those of Mtn-/-/ErrγTg/+ mice. More specifically, muscles lacking 
Myostatin showed a significant decrease in a number of blood capillary per muscle fibre (1.3 
blood vessels per myofibre) compared to control muscles (1.8 blood vessels per myofibre). 
However, Errγ overexpression in a muscle-specific manner markedly increased the number 
of blood vessels per each muscle fibre (2.6 blood vessels per myofibre). Interestingly, 
muscles from Mtn-/-/ErrγTg/+ mice showed higher (C:F) ratio not only than those from 
Myostatin null, but also exceeded those of WT mice (Figure 4.4B).  
These data with aforementioned observations on muscle fibres size, physiological functions 
and oxidative capacity, strengthen the hypothesis that muscle-specific expression of Errγ 
into Mtn-/- mice would challenge the dogma of the existence of an inverse relationship 















































Figure 4.4. Revascularization of Myostatin null muscles following Errγ overexpression  
Muscle-specific expression of Errγ normalizes capillary profile of Myostatin null mice (Mtn). 
(A) Muscle capillary density determined by CD31 staining on TA muscle sections of WT, Mtn 
and Mtn:Eγ mice.  
(B) Quantification of blood vessels per muscle myofibre in TA muscle sections. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *=P<0.05, **=P<0.05 and ***= P<0.001.  
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4.6. Remodelling of muscle NMR profile of Mtn-/- mice following Errγ modification 
We demonstrated that Errγ overexpression into Mtn-/- background mice even maintain 
muscles hyperplasia and hypertrophy statues, also attenuated muscle fatigability and drives 
a partial reversal of muscle fibre types toward normal condition, induce oxidative capacity, 
and promotes muscle vasculature. It was well established that skeletal muscle function is 
linked to its structure and metabolic processes that maintain this tissue (Jones et al., 2008, 
Krivickas et al., 2011). We speculated whether the modifications in muscle metabolic status 
that resulted from Errγ overexpression would be followed by increasing/decreasing of 
particular metabolic enzymes and amino acids that match the oxidative metabolic 
phenotype demands. To examine this line of thought, gastrocnemius muscles (n=5) from WT, 
Mtn-/- and Mtn-/-/ErrγTg/+ mice were homogenized and the metabolite profile was 
characterized by 1H NMR spectroscopy.  
To identify any metabolic variation driven by the genotypic differences, principal 
components analysis (PCA) was applied to these profiles. We found a clear clustering 
observed in the scores plot comparing all three genotypic groups demonstrating that they 
had distinctive metabolite profiles (Figure 4.5). Comparing the metabolic signature of the 
Mtn-/- muscle to the Mtn-/-/ErrγTg/+ showed clear differences between the two groups 
characterised by significantly greater levels of muscle lactate in Mtn-/- muscle compared to 
that of the Mtn-/-/ErrγTg/+consistent with a greater glycolytic phenotype. Furthermore, the 
levels of creatine/phosphocreatine were also more pronounced in the muscle from Mtn-/- 
compared to Mtn-/-/ErrγTg/+. Additionally, Errγ modification leads to higher taurine and 
anserine content in the muscle of these animals (Figure 4.5).  
We infer from the histochemical and NMR muscle profiles of the three genotypic groups 
that Errγ modification of Mtn-/- results in a remodelling of phenotype to a state that 
differentiates it not only from Mtn-/- but also WT muscles. 
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Figure 4.5. Muscle-specific expression of Errγ normalizes the metabolic of Myostatin null 
mice (Mtn)  
Pair-wise comparisons of the metabolic profiles obtained from the gastrocnemius muscle 
from WT, Mtn and Mtn:Eγ mice. Principal components analysis (PCA) score plots comparing 
WT, Mtn and Mtn:Eγ; WT and Mtn:Eγ; as well as Mtn and Mtn:Eγ; (% variance in the 
parenthesis). Colour loadings plots shown for PC1 of the model comparing Mtn and Mtn:Eγ. 
Product of PC loadings with standard deviation of the entire data set coloured by the 
square of the PC loading.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests.  
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4.7. Errγ is required for regulating of muscle energy metabolism   
The potential loss of exercise, oxidative and vascular capacity that we showed in muscles 
from Myostatin null mice, encouraged us to identify whether the expression of genes that 
encode for instance metabolic and oxygen handling features would be altered following 
germline deletion of Myostatin. And we asked whether muscle-specific expression of Errγ 
into Mtn-/- mice would be capable of restoring gene expressions to their normal levels, or 
modify them in a way that can meet the aerobic metabolic demands that were imparted by 
Errγ reprogramming.  
Previously it has been reported that Myostatin deletion or its inhibition results in high level 
of PGC1α expression (Shan et al., 2013). Several other studies have established that the 
nuclear receptors in coordinate with number of co-regulators such as PGC1α control a wide 
range of aerobic respiration signalling pathways including mitochondrial biogenesis, fatty 
acid oxidation and oxidative phosphorylation in skeletal muscles (Arany et al., 2007, Huss et 
al., 2002, Wang et al., 2004, Narkar et al., 2011). Further investigations have revealed Errγ 
potential to enhance key transcriptional regulators of skeletal muscle oxidative metabolism 
including Peroxisome proliferator-activated receptor delta (Ppard) and Peroxisome 
proliferator-activated receptor gamma coactivator 1-beta (Ppargc 1b) (Lin et al., 2002, Wang 
et al., 2004). In this section of present study, we examined the expression level of key 
transcriptional regulators and nuclear receptors that involved in regulating of muscle energy 
metabolism. Thus, gastrocnemius muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice 
were homogenised and total RNA was reverse-transcribed to cDNA and analysed using 
quantitative real-time RT-PCR. We found that the expression of PGC1α was increased 
significantly in muscles from Mtn-/- mice. However, upon overexpression of Errγ, PGC1α 
expression was normalized to that level of WT muscles (Figure 4.6A). The expression level of 
Perm1 (PPARGC1 and ESRR-induced Regulator in Muscle 1) was increased significantly 
following Errγ overexpression not only above its level in muscles from Mtn-/- but also 
exceeded that of WT muscles (Figure 4.6B). However, we found that the transcriptional 
levels of another two genes Ppard (Peroxisome proliferator-activated receptor delta) and 
Rev-erb-a that are associated with muscle oxidative metabolism were not significantly 
affected by neither Myostatin ablation, nor Errγ introducing into Mtn-/- muscle (Figure 4.6C-
D). These data show that Errγ acts as a critical upstream genetic switch that might govern 
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skeletal muscle metabolism by controlling the expression of multiple but not all aerobic 
















































































































Figure 4.6. Molecular reprogramming of Myostatin null muscle by Errγ overexpression 
and its ability to regulate expression of transcriptional regulators  
Gene expression levels of key transcriptional regulators of metabolism in muscles from WT, 
Mtn and Mtn:Eγ mice.   
(A) Quantification of PGC1α gene expression, Errγ overexpression normalised this gene 
level.  
(B) Quantification of Perm 1 gene expression. Errγ overexpression significantly increased 
this gene level.  
(C-D) Quantification of (Ppard and Rev-reb a) genes expression, show no changes of these 
genes level in muscles from the three genotypic groups. 
(n = 5) male twelve-week old mice per. One-way ANOVA followed by Bonferroni’s multiple 
comparison tests, ***= P<0.001.  
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4.8. The effects of Myostatin deletion and Errγ overexpression on biomarker genes that 
regulate glucose metabolism  
             We showed that introducing of Errγ into Mtn-/- mice was sufficient to modify the expression 
level of genes that regulate muscle energy metabolism in a way that matched the 
improvement of muscle oxidative capacity and force generation. Previous work has reported 
that cellular glucose utilization is tightly regulated by the pyruvate dehydrogenase complex 
(PDC) that mediating pyruvate entry into the TCA. The study also revealed PDC can be 
phosphorylated and thereby inactivated by members of pyruvate dehydrogenase kinase 
(PDK 1-4) family (Giguere, 2008). Further investigations have reported that PGC1α could 
influence glucose oxidation via transcriptional control of PDK4 expression (Wende et al., 
2005).  
             On the other hand, several studies have indicated that in addition to the notable 
improvement of insulin sensitivity, loss of functional Myostatin resulting in a marked 
increase of glucose utilization (Guo et al., 2009, Wilkes et al., 2009). Therefore, to further 
confirm of these findings, and to determine the potential role of Errγ to promote glucose 
metabolism and oxidation, we compared the expression levels of selective biomarkers genes 
that regulating glucose metabolism, transport and uptake. We found that the expression 
level of Glut1 (Glucose transporter type 1) gene was not significantly changed neither by 
Myostatin absence, nor by Errγ overexpression (Figure 4.7A). Moreover, both Glut4 (Glucose 
transporter type 4) and PDK4 genes showed the highest expression levels in muscles from 
Mtn-/- mice, however Errγ introducing normalizes their levels to WT condition (Figure 4.7B-
C). Of particular note, there was no significant difference between the expression level of 
Glut4 gene in muscles from WT and Mtn-/- mice, while PDK4 was increased significantly in 
Mtn-/- compared to WT muscles. Interestingly, all gene levels were similar in muscles from 
WT and Mtn-/-/ErrγTg/+ mice (Figure 4.7B-C). These data show that muscle-specific expression 
of Errγ into Mtn-/- mice was sufficient to normalize the expression level of biomarker genes 










































Figure 4.7. Molecular reprogramming of Myostatin null muscle by Errγ overexpression 
and its ability to regulate glucose metabolism genes 
Gene expression levels of selective biomarker genes that regulating glucose metabolism in 
muscles from WT, Mtn and Mtn:Eγ mice. 
(A) Quantification of Glut1 gene expression.  
(B-C) Quantification of (Glut4 and PDK4) genes expression, Errγ overexpression significantly 
normalizes these genes level.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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4.9. Errγ overexpression promotes expression level of genes regulates fatty acid 
metabolism  
Present study demonstrated that introducing of Errγ into a muscle lacking Myostatin 
normalized expression level of biomarker genes that responsible for regulating skeletal 
muscle vasculature, energy and glucose metabolism. In agreement with previous study 
(Narkar et al., 2011), we reported that Errγ overexpression tightly regulated oxidative 
metabolism and vasculature in the skeletal muscles. Furthermore, transgenic induction of 
Errγ into skeletal muscle from mdx mice resulting in restoration of fat metabolism genes like 
(Had and Cycs) (Matsakas et al., 2013). Despite the essential role of Errγ in activating of 
genes that regulates muscle metabolism has been firmly established (Huss et al., 2002, 
Zhang et al., 2006), little is known about its role that direct fat metabolism biomarker genes 
in a muscle lacking Myostatin. Therefore, we examined the expression level of key 
regulators molecules of fatty acid metabolism (Had (haloacid dehalogenase), Lpl 
(Lipoprotein lipase) and Cycs (Cytochrome c, somatic)) in muscles (n=5) from WT, Mtn-/- and 
Mtn-/-/ErrγTg/+ mice. Our findings illustrated that the expression of fatty acid metabolism 
markers were higher in muscles from Mtn-/-/ErrγTg/+ mice than the other genotypic groups. 
Of particular note, the expression levels of (Had and Lpl) were the lowest in muscle samples 
from Mtn-/-, and the highest in Mtn-/-/ErrγTg/+ mice (Figure 4.8A-B). Most importantly, both 
biomarker genes were not only higher in Mtn-/-/ErrγTg/+ than in Mtn-/-, but also more than in 
the WT (Figure 4.8A-B). The same pattern of expression level of (Cycs) gene was identified, 
without reaching significance difference between the three cohorts (Figures 4.8C). These 
data provide evidence that muscle-specific expression of Errγ into Mtn-/- mice, changes fat 




































































































Figure 4.8. Molecular reprogramming of Myostatin null muscle by Errγ overexpression 
and its ability to restore the expression of fat metabolism genes 
Expression levels of biomarker genes that regulating fat metabolism in muscles from WT, 
Mtn and Mtn:Eγ mice.  
(A-B) Quantification of (Had and Lpl) genes expression, Errγ overexpression significantly 
induces these genes level compared to Mtn-/- and WT mice. 
(C) Quantification of (Cycs) genes expression, no significant difference between any of the 
three genotypic groups. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *= P<0.05 and **= P<0.01. 
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4.10. Hyper-oxidative hypertrophic muscle fibres show high oxygen diffusion rate 
             We showed that the reverse transition driven by Errγ introducing into Mtn-/- muscle was not 
limited to the myosin heavy chain profile as a fast to slow fibres within MHCII subtypes, but 
also occurred at metabolic level (glycolytic to oxidative) indicating by SDH activity. These 
modifications were synchronized with a marked increase of muscle fibres size, capillary 
density, and re-localized of mitochondria in particular at sub-membrane areas, thereby 
breaking down the suggested constraint between muscle fibres size and oxidative capacity. 
To sustain the large oxidative myofibres developed as a consequence of muscle-specific 
overexpression of Errγ into Mtn-/-, high oxygen diffusion is required.  
It was well established that high myoglobin concentration is essential to facilitate oxygen 
diffusion from capillaries to mitochondria of hypertrophied myofibres (de Koning et al., 
1981, Masuda et al., 1997). Further work has revealed a remarkable increase of myoglobin 
expression in muscles from Errγ transgenic mice compared to WT (Narkar et al., 2011). On 
the other hand, study by Matsakas’s group (Matsakas et al., 2012a) has detected a 
reduction of myoglobin expression level in muscle from Mtn-/- mice. Here we determined 
whether the increase of muscle fibres oxidative capacity and size that induced by Myostatin 
deletion and introducing of Errγ into Mtn-/- muscle was accompanied by any changes in 
expression of marker genes for oxidative phenotypes, and that able to reduce the effects of 
destructive radicals would generate by oxidative metabolism. Therefore, we examined the 
expression level of myoglobin which facilitates oxygen diffusion, and catalase as anti-
oxidant enzyme in homogenised gastrocnemius muscles (n=5) from WT, Mtn-/- and Mtn-/-
/ErrγTg/+ mice.  
We found that the expression of myoglobin was the lowest in muscles from Mtn-/- mice. Errγ 
overexpression induced a significant increase of myoglobin transcriptional level. 
Interestingly, there was no significant difference in myoglobin level in muscle samples from 
WT and Mtn-/-/ErrγTg/+ mice (Figure 4.9A). As number of destructive radicals might produce 
in the oxidative environment, thus, we examined catalase expression, we found that this 
anti-oxidant marker was not only higher in muscles from Mtn-/-/ErrγTg/+ than Mtn-/- mice, but 
also exceeded its level in the WT muscles (Figure 4.9B). These data show that muscle-
specific expression of Errγ into Mtn-/- mice induces the expression levels of biomarkers that 
are essential for oxygen diffusion and oxidative radical scavenging.  
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Figure 4.9. Molecular reprogramming of Myostatin null muscle by Errγ overexpression 
and its ability to induce antioxidant genes  
Expression levels of oxygen handling and antioxidant genes induced significantly by Errγ 
introducing into Mtn mice.  
(A) Quantification of Myoglobin gene expression. 
(B) Quantification of Catalase gene expression. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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4.11. Errγ overexpression into Mtn-/- mice induces biomarker genes that regulate fatty 
acid transport, uptake and oxidation 
We demonstrated that muscle-specific expression of Errγ potentially contributes to the 
regulation of biomarker genes that responsible for regulating muscle angiogenesis, energy 
and metabolism profiles. Previously has been reported that inhibition of Myostatin signalling 
specifically in skeletal muscles resulting in a marked reduction of fat mass (Guo et al., 2009). 
On the other hand, several studies have illustrated that Errγ is a key regulator of a network 
of genes that linked to fatty acid oxidation and mitochondrial biogenesis (Dufour et al., 2007, 
Alaynick et al., 2007). Furthermore, genome-wide expression analysis revealed Errγ co-
ordinately inducing a number of genes that promoting oxidative of fat (Wang et al., 2004).  
Therefore, we speculate that induction of Errγ would promote fat transport, uptake and 
oxidation in a muscle lacking Myostatin. To do so, we examined the expression of genes 
controlling fat metabolism (fatty acid transport and uptake molecules: Cd36, Slc25a20 
(solute carrier family 25 member 20), Fatp1 (Fatty acid transport protein 1), Fabp3 (fatty 
acid binding protein 3), and regulators of fatty acid oxidation (Acadl (Acyl-CoA 
dehydrogenase (long chain)), Acadm (Acyl-Coenzyme A dehydrogenase medium-chain,) in 
muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice. We found that all six genes were 
expressed to a higher degree in muscles from Mtn-/-/ErrγTg/+ than Mtn-/- and WT mice (Figure 
4.10). Of particular note, all genes showed same expression level in muscles from WT and 
Mtn-/- mice, except Fabp3 gene showed a significant reduction in Mtn-/- compared to WT 
(Figure 4.10D).   
These data show that Errγ introducing into a muscle lacking Myostatin is sufficient to 
promote the expression levels of biomarker genes that regulate fatty acid transport, uptake 


























































































































































































































Figure 4.10. Molecular reprogramming of Myostatin null muscle by Errγ overexpression 
and its ability to regulate the expression of fatty acid transport, uptake and oxidation 
genes 
Errγ introducing into Mtn mice promote expression levels of genes regulate fatty acid 
transport, uptake and oxidation. 
(A) Quantification of CD36 gene expression. 
(B) Quantification of Slc25a20 gene expression. 
(C) Quantification of Fatp1 gene expression. 
(D) Quantification of Fabp3 gene expression. 
(E) Quantification of Acadl gene expression. 
(F) Quantification of Acadm gene expression. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, *= P<0.05, **= P<0.01 and ***= P<0.001. 
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4.12. Hyper-oxidative hypertrophic muscle fibres show low ROS emission rate  
Using transmission electron microscopy, we showed that germline deletion of Myostatin 
resulted in alteration of mitochondrial number, size and distribution. However, introducing 
of Errγ into Mtn-/- muscles largely normalized almost all these abnormalities, in particular re-
localization of mitochondria at the sub-membrane area. In addition, we showed that Errγ 
overexpression induced a transcriptional level of anti-oxidant (Catalase) to scavenge 
destructive radicals that might produce during oxidative metabolism. Previous work has 
reported that mitochondrial electron transport chain (ETC) pathway is the main source of 
Reactive Oxygen Species (ROS) (Harper et al., 2004). Further, chronical production of ROS as 
a result of mitochondrial dysfunction can lead to protein, DNA and lipids damage (Jackson, 
2011). Numerous studies have established a central role of Errγ in regulating of 
mitochondrial biogenesis, activity and fatty acid oxidation in skeletal muscles (Narkar et al., 
2011, Rangwala et al., 2010). Further investigation has demonstrated a marked reduction of 
expression level and activity of TCA and ETC enzymes, and severely impairment of 
mitochondrial formation thereby increase emission rate of ROS in Errγ knockout phenotype 
(Alaynick et al., 2007, Murray et al., 2013). Here we determined whether muscle-specific 
expression of Errγ into Mtn-/- mice would reduce ROS production that might follow the 
disruption in mitochondrial size and distribution we described previously in Mtn-/- muscles. 
Therefore we gauged the level of superoxide using Dihydroethidium (DHE) dye (Bindokas et 
al., 1996, Li et al., 2003a) in TA muscle sections (n=5) from WT, Mtn-/- and Mtn-/-ErrγTg/+ mice 
(Figure 4.11A). We found elevated levels of superoxide indicating by high DHE intensity in 
both small (slow oxidative) and large (fast glycolytic) myofibres in TA muscles from Mtn-/- 
mice compared to counterpart muscles from WT (Figure 4.11B). However, Errγ 
overexpression significantly lowered the level of ROS of Mtn-/- muscles indicated by low DHE 
intensity in both myofibre cohorts were examined (Figure 4.11B). Importantly, the ROS in 
large myofibres from Mtn-/-/ErrγTg/+ muscles was even lower than those of WT (Figure 4.11B). 
These data indicate an essential role of Errγ in preventing disproportionate increase of ROS, 













































































Figure 4.11. Errγ overexpression required for preventing excessive superoxide production  
Muscle-specific expression of Errγ normalizes level of Reactive Oxygen Species (ROS) of 
Myostatin null mice (Mtn).  
(A) DHE fluorescence in the body of TA muscle fibres from WT, Mtn and Mtn:Eγ mice.  
(B) Quantification of DHE intensity in small and large myofibres in TA muscles. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
multiple comparison tests, **= P<0.01 and ***= P<0.001.  
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4.13. Errγ overexpression into Mtn-/- mice does not rescue the reduction of satellite cells 
number in hyper-oxidative hypertrophic myofibres  
We demonstrated that muscle-specific expression of Errγ into Mtn-/- mice was efficacious in 
challenging the dogma of an inverse relationship between muscle fibres size and oxidative 
capacity. The deviation from this relationship may be realized by an increase of muscle 
oxidative capacity indicated by high SDH activity, increase capillary density that was 
confirmed with a marked elevation of genes that regulate angiogenesis program at the 
transcriptional level, increase myoglobin content, and re-localization of mitochondria to 
subsarcolemmal location. Importantly all these modifications were synchronised with 
maintaining muscle fibre size increase due to Myostatin absence.  
Next we examined the consequences of Myostatin absence and Errγ introducing into Mtn-/- 
on individual muscle fibres.  
It has been established that a myofibre is a cellular unit of adult skeletal muscle that is 
sustained by high numbers of post-mitotic myonuclei, and competently repaired and 
regenerated by a pool of satellite cells that located beneath the basal lamina (MAURO, 1961, 
Zammit and Beauchamp, 2001). In order to adapt to growing demand, early post-natal 
satellite cells provide the muscle with new myonuclei. However, in the adult's satellite cells 
become the source of myonuclei required for muscle repair and regeneration (Moss and 
Leblond, 1971, Zammit et al., 2006). Further studies have reported that satellite cells (SC) 
retain the ability to proliferate and differentiate in response to the routine need of myofibre 
hypertrophy or myonuclei turnover (Schmalbruch and Lewis, 2000, Snow, 1977).  
Previously it was demonstrated that muscle hypertrophy arising from Myostatin deletion is 
not associated with an increase in a number of satellite cells, a significant reduction of 
satellite cell numbers per myofibres from EDL muscle of Mtn-/- compared to WT mice was 
reported (Amthor et al., 2009). On the other hand, Murray’s review (Murray et al., 2013) has 
referred to a marked up-regulation of Errγ expression during muscle cells differentiation 
which supports a potential role of the Errγ in regulating myogenesis, a field of Errγ function 
that has not been completely explored. In addition, number of studies have shown an 
increase in satellite cells population in muscle fibres becoming oxidative (Putman et al., 
1999, Christov et al., 2007).  
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Our findings showed that Errγ overexpression into Myostatin knockout mice implicates in a 
partial shift of myofibres toward an oxidative phenotype. Therefore, we sought to 
determine satellite cells number and recruitment following germline deletion of Myostatin, 
and whether Errγ overexpression in the Mtn-/- muscles would influence the quantity of the 
resident satellite cells, and their proliferation and differentiation programs. To do so, 
satellite cells on single muscle fibre from EDL muscles (n=4) from WT, Mtn-/- and Mtn-/-
/ErrγTg/+ mice were cultured and fixed in different time points, time zero (T0) and 48 hours 
culture (T48), thereafter immunostained with two myogenic markers (Pax7 and MyoD). 
Pax7 as a marker of satellite cells, and  MyoD expressed as a marker of activated satellite 
cells and a key transcription factor for myogenic differentiation (Christov et al., 2007) 
(Figures 4.12A and 4.13A).  
We found that deletion of Myostatin resulted in fewer satellite cells per myofibre (2.8  0.3 
and 10.9  1) compared to WT (3.6 0.3 and 12.7  0.9) at T0 and T48 time points 
respectively. At both time points, the number of satellite cells was even lower in the 
muscles of the Mtn-/-/ErrγTg/+ mice (1.7  0.1 and 4.1  0.5) compared to the other genotypic 
groups (Figures 4.12A and B, and 4.13A and B). These results show that muscle-specific 
expression of Errγ in the Mtn-/- does not attenuate the deficit of satellite cell numbers that 
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Figure 4.12. Fewer number of Satellite cells in EDL myofibre of Mtn:Eγ than other 
genotypic groups  
Hypertrophied oxidative muscle developed through introduction of Errγ on the muscle of 
Myostatin null mice (Mtn) shows depletion of satellite cells.  
(A) Quiescent satellite cells stained for DAPI and Pax7 on freshly isolated (T = 0 hr) muscle 
fibres from the EDL muscles (arrowhead), scale 50µm.  
(B) Quantification of satellite cell number on freshly isolated EDL muscle fibres of WT, Mtn 
and Mtn:Eγ mice.  
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 






























































Figure 4.13. Muscle-specific expression of Errγ does not influence the satellite cell 
number 
Hypertrophied oxidative muscle developed through introduction of Errγ on the muscle of 
Myostatin null mice shows depletion of satellite cells.  
(A) Single muscle fibres from the EDL muscles after 48 hr in cell culture stained for DAPI, 
Pax7 and MyoD (arrowhead), scale 50µm.  
(B) Quantification of satellite cell number on EDL muscle fibres at 48 hr.  
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 
Bonferroni’s multiple comparison tests, *= P<0.05 and ***= P<0.001. 
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4.14. Proliferation and differentiation rate of hyper-oxidative hypertrophic myofibres 
We showed that introducing of Errγ into a muscle lacking Mtn-/- did not rescue satellite cells 
depletion that following Myostatin absence.  
The activation of satellite cells from a quiescent state and their subsequent progression 
along the myogenic lineage is controlled by the myogenic regulatory factors (MRFs) (Zammit 
and Beauchamp, 2001, Rudnicki et al., 1993, Hasty et al., 1993). Previous studies have 
illustrated that Myostatin administration to C2C12 muscle cell line results in a reduction of 
myoblast proliferation due to its interaction with the factors that control the progression of 
the cell cycle from G1 to S-phase through up-regulation of p21 inhibitor and its ability to 
downregulate Cdk2 (Thomas et al., 2000). Further work has demonstrated fewer number of 
myoblast that accumulated in clusters around the isolated myofibres from EDL muscles of 
Mtn-/-  compared to age-matched WT mice (Amthor et al., 2009). In this section we sought 
to determine proliferation and differentiation characteristics of satellite cells in EDL muscles 
from the three cohorts (WT, Mtn-/- and Mtn-/-/ErrγTg/+). Therefore, in order to examine 
whether Errγ overexpression into Myostatin null mice would influence satellite cells 
activation and proliferation, we monitored the number of these cells’ clusters around 
isolated myofibres of EDL muscles of the three genotypic groups. Our findings showed that 
during the 48 hr period of culture, satellite cells not only divide but also form clusters 
(Figure 4.14A). We also found that the number of clusters was similar in isolated myofibres 
from WT and Mtn-/- muscles, but fewer myoblast had accumulated in clusters in the Mtn-/-
/ErrγTg/+ derived cultures compared to Mtn-/- and WT mice (Figure 4.14B).   
Next, we counted the number of satellite cells per cluster along the isolated myofibres. We 
found that the number of cells per cluster was highest in WT and lowest in the Mtn-/- with 













































































Figure 4.14. Proliferation rate in myofibres of EDL muscles from three genotypic groups  
Hypertrophied oxidative muscle developed through introduction of Errγ on the muscle of 
Myostatin null mice shows reduction of clusters of satellite cells 
(A) Single EDL muscle fibres from WT, Mtn and Mtn:Eγ mice after 48 hr in cell culture 
stained for Pax7 and MyoD (arrowhead), scale 50µm. 
(B) Quantification of satellite cell clusters at 48 hr.  
(C) Cluster size at 48 hr on muscle fibres.  
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 
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Previously has been reported that most activated satellite cells then proliferate, and Pax7 
progressively become transcriptionally inactive as the progeny satellite cells committed to 
differentiation. In contrast, other proliferating cells conserve Pax7 expression but lose MyoD 
and withdraw from both cell cycle and instead myogenic differentiation, returning to a state 
resembling quiescence (Zammit et al., 2004). We determined satellite cells progression by 
examining the expression of Pax7 and MyoD markers on isolated myofibres from EDL 
muscles of WT, Mtn-/-and Mtn-/-/ErrγTg/+. Satellite cells were categorised according to the 
expression of myogenic markers into satellite cells (Pax7+), differentiating muscle cells 
(MyoD+), and myoblast (Pax7+ and MyoD+) (Figure 4.15).  
Our results showed no significant differences in numbers of satellite cells specifically express 
any of these markers (Figure 4.15). These observations, and in agreement with previous 
findings (Amthor et al., 2009), confirmed that the myofibres hypertrophy resulted from 
blocked or absence of Myostatin is independent satellite cells number or recruitment. In 
addition, it has been revealed that presence of Pax7 is compatible with myogenic 
differentiation and downregulation of this protein is not prerequisite for this process 
(Zammit et al., 2006). Therefore, high expression of Pax7 that we showed in our findings, 
might not contradict with normal differentiation process of satellite cells following Errγ 



































































Muscle-specific expression of Errγ does not affect muscle differentiation process.  
Profiling of satellite cells differentiation at 48 hr in cell culture. 
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 
Bonferroni’s multiple comparison tests. 
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4.15. Muscle-specific expression of Errγ into Mtn-/- promotes myonuclei number  
We showed that the increase of myofibres size in muscles from Mtn-/- and Mtn-/-/Errγ
Tg/+
 was 
not accompanied by increasing in satellite cells number, however, this depletion in satellite 
cells number following Myostatin deletion and Errγ overexpression did not affect 
proliferation and differentiation processes. Previous work has demonstrated that during 
muscle fibres growth, the number of myonuclei per muscle fibres reflects the accumulative 
history of muscle precursor recruitment and activity (Amthor et al., 2009). Moreover, a 
number of studies have referred to linear correlation between myonuclei number and size 
of individual muscle fibre (Bruusgaard et al., 2006, Allen et al., 1995, Roy et al., 1992). Until 
recently, data reported a slight reduction but not significantly in the average of total 
myonuclei number per individual myofibres from Mtn-/- compared to WT mice (Wang and 
McPherron, 2012). Here we determined whether introducing of Errγ into a muscle lacking 
Myostatin can impact myonuclei content.  
Therefore, we quantified myonuclei numbers at (T0) time point on isolated myofibre of EDL 
muscles from WT, Mtn-/- and Mtn-/-/Errγ
Tg/+
 mice (Figure 4.16A). Our studies showed that the 
numbers of myonuclei were similar in myofibres of EDL muscles from WT and Mtn-/-  mice, 
as well as between EDL myofibres from Mtn-/-  and Mtn-/-/Errγ
Tg/+. However, the number of 
myonuclei was significantly higher in the fibres of Mtn-/-/Errγ Tg/+ compared to WT (Figure 
4.16B). These data suggest that introducing of Errγ into Mtn-/- was sufficient to influence 















































Figure 4.16. Hyper-oxidative hypertrophy myofibres show more myonuclei  
Hypertrophied oxidative muscle developed through introduction of Errγ on the muscle of 
Myostatin null mice shows increase of myonuclei content. 
(A) Single EDL muscle fibres from WT, Mtn and Mtn:Eγ mice stained with DAPI to visualize 
myonuclei.  
(B) Quantification of myonuclear number in EDL fibres.  
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 
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4.16. Myonuclei distribution do not normalizes by introducing of Errγ into Mtn-/- mice 
We demonstrated a significant elevation in numbers of myonuclei per myofibres of EDL 
muscles from Mtn-/-/Errγ Tg/+ compared to WT, with no differences in between either WT and 
Mtn-/- or between Mtn-/- and Mtn-/-/Errγ Tg/+ muscles.   
Published study has illustrated that myonuclei distribution with individual myofibres is a 
regulated process, since myonuclei position is important to minimize issues related to 
macromolecule movement in larger cells. Therefore the degree of regulation is inversely 
proportional to random positioning of the nuclei (Bruusgaard et al., 2003). In order to 
quantify this, we calculated the distance to the nearest neighbour for the nuclei located at 
the periphery of single fibres of EDL muscles (n=4) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice. 
Confocal stacks of single fibres labelled with DAPI (Figure 4.17A) were used to generate the 
3D coordinates of each nucleus in fibre (Figure 4.17B) using Imaris software.  
Using custom made software, a simulation of randomly and optimally distributed nuclei was 
compared to the actual distribution (see methods). The WT fibres displayed an 
improvement from a random distribution of 20%. However, Mtn-/- and Mtn-/-/ErrγTg/+ fibres 
had distributions that were more random, with significantly lower improvements of 10% 
and 4%, respectively (Figure4.17C).  
Together, these results show that muscle-specific expression of Errγ in the Mtn-/- does not 



























































Figure 4.17. Myonuclei distribution in myofibres from EDL muscles of WT, Mtn and Mtn:Eγ 
mice 
Muscle-specific expression of Errγ does not normalizes myonuclei positioning 
(A) Confocal stacks of single fibres labelled with DAPI to study myonuclear organization. 
(B) Virtual reconstruction of single muscle fibres, colour encodes distance in the z-plane.  
(C) Improvement in myonuclear organization, where 0% denote a random distribution. 
Fibres were from 4 male twelve-week old mice per group; One-way ANOVA followed by 
Bonferroni’s multiple comparison tests, *= P<0.05.  
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4.17. Discussion  
Skeletal muscle is a plastic tissue composed of a heterogeneous population of muscle fibres 
that differ in their metabolic, molecular and contractile properties. It continuously adapts in 
response to a variety of stimuli (Rodriguez et al., 2014). Myostatin has been described as a 
negative regulator of muscle development, since its deletion leads to an increase in muscle 
mass that accompanied by predominantly of glycolytic fibres and reduction of oxidative 
phenotype (McPherron and Lee, 1997, Matsakas et al., 2012a). The glycolytic muscle 
phenotype that develops due to genetic deletion of Myostatin is associated with a marked 
reduction of mitochondrial enzyme activity and blood supply (McPherron et al., 1997, 
Amthor et al., 2007, Lipina et al., 2010). Furthermore, it has been reported that germline 
deletion of Myostatin results in a notable reduction of satellite cells population per myofibre 
(Amthor et al., 2009). On the other hand, several studies have described estrogen-related 
receptor gamma (Errγ) as a key molecular mediator in the mitochondrial function, 
angiogenesis and the development of oxidative phenotype in skeletal muscle (Giguere, 2008, 
Alaynick et al., 2007). Moreover, the potential role of Errγ in regulating the skeletal muscle 
intrinsic angiogenic program and oxidative metabolism pathways has been firmly established 
(Rangwala et al., 2010, Narkar et al., 2011). Currently, it was not known to what extent that 
Errγ introducing into a muscle lacking Myostatin using specific promoter (HSA) would rescue 
the metabolic, molecular and cellular deficits resulted from Myostatin absence.    
The detailed analysis of muscle metabolic status, blood supply efficiency, molecular profile 
of key marker genes that regulate angiogenesis, energy metabolism, oxygen handling and 
antioxidant, glucose and fatty acid oxidation and metabolism programs, as well as cellular 
features undertaken in this study highlight some key aspects of the skeletal muscle response 
to Myostatin deletion and specific expression of Errγ into Mtn-/- mice. Firstly, we show that 
myofibres of all muscles examined from Mtn-/- mice display a marked reduction of oxidative 
capacity indicated by low SDH activity, and high PAS activity (indicative high glycolytic 
status). However, muscle-specific expression of Errγ in the Mtn-/- restored the oxidative 
capacity to a normal level, as muscles from Mtn-/-/ErrγTg/+ mice show higher SDH activity 
than other genotypic groups. Secondly, we demonstrated that the reduced oxidative 
capacity in Mtn-/- muscles was accompanied by a significant decrease in blood supply. In 
contrast, muscles from Mtn-/-/ErrγTg/+ mice display the highest ratio of capillary per myofibre 
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(C:F), that exceeded even the vasculature level of WT mice. We also provided evidence that 
muscles from Mtn-/- and Mtn-/-/ErrγTg/+ mice had a distinctive metabolite profile 
characterised by significantly high levels of lactate and creatine/phosphocreatine in Mtn-/- 
compared to that of the Mtn-/-/ErrγTg/+ muscles which is consistent with a greater glycolytic 
phenotype. On the other hand, muscles from Mtn-/-/ErrγTg/+ mice displayed greater content 
of taurine and anserine. Our work examining gene expression levels offers interesting 
insight into the molecular program that would explain the metabolic profile of Mtn-/-/ErrγTg/+ 
muscles. We showed that Errγ introducing into Mtn-/- mice was efficacious for inducing of 
endothelial mitogenic factors expression that regulate angiogenesis program, normalizing 
expression level of the key regulators of energy metabolism, promoting the expression of 
glucose metabolism and fatty acid metabolism markers, upregulating gene levels of oxygen 
handling and antioxidant enzymes, and enhancing the level of genes that regulate fat 
metabolism. Furthermore, this data showed that the normalization of mitochondrial size and 
distribution that followed overexpression of Errγ into Mtn-/- muscles, concomitant with a 
significant reduction of ROS levels compared to muscles from Mtn-/- mice that displayed the 
highest intensity of DHE. Additionally, our results challenged the notion that slow oxidative 
muscle fibres contain a high number of muscle resident stem cells (satellite cells), as hyper-
oxidative hypertrophic myofibres from Mtn-/-/ErrγTg/+ muscles showed the lowest number of 
satellite cells per myofibre compared to the other genotypic groups. Finally, an interesting 
feature highlighted by our work in this section was the high number of myonuclei per 
myofibres of Mtn-/-/ErrγTg/+ muscles compared to WT and Mtn-/- muscles. 
In agreement with aforementioned findings (Girgenrath et al., 2005, Amthor et al., 2007), 
our study demonstrates that the key feature of Mtn-/- is the lower SDH activity, indicative of 
a low muscle oxidative capacity. We showed previously that germline deletion of Myostatin 
led to dramatic increase in muscle fibres size, which is also associated with the large 
proportion of myosin heavy chain (MHC) type IIB fibres. This combination of a low oxidative 
capacity and a large fibre size fits nicely with the concept of the trade-off between fibre size 
and oxidative capacity (Van der Laarse WJ, 1998). On the contrary, even our previous 
observations demonstrated no difference in fibre CSA between muscles from Mtn-/- and 
Mtn-/-/ErrγTg/+ mice, the latter had significantly high SDH activity. The higher SDH activity in 
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Mtn-/-/ErrγTg/+ than Mtn-/- muscles was associated with a partial normalisation of the MHC 
fibre profile, a decrease in the proportion of IIB fibres in all muscles examined. 
It is uncertain which program causes a conversion of myofibres toward glycolytic 
phenotypes following Myostatin ablation. Previously has been shown that post-natal 
blocking of Myostatin does not induce significant glycolytic muscle fibres transition 
(Matsakas et al., 2009), indicating that the glycolytic myofibres resulted from genetic 
deletion of Myostatin may be pre-natally programmed (Girgenrath et al., 2005). We showed 
earlier that mitochondrial number was reduced significantly in Mtn-/- muscles compared to 
WT, such observations that have been reported by Amthor’s group (Amthor et al., 2007), 
indicating a reduction of oxidative capacity. We also demonstrated an abnormality of 
mitochondrial distribution and size in muscles from Mtn-/- mice. This would infer that the 
mitochondrial depletion might be a causative reason for the observed myofibre type shifting 
toward glycolytic phenotype in muscles from Mtn-/- mice. To avoid fibre shifting toward the 
glycolytic phenotypes, we need to increase mitochondrial density. Numerous studies have 
demonstrated that Errγ is constitutively active orphan nuclear receptor that is highly 
expressed in metabolically active with high oxidative capacity tissues, such as the heart, 
kidneys, brain and oxidative skeletal muscles (Hong et al., 1999, Giguere, 2008, Narkar et al., 
2011). Moreover, Errγ has been described as a key regulator of a gene network linked to 
fatty acid oxidation and mitochondrial biogenesis (Dufour et al., 2007). Therefore, to 
alleviate mitochondrial deficit in Mtn-/- mice, we introduced the expression of Errγ into 
skeletal muscle using specific promoter (human α-skeletal actin promoter (HSA). Errγ 
overexpression that would induce oxidative properties on a Mtn-/- background that is 
associated with hypertrophy as we showed earlier, would challenge the trade-off that is 
thought to be existent between muscle fibre oxidative capacity and its size (Van der Laarse 
WJ, 1998, Degens, 2012). Thus, we explored the potential role of Errγ to restore the 
oxidative capacity in muscles from Mtn-/- to that level of WT, robustly mediated by 
attenuating the mitochondrial deficits that following Myostatin ablation.  
A number of studies have suggested that fibres that rely on oxidative phosphorylation limit 
their size in order that oxygen from the capillaries diffuses efficiently into the cells and to the 
mitochondria for ATP production (Kinsey et al., 2007, Van der Laarse WJ, 1998, van Wessel et 
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al., 2010). The large fibres with a low oxidative capacity in Mtn-/- mice as we showed above 
conform to this concept and have a low capillary supply per fibre.  
During compensatory hypertrophy the time course of angiogenesis and fibre hypertrophy 
are similar (Egginton et al., 1998, Plyley et al., 1998), and the capillary supply to a fibre is 
related to fibre size (Ahmed et al., 1997, Degens et al., 1992). In our study, we illustrate that 
a coupling between the fibre size and capillary supply seems to be altered in the Mtn-/- 
muscles in such a way that they have fewer capillaries than expected for the size of the fibre. 
However, overexpression of Errγ in Mtn-/- drives a robust angiogenic gene programme, 
increases the number of capillaries per fibre and ultimately increased muscle blood flow as 
we showed previously (See Figures 4.3A-B, and 4.4A and B). These observations are 
consistent with previous reports providing evidence of potential transgenic expression of 
Errγ in fast-twitch fibres trigger aerobic transformation, mitochondrial biogenesis and robust 
myofibrillar vascularization, thus it promotes and coordinates vascular supply and metabolic 
demand in oxidative slow-twitch myofibres (Narkar et al., 2011, Matsakas et al., 2012b). We 
suggest that as Errγ is highly expressed in highly vascularised organs such as skeletal muscle, 
thus its targeting to potentiate and orchestrate a reparative angiogenesis programme of a 
muscle lacking Myostatin would be very powerful. An important finding here is that the 
angiogenesis programme promoted by muscle expression of Errγ is responsive to change in 
fibre size so that when a fibre grows, it stimulates the formation of blood vessels presumably 
to ensure optimal perfusion.   
Next, we determined the mechanisms that deliver the changes in the oxidative capacity of 
Mtn-/- muscles following Errγ introduction by examining the expression of a molecule that 
regulate oxygen diffusion from capillary to mitochondria in the hyper-oxidative 
hypertrophied fibres. It has been reported that presence of molecule that facilitate diffusion 
of oxygen may be essential to overcome the problem of oxygen diffusion in large muscle 
fibres (Hoofd and Egginton, 1997). Further studies have shown that myoglobin, which 
facilitates oxygen diffusion in mammalian muscle fibres, concentration unaltered in 
hypertrophied muscles (de Koning et al., 1981, Masuda et al., 1997). 
In present study, we showed that hyper-oxidative hypertrophic muscles displayed a high 
mitochondrial density in particular at the sarcolemma. Moreover, an additional modification 
takes place, an increase of myoglobin transcription that would facilitate oxygen diffusion 
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from capillary to mitochondria, thereby sustaining large oxidative fibres developed as a 
consequence of Errγ introducing into Mtn-/- muscles. These outcomes have been postulated 
to prevent a decline in maximum steady state power as an oxidative fibre increases size 
(Hickson, 1980, Heard et al., 2000). 
Basis on our data, we challenge the notion of inverse relationship between muscle fibre size 
and oxidative capacity taking advantage of the ability of oxidative muscle fibres that 
imparted by muscle-specific Errγ overexpression to secrete cocktail of angiogenic factors. 
Thus, it allows recruitment of new blood supply, thereby improved muscle exercise capacity 
as demonstrated in advance.   
Skeletal muscle function mainly related to its structure and metabolic processes that 
conserve the tissue (Krivickas et al., 2011). Myostatin signalling suppresses muscle fibres 
enlargement and the reliance on glycolytic metabolism, thus co-ordinate muscle metabolism 
and structure (Matsakas et al., 2012a). The outcomes of present study, however, shows that 
muscle-specific expression of Errγ can modulate the phenotype of muscle from animals that 
lack Myostatin. Therefore, the oxidative phenotype not only promoted by Myostatin 
signalling, but also by Errγ overexpression. Here we show that Errγ introducing alters the 
metabolic profile of Mtn-/- muscles by increasing, hence normalizing the oxidative 
phenotype.  
Energy status (ATP/ADP or phosphocreatine) has been implicated as a determinant of 
muscle fibre type with high levels inducing ever more fast forms in keeping with their 
myofibrillar ATPase activity (Conjard et al., 1998, Bottinelli et al., 1994b). We show here 
from our NMR profiling that indeed the muscle of Mtn-/- has high levels of phosphocreatine, 
which would be in keeping with the high ATPase activity of type IIB fibres found in its muscle, 
however, Errγ introducing in Mtn-/- muscles partially normalizes this feature.  
In agreement with previous studies, we confirmed that Errγ is a key molecule in the 
development of the oxidative phenotype in skeletal muscles (Narkar et al., 2011, Rangwala 
et al., 2010). Consistent with the oxidative metabolic phenotype of the Mtn-/-/ErrγTg/+ mice 
there are higher levels of taurine and anserine observed in the NMR metabonomic analysis, 
(This work has been done by Natasa Giallourou, University of Reading, Uk), since taurine is 
positively correlated with the oxidative capacity of muscle tissues (Dunnett et al., 1997). 
Anserine is β-alanine and histidine related dipeptide with antioxidant properties commonly 
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found in skeletal muscle of many animals (Kohen et al., 1988). Furthermore, we show that 
the expression level of catalase an anti-oxidant enzyme was increased significantly in Mtn-/-
/ErrγTg/+ muscles. One possible explanation of the simultaneous robust increase of anserine 
and catalase levels in these muscles, is that both of them may act as scavenging agent of the 
byproducts arising from elevated oxidative activity in the muscle of Mtn-/-/ErrγTg/+ mice.  
The gene-profiling analysis gives an insight into the mechanisms that regulate the oxidative 
phenotype induced by muscle-specific overexpression of Errγ into Mtn-/- muscles. Our 
analysis at transcriptional level revealed that Errγ acts by co-ordinately normalising genes 
that regulate muscle energy metabolism, glucose transport and metabolism, and fat 
transport, uptake and metabolism. Apart of (Perm 1), we show that Errγ overexpression into 
Mtn-/- muscles normalised the expression of all key transcriptional inducers of oxidative 
metabolism including (PGC1α, Ppard and Rev-erb a), and biomarker genes that regulate 
glucose metabolism and transport such as (Glut1, Glut4 and PDK4). The observed increase 
of Perm 1 expression level following Errγ overexpression might indicate its role in regulating 
of glucose and lipid metabolism, mitochondrial biogenesis and energy transfer (Heesch et 
al., 2016). Important finding of our study was the normalization of PGC1α, an inducible of 
aerobic muscle, to normal condition following Errγ overexpression. It has been reported that 
de-acetylation of PGC1α is critical for its activation in the skeletal muscles (Canto et al., 
2010, Gerhart-Hines et al., 2007, Lagouge et al., 2006). We suggest that the genetic deletion 
of Myostatin resulted in a significant increase of PGC1α level mediated by de-acetylation of 
this gene. However, Errγ introducing in Mtn-/- muscles was efficacious in restoring PGC1α to 
normal expression level, probably by bringing it back to acetylated status. Moreover, it has 
been shown that PGC1α is not essential for fibre type specification in skeletal muscle 
(Zechner et al., 2010). We infer from this, Errγ is sufficient to induce both metabolic and 
vascular pathways to drive aerobic remodelling of Mtn-/- muscles independent of PGC1α.  
Previous work has been reported that PDK4 is a key molecule that initiate a switch from 
glucose oxidation to fatty acid oxidation (FAO) through inhibiting of pyruvate 
dehydrogenase complex (PDC) that regulates pyruvate entry into the TCA cycle (Giguere, 
2008). Moreover, it has been illustrated that there is a possibility of PGC1α to induce 
glucose oxidation via transcriptional control of PDK4 (Wende et al., 2005). Accordingly we 
believe that the reduction of PGC1α following Errγ overexpression results in downregulation 
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of PDK4 expression level. Another possible explanation is that the oxidative program 
promoted by Errγ introducing in Mtn-/- muscles was sufficient to downregulate PDK4 
expression to drive a shifting from glucose to fatty acid oxidation.          
Previous work has reported that high fat diet can have detrimental effects on skeletal 
muscle structure and functions, and impaired regeneration in response to injury (Nguyen et 
al., 2011). The expression gene analysis that we performed identified Errγ as a key regulator 
of multiple genes linked to both fatty acid oxidation and metabolism (Alaynick et al., 2007). 
Furthermore, it was illustrated that Errγ transgenic mice gained 35% less weight than wild 
type mice during a course of a high-fat diet (Narkar et al., 2011). An interesting outcome 
here is muscle-specific expression of Errγ into Mtn-/- muscle robustly promotes expression 
level of all examined genes that linked to fat metabolism (fatty acid transport and uptake 
molecules: Cd36, Slc25a20, Fatp1, Fabp3 and regulators of fatty acid oxidation: Acadl, 
Acadm). For instance,  acyl-coenzyme A dehydrogenase Medium-chain (Acadm) is an 
enzyme that mediates the first step in the mitochondrial β-oxidation of fatty acids (Schulz, 
1991). Subsequently, it has been firmly established that tissues utilize fatty acids as energy 
substrate such as heart and skeletal muscles express high level of Acadm gene (Nagao et al., 
1993). We have shown overexpression of Errγ in Mtn-/- muscles increased oxidative capacity 
reflecting by robust SDH activity, high capillary density and better oxygen diffusion. By way 
of explanation, we suggest that muscle-specific introducing of Errγ in Mtn-/- muscles 
significantly promoted the expression level of genes that regulate fat metabolism and fatty 
acid oxidation to maintain these parameter at high level that match the increased metabolic 
and oxidative capacity demands.          
The muscle of Mtn-/- mice not only showed notable shifting toward glycolytic fast phenotype 
fibre, and low capillary density, but also those displayed lower exercise capacity indicated by 
shorter running time compared to the other genotypic groups which might attribute to 
perturb of muscle cells organelles. In the present study using transmission electron 
microscopy (TEM), we showed a number of ultrastructural abnormalities in the organisation 
of the contractile apparatus and the cellular organelles. More specifically was the finding 
that genetic deletion of Myostatin led to a disruption in the quantity and quality of 
mitochondria in these muscles. However, Errγ introducing into Mtn-/- muscles largely 
normalised these abnormalities. It was well established that high mitochondrial number and 
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oxidative capacity are essential for integral skeletal muscle performance (Hamai et al., 1997, 
Rochard et al., 2000). Errγ has been described as a master regulator of skeletal muscle 
mitochondrial biogenesis and activity mediated by regulating a network of genes involved in 
the TCA cycle, fatty acid oxidation (FAO)  and oxidative phosphorylation pathways (Dufour et 
al., 2007, Alaynick et al., 2007). Furthermore, previous investigation of phenotypic 
characterization of Errγ knockout mice showed a reduction in the expression and activity of 
TCA and electron transport chain (ETC) complex 1 enzyme (Alaynick et al., 2007). In the line 
of this investigation, several studies have shown that mitochondrial ETC complexes I and III 
are the major sources of ROS in muscle cells (Harper et al., 2004), that resulted in protein 
and DNA damage thereby inhibit muscle activities such as contraction time and myocyte 
differentiation (Jackson, 2011, Langen et al., 2002).  
Conversely, treatment with antioxidants that can scavenge ROS leads to attenuate the 
effects of H2O2 and stimulate myocyte differentiation (Hansen et al., 2007). Our study show 
elevated levels of ROS through the profiling of DHF activity (Diaz et al., 2003) in muscles 
from Mtn-/- mice, whereas muscle-specific expression of Errγ normalized ROS level. We 
therefore suggest the Myostatin deletion leads to ultimately compromised mitochondria 
function, resulting in increased ROS production which may compromise the function of the 
contractile apparatus (Powers et al., 2012). In contrast, Errγ overexpression into Mtn-/- 
muscle was sufficient to promote mitochondrial density and re-localization in particular at 
sub-membrane areas. Furthermore, it increases the expression level of anti-oxidant, thereby 
reduces ROS emission in skeletal muscle cells of Mtn-/-/ErrγTg/+ mice.  
Present study gives new perspective on the relationship between metabolism and satellite 
cells number per muscle fibres. Our data has challenged comprehensively the generally 
accepted mechanism of Myostatin action on satellite cells in skeletal muscle. Strikingly, the 
observations of the study contradict the dogma that slow muscles contain more satellite 
cells than the fast phenotypes (Putman et al., 1999, Christov et al., 2007). We show that at 
least in the EDL as the fibres transitioned from type IIB to type IIA in muscles from Mtn-/-
/ErrγTg/+ mice, the number of associated satellite cells was significantly reduced, with a 
concurrent increase of myonuclei number. Numerous studies have revealed Myostatin as a 
negative regulator of muscle growth (McPherron and Lee, 1997, Taylor et al., 2001). 
However, there is uncertainty about how this activity is mediated. Thomas (Thomas et al., 
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2000) has demonstrated that Myostatin acts to suppress the activity of skeletal muscle stem 
cells. On the contrary, others have reported that Myostatin inhibits muscle growth and 
regeneration mediated by controlling protein synthesis and breakdown in myofibres through 
a mechanism mostly if not completely independent of satellite cells (Amthor et al., 2009, Lee 
et al., 2012b). In support of this view, previous work has shown that Myostatin propeptide-
mediated inhibition of this molecule resulted in muscle fibre hypertrophy liberated of 
satellite cell activity (Matsakas et al., 2009). 
In agreement with our findings, previous work has reported that muscles from Mtn-/- mice 
had reduced number of satellite cells without altering their rate of proliferation (Amthor et 
al., 2009). Same study has shown a constant number of clusters and satellite cells per cluster 
along isolated myofibres from Mtn-/- mice compared to the wild type (Amthor et al., 2009). 
Consistently, Welle (Welle et al., 2011) has referred that post-developmental inactivation of 
Myostatin leads to muscle fibres hypertrophy without myonuclear accretion. These findings 
were contradict by McCroskery et al. who reported that Myostatin deletion results in an 
increase in number of satellite cells (McCroskery et al., 2003). We suggest that myofibres 
hypertrophy following Myostatin deletion is independent satellite cells number. It implicates 
instead mechanism whereby Myostatin absence up-regulates PI3K/AKT/mTOR pathway that 
influences protein synthesis in hypertrophic myofibres (Chelh et al., 2009). We showed that 
muscle-specific expression of Errγ into Mtn-/- caused transition of glycolytic fibres toward 
oxidative phenotypes. As hypertrophic fibres from Mtn-/- mice showed a reduction in 
satellite cell number, imperative question is whether myofibres shifting toward oxidative 
phenotypes following Errγ overexpression would increase satellite cells number. Further, 
does the alteration in myofibre type can affect myonuclei number and distribution? We 
found fewer satellite cells and clusters per fibre, no change in the number of cells per 
cluster, and increase in myonuclei number per muscle fibre from Mtn-/-/ErrγTg/+ mice 
compared to other genotypic groups. One possible explanation for this finding is by taking 
into account the concomitant increase in the number of nuclei in the myofibre. Here, the 
relationship is opposite to satellite cell fibre number. We postulate that the absence of 
Myostatin promotes myoblast fusion at the expense of satellite cell. Furthermore, that 
overexpression of Errγ exacerbates this relationship. We provide evidence that the 
reduction in satellite cells number in myofibres of Mtn-/-/ErrγTg/+ mice does not affect these 
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cells proliferation and differentiation. By way of an explanation, Errγ overexpression might 
reduce satellite cells migration on the fibre, consequently reduces the number of clusters 
per myofibre. However, when these cells migrate to their destination, they divide into a 
similar number of daughter cells.  
The number of myonuclei per myofibres can indicate satellite cells recruitment and activity 
(Amthor et al., 2009). A number of studies have established that there is a good correlation 
between number of nuclei and muscle fibre size (Allen et al., 1999, Bruusgaard et al., 2003, 
Roy et al., 1999). In the line with this investigation, it has been demonstrated that muscle 
fibre hypertrophy is a concomitant with an increase in the number of myonuclei and a 
stable myonuclear domain (Hall and Ralston, 1989, Edgerton and Roy, 1991, Allen et al., 
1999). Additionally, accretion of myonuclei is a prerequisite for maintaining specific force 
during hypertrophy and mitochondrial protein systems have been suggested to play a role in 
defining myonuclear domain size in rodents (Liu et al., 2009). It was well established that 
fibre nuclei are not positioned randomly, but are more or less regularly spaced out in 
myofibres (Bruusgaard et al., 2003). Furthermore, proper nuclear positioning is probably 
required for normal muscle function, possibly due to irregular size and spacing of 
myonuclear domains (Metzger et al., 2012), and myonuclear disorganization is observed 
both in ageing skeletal muscle and in models of muscular dystrophies (Bruusgaard et al., 
2006, Meinke et al., 2014). Myonuclei in Mtn-/- and Mtn-/-/ErrγTg/+ muscles were more 
disorganized than those in WT fibres (Figure 4.16, myonuclei distribution work has been 
done by Jo C Bruusgaard, University of Oslo, Norway). We suggest that the increased 
number of myonuclei and increased synthesis of mitochondria in the Mtn-/-/ErrγTg/+ mice 
might compensate for the observed disorganized myonuclei, restoring specific force and 
ultrastructure, and maintain an appropriate level of transcriptional for protein synthesis to 
accommodate the increased cytoplasmic volume.    
In summary, our work challenges the dogma of an inverse relationship between muscle 
fibre size and oxidative capacity. This achieved by maintaining the increase in muscle fibre 
size exhibited my Myostatin deletion as we showed previously, increased oxidative capacity, 
promote muscle vasculature, and normalised energy, metabolic and oxidative profiles at 
transcriptional levels. Moreover, our observations contradict the notion that slow oxidative 
myofibres have to have a high number of muscle resident stem cells (Satellite cells). It 
Chapter 4 
204 
S. S. Omairi, PhD 2018 
 
remains to be determined whether the depletion in satellite cells would affect skeletal 
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5.1. Introduction  
Skeletal muscles possess a high regenerative potential underpinned by the resident 
quiescent muscle progenitors cells known as satellite cells (SCs) (MAURO, 1961, Scharner 
and Zammit, 2011). The satellite cells reside between the basal lamina and sarcolemma of 
muscle fibre as a dormant myoblast, but they are activated in response to physiological 
stimuli for instance exercise, and pathological conditions such as injury and degenerative 
diseases (Gayraud-Morel et al., 2009). Subsequently, SCs enter the cell cycle and generate a 
committed population of muscle precursors that proliferate, differentiate and then either 
fuse with existing myofibres, repairing damaged muscle fibres, or fuse with each other to 
form new myofibres (Charge and Rudnicki, 2004, Gayraud-Morel et al., 2009). In parallel, a 
subset of SCs does not differentiate, but instead re-enter quiescence, thereby replenishing 
the stem cell pool (Zammit et al., 2004, Collins et al., 2005). 
Muscle regeneration recapitulates many aspects of prenatal development, and it is an 
important homeostatic process of adult skeletal muscle. A number of chemicals have been 
utilised in order to investigate skeletal muscle degeneration/regeneration (Tajbakhsh and 
Cossu, 1997, Charge and Rudnicki, 2004). One of the most frequently used and reproducible 
method to induce muscle regeneration is based on cardiotoxin (CTX) injection (d'Albis et al., 
1988). CTX has been described as a peptide that is able to interact with membrane’s 
proteins, acts as protein kinase C-specific inhibitor, and increases cytosolic calcium, thereby 
causes cell damages (Charge and Rudnicki, 2004, Pelosi et al., 2007, Wang et al., 1997, 
Raynor et al., 1991). Moreover, it has been documented that this cytotoxic drug is a snake 
venom fraction that induces muscle injury in a way similar to those observed in disease 
cases such as inflammatory myopathies (IMs) and muscular dystrophies (MDs) (Ramadasan-
Nair et al., 2014). Furthermore, previous work has shown that CTX induces degeneration in 
the muscle fibres, but do not affect blood vessels, muscle innervation, ECM content and 
muscle resident stem cells (SCs) (Shi and Garry, 2006). Alternatively, skeletal muscle 
degeneration/regeneration can be investigate utilising other techniques, such as muscle 
crushing (Jager et al., 2014, Chatterjee et al., 2015), or the administration of different 
chemicals, such as barium chloride (Cornelison et al., 2004). 
Skeletal muscle degeneration/regeneration following CTX injection occurs in five 
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of the myofibres, loss of sarcolemma, contractile materials, and cellular organelles 
dissolution (Prisk and Huard, 2003). Necrotic fibres appear enlarged with altered internal 
architectures and presence of internal nuclei (Matsuda et al., 1995). Releasing of free radical 
species and proteases from raptured myofibres and damaged blood vessels leads to the 
necrosis in the surrounding tissues thereby accelerate inflammatory response as the second 
phase of muscle regeneration (Mann et al., 2011, Grounds, 1987). The inflammatory 
response is a critical step that controls homeostasis and regeneration of the injured skeletal 
muscle (Teixeira et al., 2003). During the first 24 hours following muscle injury, neutrophil 
invades the site of muscle damage, and secretes chemicals that stimulate other cell 
populations, namely, monocytes which rapidly differentiate into a pro-inflammatory 
macrophage (M1) when arrive at the damaged area (Tidball, 2005). Macrophages promptly 
increase in number within 24 hours after injury, and act to remove the tissue debris (St 
Pierre and Tidball, 1994). Previous work has reported that macrophages sequentially change 
their phenotypes as a response to the alterations in the surrounding microenvironment 
(Stout et al., 2005). Thus, as the degeneration process ongoing due to the effects of pro-
inflammatory cytokines, prostanoids and collagenases are secreted from M1, break up the 
surrounding tissue and stimulate it to produce cytokines, hence switch M1 to the anti-
inflammatory macrophages (M2) (Villalta et al., 2011). Macrophages change their phenotypes 
within 1-3 days after injury, and this phenotype switch from inflammatory to anti-
inflammatory macrophages occurs after phagocytosis of both apoptotic and necrotic 
myofibres (Serhan and Savill, 2005). The M2 population is subdivided into three cohorts, 
M2a that associated with chronic inflammation in particular during parasitic infection, M2b 
which with M2a exerts immunoregulatory functions, and thirdly M2c that related to the 
suppression of immune responses and stimulate tissue repair (Stout and Suttles, 2004, 
Mantovani et al., 2004).  
The anti-inflammatory macrophages and satellite cells population begin to dominant after 
day 3 of muscle injury to start the third stage. Indeed, satellite cells are initially activated 
about 24 hours following injury, once activated they either maintain MyoD expression and 
downregulate Pax7, thus commit to proliferation and differentiation. Alternatively, SCs they 
downregulate MyoD and sustain Pax7 positive quiescent satellite cells pool (Relaix and 




S. S. Omairi, PhD 2018 
 
The fourth stage of degeneration/regeneration cycle is characterised by remodelling 
connective tissue and angiogenesis. TGF-β is a key factor to induce fibrosis formation after 
skeletal muscle injury, a process that seems initially beneficial as it provides strength and 
protects the injured area. However, overproduction of collagens within the injured area 
leads to lose muscle function due to scar formation (Li et al., 2004).  
Finally, the rescuing of myofibre functional performance and contractile apparatus, 
complete the reparative process (Pelosi et al., 2007). Moreover, previous work has 
illustrated that the regenerated muscles become effectively innervated within two weeks, 
as newly formed neuromuscular junctions (NMJs) between the surviving axons and the 
regenerated myofibres can be identified (Mozdziak et al., 2001) (Figure 5.1). 
Work carried out in the previous chapters demonstrated that muscle-specific 
overexpression of Errγ onto Myostatin null background led to a decrease in satellite cell 
number. We infer from this, that all the changes in muscle resulting from the introducing of 
Errγ in the Mtn-/- muscles were beneficial except for a lower number of satellite cells. Thus, 
in this section we want to determine the consequences of the reduction in SCs number on 
the ability of skeletal muscle to regenerate. 
A number of studies have demonstrated that the genetic manipulations which induce 
muscle oxidative properties accelerate muscle regeneration capacity (Li et al., 2007b). We 
hypothesised that the increased oxidative capacity and microvascular network following 
superimposition of Errγ in the Mtn-/- background muscles might enhance the regeneration 
capacity of these muscles. To test this hypothesis, we induced injury of the TA muscles from 
male (WT, Mtn-/- and Mtn-/-/ErrγTg/+) mice at 12 weeks old age using cardiotoxin (CTX) (Naja 
mossambica mossambica) and assessed the progression of regeneration at three crucial 
time points; day three (D3) as the process of debris clearance is on-going and regeneration 
of fibres begins, day six (D6) when a robust fibre regeneration can be quantified, and day 
fourteen (D14) when debris clearance has been completed.   
Observations of this chapter show advance clearance process of necrotic fibres in TA 
muscles from Mtn-/-/ErrγTg/+ mice than WT and Mtn-/- counterpart muscles at day 3 and day 
6 after CTX treatment. Secondly, at both day 3 and day 6, macrophages density was the 
highest in the Mtn-/-/ErrγTg/+ compared to either Mtn-/-or WT muscles. Thirdly, TA muscles 
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genotypic groups at both time points (day 3 and day 6). Furthermore, there was a greater 
degree of regeneration (number and size of newly formed eMHC+ fibres) in Mtn-/-/ErrγTg/+ 
compared to either Mtn-/- or WT mice after six days of CXT injection. In addition, we show a 
lower amount of cell death in the regenerating areas of Mtn-/-/ErrγTg/+ muscles than the 
other two cohorts. Finally, we provided evidence that there was a reduction in the density 
of fibres expressing eMHC at day 14. Moreover, newly regenerated fibre in the Mtn-/-





































Figure 5.1. Schematic model of muscle degeneration/regeneration cycle 
Five phases of muscle degeneration/regeneration cycle after injury. Muscle fibre necrosis 
activates muscle inflammation to remove necrotic cellular debris. Inflammation is followed 
by a regeneration phase that driving by satellite cells to replace damaged fibres. Fourth 
phase characterized by the remodeling of ECM and angiogenesis. The cycle completed by 
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5.2. Assessment of skeletal muscles degeneration after 3 days of cardiotoxin injection 
The injury model of this study was obtained by injecting 30 µl of 50 µM of cardiotoxin (CTX) 
in the tibialis anterior (TA) muscles from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice. The injected 
animals were allowed to convalesce for at least three days after CTX treatment, and the 
injured muscles were collected at day 3, day 6 and day 14 following the injection.  
To determine skeletal muscle injury level, Hematoxylin and Eosin stain (H and E) was 
performed on 10 μm thickness sections from the mid-belly of collected TA muscles (n=5) of 
the three mentioned genotypic groups (Figure 5.2A-C). We found that all muscles have an 
adequate damaged level that enables an appropriate assessment of 
degeneration/regeneration process.   
Next we examined whether overexpression of Errγ in the Mtn-/- background muscles would 
affect the severity of CTX damage after three days of injury. Thus, we analysed acid 
phosphatase (a marker for lysosomal activity) stained TA muscle sections (n=5) from the 
same three animal cohorts. 
In order to measure muscle damage levels, a value of 0 - 3 was set to damaged TA muscle 
sections for overall intensity of acid phosphatase staining.   
Following this scheme of score, we found that the intensity of acid phosphatase was the 
highest in TA muscle sections from Mtn-/- mice (2.7 ± 0.14), and the lowest in Mtn-/-/ErrγTg/+ 
muscles (2 ± 0.57), with WT in between (2.2 ± 0.11) (Figure 3.3 A and B).  
These data show that overexpression of Errγ in the Mtn-/- background reduced damage 
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Figure 5.2. Intramuscular administration of cardiotoxin induces different levels of injury 
in TA muscles from WT, Mtn and Mtn:Eγ mice 
(A) Harvested TA muscles after 3 days of CTX administration. 
(B) Representative images for Hematoxylin and Eosin staining on the TA muscles were 
injected with 30 µl of PBS. 
(C) Representative images for Hematoxylin and Eosin staining on the TA muscles were 
injected with 30 µl of CTX, after 3 days. 
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Figure 5.3. Intramuscular administration of cardiotoxin induces different levels of 
degeneration in TA muscles from WT, Mtn and Mtn:Eγ mice  
(A) Representative images for acid phosphatase staining in the damaged TA muscles from 
WT, Mtn and Mtn:Eγ mice after 3 days of receiving IM 30 µL of cardiotoxin .  
(B) Quantification of acid phosphatase intensity in the injured areas of TA muscles at day 3 
post-injury. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.3. Muscle-specific overexpression of Errγ in the Mtn-/- background attenuates necrosis 
induced by cardiotoxin treatment at day 3 post-injury   
Previous work has shown that CTX injection induces skeletal muscle necrosis that is mainly 
triggered by an overload of calcium in the cytoplasm (Langone et al., 2014). At day 3 post-
injection, the damaged muscle fibres became infiltrated with circulating IgG molecules, 
fibres that identified as necrotic fibres, which characterized by the present of internal nuclei, 
and altered architectures (Matsuda et al., 1995). As removing of necrotic myofibres is 
required to carry out the regeneration process, so counting the number and measuring the 
size of these fibres were performed to assess the progression of muscle 
degeneration/regeneration cycle.  
We investigated this by staining damaged TA muscle sections (n=5) from WT, Mtn-/- and 
Mtn-/-/ErrγTg/+ mice for (IgG) expression in order to identify the necrotic fibres.  
Counting the number of necrotic myofibres at day 3 of CTX injection showed that TA 
muscles from Mtn-/- mice contain the highest number of necrotic myofibres (217.5 ± 11.2) 
compared to other genotypic groups (146.5 ± 25.1 and 194 ± 5.1) for WT and Mtn-/-/ErrγTg/+ 
respectively (Figure 5.4 A and B). 
Measurement of necrotic myofibres area found that the CSA of these fibres was the largest 
in Mtn-/- muscles, and the smallest in TA muscles from WT mice, with CSA of necrotic fibres 
of Mtn-/-/ErrγTg/+ muscles in between (Figure 5.4 A and C).      
Together, these data suggest that the clearance process of necrotic fibres was the slowest in 
muscles from Mtn-/- mice after 3 days of CTX treatment. However, muscle-specific 
expression of Errγ in the Mtn-/- background enhanced the necrotic fibres removal that 























































Figure 5.4. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through enhanced clearing of necrotic fibres in response to 
cardiotoxin injury  
(A) Muscle necrotic fibres (white arrows) visualized by IgG staining on damaged TA muscles 
of WT, Mtn and Mtn:Eγ mice at day 3 after CTX injection.  
(B) Quantification of dying fibre number after 3 days of CTX injection.  
(C) Measurement of dying fibre size after 3 days of CTX injection.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.4. Lower levels of cell death in injured TA muscles of Mtn-/-/ErrγTg/+ mice after three days 
of cardiotoxin treatment 
Previous work has reported that cell death is one of the main factors that negatively impact 
satellite cells cycle, thereby delay formation of new myofibres during muscle regeneration 
(Castets et al., 2011). Moreover, it has been shown that phagocytosis of both apoptotic and 
necrotic myofibres is essential for macrophage to switch from inflammatory to anti-
inflammatory phenotype (Serhan and Savill, 2005).  
Since CTX treatment is well known to induce skeletal muscle cells death (Ramadasan-Nair et 
al., 2014). Thus, to further characterize the potential of Errγ overexpression in the Mtn-/- 
background muscles in clearing process of debris in damaged areas following CTX treatment, 
we expanded our investigation to determine its effect on the amount of cell death.  
To assess this, immunostaining of Cleaved caspace-3 (marker of apoptotic cells) was carried 
out on damaged TA muscle sections (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice at day 3 
post CTX injection. 
Counting the number of apoptotic cells per damaged areas of TA muscles showed no 
significant difference in these cells number between muscles of the three genotypic groups 
(Figure 5.5A and B).  
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Figure 5.5. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through reduced amount of cell death 
(A) Representative images of damaged TA muscle sections of WT, Mtn and Mtn:Eγ mice 
immunostained for Cleaved caspase 3 at day 3 post-injury as a marker of apoptosis (white 
arrows).  
(B) Quantification of apoptotic fibres density after three days of CTX injection.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 




S. S. Omairi, PhD 2018 
 
5.5. Overexpression of Errγ promotes macrophages accumulation in damaged muscle 
Macrophages role in skeletal muscle regeneration has been known (McLennan, 1996, St 
Pierre and Tidball, 1994), and several studies have shown that they actually contribute in 
clearing of damaged tissues, apoptotic and necrotic cells, thereby participate in 
regeneration and repairing processes (Novak et al., 2011, Arnold et al., 2007). Moreover, a 
number of researchers have observed a clear retardation of skeletal muscle regeneration 
indicating by a delay in the formation of new myofibres due to a decrease in 
monocyte/macrophages entry into injured areas (Shireman et al., 2007).  
Here we examined whether Myostatin deletion would affect the entry of macrophages into 
the injured sites of TA muscle, and sought to determine the consequences of Errγ 
overexpression in the Mtn-/- background on macrophages infiltration into the damaged 
areas. To do so, immunostaining for F4.80 (macrophage marker) was performed on injured 
TA muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice at day 3 post-injection.  
We found that the density of macrophages in damaged TA muscles of Mtn-/-/ErrγTg/+ mice 
was the highest (7127 ± 93.5) compared to either counterpart muscles from Mtn-/- (5289.5 ± 
64.3) or WT (3263.7 ± 44.6) mice. Of particular note, macrophage density was significantly 
higher in injured areas of TA muscles from Mtn-/- compared to WT mice (Figure 5.6A and B).  
These data suggest that overexpression of Errγ in the Mtn-/- background was sufficient to 

































































Figure 5.6. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through promoted macrophages activity in response to cardiotoxin 
injury  
(A) Representative images of macrophage infiltration in the TA muscle sections of WT, Mtn 
and Mtn:Eγ mice at day 3 post-injury using an F4.80 antibody ( black arrows).  
(B) Quantification of macrophage density per 1 mm2 of damaged TA muscles.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.6. High number of committed muscle cells in the damaged TA muscles from Mtn-/-
/ErrγTg/+ mice at day 3 post-injury   
Following muscle injury, satellite cells activate and either downregulate MyoD and maintain 
a pool of quiescent Pax7+ satellite cells, or maintain MyoD expression but downregulate 
Pax7 and activate myogenin, thereby committing to differentiate (Relaix and Zammit, 2012).  
In this section, we examined whether genetic alteration of Myostatin, and overexpression of 
Errγ in the Myostatin null muscles affected damaged TA muscle capacity to generate 
committing cells, hence affect muscle regeneration pace.  
To that end, damaged TA muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice at day 3 
post-injection were immunostained for Pax7 and MyoD antibodies. Satellite cells were 
categorised according to the expression of myogenic markers into uncommitted muscle cells 
(quiescent) (Pax7+/MyoD-), precursor muscle cells (Pax7+ and MyoD+), and committed cells 
(Pax7-/MyoD+).  
We found that TA muscles from Mtn-/-/ErrγTg/+ mice contain the highest percentage of 
committed muscle cells (18 ± 1.4) after three days of CTX injection, and Mtn-/- muscles have 
the lowest percentage (4 ± 0.7), with TA muscles from WT mice in between (8.5 ± 0.8). Of 
particular note, there was no significant difference in a number of quiescent, and 
proliferated cells between the three muscle cohorts (Figure 5.7A and B). 
Taken together, these observations suggest that muscle-specific expression of Errγ in the 
Mtn-/- background muscle promoted muscle stem cells proliferation and differentiation at 









Figure 5.7. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through enhanced myoblast response to cardiotoxin injection 
(A) Myogenic progenitors in TA muscles of WT, Mtn and Mtn:Eγ mice at day 3 post injection 
with CTX. Pax7 detection in green, MyoD expressing cells in red (white arrows).  
(B) Quantification of uncommitted muscle cells (Pax7+/MyoD-), precursor muscle cells 
(Pax7+/MyoD+), and committed muscle cells (Pax7-/MyoD+) at day 3 post-injury.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.7. Less severity of TA muscle damage at day 6 compared to day 3 post-injury 
Six days after CTX injection, robust fibres regeneration should be evidenced. In order to 
determine the damage severity at day 6 post-injury, acid phosphatase stain was applied on 
the injured TA muscle sections (n=5) of the three animal cohorts of this study.  
To quantify the level of staining, a scoring system was used as in Figure 5.2, with a score 
between 0 - 3 assigned. This grading showed a reduction in the staining intensity on the TA 
muscle sections from the three genotypic groups at day 6 compared to day 3 post-injection 
with CTX. Of particular note, the same pattern of acid phosphates intensity level at day 3 
post-injury was identified at this time point (day 6). TA muscles from Mtn-/- mice showed the 
highest intensity level (2.4 ± 0.12) compared to both WT and Mtn-/-/ErrγTg/+ muscles (1.7 ± 
0.08 and 1.8 ± 0.12) respectively, with no significant difference in stain intensity between 
WT and Mtn-/-/ErrγTg/+ muscles (Figure 5.8A and B).  
These data show that the damage level in TA muscles was reduced within 6 days post-injury. 
Importantly, muscles of Mtn-/-/ErrγTg/+ mice show significant low level of muscle damage 































Figure 5.8. Intramuscular administration of cardiotoxin induces different levels of 
degeneration in TA muscles from WT, Mtn and Mtn:Eγ mice at day 6  
(A) Representative images for Acid phosphatase staining in the damaged TA muscles after 6 
days of cardiotoxin injection.  
(B) Quantification of acid phosphatase intensity in the injured areas of TA muscles at day 6 
post-injury.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.8. Advanced removal of necrotic and dying cells in Mtn-/-/ErrγTg/+ muscle at day 6 post-
injury  
After six days of CTX treatment, degenerated myofibres are usually removed and replaced 
with regeneration fibres (Pelosi et al., 2007). To evaluate muscle degeneration level at this 
time point (6 days), a measurement of necrotic myofibre number and size was carried out 
via immunohistochemistry. 
We found that the number of necrotic fibres in whole TA muscle sections from the three 
genotypic groups (WT, Mtn-/- and Mtn-/-/ErrγTg/+) of the study was reduced compared to day 
3 post-injury. However, while muscle sections from Mtn-/- mice still showed a considerable 
presence of necrotic fibres (33 ± 16.1) compared to WT muscles (2 ± 1.1), we observed a 
significantly lower number of necrotic fibres in TA muscles from Mtn-/-/ErrγTg/+ mice (13.3 ± 
3.3) (Figure 5.9A and B). Nevertheless, necrotic fibre numbers were significantly higher in 
Mtn-/-/ErrγTg/+ compared to WT muscles (Figure 5.9A and B).  
Similar to the degeneration fibres size in damaged TA muscles after 3 days of CTX injection, 
CSA of necrotic fibres from Mtn-/- muscles was the largest compared to those in muscles 
from both WT and Mtn-/-/ErrγTg/+ mice after 6 days of CTX injection (Figure 5.9A and C).  
Next we examined the number of apoptotic cells in the damaged areas of TA muscles 
following 6 days of CTX treatment. We observed that muscle sections from Mtn-/-/ErrγTg/+ 
mice showed much lower number of apoptotic cells (7.6 ± 0.9) compared to either WT 
(19.25 ± 2) or Mtn-/- (31 ± 3.3) muscles (Figure 5.10A and B).  
Taken together, these data suggest that damaged TA muscles from all animal cohorts 
displayed a reduction in numbers and size of necrotic myofibres at day 6 compared to day3 
post-injury. Importantly, overexpression of Errγ in the Mtn-/- background muscles markedly 
promoted elimination of necrotic fibres, and reduced amount of cell death.  









Figure 5.9. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through enhanced clearing of necrotic fibres in response to 
cardiotoxin injury at day 6 post-injury 
(A) Muscle necrotic fibres visualized by IgG staining on TA muscles of WT, Mtn and Mtn:Eγ 
mice at Day 6 ( white arrows).  
(B) Quantification of dying fibre number at day 6 post-injury.  
(C) Quantification of dying fibre size at day 6 post-injury. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 



























































































Figure 5.10. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through reduce cell death 
(A) Representative images of Cleaved caspase-3 immunostaining at day 6 post-injury as a 
marker of apoptosis (white arrows) in injured TA muscles of WT, Mtn and Mtn:Eγ mice.  
(B) Quantification of apoptotic cells density at day 6 post-injury. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.9. High macrophages activity in Mtn-/-/ErrγTg/+ muscles at day 6 post-injury  
We showed that damaged TA muscles from Mtn-/-/ErrγTg/+ mice displayed more advance 
removal of dying myofibres with a lower amount of cell death after 6 days of CTX injection. 
At this time point post-injury, damaged skeletal muscles would be expected to contain 
mostly M2 macrophages that are associated with deactivation of M1 macrophages, 
simultaneously induce tissue healing and repair (Chazaud et al., 2009, Serhan and Savill, 
2005).  
A macrophage marker (F4.80) was used to determine the rate of macrophages infiltration 
into the damaged TA muscles (n=5) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice at day 6 post-
injury.   
Counting the number of macrophages in the damaged areas of TA muscles showed a 
reduction in these cells number in WT and Mtn-/-/ErrγTg/+ muscles, but not Mtn-/- compared 
to day 3. Interestingly, damaged areas of TA muscles from Mtn-/-/ErrγTg/+ displayed 
significantly high activity of macrophages (6991.5 ± 64.3) compared to either WT (2833.5 ± 
53.9) or Mtn-/- (5872.5 ± 50.5) muscles following 6 days of CTX injection (Figure 5.11A and B). 
These observations imply that muscle-specific expression of Errγ in the Mtn-/- background 













































Figure 5.11. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through promoted macrophages activity in response to cardiotoxin 
injury  
(A) Representative images of macrophage infiltration in the TA muscles of WT, Mtn and 
Mtn:Eγ mice at day 6 using an F4.80 antibody (black arrows).  
(B) Quantification of macrophage density in 1 mm2 of damaged TA muscle.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.10. Errγ overexpression increases the number of committed cells at day 6 post-injury  
We showed previously that muscle-specific overexpression of Errγ in the Mtn-/- background 
muscles induced the number of committed progenitor cells at day 3 post-injury of CTX.  
Here we examined whether the population of the committed muscle cells would be affected 
by metabolic reprogramming imparted by muscle-specific Errγ overexpression in the Mtn-/- 
muscles after six days of CTX treatment.  
Counting the number of uncommitted (quiescent) (Pax7+/MyoD-), precursor (Pax7+/MyoD+), 
and committed (Pax7-/MyoD+) muscles cells at day 6 showed a difference in the average of 
these cells cohorts between TA muscles sections from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice. Of 
particular note, the regenerated areas of TA muscles from Mtn-/-/ErrγTg/+ mice showed 
significantly high percentage of committed muscle cells (17.6 ± 2.1) compared to either WT 
(2.5 ± 1.03) or Mtn-/- (1.1 ± 0.5) muscles (Figure 5.12A and B). Moreover, the highest 
percentage of precursor muscle cells was seen as well in TA muscle sections of Mtn-/-
/ErrγTg/+ mice, with no significant difference in a number of uncommitted muscle cells 
between any of the genotypic groups (Figure 5.12A and B). 
These data show that muscle-specific expression of Errγ in the Mtn-/- muscles markedly 
elevates the number of committed progenitor cells after six days of CTX, thereby raising the 








































Figure 5.12. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through enhanced myoblast population in response to cardiotoxin 
injection 
(A) Myogenic progenitors in TA muscles of WT, Mtn and Mtn:Eγ mice at day 6. Pax7 
detection in green, MyoD expressing cells in red (whit arrows).  
(B) Quantification of uncommitted muscle cells (Pax7+/MyoD-), precursor muscle cells 
(Pax7+/MyoD+), and committed muscle cells (Pax7-/MyoD+) at day 6 post-injury.  
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.11. Greater degree of regeneration in Mtn-/-/ErrγTg/+ muscles at day 6 post-injury 
Building on our observations, we examined whether besides the observed protective effect 
on muscle degeneration and promote oxidative metabolism, introducing of Errγ in the Mtn-/- 
background has also effect on the muscle regeneration efficiency following six days of CTX 
injection.  
To that end, immunostaining for embryonic myosin heavy chain (MHC3) was undertaken on 
the damaged TA muscle sections (n=5) of WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice at day 6 post-
injury. Regenerating fibres can be identified by the presence of centrally located nuclei, not 
in peripheral as in mature myofibres.   
Counting number and measuring the size of newly formed eMHC indicated a greater degree 
of regeneration in Mtn-/-/ErrγTg/+ muscle compared to other two cohorts. More specifically, 
the density of eMHC fibres in regenerated areas of Mtn-/-/ErrγTg/+ muscles was significantly 
higher (522 ± 35.3) than the fibre numbers in either WT (428 ± 21.90) or Mtn-/- (455 ± 14.5) 
muscles at day 6 post-injury (Figure 5.13A-C). 
The area of regenerated myofibres was bigger in TA muscles of Mtn-/-/ErrγTg/+ mice than 
their counterpart myofibres in WT and Mtn-/- muscles albeit, non-significant (Figure 5.13B 
and D).  
Together, these observations highlight the beneficial role of overexpression of Errγ on the 
Mtn-/- background muscles to induce muscle regeneration capacity after six days of CTX 
treatment, which indicated by large number of newly formed eMHC. Thereby, challenge the 
notion that oxidative muscle fibres have to have a high number of satellite cells to 
regenerate normally.   
 
  
       






























































































Figure 5.13. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice at day 6   
(A) Expression of embryonic myosin heavy chain fibres visualized by MHC3 staining on 
whole TA muscles of WT, Mtn and Mtn:Eγ mice at Day 6 post-injury. 
(B) Expression of embryonic myosin heavy chain fibres visualized by high magnification 
images of MHC3 staining on injured TA muscles of WT, Mtn and Mtn:Eγ mice at day 6 post 
treatment  (white arrows).  
(C) Quantification the number of regenerating muscle fibres at day 6 post-injury. 
(D) Measurement area of regenerating muscle fibres at day 6 post-injury. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.12. Day 14 post-injury show high regeneration capacity of Mtn-/-/ErrγTg/+ muscles  
The muscles of Mtn-/-/ErrγTg/+ have fewer satellite cells than other muscles of WT and Mtn-/- 
mice, but their regeneration capacity exceeded that of both WT and Mtn-/- muscles. 
Precocious muscle cells differentiation could lead to an exhaustion of cells which would 
ultimately attenuate myofibre size.  
In order to test this notion, we examined damaged TA muscles of the three genotypic 
groups of present study (WT, Mtn-/- and Mtn-/-/ErrγTg/+) at advanced stage of muscle 
regeneration process (day 14). Thus, immunostaining for embryonic myosin heavy chain 
(MHC3) was performed to determine density and size of the newly regenerated fibre. 
Counting the number of newly formed fibres provided evidence for accelerated 
regeneration capacity in Mtn-/-/ErrγTg/+ muscles indicated by significantly lower density of 
fibres still expressing eMHC (10.6 ± 4.09) compared to both Mtn-/- (30.6 ± 1.3) and WT (23.6 
± 3.7) muscles (Figure 5.14 A and B).  
Next we examined whether the size of newly generated fibres in Mtn-/-/ErrγTg/+ muscles was 
reduced. Therefore, measurement of CSA for regenerating fibres was performed on TA 
muscle sections of the three cohorts. We found no difference in the size of newly 
regenerated fibres in the TA muscles of Mtn-/-/ErrγTg/+ mice compared to either Mtn-/- or WT 
at day 14 post-injury (Figure 5.14 A and C).  
These data indicate the potential of Errγ overexpression in the Mtn-/- background muscles to 





























































































Figure 5.14. Skeletal muscle regeneration is accelerated by the expression of Errγ in 
Myostatin null mice through decrease density of the eMHC fibres, and generates new 
fibres with normal size   
(A) Expression of embryonic myosin heavy chain fibres visualized by MHC3 staining on 
whole TA muscles and magnified areas from the same muscles of WT, Mtn and Mtn:Eγ 
mice after 14 days of cardiotoxin injection (white arrows). DAPI stain (blue) was used to 
visualize myonuclei.  
(B) Quantification of eMHC muscle fibres number at day 14 post-injury.  
(C) Measurement of regenerating muscle fibres size at day 14 post-injury. 
(n = 5) male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s 
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5.13. Discussion  
Following the observations in previous chapters, we can infer that muscle-specific 
superimposition of Errγ on the Mtn-/- background muscles was sufficient to normalize 
muscles histological, ultrastructural and molecular features, and clearly improved muscles 
oxidative capacity and vascularization, hence enhanced animals exercise capacity. However, 
the metabolic reprogramming imparted by this genetic manipulation was not able to restore 
satellite cells population that was markedly diminished due to genetic deletion of Myostatin.  
Skeletal muscle regeneration dependent on the resident muscle satellite cells SCs, that are 
capable of forming new fibres while simultaneously maintaining initial SCs pool through self-
renew (Collins et al., 2005). Moreover, it has been implied that slow muscle fibres contain 
higher number of satellite cells than the fast phenotypes (Putman et al., 1999, Christov et al., 
2007). We showed that overexpression of Errγ on the Mtn-/- muscles caused partial reversal 
transition of muscle fibres from fast-twitch to slow-twitch phenotypes within MHCII subsets. 
However, there was a significant decrease in number of satellite cells at least in EDL muscles.  
Numerous studies have revealed high regeneration capacity of skeletal muscles that show a 
high level of oxidative metabolism (Lowrie et al., 1982, Matsakas et al., 2012b). Previous 
work has revealed vital role of blood supply for tissue repair, as the microenvironment that 
is created by circulating factors is essential for proper muscle regeneration process (Conboy 
et al., 2005, Bencze et al., 2012). 
We have demonstrated in previous chapters that genetic deletion of Myostatin led to 
compromise muscle capillary density and oxidative properties (Amthor et al., 2007, Lipina et 
al., 2010). However, we and others have shown that muscle-specific expression of Errγ is 
sufficient to induce skeletal muscle neoangiogenesis, triggers revascularization, and 
promotes oxidative capacity (Rangwala et al., 2010, Matsakas et al., 2012b).  
Building on these observations, we investigated the effects of muscle-specific 
overexpression of Errγ on the Mtn-/- background on skeletal muscles response to injury 
induced by CTX treatment. The hypothesis was that the metabolic reprogramming imparted 
by Errγ introducing in a muscle lacking Myostatin would promote protection against muscle 
damage and enhance regeneration. In this in vivo experimental model, we showed that 
muscle-specific introducing of Errγ in the Mtn-/- muscles was efficacious to reduce damage 
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amount of cells death, increased the proportions of committed muscle cells at both day 3 
and day 6 post-injury. Importantly, the metabolic reprogramming driven by Errγ strongly 
promoted muscle capacity to generate new embryonic myosin heavy chain (eMHC) fibres in 
the regenerated areas at day 6 post-injury. We also provided evidence for accelerated 
regeneration process in the Mtn-/-/ErrγTg/+ muscles at advance stage indicated by few 
number of eMHC, and normal size of newly regenerated fibres after 14 days of CTX injection.   
The Mtn-/-/ErrγTg/+ muscles that were injected with CTX showed a significant reduction in 
their myofibre permeability compared to the counterpart damaged muscles from WT and 
Mtn-/- animals indicated by a reduction in acid phosphatase intensity at day 3 and day 6 
post-injury. At both time points, the same muscles showed a drop-in cells death events, 
decreased number of necrotic fibres, and these fibres were significantly smaller than their 
counterparts in WT and Mtn-/- muscles.  
A number of studies have reported that CTX injection induces skeletal muscle fibres necrosis 
and cells death, that are probably due to a high influx of Ca+ from the extracellular milieu 
into the muscle cytoplasm, which leads to rapture of the membrane within the myofibres 
(Zhao et al., 2009, Ramadasan-Nair et al., 2014). Accordingly, there is a release of acid 
phosphatase from the lysosome (Shu et al., 2007). Therefore, the increased acid 
phosphatase intensity of Mtn-/- muscles evidences a high level of muscle degeneration that 
was significantly reduced by muscle-specific expression of Errγ. Previous work has reported 
a disruption of muscle membrane integrity due to altered in calcium concentration that 
subsequently resulted in lipid peroxidation by elevating ROS production (Duncan and 
Jackson, 1987, Nethery et al., 2000).  
Since we observed that introducing of Errγ into Mtn-/- muscles reduced membrane 
permeability induced by CTX injection, we wondered whether the protective effect of Errγ 
overexpression could be attributed in some way to regulate calcium concentration.  
By a way of explanation, it was documented that healthy mitochondria perform several 
functions and biochemical processes such as (OXPOS) pathway and calcium homeostasis 
(Scarpulla, 2008). Further study has revealed a vital role of Errγ in regulating expression level 
of genes that encode pathways for muscle calcium handling and contractile proteins for 
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abnormalities that were accompanied with a high level of ROS production in Mtn-/- muscles, 
were largely normalised by overexpression of Errγ.  
Thus, we suggest that one main mechanism by which Errγ overexpression in the Mtn-/- 
muscles limits the CTX damage, is by protecting against necrosis and apoptosis induced by 
calcium influx.  
Following muscle fibres degeneration, the efficient inflammatory response is required for 
effective repair and regeneration processes. Conversely, delaying the inflammatory or pro-
inflammatory response would negatively affect the rate of fibres clearance, thereby 
preventing generation of new tissue (Mann et al., 2011). Further, a critical role of 
microenvironment to promote stem cells commitment and differentiation has been 
reported (Carlson and Faulkner, 1989). Building on these observations, high inflammatory 
response, diminish tissue necrosis and fibrosis, possibly provides an environment that 
sustains efficient muscle regeneration.   
We showed previously that hypertrophic myofibres that resulted from the genetic alteration 
of Myostatin displayed a marked decrease in a number of blood vessels that serve each 
muscle fibre. However, overexpression of Errγ on the Mtn-/- background muscles was 
sufficient to drive a robust angiogenesis program that restored capillary density to even 
more than in WT muscles (Figure 4.4). An interesting feature highlighted in this chapter was 
the high density of macrophages in the regenerated areas of Mtn-/-/ErrγTg/+ muscles at both 
day 3 and day 6 post-injury (Figures 5.6 AND 5.11). Therefore, the central question to be 
addressed in this chapter is to what extent that the rich microcirculation environment 
established by Errγ overexpression would promote muscle regeneration capacity following 
CTX treatment, even with a low population of satellite cells as we showed previously 
(Figures 4.12 and 4.13).  
Prior to the regeneration, tissue necrotic debris needs to be cleaned, which can mainly be 
achieved by recruiting monocytes from the circulation that subsequently differentiate into 
pro-inflammatory macrophages (M1) within the tissue (Zhang et al., 2013). In support of this 
view, previous studies have revealed a marked reduction in muscle repair process due to 
depletion of monocyte from blood that gives an origin for both M1 and M2, or because of 
the impairment in monocyte/macrophage recruitment into the damaged areas (Arnold et al., 
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in the damage areas, they are preventing myogenic differentiation too early in the repair 
process (Serhan and Savill, 2005, Rigamonti et al., 2014). Approximately 24 hours after 
injury, the pro-inflammatory macrophages M1 convert to macrophages M2. These anti-
inflammatory macrophages derive the second phase of muscle repair by reducing 
environmental inflammatory signals, stimulate satellite cells, and directly support 
myogenesis process and myofibre growth (Prisk and Huard, 2003).  
It seems that a regulated sequence of macrophage phenotypes is necessary for the effective 
regeneration process. Study by Bordon (Bordon, 2013) has revealed a critical role of AMPK 
(a master regulator of energy homeostasis) in particular AMPKα1 subunit, in macrophages 
skewing from M1 to M2. Consistently, it has been reported that the ablation of AMBKα1 
causes accumulation of necrotic tissue and a deficit in the acquisition of the M2 macrophage 
phenotype, thereby impairing skeletal muscle regeneration (Mounier et al., 2013). Along the 
same line of thought, it has been shown that AMPK, which is essential for the exercise-
mediated switch to aerobic myofibres, is activated by Errγ in skeletal muscles (Jensen et al., 
2007).  
Thus, we believe that the high proportion of committed muscle cells in the regenerated 
areas of Mtn-/-/ErrγTg/+ muscles (Figures 5.7 and 5.12), could be attributed to, firstly, high 
density of macrophages in these muscles that reflected high vascularization, and promoted 
clearing process of necrotic and apoptotic cells. And secondly, proper conversion of pro-
inflammatory M1 to anti-inflammatory M2 macrophages that is in a part regulated by AMPK 
which is upregulated following overexpression of Errγ in these muscles.  
Upon muscle injury, satellite cells activate, enter the cell cycle, and give arise of muscle 
precursor population that proliferate, differentiate and then fuse to form new myofibres, 
allowing muscle regeneration. At the same time, a subpopulation of SCs return to their 
quiescent state to replenish the initial pool (Charge and Rudnicki, 2004). The onset 
activation of satellite cells is due to a signal from infiltrating anti-inflammatory macrophages, 
that occurs following ordinary stages of muscle degeneration (Prisk and Huard, 2003). 
Consistent with this notion, it has been reported that pro-inflammatory M1 macrophages 
exert a negative effect on satellite cells differentiation and fusion. Conversely, anti-
inflammatory macrophages M2 stimulates differentiation and increases myoblast fusion 
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Pax7, whereas activated SCs co-express Pax7 and MyoD, upon differentiation SCs maintain 
MyoD expression and downregulate Pax7 (Seale et al., 2000). It is worth noting that absence 
of MyoD negatively impacts on muscle regeneration, as it delays myoblast transition from 
proliferation to differentiation (Megeney et al., 1996, Sabourin et al., 1999).  
An interesting finding made with satellite cell populations induced by CTX treatment is that 
the Mtn-/-/ErrγTg/+ muscles showed high proportion of committed muscles cells (Pax7-
/MyoD+) at both time points (day 3 and day 6) post-injury compared to the other genotypic 
groups. This may be explained by the vast capacity of the satellite cells in these muscles 
(Mtn-/-/ErrγTg/+) to expand, proliferate and differentiate, which is probably induced by the 
surrounding environment (hyper-oxidative and hyper-vascularization) provided by Errγ 
overexpression in the Mtn-/- mice. 
Our work examining the effect of muscle-specific overexpression of Errγ in the Mtn-/- 
muscles on the regenerating capacity even with a lower number in satellite cells as we 
showed in the previous chapter, offers interesting insights into the importance of 
surrounding environment on muscle regeneration process. The Mtn-/-/ErrγTg/+ muscles 
showed high regeneration degree indicated by large size and high numbers of newly formed 
centrally located nuclei myofibres (eMHC+) at day 6 post-injury.  
Previous work has reported that metabolism perturbation modulates stem cells function 
and fate, thereby affecting muscle recovery from injury (Cerletti et al., 2012). Consistently, a 
number of studies have demonstrated that muscle with oxidative metabolism have high 
rate of regeneration capacity (Lowrie et al., 1982). Moreover, genetic manipulation that 
increased muscle oxidative capacity accelerates regeneration pace (Li et al., 2007b). 
Conversely, it was well established that muscle metabolic deficit leads to elevate ROS 
production that markedly contributes to attenuate muscle differentiation, since it impairs 
myogenesis process (Langen et al., 2002, Ardite et al., 2004). Given these considerations, 
our work carried out in previous chapters showed that genetic deletion of Myostatin 
resulted in a reduction of muscle oxidative capacity, capillary density, and increased ROS 
level. However, muscle-specific expression of Errγ in the Mtn-/- background robustly restored 
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Linking the mentioned observations with previous work that revealed an increase in ROS 
production, and impairment of myogenesis process in Errγ-/- monocytes (Murray et al., 
2013), support a potential role of Errγ in regulating muscle myogenesis. 
By a way of explanation of our findings that Errγ induces muscle regeneration even with the 
depletion of SCs to less than 50% of their normal population, that the oxidative environment 
established by introducing of Errγ on a muscle lacking Myostatin is the key determinant in 
accelerating regeneration. Moreover, angiogenesis is an imperative factor for muscles 
regeneration process. Therefore, we suggest that the reduction in SCs did not impact 
regeneration capacity in Mtn-/-/ErrγTg/+ muscles, because of Errγ ability to promote muscle 
vascularization, thereby induce clearance of necrotic and damaged tissues, ultimately 
allowing the small number of satellite cells to expand greatly to achieve rapid repair of the 
damaged tissue. Such opinion is supported by our data showed high macrophages density, 
and generation of myoblast in Mtn-/-/ErrγTg/+ muscles compared to either WT or Mtn-/-.   
Finally, we expanded our investigation in the present study by examining the impact of 
muscle-specific overexpression of Errγ in the Mtn-/- background on muscle regeneration at 
advance stage (day 14 post-injury). We provided further evidence for accelerated 
regeneration process in Mtn-/-/ErrγTg/+ muscles compared to other genotypic groups, that 
evidenced by few number of fibres still express eMHC, with the normal size of newly formed 
myofibres in these muscles. Previous work has revealed that muscle repair programme is 
usually at expense of SCs population, which is presumed not to be available for future 
degeneration/regeneration cycles, thereby affecting the size of newly generated muscle 
fibres (Castets et al., 2011). Moreover, adult satellite cells are the primary source of muscle 
regenerating after repetitive injury (Kuang et al., 2008, Zammit, 2008), and more particular 
satellite cells that express Pax7 are required for this capability (Seale et al., 2000). 
Importantly, we found that despite Mtn-/-/ErrγTg/+ muscles displayed high populations of 
myogenic precursors (Pax7+/MyoD+), as well as committed muscle cells (Pax7-/MyoD+) at 
day 6 post-injury, this was not at expense of satellite cells character (Pax7+/MyoD-).         
Although precocious differentiation might cause cells exhaustion, the myofibres 
regenerating at a quick cadence, it also indicates a fast degeneration steps. There is a wide 
body of evidence that a correct inflammatory response following muscle injury, which 
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(Goetsch et al., 2003, Tidball, 2005). This hypothesis supported by our observations 
investigating capillary and macrophages density, as well as necrotic fibre numbers. 
In summary we can conclude, the increased oxidative capacity and microvascular network 
that was imparted by superimposition of Errγ in a muscle lacking Myostatin played a vital 
role to reduce muscle damage, stimulate functioning inflammatory response, induce 
clearing of necrotic and died tissues, thereby accelerated muscle regeneration capacity 
following CTX treatment. Importantly, we demonstrate that even decreased number of 
satellite cells in the Mtn-/-/ErrγTg/+ muscles had a very little impact on regeneration. Indeed, 
their regeneration capacity exceeded not only Mtn-/- but also WT muscles. We also provided 
evidence that the metabolic reprogramming driven by Errγ overexpression was efficacious 
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Impact of post-natal antagonism of Myostatin 
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6.1. Introduction 
Skeletal muscle is a composite structure that composed of muscle fibres, blood vessels, 
sensory cells and connective tissue (Gumerson and Michele, 2011, Gillies and Lieber, 2011). 
It is a highly adaptable tissue that changing its phenotype with regards to size and 
composition as a response to the physiological and environmental stimuli. Thus a series of 
alterations in the metabolic, molecular, and physiological profiles of the tissue habitually 
accompanied muscle mass changes (Matsakas and Patel, 2009a). Despite the profound 
impact of the animal breed and genetic background on muscle mass, it is mainly determined 
by muscle fibre numbers and size (Martyn et al., 2004). Myofibre numbers are fixed at 
prenatal stage (Sandri, 2008), whereas the balance between muscle protein synthesis and 
degradation rates fundamentally determines muscle mass by influencing fibre size (Nader, 
2005). A huge amount of research has revealed a vital role of Insulin-like Growth Factor 
(IGF-I and IGFII) in promoting muscle fibres hypertrophy by activating signalling pathways 
that attenuate proteolysis and induce protein synthesis (Glass, 2005, Giannoulis et al., 2012). 
In contrast, we and others have focused on attenuating signalling mechanisms that usually 
inhibit muscle development, to promote muscle growth. One of the potent inhibitors of 
skeletal muscle development is Myostatin, an evolutionary conserved member of the 
Transforming Growth Factor beta (TGF-β) superfamily of secreted proteins (McPherron et 
al., 1997). We have previously shown that genetic alteration of Myostatin leads to the 
development of a hypermuscular phenotype through both myofibre hyperplasia and 
hypertrophy, these observations were conformed to the aforementioned studies 
(McPherron and Lee, 1997, Schuelke et al., 2004, Clop et al., 2006). In addition, it was well 
documented that Myostatin promotes muscle oxidative capacity and connective tissue 
development, since its deletion leads to the development of glycolytic phenotype, and 
reduce fibroblast proliferation (McPherron et al., 1997, Mendias et al., 2006, Zhu et al., 
2000).  
An adequate level of skeletal muscle size and functions is very important for health and 
quality of life (Pistilli et al., 2011, Cooper et al., 2010, Zhou et al., 2010). Skeletal muscle 
wasting occurs as a result of a variety of pathophysiological settings, including muscular 
dystrophies (Whittemore et al., 2003, Patel and Amthor, 2005), and progressive loss of 
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muscle strength and increased fatigability (Faulkner et al., 1990). Furthermore, prolonged 
bed rest and immobilization are inducing muscle atrophy (Han et al., 2013). Therefore, 
bearing in mind the inhibitory effects of Myostatin on skeletal muscle growth, a number of 
strategies have been developed in order to inhibit Myostatin signalling post-natally as 
promising therapeutic approaches against muscle wasting. For instance, it has been 
reported that Myostatin is synthesized as a precursor protein that gives arise to N-terminal 
propeptide and a C-terminal biologically active following proteolysis process (Lee et al., 
2004). The N-terminal peptide is capable to maintain Myostatin in a latent state by direct 
binding, then inhibiting of the biologically active C-terminal peptide (Shelton and Engvall, 
2007, Zimmers et al., 2002). Adeno-associated virus (AAV) mediated Myostatin pro-peptide 
systemic delivery has been applied to enhance muscle growth in adult and aged mice 
(Collins-Hooper et al., 2014, Matsakas et al., 2009). Moreover, muscle mass can be 
increased by follistatin administrating that neutralizing Myostatin (Hill et al., 2002, Lee and 
McPherron, 2001). Previous other work has revealed a robust increase in skeletal muscle 
mass following mice treatment with Myostatin neutralizing antibody (Whittemore et al., 
2003). A significant number of studies have established that Myostatin initiates an 
intracellular signalling by binding its transmembrane activin receptor IIB (AcRIIB), thus 
suppressing of this pathway may greatly stimulate muscle growth (Lee and McPherron, 2001, 
Schuelke et al., 2004). Although the above mentioned methods that inhibits Myostatin 
signalling at post-natal stage offered a good increase in muscle growth, administration of 
soluble ActRIIB (sActRIIB) resulted in greater increase in muscle mass, suggesting that in 
addition to Myostatin, there are other ligands that limit muscle development (Lee et al., 
2005, Zhou et al., 2010). Thus, we believe that weekly injection of sActRIIB that mediate 
inhibition of Myostatin and relative proteins would lead to greater level of muscle growth.  
Despite the variable levels of increase in muscle mass following Myostatin inhibition at post-
natal stage using different strategies, there is evidence that muscles with Myostatin blocking 
have number of abnormalities besides fibre hypertrophy. Previous work has reported that 
the expression levels of a network of genes linked to mitochondrial function and oxidative 
phosphorylation pathways are reduced markedly in WT muscles after sActRIIB treatment 
(Rahimov et al., 2011). Further investigation has revealed a shift of aged muscle fibres 
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AAV8MyoPPT injection (Collins-Hooper et al., 2014). In the line with these findings, it has 
been demonstrated that blocking of Myostatin signalling in muscles from mdx mice via 
sActRIIB treatment lead to compromise muscle angiogenic program, capillary density, and 
oxidative metabolism thereby a declines of muscle force generation capacity and increase 
fatigability (Relizani et al., 2014). In addition, both Wagner and Krivickas (Krivickas et al., 
2009, Wagner et al., 2008) failed to find any evidence of improved muscle function in 
human dystrophy following the systemic administration of MYO-029, a neutralizing antibody 
to MYOSTATIN. 
On the other hand, a number of elegant studies have shown the potential of Errγ transgenic 
to promote muscle angiogenesis and enhance oxidative capacity, hence promote aerobic 
muscles properties (Narkar et al., 2011, Rangwala et al., 2010). It was established that ETC 
and TCA, mitochondrial pathways considered as an important source of ROS production, are 
controlling by a number of genes that are profoundly regulated by Errγ to prevent the 
excessive generation of superoxide leads to oxidative stress (Harper et al., 2004, Eichner and 
Giguere, 2011). Additionally, we have shown previously that muscle-specific expression of 
Errγ in Mtn-/- background mice was sufficient to develop hyper-oxidative hypertrophic 
myofibres, thereby challenging the trade-off that thought to be existent between muscle 
fibre oxidative capacity and its size (Van der Laarse WJ, 1998). 
The newly generated hyper-muscular, hyper-oxidative mouse line (Mtn-/-/ErrγTg/+) displays a 
number of characteristics that make them attractive both in terms of physiology and 
regeneration capacity. However, the muscle phenotype in these models is largely 
established during embryonic stage. Here we asked whether similar phenotypes could be 
obtained via non-genetic modifications. To do so, we inhibited Myostatin at post-natal 
stages in ErrγTg/+ (which displays an increased oxidative profile) and WT mice (n=5) by twice 
weekly injections for 8 weeks (start at week 5 and stop at week 12 of age) of soluble activin 
receptor IIB protein (sActRIIB) which has been shown to antagonize signalling mediated by 
Myostatin and related-proteins.  
Representative muscles of fast and slow phenotypes (EDL and soleus respectively) were 
isolated, weighed and frozen. The sectioned slides were stained for (SDH), and (DHE) stains 
to identify muscle oxidative capacity, and Reactive Oxygen Species (ROS) level respectively. 
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myosin heavy chains (MHCs) (type I, IIA and IIB) to identify total muscle fibre number, types 
and size (CSA), and CD31 antibody to identify capillary density. Finally, immunostaining for 
Collagen type IV, dystrophin and laminin antibodies accompanied with MHCIIB was 
performed on muscle sections from all cohorts in order to examine the signal intensity and 
expression domain thickness of these proteins in intracellular and extracellular 
compartments, and basement membrane.  
This study shows that weekly injection of sActRIIB, which has been shown to antagonize 
Myostatin signalling, firstly induce a significant increase in body and muscle mass due to 
myofibres hypertrophy. Secondly, administration of sActRIIB for 8 weeks do not cause any 
change in myofibres composition at MHC level, however, it compromises oxidative capacity 
of muscles from WT, but not ErrγTg/+ mice. Subsequently, sActRIIB treatment promotes the 
capillary density in ErrγTg/+, but not WT muscles. Furthermore, treated WT muscles show 
high level of ROS, with no change in ROS generation in treated muscles from ErrγTg/+ 
compared to the control. Finally, sActRIIB injection reduces connective tissue content in WT 
























































6.2. Errγ expression following post-natal inhibition of Myostatin using sActRIIB  
Here we examined whether post-natal inhibition of Myostatin using a systemic injection of 
sActRIIB would affect Errγ level prompted through transgenic approach. Therefore, Errγ 
expression was determined in soleus muscles (n=5) from (WT, ErrγTg/+, WT.sActRIIB and 
ErrγTg/+.sActRIIB). We found a significant increase in expression level of Errγ in soleus 
muscles from the transgenic mice compared to its level in muscles from WT.PBS and WT 
injected with sActRIIB mice. Interestingly, the expression level of Errγ was similar in soleus 
muscles from ErrγTg/+ and ErrγTg/+.sActRIIB mice (Figure 6.1). These data indicate that 
sActRIIB treatment for 8 weeks to inhibit Myostatin signalling did not affect Errγ expression. 




























Figure 6.1. Post-natal inhibition of Myostatin in the WT and muscle-specific Eγ mice 
doesn’t affect Eγ expression  
Displaying Errγ mRNA level in soleus muscles of wild type (WT), Errγ transgenic (Eγ), wild 
type injected with sActRIIB (WT.sActRIIB) and Errγ transgenic injected with sActRIIB 
(Eγ.sActRIIB) mice.  
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
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6.3. Treatment with Activin ligand trap increases body and muscle mass in WT and ErrγTg/+ 
mice  
We showed previously that body mass of mice with Myostatin mutation was similar to those 
of WT, and muscle-specific expression of Errγ into Mtn-/- background muscles did not affect 
this parameter. Previous work has reported that type of effects of Myostatin absence on 
individual muscle and body mass depending on whether Myostatin loss of function occurs 
prenatally or post-natally (McPherron, 2010).  
Here we examined the effect of 8 weeks intraperitoneally injection (IP) on a twice weekly 
basis with sActRIIB which antagonize signalling mediated by Myostatin, on body mass of WT 
and ErrγTg/+ mice. We found that the increase of body mass started from the first two weeks 
of injection (Figure 6.2A). At the day of animals culling (12 weeks old) WT and ErrγTg/+ mice 
injected with sActRIIB were significantly heavier than their counterpart injected with PBS 
(Figure 6.2B).  
Unlike in the genetic deletion of Myostatin, these data show that post-natal inhibiting of 
Myostatin by systemic administration of sActRIIB induces a remarkable increase of animals’ 
body mass.     
Next we determined the change in hind limb muscles (EDL, gastrocnemius, soleus and TA) 
mass from WT and ErrγTg/+ mice following 8 weeks of treatment with sActRIIB. Previously we 
demonstrated a significant increase in mass of muscles from Mtn-/- and Mtn-/-/ErrγTg/+ 
compared to muscles of WT mice. In agreement with previous studies (Relizani et al., 2014, 
Collins-Hooper et al., 2014), our data showed a significant increase in weight of all muscles 
examined (n=10) following post-natal inhibition of Myostatin (Figure 6.3). Strikingly we 
found an apparent muscle-specific response to the sActRIIB treatment with TA muscles 
showing the largest gain in mass (~82% and 77%) in WT.sActRIIB and ErrγTg/+.sActRIIB mice 
respectively, and the soleus muscles with the smallest increase (46%) in WT with no 
significant increase in ErrγTg/+ mice following 8 weeks of sActRIIB injection (Figure 6.3). 
Together, these data show that while germline deletion of Myostatin induced muscle mass 
increase without change in body weight, the post-natal inhibition of Myostatin via sActRIIB 
injection resulted in a significant increase in both body and muscle mass with specific 
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Figure 6.2. Post-natal inhibition of Myostatin in the WT and muscle-specific Eγ mice 
induces body weight   
Body weight of WT and Eγ mice increased significantly following 8 weeks of intra peritoneal 
(IP) injection of sActRIIB. 
(A) Relative changes in body mass over time. IP injection of WT and Eγ mice with sActRIIB 
started at week 5 and tissues collected at the end of week 12. 
(B) Body weight of WT, Eγ, WT.sActRIIB and Eγ.sActRIIB mice. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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Figure 6.3. Post-natal inhibition of Myostatin in the WT and muscle-specific Eγ mice 
increases muscle mass 
Quantification of skeletal muscles (EDL, gastrocnemius, soleus and TA) mass of WT, Eγ 
WT.sActRIIB and Eγ.sActRIIB mice. 
Display a significant increase in muscles mass due to post-natal blocking of Myostatin using 
sActRIIB. 
(n=10) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 







































































































6.4. Skeletal muscle enlargement induced by sActRIIB treatment is not associated with 
muscle fibre hyperplasia   
Next we examined whether the increase in muscle mass was due to muscle hyperplasia, 
muscle hypertrophy or a combination of both. Therefore, Immunohistochemistry protocol 
using antibodies against myosin heavy chain (MHC) isoforms (type I, IIA and IIB) was 
performed to determine the cellular changes elicited by administration of sActRIIB in a 
representative muscle of fast and slow phenotypes (EDL and soleus respectively) (n=5) of 
WT, and ErrγTg/+, WT.sActRIIB and ErrγTg/+.sActRIIB mice (Figure 6.4A and B).  
Quantification of the total fibre number of EDL and soleus muscles at 12 weeks old age mice 
revealed no significant difference between the fibre numbers of muscles injected with PBS 
and muscles treated with sActRIIB from WT and ErrγTg/+ mice (Figure 6.4C and D).  
These data indicate that the enlargement in muscle mass of WT and ErrγTg/+ following 8 
weeks intraperitoneal injection of sActRIIB occurred in both muscles (EDL and soleus) 
















































































Figure 6.4. Myostatin blocking doesn’t change fibre number of WT and muscle-specific Eγ 
mice 
Display total fibre number of EDL and soleus muscles. 
(A) Immunohistochemical images of EDL muscles from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB 
mice. Green fibres signify the expression of MHCIIA with MHCIIB appearing as red. 
(B) Immunohistochemical images of soleus muscles from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. Green fibres signify the expression of MHCIIA with MHCI appearing as 
red. 
(C) Quantification of total fibre number in EDL muscles. 
(D) Quantification of total fibre number in soleus muscles. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.5. Increase in muscle mass following sActRIIB administration is caused by myofibre 
hypertrophy 
Having shown no evidence for an increase in fibre numbers of muscles from WT and ErrγTg/+ 
mice following 8 weeks of sActRIIB treatment in the present study, we next examined the 
reason underpinning the increase in muscle mass of WT.sActRIIB and ErrγTg/+.sActRIIB mice. 
Thus, we determined the cross-sectional area of myofibres in representative muscles of fast 
and slow phenotypes (EDL and soleus respectively) from WT, ErrγTg/+, WT.sActRIIB and 
ErrγTg/+.sActRIIB mice (n=5). Muscle sections were immunostained using antibodies against 
MHC isoforms (type I, IIA and IIB). A minimum of 150-200 measurements per myofibre type 
was taken in each muscle section (Figure 6.5A and B). 
We found that the CSA of all muscle fibre types of WT and ErrγTg/+ mice were increased 
significantly by sActRIIB treatment, except MHCI isoform which was absent in EDL muscle 
sections from WT.PBS and WT.sActRIIB mice (Figure 6.5C). Of particular note was that the 
MHCIIA in EDL muscles of WT.sActRIIB and ErrγTg/+.sActRIIB were significantly larger than 
those from EDL muscles of WT.PBS and ErrγTg/+.PBS mice respectively, with that of the 
MHCIIA from ErrγTg/+.sActRIIB greater than the counterpart myofibre from WT.sActRIIB 
(Figure 6.5A and C). Same scenario of CSA increase was noticed in MHCIIX and MHCIIB 
isoforms of EDL muscles. Notably, fast phenotypes (MHCIIX and MHCIIB) from both 
genotypic groups were more prone to size increase than the slow phenotypes (MHCI and 
MHCIIA) (Figure 6.5C).   
Next we examined muscle fibres CSA in the soleus muscles. We found that the size of 
myofibre type I in the soleus muscles of WT.sActRIIB and ErrγTg/+.sActRIIB were significantly 
larger than their counterpart from soleus muscles of WT.PBS and ErrγTg/+.PBS mice 
respectively. The size of muscle fibre type I was larger in soleus muscles from 
ErrγTg/+.sActRIIB than the WT.sActRIIB mice (Figure 6.5B and D). Measurement of MHCIIA 
and MHCIIX size of soleus muscles showed same pattern of increase was observed in MHCI 
fibres, with no significant difference in size of myofibre type IIA in soleus muscles from  
WT.sActRIIB and ErrγTg/+.sActRIIB (Figure 6.5D).  
These findings show that the post-natal increase in muscle mass of WT and ErrγTg/+ mice 

















data in particular the increase in myofibre CSA of ErrγTg/+ muscles that showed hyper-
oxidative properties raises the possibility of breaking the inverse relationship between 
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Figure 6.5. Treatment of WT and Eγ mice with sActRIIB increases muscle fibres cross-
sectional area   
Large muscle fibres from WT and Eγ mice following Myostatin inhibition using sActRIIB 
(A) Immunohistochemical images of EDL muscles from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB 
mice. Green fibres signify the expression of MHCIIA with MHCIIB appearing as red. Non 
green and red fibres represent MHCIIX. 
(B) Immunohistochemical images of soleus muscles from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. Green fibres signify the expression of MHCIIA with MHCI appearing as 
red. Non green and red fibres represent MHCIIX. 
(C) Quantification of muscle fibres cross-sectional area in EDL muscles. 
(D) Quantification of muscle fibres cross-sectional area in soleus muscles. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.6. Myosin heavy chain profile does not alter by sActRIIB treatment  
Given our data of this study showed muscle-specific enlargement of skeletal muscles from 
WT and ErrγTg/+ mice following 8 weeks of post-injection of sActRIIB was completely 
attributed to the increase of muscle fibres size with no change in muscle fibre numbers. On 
the contrary, we and others have demonstrated that the constitutive deficiency of 
Myostatin (Mtn-/-) resulted in a dramatic increase in muscle mass due to both muscle fibre 
hyperplasia and hypertrophy (McPherron and Lee, 1997, Amthor et al., 2007). Interestingly, 
our observations showed that the metabolic reprogramming imparted by muscle-specific 
overexpression of Errγ into Mtn-/- background was efficacious to maintain the increase of 
muscle fibre size and number exhibited by Myostatin deletion. Meanwhile driven a partial 
reversal transition of myofibres profiling within MHCII isoforms toward WT condition, and 
promoted muscle oxidative capacity.   
A number of studies have documented that skeletal muscle is a highly adaptable tissue that 
capable to change its phenotype with regard to the size and composition in response to 
various stimuli (Matsakas and Patel, 2009a, Hornberger et al., 2006). However, recent 
studies have reported that blocking of Myostatin/ActRIIB signalling through post-natal 
treatment with sActRIIB-Fc induces skeletal muscle mass of adult mice without altering 
muscle fibre type composition (Akpan et al., 2009, Cadena et al., 2010). Similarly, other 
studies in the mdx mice model of duchenne muscular dystrophy (DMD) have confirmed that 
post-natal inhibition of Myostatin has no impact on muscle fibre type distribution (Morine et 
al., 2010, Pistilli et al., 2011). On the other hand, previous work has reported that Errγ 
overexpression into WT background mice leads to an increase in the proportions of slow-
twitch myofibres (IIA and IIX), and decreases proportions of fast-twitch phenotypes (IIB) 
(Matsakas et al., 2012b). However, there are no studies regarding the Errγ potential to 
maintain the high proportions of the slow muscle fibres following post-natal modification 
that induces glycolytic status. Therefore, we examined MHC profiling in representative 
muscles of fast and slow phenotypes (EDL and soleus respectively) (n=5) from four cohorts 
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In agreement with previous studies (Rangwala et al., 2010, Matsakas et al., 2012b), our 
findings showed high proportions of MHCIIA and MHCIIX, with a concomitant reduction in 
the percentage of MHCIIB phenotypes in EDL muscle sections from ErrγTg/+ compared to WT 
mice. Of particular note, EDL muscles from ErrγTg/+ displayed presence a number of MHC 
type I isoform which was absent in counterpart muscles from WT.PBS (Figure 6.6A and C). 
Most importantly, we found that 8 weeks of post-natal treatment with sActRIIB did not 
change myofibres distribution either in EDL from WT, nor in hyper-oxidative muscles from 
ErrγTg/+ mice (Figure 6.6C).  
Next we examined soleus muscle fibre profiling. We found that muscles from ErrγTg/+ mice 
displayed greater proportion of MHCIIA, and lower proportion of MHCIIX isoforms compared 
to the WT. More specifically, soleus muscle from WT and transgenic Errγ mice showed same 
percentages of MHC type I (Figure 6.6 B and D). Interesting, myofibres profiling in soleus 
muscles from both WT and transgenic Errγ mice was conserved followed sActRIIB treatment 
(Figure 6.6D). 
These data show that even hind limb muscles from ErrγTg/+ mice displayed high numbers of 
slow-twitch muscle fibres compared to WT, the post-natal treatment with sActRIIB did not 
affect these muscle fibres distribution. Moreover, the sActRIIB injection to antagonise 
Myostatin signalling post-natally did not affect MHC profiling of the WT muscles as well.     

























































































   
Figure 6.6. Post-natal inhibition of Myostatin do not impact myosin heavy chain profile of 
EDL and soleus muscles of WT and Eγ mice  
Same muscle fibre phenotype of WT and Eγ mice following sActRIIB treatment. 
(A) Immunohistochemical images of EDL muscles from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB 
mice. Green fibres signify the expression of MHCIIA with MHCIIB appearing as red. Non 
green and red fibres represent MHCIIX.  
(B) Immunohistochemical images of soleus muscles from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. Green fibres signify the expression of MHCIIA with MHCI appearing as 
red. Non green and red fibres represent MHCIIX.  
(C) Graph showing fibre type composition in EDL muscles from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. 
(D) Graph showing fibre type composition in soleus muscles from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 





S. S. Omairi, PhD 2018 
 
6.7. Treatment with sActRIIB attenuates oxidative capacity of muscles from WT, but not 
ErrγTg/+ mice 
We demonstrated that post developmental inhibition of Myostatin by administrating 
sActRIIB for a period of 8 weeks resulted in an enlargement of muscle fibres thereby 
increased muscle and body mass of both WT and ErrγTg/+ mice. However, the increase was 
not accompanied by any alteration in muscle fibre numbers and MHC distribution. Our 
previous findings showed that germline deletion of Myostatin leads to a significant 
reduction in muscle oxidative capacity, however, muscle-specific expression of ErrγTg/+ into 
Mtn-/- background was sufficient to restore the proportion of oxidative myofibres to normal 
condition. We therefore investigated myofibres distribution at metabolic level following 
sActRIIB treatment.      
It has been illustrated that post-injection of sActRIIB-Fc resulted in a marked reduction in 
level of molecules that involved in regulation of skeletal muscle mitochondrial functions and 
oxidative phosphorylation (Rahimov et al., 2011).  
However we have shown that Errγ is a key regulator of skeletal muscle aerobic metabolism 
and mitochondrial functions and biogenesis. Thus we sought to investigate systemically how 
post-natal blocking of Myostatin signalling by sActRIIB injection might affect oxidative 
capacity in WT muscles and hyper-oxidative muscles from ErrγTg/+ mice. To do so, we 
performed staining for the mitochondrion-associate enzyme succinate dehydrogenase (SDH) 
in sections of EDL and soleus muscles (n=5) from four cohorts of mice (WT, ErrγTg/+ 
WT.sActRIIB and ErrγTg/+.sActRIIB) (Figure 6.7A and B).  
We found a few number of strongly stained oxidative muscle fibres (SDH+), with a 
concomitant increase in the proportion of pale non-oxidative fibres (SDH-) in muscles from 
WT.sActRIIB compared to WT.PBS muscles. However, the proportion of oxidative myofibres 
in muscles from ErrγTg/+ and ErrγTg/+.sActRIIB was similar (Figure 6.7A-D). Of particular note, 
EDL muscles from WT mice injected with sActRIIB displayed lower percentage of oxidative 
myofibres (26.2%) compared to control (39.7%). Interestingly, post-natal treatment with 
sActRIIB didn’t affect the percentage of oxidative myofibres in EDL muscles from the 
transgenic mice, hence no significant difference noticed in numbers of oxidative fibres 

















that we found EDL muscle fibres of ErrγTg/+.PBS and ErrγTg/+.sActRIIB mice showed 
significantly higher oxidative capacity compared to counterpart muscles from WT and 
WT.sActRIIB mice respectively (Figure 6.7A and C). Same scenario of myofibres distribution 
of EDL muscles at metabolic level was seen in soleus muscle sections from the four 
genotypic groups (WT, ErrγTg/+ WT.sActRIIB and ErrγTg/+.sActRIIB) (Figure 6.7B and D).      
These data suggest that muscle-specific expression of Errγ was sufficient to avert the 
reduction in oxidative capacity of hypertrophic muscle fibres developed following post-natal 
treatment with sActRIIB, thereby challenging the tread-off between myofibre size and its 
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Figure 6.7. sActRIIB treatment induces glycolytic transformation of WT but not Eγ 
muscles 
Post-natal inhibition of Myostatin doesn’t affect muscle-specific Eγ myofibres profiling at 
metabolic level. 
(A – B) Succinate dehydrogenase (SDH) staining Images of (EDL and soleus) muscles from 
WT, Eγ, WT.sActRIIB and Eγ.sActRIIB mice. Black fibres signify the SDH positive fibres 
(Oxidative fibres), and pale (white) fibres signify the SDH negative fibres (Glycolytic fibres).    
(C) SDH-positive and negative fibre profile of EDL muscle from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. 
(D) SDH-positive and -negative fibre profile of soleus muscle from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.8. Post-natal inhibition of Myostatin caused an increase in CSA of both SDH+ and SDH- 
muscle fibres  
We showed that 8 weeks of intraperitoneal injection of sActRIIB to inhibit Myostatin 
signalling didn’t diminish the oxidative capacity of myofibres from hind limb muscles of 
ErrγTg/+ mice, while reduced proportion of oxidative fibres in WT muscles. However, whether 
the oxidative myofibre phenotypes developed in the ErrγTg/+ muscles would be able to get 
hypertrophied following sActRIIB treatment, remain to be elucidated. To that end we 
determined the cross-sectional area (CSA) of oxidative and glycolytic myofibres in EDL and 
soleus muscles from WT, ErrγTg/+ WT.sActRIIB and ErrγTg/+.sActRIIB mice.  A minimum of 150-
200 measurements per myofibre types were taken in each muscle section (Figure 6.7A and 
B).  
In both muscles examined, there was a significant increase in the CSA of both SDH+ and SDH-  
muscle fibres of WT.sActRIIB and ErrγTg/+.sActRIIB compared to WT.PBS and ErrγTg/+.PBS mice 
(Figure 6.7A and B, and Figure 6.8A and B). More specifically, we found that both SDH+ and 
SDH- myofibres of EDL muscles from ErrγTg/+.sActRIIB displayed larger CSA than their 
counterpart from WT.sActRIIB animals (Figure 6.8A). Soleus muscles showed no significant 
difference neither between SDH+, nor SDH- myofibres CSA from WT.sActRIIB and 
ErrγTg/+.sActRIIB mice (Figure 6.8B). 
Taken together, these data indicate that post-natal inhibition of Myostatin by systemic 
administration of sActRIIB that increased CSA of ErrγTg/+ muscle fibres which is associated 
with hyper-oxidative phenotype would challenge the trade-off that is thought to exist 
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Figure 6.8. sActRIIB induces enlargement of both SDH+ and SDH- myofibres  
Post-natal inhibition of Myostatin in WT and Eγ leads to hypertrophy SDH+ and SDH- 
muscle fibres.  
(A) Quantification of SDH+ and SDH- muscle fibres cross-sectional area in EDL muscles 
from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB  mice.  
(B) Quantification of SDH+ and SDH- muscle fibres cross-sectional area in soleus muscles 
from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB  mice.  
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.9. sActRIIB treatment increases blood vessels density of ErrγTg/+ muscles  
We demonstrated fibres enlargement of muscles from ErrγTg/+ mice with no change in their 
oxidative capacity indicated by constant level of SDH expression.  
It has been shown that the number of blood vessels per muscle fibre is correlated with 
myofibre cross-sectional area, thereby increases the average of oxygen diffusion to 
mitochondria (Plyley et al., 1998). Further studies have referred to a unique feature of 
skeletal muscle beds that the oxidative capacity of myofibres is tightly coupled to the tissue 
vascular supply (Fluck and Hoppeler, 2003, Pette and Staron, 2000). Moreover, investigation 
of the effect of sActRIIB treatment on mice as well as on C2C12 myotubes unveiled a drop in 
the expression of molecules that regulate muscle angiogenesis program and the capillary 
density (Relizani et al., 2014, Personius et al., 2010). In contrast, Errγ has been described a 
key transcriptional regulator that induces skeletal muscles vascular features and oxidative 
phosphorylation properties (Narkar et al., 2011). Therefore, we here investigated the effect 
of administration of sActRIIB would have on the vascularization of muscles from ErrγTg/+ mice 
that displayed fibre hypertrophy while prevented the reduction of oxidative capacity might 
be prompted by Myostatin inhibition. To test this we examined the density of blood vessels 
in EDL muscle sections (n=5) from WT, ErrγTg/+, WT.sActRIIB and ErrγTg/+.sActRIIB mice using 
the endothelial cell marker (CD31) (Figure 6.9A). 
We found that capillary to fibre ratio (C:F) was the highest in muscles of ErrγTg/+.sActRIIB 
mice (Figure 6.9A and B). Of particular note, WT muscles were treated with sActRIIB did not 
show any significant difference in capillary density compared to muscles from WT.PBS. 
Interestingly, the 8 weeks injection of sActRIIB caused an increase in the number of 
capillaries serving each myofibre in muscles from ErrγTg/+ mice (Figure 6.9A and B). We also 
showed that the capillary density was higher in muscle from ErrγTg/+ than the control (Figure 
6.9A and B). 
These observations suggest that 8 weeks of treatment with sActRIIB was efficacious to 
induce capillary density, hence matched the increased size and oxidative capacity demands 




































































Figure 6.9. Post-natal inhibition of Myostatin induces blood vessels number in muscle-
specific Eγ mice  
sActRIIB treatment increases capillary density of muscle-specific Eγ muscles but not WT. 
(A) Muscle capillary density determined by CD31 staining on EDL muscle sections from WT, 
Eγ, WT.sActRIIB and Eγ.sActRIIB mice.  
(B) Quantification of blood vessels per myofibre in EDL muscles. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.10. Inhibition of Myostatin causes elevation in level of superoxide in WT but not in 
ErrγTg/+ muscles 
It has been documented that Reactive Oxygen Species (ROS) are produced through the  
mitochondrial electron transport chain (ETC) pathway of the dysfunctional mitochondria 
(Harper et al., 2004). Further investigation of transcriptome profiling of skeletal muscles 
were treated with sActRIIB-Fc has shown a remarkable reduction in expression level of genes 
that regulate mitochondrial functions (Rahimov et al., 2011). In contrast, previous work has 
revealed a vital role of Errγ in regulating of mitochondrial biogenesis and functions in 
skeletal muscles (Rangwala et al., 2010), therefore its knockout severely impaired 
mitochondrial formation hence resulted in high level of ROS production (Murray et al., 
2013). Here we investigated whether the deficit in mitochondrial enzyme activity that we 
showed in WT muscles followed post-natal inhibition of Myostatin would induce ROS level, 
as well as sought to determine the potential of Errγ to mitigate ROS production. Therefore, 
we evaluated the level of superoxide using Dihydroethidium (DHE) dye (Bindokas et al., 
1996, Li et al., 2003) in EDL muscle sections (n=5) from WT, ErrγTg/+ WT.sActRIIB and 
ErrγTg/+.sActRIIB mice (Figure 6.10A). We found elevated levels of superoxide indicated by 
high DHE intensity in both small (slow oxidative) and large (fast glycolytic) myofibres in EDL 
muscles from WT.sActRIIB compared to counterpart muscles from WT.PBS mice (Figure 
6.10A and B). Interestingly, introduction of sActRIIB into ErrγTg/+ muscles did not induce DHE 
intensity (Figure 6.10 A and B). We also showed that ROS levels was significantly lower in 
EDL muscles from ErrγTg/+ compared to WT (Figure 6.10 A and B). These data suggest that 
post-natal inhibition of Myostatin using systemic administration of sActRIIB leads to increase 
ROS level in WT muscles. However, same treatment did not affect superoxide level in 
































Figure 6.10. Eγ overexpression is necessary to mitigate ROS emission   
Muscle-specific expression of Eγ prevents post-natal inhibition of Myostatin to promote 
excessive level of reactive oxygen species (ROS). 
(A) DHE fluorescence in the body of EDL muscle fibres from WT, Eγ, WT.sActRIIB and 
Eγ.sActRIIB mice. 
(B) Quantification of DHE intensity in small and large myofibres in EDL muscles. 
(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
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6.11. Muscle-specific expression of Errγ prevents the decrease in connective tissue level 
that induced by sActRIIB treatment in WT muscles.  
It was well established that extracellular matrix (ECM) of skeletal muscle is a dynamic tissue 
that it is essential for myofibres force transmission and protection of these fibres against 
injury (Alameddine, 2012, Gustafsson, 2011). Further investigations have reported that the 
molecules which are constituting the ECM vary depending on the mechanical demands of 
the tissue that helps to optimize efficient force transmission (Koskinen et al., 2004, Mackey 
et al., 2004). The main structural and functional component of muscle ECM is collagen 
(Heinemeier et al., 2007). Moreover, it was well established that skeletal muscle fibres are 
protected from contraction induced damages by a number of proteins that collectively 
known as the dystrophin-glycoprotein complex (DGC) (Gumerson and Michele, 2011). 
Dystrophin is the largest identified member of the DGC that with the other members link 
the cytoskeleton to collagen in the ECM of perimysium and endomysium (Gumerson and 
Michele, 2011, Gillies and Lieber, 2011). In addition, it has been revealed that laminin links 
the ECM to the DGC through its ability to bind collagen with the members of DGC (Gao and 
McNally, 2015).  
Previous work has shown that the endomysium of muscles from Myostatin null mice is 
thinner than the counterpart muscles from WT mice (Elashry et al., 2012). Moreover, a 
number of studies have reported that glycolytic/fast contraction muscle fibres which 
characterised by large cross-sectional area are invested with less amount of ECM than the 
oxidative/slow contraction fibres (Kovanen et al., 1980). As Myostatin might potentially 
contribute in regulating and promoting of muscle connective tissue, we here investigated 
whether post-natal inactivation of this negative regulator of skeletal muscle development by 
systemic administration of sActRIIB would affect the whole amount of ECM in muscles from 
WT and ErrγTg/+ mice. To that end, we examined the relationship between MHC fibres and 
expression of collagen type IV, dystrophin and laminin within muscle fibres of the same 
genotypes, and we also compared the amount of these proteins in muscles from each 
cohort using semi-quantitative immunofluorescence methods. The protocols that have been 
developed allowed us to determine expression levels of particular proteins at the 
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and correlate this with fibres phenotypes. Furthermore, we measured the thickness of the 
expression domain size (de Bruin et al., 2014) for each of the three marker proteins.   
Muscle sections of fast and slow phenotypes (EDL and soleus respectively) (n=5) from WT, 
ErrγTg/+, WT.sActRIIB and ErrγTg/+.sActRIIB mice were immunostained using antibodies for 
(MHCIIB, collagen type IV, dystrophin and laminin) (Figures 6.11A, 6.12A, 6.13A and 6.14A) 
to determine the intensity and the thickness of these proteins between MHCIIB+ and 
MHCIIB- in EDL muscles. As we found that soleus muscles of WT did not contain MHCIIB+, 
and as we showed sActRIIB treatment did not change MHC profiling in any muscle of both 
genotypes (WT and ErrγTg/+), we used soleus muscle sections that were immunostained 
previously for antibodies against (MHCIIA and MHCI) (Figure 6.4) as a guide to measure the 
intensity and thickness of collagen type IV, dystrophin and laminin between MHCI+ only in 
serial sections (Figures 6.11B, 6.12B, 6.13B and 6.14B). Connective tissue intensity and 
thickness between approximately 50 fibres of same MHC isoform (MHCIIB+-IIB+ and MHCIIB--
IIB-) in EDL muscles, and between (MHCI+-I+) in soleus muscles from the four cohorts were 
measured.   
Using these techniques we first examined the expression level and domain size of collagen 
IV in the endomysium between MHCIIB- and MHCIIB+ of EDL muscles within the individual 
cohort. Then we compared these parameters in the endomysium between MHCIIB- and  
MHCIIB+ in EDL muscles, and between MHCI+ in soleus muscles from the four cohorts of this 
study (WT, ErrγTg/+, WT.sActRIIB and ErrγTg/+.sActRIIB). Our findings supported previous 
observations (Kovanen et al., 1980) that the collagen IV expression level and domain size 
were significantly greater in the endomysium between MHCIIB- relative to MHCIIB+ in all EDL 
muscle samples examined from the four genotypic groups (Figure 6.12A, C and D). 
Quantification of signal intensity as well as thickness between MHCIIB- and MHCIIB+ in EDL 
muscles, and between MHCI+ in soleus muscles of all cohorts demonstrated that 8 weeks of 
sActRIIB treatment caused an overall decrease in the collagen type IV in all myofibres of 
WT.sActRIIB muscles compared to the counterpart of WT.PBS. Importantly, we found that 
muscle-specific expression of Errγ that induces oxidative metabolism was sufficient to 
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MHCIIB+ in EDL muscles (Figure 6.12C and D), and between MHCI+ in soleus muscles (Figure 
6.12E and F), following post developmental inhibition of Myostatin using activin ligand trap.  
Next we examined intracellular membrane associated protein (dystrophin), as well as 
extracellular component that link the myofibre cytoskeleton to the collagen (laminin).   
We found that the expression of these proteins displayed marked changes in relation to 
MHCIIB within muscles of individual genotypic group. Of particular note, the expression of 
dystrophin and laminin based on intensity and thickness measurements were significantly 
greater in the endomysium between MHCIIB- than MHCIIB+ myofibre in EDL muscles 
examined from the four cohorts (Figure 6.13A, C and D) and (Figure 6.14A, C and D) 
respectively. We next examined the signal intensity and thickness in the endomysium 
between MHCIIB- and MHCIIB+ in EDL muscles, and in the endomysium between MHCI+ in 
soleus muscles from mice treated with PBS versus mice treated with sActRIIB. We found 
that the intensity and thickness of dystrophin and laminin were significantly lower in 
between all MHC cohorts (MHCIIB-, MHCIIB+ and MHCI+) of EDL and soleus muscles from 
WT.sActRIIB compared to their counterpart from WT.PBS animals (Figure 6.13A-F) and 
(Figure 6.14A-F) respectively. Interestingly, we found that expression of Errγ had profound 
impact on the intracellular and extracellular protein levels. More specifically, the 
hypertrophic MHCIIB- and MHCIIB+ in EDL muscles, and hypertrophic MHCI+ in soleus 
muscles from ErrγTg/+.sActRIIB mice showed similar intensity and thickness of dystrophin and 
laminin following 8 weeks of twice weekly injection of sActRIIB (Figure 6.13A-F) and (Figure 
6.14A-F).  
Together, these data firstly indicate that fibre type based on myosin Heavy Chain IIB 
influences the level of collagen IV, dystrophin and laminin within the same genotype 
muscles. Secondly, the levels of all three proteins examined were decreased in muscles from 
WT.sActRIIB compared to WT.PBS. Interestingly, we show that levels of the examined 
protein at sarcolemma does not change in muscles of ErrγTg/+ mice following sActRIIB 
treatment, which suggest a robust impact of the metabolic programme imparted by Errγ 



















Figure 6.11. Expression of dystrophin in the entire EDL and soleus muscle sections 
A) Immunohistochemical images of EDL muscles from WT, Eγ, WT.sActRIIB and Eγ.sActRIIB       
mice. Green colour signifies the expression of dystrophin, with MHCIIB appearing as red. 
B) Immunohistochemical images of soleus muscles from WT, Eγ, WT.sActRIIB and 




(n=5) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 












































































































































Figure 6.12. sActRIIB treatment caused a reduction in collagen IV intensity and thickness 
in muscles from WT but not Eγ  
A) Serial sections of EDL muscles staining with MHCIIB and collagen IV. MHCIIB was used to 
identify MHCIIB
-
 (yellow stars) and MHCIIB
+
 fibres (white stars). Expression of collagen IV 
more robust in ECM between two MHCIIB
-
 fibres (yellow arrow) compared to that between 
MHCIIB
+
 fibres (white arrows) in wild type muscle. Same relationship with lower levels in 
WT.sActRIIB muscles. Similar expression domain in ECM between MHCIIB
-
 (yellow arrows) 
as well as MHCIIB
+
 (white arrows) of EDL muscles from Eγ and Eγ.sActRIIB mice. 
B) Serial sections of soleus muscles staining with MHCIIB and collagen IV. Lower level of 
collagen IV between MHCIIB
+ 
(red arrows) in WT.sActRIIB compared to WT.PBS muscles. 
Similar expression domain in ECM between MHCI
+ 
(red arrows) soleus muscles from Eγ and 
Eγ.sActRIIB mice. 
C) Expression of collagen IV quantifies by intensity by setting standard value of 1 for the 
level between MHCIIB
-
 fibres from WT mice.  
D) Collagen IV expression quantifies in terms of thick domain in EDL muscles.  
E) Expression of collagen IV quantifies by intensity by setting standard value of 1 for the 
level between MHCI
+
 fibres from WT mice.  
F) Collagen IV expression quantifies in terms of thick domain in soleus muscles.  
(n=50) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
compare replicate means by row, and Two-tailed Student’s t-test for independent 
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Figure 6.13. sActRIIB treatment caused a reduction in dystrophin intensity and thickness 
in muscles from WT but not Eγ 
A) Serial sections of EDL muscles staining with MHCIIB and dystrophin. MHCIIB expression 
in red and dystrophin in green. MHCIIB was used to identify MHCIIB
-
 (yellow stars) and 
MHCIIB
+
 fibres (white stars). Expression of dystrophin more robust in ECM between two 
MHCIIB
-
 fibres (yellow arrow) compared to that between MHCIIB
+
 fibres (white arrows) in 
wild type muscle. Same relationship with lower levels in WT.sActRIIB muscles. Similar 
expression domain in ECM between MHCIIB
-
 (yellow arrows) as well as MHCIIB
+
 (white 
arrows) of EDL muscles from Eγ and Eγ.sActRIIB mice. 
B) Serial sections of soleus muscles staining with MHCIIB and dystrophin. Lower level of 
dystrophin between MHCI
+ 
(red arrows) in WT.sActRIIB compared to WT.PBS muscles. 
Similar expression domain in ECM between MHCI
+ 
(red arrows) soleus muscles from Eγ and 
Eγ.sActRIIB mice. 
C) Expression of dystrophin quantifies by intensity by setting standard value of 1 for the 
level between MHCIIB
-
 fibres from WT mice.  
D) Dystrophin expression quantifies in terms of thick domain in EDL muscles.  
E) Expression of dystrophin quantifies by intensity by setting standard value of 1 for the 
level between MHCI
+
 fibres from WT mice.  
F) Dystrophin expression quantifies in terms of thick domain in soleus muscles.  
(n=50) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
compare replicate means by row, and Two-tailed Student’s t-test for independent 


























































































































Figure 6.14. sActRIIB treatment caused a reduction in laminin intensity and thickness in 
muscles from WT but not Eγ  
A) Serial sections of EDL muscles staining with MHCIIB and laminin. MHCIIB expression in 
red and laminin in green. MHCIIB was used to identify MHCIIB
-
 (yellow stars) and MHCIIB
+
 
fibres (white stars). Expression of laminin more robust in ECM between two MHCIIB
-
 fibres 
(yellow arrow) compared to that between MHCIIB
+
 fibres (white arrows) in wild type 
muscle. Same relationship with lower levels in WT.sActRIIB muscles. Similar expression 
domain in ECM between MHCIIB
-
 (yellow arrows) as well as MHCIIB
+
 (white arrows) of EDL 
muscles from Eγ and Eγ.sActRIIB mice. 
B) Serial sections of soleus muscles staining with MHCIIB and laminin. Lower level of 
laminin between MHCI
+ 
(red arrows) in WT.sActRIIB compared to WT.PBS muscles. Similar 
expression domain in ECM between MHCI
+ 
(red arrows) soleus muscles from Eγ and 
Eγ.sActRIIB mice. 
C) Expression of laminin quantifies by intensity by setting standard value of 1 for the level 
between MHCIIB
-
 fibres from WT mice.  
D) Laminin expression quantifies in terms of thick domain in EDL muscles.  
E) Expression of laminin quantifies by intensity by setting standard value of 1 for the level 
between MHCI
+
 fibres from WT mice.  
F) Laminin expression quantifies in terms of thick domain in soleus muscles.  
(n=50) three months old male WT and Eγ injected with PBS, and WT and Eγ injected with 
sActRIIB twice weekly for 8 weeks; Two-way ANOVA followed by Bonferroni post-tests to 
compare replicate means by row, and Two-tailed Student’s t-test for independent 
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6.12. Discussion 
The important health implications of maintaining an adequate level of skeletal muscle size 
and functions, and its consequences on the life quality has been recognized during the past 
few years by a number of researchers (Anker et al., 1997, Wolfe, 2006, Pistilli et al., 2011). It 
has been established that the skeletal muscle has internal mechanisms to prevent 
overgrowth. This crucial function is performed at least in part by members of the 
Transforming Growth Factor-β (TGF-β) family, especially Myostatin (McPherron et al., 1997). 
Myostatin signals through its transmembrane activin receptor IIB (ActRIIB), and suppression 
of this pathway induces skeletal muscle growth (Lee and McPherron, 2001, Schuelke et al., 
2004). Therefore, a number of studies have used different strategies that interfere with the 
ActRIIB receptor mediated Myostatin pathway in order to ameliorate muscle wasting 
through either injection of sActRIIB-Fc (Pistilli et al., 2011, George Carlson et al., 2011), AAV-
mediated gene transfer (Morine et al., 2010), or antibodies direct against the ActRIIB 
receptor (Lach-Trifilieff et al., 2014). However, it remains a matter to determine whether 
the increase in muscle mass following post-natal blocking of Myostatin would have any 
functional benefits, because we and others have shown a reduction in mitochondrial 
quantity, oxidative capacity and capillary density thereby loss of specific force and increase 
fatigability of large muscles from Myostatin null mice (Amthor et al., 2007, Mendias et al., 
2006). Previous studies have revealed a remarkable decrease in the markers of oxidative 
energy production capacity of skeletal muscle following Myostatin blocking (Rahimov et al., 
2011, Relizani et al., 2014). Moreover, it has been documented that Myostatin inhibition 
leads to compromise muscle capillary density (Personius et al., 2010). In addition, a marked 
decline in the expression levels of biomarker genes that regulate mitochondrial functions 
has been found in muscles were treated with sActRIIB-Fc (Rahimov et al., 2011). On the 
contrary, estrogen-related receptor gamma (Errγ) has been identified as a key molecule that 
capable to enhance muscle fibre oxidative properties in parallel with promoting a network 
of genes that regulate skeletal muscle energy production and vascularization (Alaynick et al., 
2007, Narkar et al., 2011, Matsakas et al., 2012b). Furthermore, both Rangwala and 
Dufour’s groups have revealed a vital role of Errγ in regulating of mitochondrial biogenesis 
and biomarker genes that encoding slow muscle fibres contractile pathways (Rangwala et al., 
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Therefore, we asked whether Errγ and its metabolic and angiogenic targets are able to 
prevent muscle’s metabolic and functional deficits that resulted from Myostatin inhibition. 
And we sought to identify to what extent that inhibition of Myostatin at a post-natal stage in 
ErrγTg/+ mice by weekly injection of sActRIIB would affect oxidative features that imparted by 
Errγ overexpression.  
Our analysis shows that 8 weeks of a weekly injection of sActRIIB caused a significant 
increase in the body mass of both WT and ErrγTg/+ mice. Further, examination of isolated 
muscles showed an increase in the mass of all examined muscles from WT and ErrγTg/+ mice 
following sActRIIB treatment compared to age-matched control animals. We provided 
evidence that the increase in muscle mass was not due to an increase in muscle fibre 
numbers, but resulted from an increase in CSA of all MHC fibre types. We showed that the 
injection of sActRIIB induced a decrease in the oxidative capacity of the muscle in WT mice 
as indicated by the low proportion of SDH+ fibres. Strikingly, sActRIIB did not cause a 
reduction in muscle oxidative capacity of ErrγTg/+ mice indicated by the same proportion of 
oxidative myofibres (SDH+) in both ErrγTg/+.PBS and ErrγTg/+.sActRIIB muscles. Furthermore, 
this study showed that the high level of oxidative capacity in muscles from ErrγTg/+.PBS and 
ErrγTg/+.sActRIIB was accompanied by an elevated number of blood vessels. However, 
sActRIIB treatment does not cause any change in capillary density of WT muscles. We also 
provided evidence that the diminish in the mitochondrial enzyme (SDH) activity in WT 
muscles following 8 weeks of sActRIIB injection accompanied with an increase in ROS level 
indicated by high intensity of DHE. However, muscles of ErrγTg/+.PBS and ErrγTg/+.sActRIIB 
mice display a similar level of DHE intensity. Additionally, our observations demonstrated 
lower levels of intensity and thickness of collage IV, dystrophin and laminin in WT muscles 
injected with sActRIIB compared to the control. Importantly, muscles from ErrγTg/+.PBS and 
ErrγTg/+.sActRIIB mice show no significant differences in either intensity or thickness of all 
examined proteins.  
Despite the enlargement of individual muscles mass from Mtn-/- and Mtn-/-/ErrγTg/+ 
compared to their counterparts from WT mice, we have previously shown that all three 
genotypic groups displayed same body weight, which might attribute to a decrease of fat 
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present study demonstrated that weekly IP injection of sActRIIB for 8 weeks which 
antagonize signalling mediated by Myostatin caused a significant increase in body and all 
examined muscles mass of both WT and ErrγTg/+ mice. Previous studies have reported that 
there is an age window for inducing body and muscle mass by antagonizing action of 
Myostatin might be limited to relatively early post-natal life (Qiao et al., 2009, Qiao et al., 
2008). Subsequently, there was no change in body mass following Myostatin blocking at 16 
weeks age (Qiao et al., 2008). Therefore, we performed Myostatin inhibition using sActRIIB 
injection for 8 weeks within this period (4-12 weeks), and we showed that the increase in 
body mass can be brought about when the animal at this age. A number of studies have 
reported a significant increase in body weight together with a robust growth of individual 
skeletal muscle following four months administration of sActRIIB to wild type mice (Relizani 
et al., 2014, Lee et al., 2005). Further investigations have demonstrated that treatment of 
healthy adult mice using a soluble form of activin receptor for four weeks resulted in clearly 
hypertrophied muscles without any effect on fat mass in mice fed a standard diet 
(Whittemore et al., 2003, Akpan et al., 2009). Moreover, a study by Benny Klimek et al 
found an increase in abdominal fat pad weight following injection of athymic nude mice with 
a chinese hamster ovary (CHO) cell line engendered to secret the sActRIIB (Benny Klimek et 
al., 2010). By a way of explanation, the significant increase in body weight of both genotypic 
groups (WT and ErrγTg/+) in present study following 8 weeks of weekly injection of sActRIIB 
might in addition to muscle hypertrophy, it attributes to the increase or at least no change 
in fat mass (Benny Klimek et al., 2010, Whittemore et al., 2003), which was decreased in 
mice with genetic alteration of Myostatin (Lebrasseur, 2012), thereby no difference in body 
weight of WT and Mtn-/- mice as we showed previously (Figure 3.2). We believe that muscle 
response to post-natal blocking of Myostatin in term of secreting myokines that mediate the 
cross-talking between skeletal muscle and adipose tissue, was however very slow, hence did 
not affect fat mass.   
Our data examining individual muscle weights showed that the changes were dependent on 
specific muscles. We found at 12 weeks old age, the EDL, gastrocnemius and TA muscles 
from sActRIIB treated WT and ErrγTg/+ animals were significantly heavier than muscles from 
the untreated mice, whereas soleus muscle was only significantly heavier in WT treated but 
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from WT.sActRIIB showed high percentages of increase in their weights than those from 
ErrγTg/+.sActRIIB mice compared to the untreated muscles from both cohorts respectively. 
These findings supported observations of Matsakas et al (Matsakas et al., 2009), that 
referred to a varying degree of muscles response to post-natal inhibition of Myostatin using 
AAV8ProMyo injection. Further investigation of Myostatin inhibition effects on muscles 
mass from aged mice (20 months) using same treatment above (AAV8ProMyo) displayed a 
disparate significant increase in muscle weights from treated animals compared to the aged-
match controls (Collins-Hooper et al., 2014). Giving our interpretation, the differences in 
muscle weights response to the sActRIIB treatment could be attributed to infiltration rate of 
the treatment through connective tissue compartments, that is supposed to differ in 
relative to muscle fibre profile (Elashry et al., 2012). Alternatively, we believe that some 
muscle may have received more sActRIIB treatment than the others, however, even if that 
occurred, it would has only a minor impact on muscle weights.  
To investigate this further, we examined whether the increase in muscles mass following 
sActRIIB injection was due to an increase in muscle fibre number, size, or both of them as 
we noticed previously in muscles from Mtn-/- mice. In agreement with aforementioned 
reports (Whittemore et al., 2003, Lee et al., 2005, Zhu et al., 2000), we found a hypertrophy 
without hyperplasia in all muscle fibres following 8 weeks of a weekly injection of sActRIIB. 
Moreover, the hypertrophy seems to affect all muscle fibres from treated mice, particularly 
the most glycolytic types, entitled the MHCIIB fibres, such data supported by a number of 
studies (Foster et al., 2009, Matsakas et al., 2009). A number of investigators have 
established that Myostatin controls both skeletal muscle fibre numbers through inhibition of 
myoblast proliferation and differentiation, and muscle fibres size by inhibiting protein 
synthesis mediating by reducing of Akt level, while upregulating FoxO activity (Thomas et al., 
2000, Yang et al., 2007). Therefore, we and others have shown that germline deletion of 
Myostatin led to a dramatic increase in muscle mass as a result of both hyperplasia and 
hypertrophy (McPherron et al., 1997, Hulmi et al., 2013b). However, in this experiment we 
found no evidence of an increase in the total fibre numbers within each examined muscle, 
confirming that the post-natal elevation of muscle mass due to Myostatin inhibition using 
sActRIIB injection was not relative to muscle hyperplasia. Previous work has revealed a 
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injected with AAV8ProMyo compared to the controls, indicating no effect of post-natal 
inhibition of Myostatin on satellite cell numbers (Matsakas et al., 2009). In the line of 
investigation, an important finding of in vitro study by Amthor et al. (Amthor et al., 2009) 
has shown that there is no significant difference in the rate of myoblast proliferation 
following Myostatin blocking. Further investigation has revealed a normal rate of satellite 
cells differentiation following postnatal inhibition of Myostatin (Foster et al., 2009). The 
absence response of satellite cells to the post-natal blocking of Myostatin is might be 
explained by the downregulation of activin receptors of these cells (Amthor et al., 2009). It 
seems that there is no impact of post-natal inhibition of Myostatin using sActRIIB on neither 
proliferation, nor differentiation abilities of satellite cells, thereby myofibre numbers.  
Observations of the present study revealed that a significant increase in the average of the 
cross-sectional area of all myofibre types of the EDL and soleus muscles from WT mice 
treated with sActRIIB for 8 weeks was statistically detectable compared to the control. As 
we stated above there was no change in total fibres number in examined muscles of both 
genotypes (WT and ErrγTg/+), thus we infer that the main means of muscle enlargement in 
this study has been brought about through a cellular hypertrophic response. Although all 
muscle fibre types of EDL and soleus muscles from treated WT and ErrγTg/+ mice underwent 
enlargement, we found that the glycolytic fast myofibres IIB displayed the greatest response 
to sActRIIB treatment. Previous work has reported that myofibres IIB have the highest levels 
of ActRIIB and Myostatin expression (Mendias et al., 2006), therefore releasing these fibres 
from Myostatin inhibitory effect lead them to display the larges CSA. Further investigation 
has reported that there is an upper threshold for each muscle fibre type, and muscles with a 
high proportion of MHCIIB fibres can reach the greatest size (Thomas, 2007). In this line of 
thought, it has been documented that post-natal inhibition of Myostatin had no effect on 
the myonuclei numbers, thus the increase in CSA of all fibre types might indicating a 
reduction of the nuclear: cytoplasmic ratio following inactivation of Myostatin (Matsakas et 
al., 2009). We have previously shown that Myostatin absence resulted in a significant 
increase in muscle fibre size compared to WT, due to a marked elevation of protein 
synthesis process mediated by Akt, simultaneously suppressed FoxO3 expression that 
mediating protein degradation pathways. As stated above that myonuclear number was not 
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sActRIIB could induce muscle fibre hypertrophy through inhibiting Myostatin ability to 
repress protein synthesis, possibly by the Akt pathway (Yang et al., 2007). Importantly, 
several other studies, however, revealed no evidence of strength or function benefits in 
human with muscle dystrophy accompanied the enlargement muscle fibres following post-
natal inactivation of MYOSTATIN (Krivickas et al., 2009, Wagner et al., 2008). Moreover, it 
has been demonstrated that post-natal treatment with sActRIIB-Fc resulted in 
downregulation of genes that involve in mitochondrial function and oxidative 
phosphorylation (Rahimov et al., 2011). Therefore, we induced muscle oxidative metabolism 
in advance through muscle-specific overexpression of Errγ that described as a key regulator 
of a network of biomarker genes linked to mitochondrial biogenesis and function, oxidative 
metabolism, angiogenic programme and fatty acid oxidation (Narkar et al., 2011, Rangwala 
et al., 2010).  
Our examining of myofibre proportions in the controls and sActRIIB treated EDL and soleus 
muscles from both genotypic groups of this study at the first time confirmed previous 
studies (Matsakas et al., 2012b, Narkar et al., 2011), that Errγ transgenic muscles have a 
higher percentages of slow-twitch than the fast-twitch myofibres compared to WT control 
muscles. Secondly, there was no change in the fibre type distribution at myosin heavy chains 
(MHC) level following 8 weeks of sActRIIB treatment in any muscle of both genotypic groups. 
We and others have demonstrated previously that muscles with germline deletion of 
Myostatin displayed a predominant of MHCIIB myofibres concomitant with a marked 
reduction in numbers of MHCIIA and MHCIIX (Girgenrath et al., 2005, Amthor et al., 2007). 
Unlike in the genetic mutant, previous work has unveiled that inactivation of Myostatin in 
aged mice using AAV8MyoPPT did not cause any change in the expression of myosin heavy 
chain (Collins-Hooper et al., 2014). Further studies have reported that blocking of ActRIIB 
signalling in adult WT mice do not have any impact on fibre types composition (Relizani et 
al., 2014, Cadena et al., 2010). We infer from these studies that the shift of muscle fibres of 
Mtn-/- mice toward the fast phenotypes commonly attributed to the changes in muscle-
specification during a developmental period (Baligand et al., 2010, Savage and McPherron, 
2010). Moreover, these investigations imply that protocol of post-developmental blocking 
of Myostatin through 8 weeks of sActRIIB injection is unable to influence myofibre 
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development as occurred in Mtn-/- mice. Additionally, MHC proteins are stable to some 
extent, thus their turnover rates might require many weeks (Papageorgopoulos et al., 2002).  
The hypertrophied myofibres from WT.sActRIIB mice showed a marked decrease of muscle 
oxidative capacity indicated by low SDH activity. Such combination of large muscle fibres 
with low oxidative capacity fits nicely with the trade-off that thought to exist between 
muscle fibres size and oxidative capacity (Van der Laarse WJ, 1998). In contrast, an 
interesting feature highlighted by our work is the significant increase in myofibres size of 
ErrγTg/+ muscles following sActRIIB treatment, was not accompanied with reduction in 
muscle oxidative capacity as occurred in WT mice, thereby challenging the inverse 
relationship between muscle fibre oxidative capacity and its size (van Wessel et al., 2010, 
Degens, 2012). It was well established that ActRIIB/Myostatin signalling is essential to 
maintain the balance between muscle fibres size and strength via optimizing muscle energy 
metabolism (Relizani et al., 2014). Same study unveiled a direct effect of the mentioned 
signalling on muscle oxidative metabolism indicating by a significant reduction in the 
expression of genes that controlling muscle aerobic metabolism following 24hr of C2C12 
treatment with sActRIIB (Relizani et al., 2014). In agreement with our findings in WT mice, 
previous work has reported that inactivation of Myostatin in aged mice leads to a significant 
diminishing of muscle oxidative capacity indicating by lower number of SDH+ fibres  (Collins-
Hooper et al., 2014). In addition, our results are in agreement with the phenotype of 
Myostatin null mice that we and others showed previously, which displayed an increase in 
glycolytic fibres, a meanwhile decrease of oxidative fibres compared to WT (Girgenrath et al., 
2005). These findings can be interpreting that the metabolic profile of skeletal muscle which 
is mirrored in part by SDH concentration can be quickly manipulated (George Carlson et al., 
2011), whereas MHC profiling seems more stable (Lach-Trifilieff et al., 2014). Strikingly, 
sActRIIB treatment did not change the oxidative capacity of ErrγTg/+ muscles. We showed 
previously that the reduction in oxidative capacity of muscles from Mtn-/- mice was coupled 
with depletion in mitochondrial number, as reported by Amthor et al (Amthor et al., 2007). 
In contrast, we found that muscle-specific overexpression of Errγ into Mtn-/- background 
muscles was sufficient to induce mitochondrial density, thereby restored muscle oxidative 
capacity to the control conditions. Moreover, it has been documented that Errγ is highly 
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Giguere, 2008). This would infer that the robust oxidative metabolic reprogram imparted by 
muscle-specific Errγ overexpression was efficacious to prevent metabolic shifting toward 
glycolytic profile that would be influenced by post-natal inhibition of Myostatin via sActRIIB 
treatment.  
Previous studies have reported that skeletal muscle oxidative capacity and vascular supply 
are strongly relative to each other (Fluck and Hoppeler, 2003, Pette and Staron, 2000). 
Further investigation has unveiled that the blood supply per each muscle fibre is correlated 
to muscle fibre size (Degens et al., 1992), thus muscle fibres with high oxidative 
phosphorylation try to limit their size for better diffusion of oxygen from capillaries to 
mitochondria (van Wessel et al., 2010, Kinsey et al., 2007). To further solidify of our results, 
we quantified capillary density per each myofibre; we found that the elevated oxidative 
capacity was accompanied with an increase in the capillary to muscle fibres ratio (C:F) in 
muscles from ErrγTg/+, but not WT mice following 8 weeks of sActRIIB treatment. Previous 
work has demonstrated a clear drop in capillary density in muscles from mdx mice following 
sActRIIB treatment (Relizani et al., 2014, Personius et al., 2010). Interestingly, it has been 
revealed a high expression of Myostatin is essential to improve metabolic functioning and to 
increase capillary density in the state of chronic hypoxia, indicating a direct effect of 
Myostatin on endothelial cells proliferation, at the same time explaining the muscle wasting 
of those patients (Hayot et al., 2011). In this line of thought, it has been established that 
muscle-specific transgenic expression of Errγ is sufficient to induce mitochondrial biogenesis 
and muscle capillary supply, hence coordinates metabolic and vasculature demand in 
oxidative myofibres (Narkar et al., 2011, Matsakas et al., 2012b). Giving our explanation, 
post-natal inhibition of Myostatin altered the supposed correlation between muscle fibres 
size and its capillary numbers, however, Errγ overexpression in advance was sufficient to 
increase the number of blood vessels that serve each muscle fibres, thereby matched the 
increased CSA, and oxidative capacity demands. Such coinciding of hypertrophic myofibres, 
high oxidative capacity and capillary density would challenge the dogma that large fibres 
have to be glycolytic (Van der Laarse WJ, 1998).  
We and others showed previously that the reduction in oxidative capacity and capillary 
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quantity and quality (Amthor et al., 2007, Rehfeldt et al., 2005). Furthermore, we 
demonstrated that the high fatigability of Mtn-/- muscles might attribute to the 
mitochondrial perturbing that resulted from germline deletion of Myostatin, such data 
confirmed outcomes of previous work (Amthor et al., 2007). In addition, we found a high 
level of ROS synchronous with the mitochondrial depletion as consequent to Myostatin 
ablation. Previous work has reported an increase in muscle fatigue, and mice exhaustion 
during incremental running test following post-natal inhibition of Myostatin via sActRIIB 
treatment (Relizani et al., 2014). Further study has illustrated a drop in muscle autophagy 
level concurrently with running decrease following two weeks of sActRIIB administration 
(Mizushima et al., 2010). On the other hand, we showed previously that superimposition of 
Errγ into Mtn-/- muscles was sufficient to induce muscle oxidative capacity and blood supply, 
normalised mitochondrial abnormalities, numbers and location, and reduced ROS level, 
ultimately improved muscle physiology and enhanced exercise capacity. Moreover, Dufour’s 
(Dufour et al., 2007) revealed a central role of Errγ in regulating of mitochondrial biogenesis 
in skeletal muscles. Along the same lines of investigation, observations of the present study 
showed a high level of ROS indicated by high DHE activity (Diaz et al., 2003) following 8 
weeks of a weekly injection of sActRIIB in WT muscles but not ErrγTg/+. These data add to 
growing body of evidence that the reduction of muscle autophagy level, cellular route to 
remove unwanted long-live proteins and cytoplasmic organelles (Giannoulis et al., 2012, 
Cooper et al., 2010), as a consequence of Myostatin inhibition leads to accumulation of 
dysfunctional mitochondria, hence more ROS emission. However, muscle-specific expression 
of Errγ maintains muscle mitochondrial biogenesis and function, controls the expression of 
genes that regulate ETC pathway in mitochondria (Alaynick et al., 2007), prevent excessive 
ROS production, ultimately promotes muscle functions.  
Finally, we investigated the effect of Myostatin inhibition on the connective tissue 
development. Our observations highlighted a number of interesting features of connective 
tissue changes in relation to myofibres type and muscle metabolic status. We found higher 
levels of all examined proteins (collagen IV, dystrophin and Laminin) between MHCIIB- than 
MHCIIB+ myofibres in all muscle cohorts. We also found that the intensity signal and domain 
size were lower in WT.sActRIIB muscles compared to controls. Most importantly, we found 
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intensity and thickness of connective tissue following sActRIIB treatment. Previous study has 
demonstrated that Myostatin controls muscle development via myogenesis inhibition, 
whereas the same pathway induces fibroblast proliferation and development of connective 
tissue (Li et al., 2008, Zhang et al., 2012). Others have reported that the large glycolytic/fast 
contracting myofibres have thinner connective tissue compared to the small oxidative/slow 
muscle fibres (Kovanen et al., 1980). Moreover, it has been illustrated that the formation of 
muscle and connective tissue is Myostatin independent, however, Myostatin then mediates 
these two tissues modification via paracrine and autocrine- positive feedback mechanisms 
that have been demonstrated in myogenic and fibroblast cells (Zhu et al., 2000). We suggest 
that inhibition of Myostatin in WT mice via sActRIIB administration resulted in the 
development of thin connective tissue suited to the glycolytic myofibres induced by 
Myostatin blocking. However, the high oxidative phosphorylation induced in hypertrophic 
muscle fibres via Errγ overexpression prevents the reduction in ECM protein levels. The 
possible explanations here, Myostatin inhibition in WT muscles resulted in increased CSA, 
while reduced fibroblast proliferation which resulted in less connective tissue production. 
Interestingly, muscle-specific expression of Errγ either increase fibroblast numbers, or 
stimulate their activity, thereby attenuating connective tissue decrease. Additionally, the fast 
glycolytic fibres in all muscles examined have less ECM compared to the slow oxidative 
phenotypes to reduce the amount of energy stored in connective tissue and use it for force 
exertion on tendons.  
In conclusion, post-natal inhibition of Myostatin via sActRIIB administration increased 
muscle mass, but decreased muscle oxidative capacity and connective tissue content, and 
induced superoxide level in WT muscles. These changes may negatively contribute to reduce 
physical activity and be potentially associated with various health risks (Zhou et al., 2010, 
Faulkner et al., 1990). However, we demonstrate that muscle-specific overexpression of Errγ 
in combination with Myostatin blocking; muscle preserved its large size, displayed high 
oxidative capacity and capillary density, reduced ROS emission and avoided connective 
tissue reduction. These manifestations imply that it is possible to develop hyper-oxidative 
hypertrophic muscle fibres phenotypes during post-natal life via non-genetic methods.     
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7.1. Introduction  
Skeletal muscle consists of a number of compartments that are working co-ordinately in 
order to form a functional organ. In addition to muscle fibres, skeletal muscle contains 
additional entities that play a supportive role to maintain muscle structure and health 
(Gillies and Lieber, 2011). An important support compartment is dystrophin-glycoprotein 
complex (DGC), a complex of proteins that link the cytoskeleton to the extracellular matrix 
(ECM) (Gumerson and Michele, 2011, Gillies and Lieber, 2011). It is well established that 
dystrophin binds beat-Dystroglycan (β-DG) in transmembrane, which is bound to α-DG on 
the extracellular surface of the myofibre. Laminin, a component of the ECM binds to α-DG 
as well as to collagen IV in the basal lamina and indirectly to collagen I in the interstitial 
matrix (Allamand et al., 2011). 
In fact, the elaborate network of proteins in DGC provide skeletal muscle with the ability to 
transmit force to tendons to produce locomotion, as well as protecting it from contraction 
induce damage (Kjaer, 2004). Moreover, It has been demonstrated that ECM, rather than 
the muscle fibres, actually bear the stress during skeletal muscle contraction (Meyer and 
Lieber, 2011). In support of this view, previous work revealed a number of pathological 
conditions that occurred due to mutations in genes of DGC or ECM, for example Dystrophin 
mutation leads to Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy 
(BMD) (Kunkel et al., 1989). Limb-Girdle muscular dystrophies and other pathologies result 
from mutations in Dystroglycan (DG) and Sarcoglycans (SG) (Hara et al., 2011, Wicklund and 
Kissel, 2014). 
Skeletal muscle is a highly compliant tissue that undergoes both qualitative and quantitative 
alterations as a part of its adaptation to the physiological and environmental stimuli 
(Matsakas and Patel, 2009b). As the ECM and DGC represent a dynamic environment that 
supports the cellular elements and maintains muscle integrity; this raises the possibility of 
their changes as a part of skeletal muscle adaptation in response to intrinsic or extrinsic 
stimuli. This is clearly demonstrated in the phenotype of mice lacking Myostatin (Mtn-/-), a 
member of the TGF-ß family of secreted proteins. Previous studies have shown that in 
addition to muscle fibre hypertrophy and MHC transition toward glycolytic fast phenotypes 
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there is a remarkable reduction of ECM components compared to age and sex-matched wild 
type muscles (Elashry et al., 2012). These changes in ECM following Myostatin absence were 
either due to the increase in muscle fibre size which was not accompanied with a 
proportional increase in ECM production, or an adaptive change to complement ECM to 
muscle physiology. The later hypothesis is robustly supported by previous findings of 
Kovanen’s study, who showed less ECM content surrounds the glycolytic/fast myofibres 
compared to the oxidative/slow ones (Kovanen et al., 1980).  
Investigation of DGC and ECM in skeletal muscle is an important approach that can give 
insights of the communication and interaction between muscle fibres and the surrounding 
environment. Changes in skeletal muscle connective tissue in response to a diseases context 
have been intensely studied (Matsumura et al., 1993, Williams et al., 2015). However, little 
is known about the effect of non-disease scenarios on these components of skeletal muscle 
tissue. Therefore, we believe it is vital to investigate the relationship between myofibre 
phenotype (size and composition) and its force transduction apparatus that mainly formed 
from DGC and ECM.  
To do so, the hind limb muscles (EDL, soleus and TA) from three months old WT, Mtn-/- and 
Mtn-/-/ErrγTg/+ were utilised in this study. Muscle sections were immunostained using 
antibodies for collagen IV, collagen I, dystrophin, α, β, γ, δ-sarcoglycan, α, β-dystroglycan, 
and laminin. In order to determine levels of specific proteins at the sarcolemma and 
correlate this with fibre phenotype, semi-quantitative immunofluorescence methods were 
applied (Arechavala-Gomeza et al., 2010, Taylor et al., 2012). A number of soleus muscles 
were homogenized and RNA samples extracted to determine the expression of a number of 
genes that encoded ECM and DGC proteins using RT-PCR technique. Other soleus muscles 
were used to determine the expression of ECM and DGC molecules via western blotting. 
Here we show that fibre type, based on myosin heavy chain IIB expression (MHCIIB), 
influences the levels of DGC and ECM components at the sarcolemma. Secondly, 
sarcolemmal levels of all DGC proteins examined were lower in hypertrophic muscle from 
Mtn-/- mice compared to WT. Thirdly we show that levels of DGC at the sarcolemma were 
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programme established by Errγ. These results demonstrate that the metabolic programme 
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7.2. Muscle-specific expression of Errγ restores the reduction in basal lamina and 
interstitial components of ECM resulted from Myostatin absence  
Previous work using cryo-scanning electron microscopy has reported that genetic deletion of 
Myostatin leads to develop a thinner endomysium layer compared to age and sex matched 
WT muscles (Elashry et al., 2012). Moreover, deposition level of collagen I and collagen IV 
was higher in between MHCIIB- relative to between MHCIIB+, this relationship was constant 
in both WT and Mtn-/- muscles (Elashry et al., 2012).  
In this study, we used florescence microscopy based techniques in order to determine how 
they compared to electron microscopic approaches to quantify the ECM content of skeletal 
muscle. In fact, recently developed protocols enable the investigators to semi-quantitatively 
determine expression levels of a target protein based on intensity of signal (Arechavala-
Gomeza et al., 2010, Cirak et al., 2012, Taylor et al., 2012), as well as thickness of the 
connective tissue based on expression domain size (de Bruin et al., 2014). 
We first assessed the expression levels and thickness of collagen IV in the endomysium 
between MHCIIB- - IIB-, as well as between MHCIIB+ - IIB+ fibres. Measurements were taken 
from four non-overlapping regions from three WT muscles that represent differing MHC and 
metabolic profiles (EDL, soleus, deep and superficial portions of the TA muscles). 
Specifically, MHC profile, going from fast to slowest, adheres to the following order: 
superficial TA, EDL, deep TA, soleus. In agreement with aforementioned report’s findings 
(Elashry et al., 2012), we found that collagen IV signal intensity and thickness was greater 
between MHCIIB- fibres compared to MHCIIB+ fibres in all examined wild type muscles 
(Figure 7.1A-C) (note that there was no MHCIIB+ fibres in soleus muscles from WT mice). 
Knockout of Myostatin resulted in an overall decrease in collagen IV around all fibres 
compared to WT. Importantly, immunofluorescence quantifications confirmed that the 
difference in collagen IV levels between MCHBII- and MHCBII+ fibres is not affected by the 
loss of Myostatin expression in any of the muscles examined, so MHCBII+ contained less 
collagen IV than MCHBII- fibres (Figure 7.1A-C).   
Next we examined the effect of over-activation of the oxidative programme on collagen IV 
deposition in mice over-expressing Errγ on the Myostatin null background (Mtn-/-/ErrγTg/+) 
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to normalise collagen IV levels in Mtn-/- to that level of WT mice. This increase in both 
intensity and thickness of collagen IV staining in-between fibres occurred in all muscles 
examined and was irrespective of MHCIIB expression (Figure 7.1A-C). 
Thereafter, we examined the expression of collagen type I, an interstitial component of the 
ECM. Our observations found that the signal intensity and thickness of this protein showed 
the same pattern as collagen IV with respect to MHCIIB expression and genotypes of the 
three cohorts (Figure 7.2.A-C). 
These data suggest that loss of Myostatin expression causes a global decrease in collagen IV 
and I, and the decrease levels were similar on MCHBII- and MHCBII+ fibres. Interestingly, 
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Figure 7.1. Collagen IV profiles in WT, Mtn and Mtn:Eγ mouse muscle 
(A) Expression of collagen IV in relation to MHC fibre type.  Serial sections processed with 
an anti-MHCIIB antibody was used to identify MHCIIB- and MHCIIB+ fibres. Representative 
MHCIIB- fibres indicated with yellow stars and MHCIIB+ fibres by white stars. Expression of 
collagen IV more robust in ECM between two MHCIIB- fibres (yellow arrows) compared to 
that between MHCBII+ fibres (white arrows) in wild type muscles. The same relationship 
albeit at lower levels was noted in Mtn muscles. Expression levels were increased by Errγ 
in ECM between MHCIIB- (yellow arrows) as well as MHCIIB+ (white arrows) compared to 
Mtn fibres.  
(B) Intensity of collagen IV expression quantified by setting standard value of 1 for the 
level between MHCIIB- fibres from WT mice.  
(C)  Collagen IV expression also quantified in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
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Figure 7.2. Collagen I profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Expression of collagen I in relation to MHC fibre type. Serial sections processed with an 
anti-MHCIIB antibody was used to identify MHCIIB- and MHCIIB+ fibres. Representative 
MHCIIB- fibres indicated with yellow stars and MHCIIB+ fibres indicated by white stars.  
Expression of collagen I more robust in ECM between two MHCIIB- fibres (yellow arrows) 
compared to that between MHCBII+ fibres (white arrows) in wild type muscles. Same 
relationship albeit at lower levels in Mtn muscles. Expression domain increased by Errγ in 
ECM between MHCIIB- (yellow arrows) as well as MHCIIB+ (white arrows) compared to Mtn 
fibres.  
(B) Expression of collagen I quantified through intensity measurements by setting standard 
value of 1 for the level between MHCIIB- fibres from WT mice.  
(C) Collagen I expression also quantified in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
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7.3. Overexpression of Errγ redresses the decrease of dystrophin level in Mtn-/- muscles 
In order to investigate whether the metabolic reprogramming established in this study 
induce changes in the expression of intercellular component of DGC, fluorescence 
microscopy based techniques were applied to identify the signal intensity and thickness of 
dystrophin, the first identified member of DGC that binds actin to β-DG in muscle 
membrane (Hoffman et al., 1987, Ervasti and Campbell, 1993). Based on intensity and 
thickness measures, we found that dystrophin expression was greater between MHCIIB- 
than between MHCIIB+ fibres in EDL, soleus, and TA muscles from WT mice. Myostatin 
deletion induces a significant reduction in dystrophin expression in both MHCBII- and 
MCHBII+ when compared to their counterparts from WT muscles. Importantly, expression of 
Errγ on the Mtn-/- background muscles revealed a profound impact of the oxidative 
programme on dystrophin level. Mtn-/-/ErrγTg/+ MHCIIB- and MHCIIB+ fibres showed 
significantly greater expression of dystrophin than their Mtn-/- counterparts, with most 
instances in the four muscle regions examined reaching WT levels (Figure 7.3A-C). These 
data indicate that muscle fibre size and metabolic activity can induce changes in muscle 







































































































































































Figure 7.3. Dystrophin profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Immunofluorescence profile of dystrophin in relation to MHC fibre type. MHCIIB 
expression in red. Representative MHCIIB- fibres indicated by yellow stars and MHCIIB+ 
fibres by white stars. Expression of dystrophin was stronger in ECM between two MHCIIB- 
fibres (yellow arrow) compared to between MHCBII+ fibres (white arrows) in wild type 
muscles. Same relationship albeit at lower levels in Mtn muscles between MHCIIB- fibres 
and MHCIIB+ fibres. Expression increased in by Errγ in ECM between MHCIIB- (yellow 
arrows) as well as between MHCIIB+ (white arrows) fibres compared to those from Mtn 
mice.  
(B) Expression of dystrophin quantified by intensity by setting standard value of 1 for the 
level between MHCIIB- fibres from WT mice.  
(C) Dystrophin expression quantification in terms of thickness.  
(n= 30) for each cohort. Statistical analysis performed by One-way ANOVA followed by 
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7.4. Myostatin mutation has disparate impacts on expression levels of transmembrane 
proteins of DGC.  
Measurements of signal intensity and thickness of membrane-associated proteins of DGC 
(β-dystroglycan (DG), α, β, γ and δ-sarcoglycan (SG)) revealed that expression of these 
proteins relative to MHCIIB expression and genotype segregated into one of two groups. 
Group 1 consisted of β-DG, α and γ-SG, and group 2 consisted of β and δ-SG.  
Group 1 proteins of DGC had expression profiles that changed with regards to MHCIIB 
expression and genotype in a manner similar to that of collagens IV, I and dystrophin. All the 
proteins (β-DG, α and γ-SG) displayed high level between MHCIIB- than MHCIIB+ fibres in all 
muscles examined from the three genotypic groups. Importantly, the significant reduction in 
these protein levels due to Myostatin ablation, were restored to normal conditions 
following introducing of Errγ on the Mtn-/- muscles (Figure 7.4A-C, Figure 7.5A-C and Figure 
7.6A-C).  
Next we examined the expression levels of group 2 members. We discovered that 
expression of β and -SG failed to follow the trend of group 1 proteins and were thereafter 
designated to comprise a distinct group. Group 2 proteins like group 1 show higher 
expression in MHCIIB- fibres compared to MHCIIB+ in all three cohorts. However, the 
expression of group 2 proteins was higher in the fibres from Mtn-/- compared to their 
MHCIIB-/MHCBII+ counterparts from WT animals. Lastly, our study revealed that the 
expression of group 2 proteins in Mtn-/- fibres was largely refractory to the expression of 
Errγ; their higher levels of expression being maintained to those levels found in the Mtn-/- 
fibres (Figure 7.7A-C and Figure 7.8A-C).  
Together, these observations demonstrate that membrane-associated molecules of DGC 
show different manners of influencing following metabolic programmes established in 


































































































































































Figure 7.4. ß-dystroglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle 
(A) Immunofluorescence profile of ß-dystroglycan in relation to MHC fibre type. MHCIIB 
expression in red. Representative MHCIIB- fibres indicated by yellow stars and MHCIIB+ 
fibres by white stars. Expression of ß-dystroglycan was stronger in ECM between two 
MHCIIB- fibres (yellow arrow) compared to between MHCBII+ fibres (white arrows) in wild 
type muscles. Same relationship albeit at lower levels in Mtn muscles between MHCIIB- 
fibres and MHCIIB+ fibres. Expression increased in by Errγ in ECM between MHCIIB- (yellow 
arrows) as well as between MHCIIB+ (white arrows) fibres compared to those from Mtn 
mice. 
(B) Expression of ß-dystroglycan quantified by intensity by setting standard value of 1 for 
the level between MHCIIB- fibres from WT mice.  
(C) ß-Dystroglycan expression quantification in terms of thickness domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 


































































































































































Figure 7.5. α-Sarcoglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Immunofluorescence profile of α-sarcoglycan in relation to MHC fibre type. MHCIIB 
expression in red. Representative MHCIIB- fibres indicated by yellow stars and MHCIIB+ 
fibres by white stars. Expression of α-sarcoglycan was greater in ECM between two 
MHCIIB- fibres (yellow arrow) compared to between MHCBII+ fibres (white arrows) in wild 
type muscles. Same relationship albeit at lower levels in Mtn muscles between MHCIIB- 
fibres and MHCIIB+ fibres. Expression increased in by Errγ in ECM between MHCIIB- (yellow 
arrows) as well as between MHCIIB+ (white arrows) fibres compared to those from Mtn 
mice.  
(B) Expression of α-sarcoglycan quantified by intensity by setting standard value of 1 for 
the level between MHCIIB- fibres from WT mice.  
(C) α-Sarcoglycan expression quantification in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 





















































































































































Figure 7.6. γ-Sarcoglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle 
(A) Immunofluorescence profile of γ-Sarcoglycan in relation to MHC fibre type. MHCIIB 
expression in red. Representative MHCIIB- fibres indicated by yellow stars and MHCIIB+ 
fibres by white stars. Expression of γ-sarcoglycan was greater in ECM between two 
MHCIIB- fibres (yellow arrow) compared to between MHCBII+ fibres (white arrows) in wild 
type muscles. Same relationship albeit at lower levels in Mtn muscles between MHCIIB- 
fibres and MHCIIB+ fibres. Expression increased in by Errγ in ECM between MHCIIB- 
(yellow arrows) as well as between MHCIIB+ (white arrows) fibres compared to those 
from Mtn mice.  
(B) Expression of γ-Sarcoglycan quantified by intensity by setting standard value of 1 for 
the level between MHCIIB- fibres from WT mice.  
(C) γ-Sarcoglycan expression quantification in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 





















































































































































Figure 7.7. ß-Sarcoglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Immunofluorescence profile of ß-sarcoglycan in relation to MHC fibre type. MHCIIB 
expression identified by bright red colouring. Representative MHCIIB- fibres indicated by 
yellow stars and MHCIIB+ fibres by white stars. Note higher levels of ß-sarcoglycan in all 
genotypes between MHCIIB- (yellow arrows) compared to MHCIIB+ (white arrows).  
(B) Expression of ß-sarcoglycan quantified by intensity by setting standard value of 1 for 
the level between MHCIIB- fibres from WT mice.  
(C) ß-Sarcoglycan expression quantification in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
















































































































































Figure 7.8. δ-Sarcoglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Immunofluorescence profile of δ-sarcoglycan in relation to MHC fibre type. MHCIIB 
expression in red. Representative MHCIIB- indicated by yellow stars and MHCIIB+ fibres by 
white stars. Note higher levels of δ-sarcoglycan in all genotypes between MHCIIB- (yellow 
arrows) compared to MHCIIB+ (white arrows).  
(B) Expression of δ-sarcoglycan quantified by intensity by setting standard value of 1 for 
the level between MHCIIB- fibres from WT mice.  
(C) δ-Sarcoglycan expression quantification in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
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7.5. Superimposition of an oxidative metabolic programme increases expression levels of 
extracellular components of DGC 
Our results showed that collagen IV and I, intracellular and membrane associated 
components of DGC are influenced following metabolic reprograms in this study. Next, we 
performed details investigation to address the changes in extracellular molecules of DGC 
following Myostatin deletion or introducing of Errγ in the Mtn-/- muscles. To do so, we 
profiled the expression of α-DG in EDL, soleus, and TA muscles, and laminin in only EDL and 
TA muscles from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice, as an extracellular entities.  
We firstly found that expression of these proteins was greater between MHCIIB- fibres 
based on intensity and thickness measures compared to MHCIIB+ fibres in WT muscle. 
Secondly, expression of α-DG and laminin was lower in muscle fibres from Mtn-/- mice when 
compared to their MHCIIB-/MHCBII+ counterparts from WT animals. Finally, the oxidative 
metabolism programme imparted by introducing of Errγ in the Mtn-/- was efficacious to 
induce the expression levels of α-DG and laminin but not in all muscles in particular for α-DG 
protein (Figure 7.9A-C and Figure 7.10A-C). These indicate that muscle fibre metabolic 






























































































































































Figure 7.9. α-Dystroglycan profiles in WT, Mtn and Mtn:Eγ mouse muscle 
(A) Expression of α-dystroglycan in relation to MHC fibre type. MHCIIA in green. Note 
higher levels of α-dystroglycan expression in all genotypes between MHCIIB- compared to 
MHCIIB+.  
(B) Expression of α-dystroglycan quantified through intensity measurements by setting 
standard value of 1 for the level between MHCIIB- fibres from WT mice.  
(C) α-Dystroglycan expression also quantified in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
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Figure 7.10. Laminin profiles in WT, Mtn and Mtn:Eγ mouse muscle  
(A) Immunofluorescence profile of laminin in relation to MHC fibre type. MHCIIB 
expression in established by serial sections staining (data not shown). Note higher levels 
of laminin in all genotypes between MHCIIB- (yellow arrows) compared to MHCIIB+ (white 
arrows).  
(B) Expression of laminin quantified by intensity by setting standard value of 1 for the 
level between MHCIIB- fibres from WT mice.  
(C) Laminin expression quantification in terms of thick domain.  
(n= 30) from each cohort. Statistical analysis performed by One-way ANOVA followed by 
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7.6. Muscle fibre properties influence DGC molecules at transcriptional level and total 
protein expression 
The potential impact of muscle fibres size and metabolic nature on the levels of DGC 
proteins at the myofibre membrane, encouraged us to identify whether the effects of 
metabolic reprogramming would be mirrored at the transcriptional level, and total protein 
expression. Therefore, we examined how differences in the intensity of protein labelling 
among the three genotypes correlate with mRNA expression levels as well as protein 
amounts. To do so, soleus muscles (n=4) from WT, Mtn-/- and Mtn-/-/ErrγTg/+ mice were 
homogenised and total RNA was reverse-transcribed to cDNA and analysed using 
quantitative real-time RT-PCR. Profiling of transcript abundance revealed a number of 
interesting features. We found that the expression level of Dystrophin, α-DG and ß-SG genes 
showed exactly the same relationship with regards to the three genetic cohorts as the 
immunofluorescence survey. Of particular note, expression levels of Dystrophin and α-DG 
genes reduced significantly due to Myostatin deletion, however, overexpression of Errγ 
restored their expression to WT level, or even more for Dystrophin biomarker gene (Figure 
7.11A). Moreover, introducing of Errγ maintained the increased expression level of ß-SG in 
Mtn-/- muscles (Figure 7.11A).  
Thereafter, western blot analysis was performed in order to compare the DGC protein levels 
between soleus muscles from the three animal cohorts of this study. Our analysis showed 
that even though differences in Dystrophin and ß-SG levels did not reach significance, they 
displayed same profile in terms of level and the influence of the different genotypes as 
shown by immunofluorescence and RT-PCR. Interestingly, both α and ß-DG appeared to be 
expressed at higher levels in Mtn-/-/ErrγTg/+ muscle compared to either wild type or Mtn-/- 
muscles. Moreover, densitometric analysis confirmed the elevated expression of α and ß-DG 
in Mtn-/-/ErrγTg/+ muscles analysed (Figure 7.11B).  
These data confirm our histochemical results and suggest that muscle fibres metabolic 
status effects on DGC molecules can be extended to transcriptional and total protein 



















Figure 7.11. Molecular and Western blot profiling of soleus ECM associated molecules  
(A) RT.PCR profile of DGC associated genes in soleus muscles (n= 4) muscle.  
(B) Western blot data and quantification of protein levels in soleus muscles (n= 2) mice per 
genotype.  
Statistical analysis performed by One-way ANOVA followed by Bonferroni’s multiple 
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7.7. Discussion 
In this section we exploited a technique that permits an accurate measurement of force 
transduction apparatus components relative to muscle fibre type. Skeletal muscle is a 
composite tissue that formed from muscle fibres, blood vessels, nerves and connective 
tissue. In spite of the essential role of the latter component in skeletal muscle function, it is 
the least studied portion of this tissue. In order to expand our understanding of skeletal 
muscle functionality, investigation of its components is required. Indeed, very few studies 
have examined the relationship between muscle ECM and metabolism at the single fibre 
level. This is mainly due to lack of techniques that afford the resolution and sensitivity 
required to quantify ECM components and their receptors at the membrane of single fibres. 
Thus, in this study we have taken advantage of the development of semi-quantitative 
immunofluorescence-based techniques that allow us to investigate levels of DCG and ECM 
entities in specific myofibre types (Arechavala-Gomeza et al., 2010, Anthony et al., 2011).  
Results of this study reveal new features regarding the molecules associated with physically 
coupling the force generating sarcomeres with the ECM via sarcolemma spanning proteins. 
Firstly, we showed that fibre type related to the expression of MHCIIB influences levels of 
DGC proteins at the sarcolemma. Secondly, results of the current study confirmed previous 
findings (Elashry et al., 2012) that demonstrated low levels of connective tissue components 
in hypertrophic myofibres developed in the absence of Myostatin. Importantly, our analysis 
showed that the oxidative programme imparted by introducing of Errγ in the Mtn-/- 
background muscles was able to increase levels of many DGC and ECM components in Mtn-/- 
muscles. We also found that membrane-associated proteins of DGC could be divided into 
two groups. First one that consists of β-DG and α, γ-SG proteins showed higher levels in WT 
fibres than those from Mtn-/- mice for a specific MHCII isoform, and a second group which 
consists of ß and -SG proteins displayed reversed relationship (higher levels in Mtn-/- than 
WT muscle fibres).  
Several studies have documented that Myostatin regulates muscle development and growth 
through Smad and AKT signalling pathways which in turn inhibit muscle myogenesis, same 
pathways known to induce fibroblast proliferation thereby connective tissue production 
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of Myostatin results in the development of large muscle fibres with less connective tissue 
content. In support of this view, previous work showed that hypertrophic muscle fibres from 
Mtn-/- have less collagen compared to counterparts muscles from WT mice (Elashry et al., 
2012). This hypothesis confirmed by our observations in this study. By a way of an 
explanation of the reduction in DGC and ECM components in Mtn-/- muscles, it is might be 
an adaptive change to the fast contracting glycolytic nature of the mutant muscle (Kovanen 
et al., 1984b). Moreover, the hypertrophic muscle fibre would have a limited amount of key 
proteins and therefore due to its size, there would be less of each component relative to the 
size of hypertrophic muscle fibre. In the latter, fast contracting muscle fibres are postulated 
to have lower levels of ECM in order to decrease the amount of energy stored in the 
connective tissue thereby making more available for force exertion on tendons (Kovanen et 
al., 1984a). In fact, a variety of studies have shown that slow muscle fibre has more 
abundant of ECM than the fast phenotypes (Kovanen et al., 1980, Kovanen et al., 1984b).  
An interesting feature highlighted by our work in this chapter is that irrespective of 
genotype, MHCIIB- fibres have higher levels of DGC than MHCIIB+ fibres. Most importantly, 
muscle-specific expression of Errγ in the Mtn-/- results in an increase of almost all DGC 
proteins at the sarcolemma. It is important to note that due to the nature of our 
experimental design we are detecting these effects independent of fibre type switching. We 
believe that these results highlight novel and unexpected findings. Kovanen and colleagues 
(Kovanen et al., 1980, Kovanen et al., 1984a) predicted that equivalent MHCII myofibres 
from differing genotypes should have the same levels of DGC proteins. Interestingly, our 
data contradict this prediction, meanwhile reveals that the metabolic feature of muscle is 
more important than the MHCII isoform being expressed. 
Our work examining the intercellular and extracellular components of the DGC and the ECM 
offers interesting insights into the ability of muscle metabolic programme to influence not 
only the muscle fibre but also the cells that give origin of ECM compositions, named 
fibroblast (Kuhl et al., 1984, Fry et al., 2017). To our knowledge, there are no experimental 
data available on fibre metabolic specific expression of DGC and ECM proteins in healthy 
muscles. Therefore, a central question to be addressed here is whether metabolic 
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from these two cellular sources to generate appropriate stoichiometric levels for a 
particular muscle (oxidative/glycolytic) phenotype. We believe that our work highlights an 
interesting relationship between muscle and fibroblasts in relation to ECM production. 
Myostatin null muscles show less intracellular, extracellular, and many membrane-
associated components in all muscle examined compared to counterparts muscles from WT 
mice. However, our remodelling of Mtn-/- muscles through the muscle-specific expression of 
Errγ reveals that the oxidative metabolic programme of the muscle fibre is able to overcome 
whatever effects of the absence of Myostatin might have on not only muscle fibres but also 
associated fibroblasts. This could be on either the secretion of signalling molecules from 
muscle that increase fibroblast number or by augmenting fibroblast secretion of ECM 
components. These outcomes again suggest that features induced by a germline deletion of 
Myostatin are not genetically locked down, but can be modified by metabolic reprogram 
established by Errγ overexpression.   
A number of studies have demonstrated that sarcoglycan subcomplex within DGC is 
essential to provide support for the plasma membrane because it associates with dystrophin 
and dystroglycan complex, which they in turn interact with actin and laminin respectively, 
this molecular linkage directly connects the cytoskeleton and the ECM (Yoshida et al., 1994, 
Ervasti and Campbell, 1993). It has been shown by a number of investigators that β and δ-
SG are forming a core of the sarcoglycan complex (Chan et al., 1998, Vainzof et al., 1999). 
Further work reported that mutation in δ-SG gene results in complete absence of other 
members of sarcoglycan subcomplex, in contrast, loss of γ-SG might reduce but did not 
eliminate expression of other components (Hack et al., 1998).  
An important finding from our study relates to the impact of the Mtn mutation on the 
composition of the DGC, is the considerable variation in the fully formed DGC complex at 
the sarcolemma. In this case, we identified increased levels of β-SG and -SG in Mtn-/- fibres 
compared to other DGC components (Figures 7.7 and 7.8). The biological significance of 
changes in the stoichiometry of the DGC complex in Mtn-/- mutant remains to be 
established. This is certainly important since a body of work has demonstrated that a fully 
assembled sarcoglycan subcomplex increases stability and renders it less prone to 
degradation (Jung et al., 1996a). Additional study has illustrated that absence of one 
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the stability of the other components that depending on the specific sarcoglycan 
subcomplex mutated  (Bushby, 1999, Araishi et al., 1999, Liu and Engvall, 1999). Therefore, 
based on the essential role of β and δ-SG to support the plasma membrane against the force 
generated during muscle contraction (Hack et al., 1998), Mtn-/- muscles maintained these 
molecules in order to avoid the complete loosing of this complex function as it could be 
stable with fewer than four members (Straub et al., 1997). Interestingly, the high levels of 
these molecules preserved in Mtn-/-/ErrγTg/+ muscles to provide entities required for the 
functional unit.     
In addition, we propose a functional significance for altered SG content of the DGC in 
hypertrophic fibres based on the fact that each SG seems to have a unique biological 
property. This hypothesis supported by a huge body of work that has shown that mutations 
in each SG manifest in a specific disease (mutations in α, ß, γ, δ cause limb-girdle muscular 
dystrophy type (LGMD) 2D, 2E, 2C and 2F respectively (Wicklund and Kissel, 2014).  
Finally, we provide additional evidence of the impact of muscle metabolic nature to 
influence DGC molecules at the transcriptional level. A number of biomarker genes that 
encoded DGC proteins (Dystrophin, α-DG and ß-SG) display similar differences remarked by 
immunofluorescence survey, the expression of these genes detected by RT-PCR technique 
(Figure 7.11A). However, results from Western blot analysis of total protein lysates did not 
mirror our semi-quantitative immunofluorescence findings (Figure 7.11B). Possible 
explanations include differences in sensitivity or protein localization. Changes in 
immunofluorescence intensity between genotypes are relatively small and may be below 
the resolution of densitometry performed on Western blot. Furthermore, while 
immunofluorescence quantifications focused on proteins at the plasma membrane level, 
Western blot analyses were performed on total protein lysates without enrichment for 
membrane fractions. However, even with membrane fractionation, Western blot analysis 
would not be able to resolve differences in ECM and DGC proteins between different fibre 
types. Therefore, Western blot analysis and semi-quantitative immunofluorescence provide 
complementary information. Of note, Western blot analyses suggest a possible increase in 
α-DG and β-DG proteins in Mtn-/-/ErrγTg/+ compared to either WT or Mtn-/- muscles. This 
increase was not accompanied by a similar increase in dystrophin or β-SG, suggesting that 
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dystrophin (Johnson et al., 2013). Further studies with larger numbers of animals and more 
targeted biochemical approaches will be needed to confirm and define the connection 
between oxidative metabolism and dystroglycan. Moreover, the multifunctional nature of 
the sarcoglycan complex, and the entire DGC, highlights the importance of understanding 
the full role of each component in both healthy muscle function and disease.  
In summary, this study provided a detailed examination of DGC and ECM components 
alterations due to muscle fibres size and metabolic status change. It adds to the growing 
body of work that the muscle metabolic nature is not only affects muscle fibres but also 
influences the components of DGC and ECM. Glycolytic phenotypes develop in the absence 
of Myostatin have less level of many of these compartments. Importantly, oxidative 
metabolic programme imparted by overexpressing of Errγ was efficacious to overcome the 
impacts of Myostatin deletion on these compartments. Furthermore, our work highlights 
the benefit of the semi-quantitative immunofluorescence protocol.  
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General discussion  
The principle endeavour behind this project was to determine whether it is possible to 
produce large muscle fibres, at the same time able to support prolonged period of work. For 
the last few decades, it was thought that large muscle fibres have to be fast and glycolytic, 
as there is a trade-off between muscle fibre size and its oxidative capacity (Van der Laarse 
WJ, 1998, Degens, 2012). The greater our knowledge of hypertrophic fibre functions, in 
particular exercise and regeneration capacity, the better we are able to develop clinical 
treatments and so improve the quality of life for people. Skeletal muscle possesses a 
remarkable plasticity and responds to environmental and physiological stimuli by changing 
its phenotype in terms of size, composition, and metabolic properties (Pette and Staron, 
2001, Mounier et al., 2015, Matsakas and Patel, 2009b). Myostatin is a negative regulator of 
muscle development belongs to the Transforming Growth Factor-ß (TGF-ß) superfamily 
(McPherron and Lee, 1997). Genetic or pharmacological inhibition of its signalling has been 
utilised to induce muscle mass (McPherron et al., 1997, Pistilli et al., 2011). Despite the 
enlarged muscles appearing normal at the histological level, their ability to generate tension 
is markedly reduced (Mendias et al., 2006, Relizani et al., 2014). On the other hand, Errγ is 
an orphan nuclear receptor with abundant expression in mitochondrial rich, and high energy 
demands tissues (Giguere, 2008, Narkar et al., 2011). It has emerged as a key transcriptional 
regulator of pathways crucial in the regulation of muscle energy metabolism, contractile 
function, and growth (Rangwala et al., 2010, Cho et al., 2013).  
Over the last decade, the generation of tissue-specific Errγ transgenic or knockout has 
rapidly advanced our understanding of its roles in regulating different aspects of muscle 
metabolism and energy production. Transgenic mice expressing Errγ in the skeletal muscle 
showed an increase in mitochondrial size, improved oxidative capacity, and increased 
exercise tolerance, indicating that Errγ may control the metabolic response of skeletal 
muscle during exercise (Narkar et al., 2011, Badin et al., 2016). 
For this study, we introduced the expression of Errγ into a muscle lacking Myostatin using 
specific promote named human α-skeletal actin (HSA).  We hypothesis that superimposition 
of Errγ that would induce oxidative metabolism in a Mtn-/- muscles that are associated with 
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hypertrophy, challenges the suggested inverse relationship between muscle fibre oxidative 
capacity and its size. 
 
Large muscle mass developed in the absence of Myostatin is conserved in Mtn-/-
/ErrγTg/+muscles    
Lack or inhibition of Myostatin function produces mice with a phenotype exhibiting a 
dramatic increase in muscle mass (McPherron and Lee, 1997, Hulmi et al., 2013a). The work 
carried out in chapter 3 showed that despite the increased muscle mass, body weight of 
Mtn-/- and Mtn-/-/ErrγTg/+ was similar to that of WT mice, indicating a reduction in other 
tissues mass. We and others have shown a remarkable reduction of connective tissue 
content in hypertrophic muscle of Mtn-/- mice (Elashry et al., 2012). Moreover, a study by 
Lebrasseur has revealed that the large muscle in Mtn-/- phenotypes develops concurrently 
with a decrease in fat deposition (Lebrasseur, 2012). In fact, the newly known myokine Irisin 
that is secreted from skeletal muscles in blood effectively promotes thermogenesis in 
adipose tissue (Bostrom et al., 2012). Importantly, it was reported that Myostatin deletion 
results in an increase of Irisin production from skeletal muscle, hence promotes tissue 
thermogenesis and reduces fat deposition (Shan et al., 2013). Although the Mtn-/-/ErrγTg/+ 
muscles showed a restoration of most DGC and ECM proteins at the sarcolemma to normal 
levels as shown in chapter seven, the body weight of these animals still similar to WT and 
Mtn-/- mice. It has been demonstrated that Errγ can promote expression level of uncoupling 
protein 1 (UCP1) mediated by ERR response element (ERREs) that is present in the enhancer 
of the UCP1 (Giguere, 2008, Dixen et al., 2013). Moreover, the elevated expression of UCP1 
gene that transduces brown adipocytes in Errγ transgenic muscles was concomitant with an 
enhanced rate of fatty acid oxidation (Dixen et al., 2013). The later hypothesis robustly 
supported by our results at the transcriptional level, evidenced by upregulation of fatty acid 
oxidation and metabolism genes following Errγ overexpression in Mtn-/- muscles. We suggest 
that Myostatin deletion increases muscle mass, at the same time reduces connective tissue 
production, and promote browning of WAT, thereby preventing an excessive increase in 
body weight. Interestingly, introducing of Errγ provides the requirements of browning 
process that include high expression of UCP1, and high mitochondrial number and activity 
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(Cannon and Nedergaard, 2004). Ultimately, it prevents WAT accumulation, and hence 
displays same body weight of other two genotypic groups. 
The reasons behind an increase in muscle mass are related to the stage of Myostatin 
absence. Unlike in genetic alteration, post developmental blocking of Myostatin induces 
muscle mass due to the increase in muscle fibre size but not the number (McPherron et al., 
1997, Whittemore et al., 2003). Previous studies have shown that Myostatin acts as a 
regulator of embryonic muscle progenitors proliferation and differentiation mediating by 
interfering with the cells cycle progression from G1 to S-phase through upregulation of P21 
and a Cdk inhibitors (Manceau et al., 2008, McCroskery et al., 2003). Further work that 
supported the developmental origin of the hypermuscular phenotype, has shown a marked 
acceleration of the myogenic programs of primary and secondary myogenesis due to 
Myostatin absence (Matsakas et al., 2010). These data with our results clearly evidenced the 
embryonic origin of myofibre hyperplasia without a post-natal change in fibre number. 
Consequently, the only determinate factor that causes the increase in muscle mass 
following sActRIIB injection is the enlargement of muscle fibres.  
In fact, this action directed our plans to investigate the relationship between the increase in 
muscle mass in Mtn-/- and Mtn-/-/ErrγTg/+, as well as WT and ErrγTg/+ mice injected with 
sActRIIB, and protein synthesis that might profoundly contribute to this increase.  
Our work examining muscle fibre size extends previous findings of Mendias et al. and 
Relizani et al. (Mendias et al., 2006, Relizani et al., 2014), who demonstrated a dramatic 
increase in muscle fibre size following Myostatin deletion or post-natal inhibition of its 
function. Myostatin was suggested to negatively regulate muscle growth by inhibiting 
myoblast differentiation, and Akt/mTOR pathway by promoting phosphorylation of Smad2 
and Smad3, that in turn preventing Akt phosphorylation, ultimately induce muscle atrophy 
(Glass, 2005). In addition to Myostatin, (IGF1/ PI3K/ Akt/ mTOR) (Sakamoto et al., 2002), and 
FoxO3, mediated proteasomes and autophagy (Stitt et al., 2004) pathways are known for 
their roles in regulating of muscle fibre size. The interaction between these pathways 
determines the rates of protein synthesis and degradation. It has been shown that during 
conditions of disuse, FoxO transcription factors are strongly upregulated expression of 
Atrogin1 and MuRF, which are associated with protein degradation (Sandri et al., 2004, Stitt 
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et al., 2004). In response to muscle fibre hypertrophy following Myostatin deletion or 
blocking, Akt is activated, and subsequently inhibits protein degradation by phosphorylating 
FoxO, that results in a decrease in transcription of FoxO target genes (Sandri et al., 2004). 
This hypothesis is supported by our data shown in chapter 3. Alternative reason beyond the 
large mass of Mtn-/- muscles, is a high proportion of glycolytic phenotypes that associated 
with large CSA as shown in chapter three.   
Additional evidence has been provided in chapter four that despite the increase in muscle 
fibres size of Mtn-/- muscles, myonuclei number per each muscle fibre is not proportionally 
increased, resulted in a reduction of nuclear : cytoplasmic ratio. These data are supported 
by Amthor’s findings (Amthor et al., 2009). Based on the idea that each nucleus can supply a 
limited volume of cytoplasm with gene transcripts, the addition of myonuclei is a 
prerequisite for muscle fibre hypertrophy (McCarthy et al., 2011). Further investigators have 
shown that the accretion of myonuclei number is correlated linearly to muscle cross-
sectional area increase, thus cytoplasmic volume per nucleus is constant (Hall and Ralston, 
1989, Roy et al., 1999). Here we show a significant increase in myonuclei number following 
Errγ overexpression onto Mtn-/- background muscles. In support of this view, it has been 
illustrated that high oxidative muscle fibres contain a high number of myonuclei compared 
to low oxidative ones (Allen et al., 1995). Interestingly, the oxidative fibres are characterised 
by large potential for transcription (i.e., myonuclei and mitochondria), as well as possessing 
high capacity for protein synthesis (van Wessel et al., 2010). Such higher myonuclear density 
in oxidative fibres that developed due to Errγ overexpression may indicate that these fibres 
have relatively higher potential for transcription and protein synthesis, thereby maintain the 
increase in muscle fibres size.  
Additionally, previous work has reported that the rate of protein degradation is mainly 
induced by oxidative stress (Powers et al., 1999). Thus, the low oxidative stress that 
indicated by low level of ROS production in Mtn-/-/ErrγTg/+ and ErrγTg/+ muscles treated with 
sActRIIB, may provide additional evidence of the potential of Errγ transgenic to support 
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High oxidative metabolism, energy production and physiological activity in Mtn-/-/ErrγTg/+ 
muscles 
The balance between myofibrillar protein synthesis, mitochondrial biosynthesis and 
degradation is a major factor that determines muscle fibre size and oxidative capacity. 
Indeed, the relationship between muscle fibre CSA and mitochondrial number denotes that 
muscle fibres can get larger at the expense of endurance capacity (van Wessel et al., 2010).  
In order to prevent the decrease in maximum steady state power of hypertrophic fibre, 
oxygen supply to the mitochondria must be maintained. To accomplish this, high level of 
capillary density is required to increase oxygen transport to muscle fibres (Des Tombe et al., 
2002), as well as an appropriate media needed to facilitate oxygen transport to 
mitochondria (van Beek-Harmsen et al., 2004). Moreover, the diffusion distance of oxygen 
from blood vessels to mitochondria should be reduced, which might be in a part mediated 
by increasing the number of mitochondria into the sub sarcolemma region (Deveci et al., 
2001). Taken together, these studies might explain why muscle fibres with high oxidative 
capacity try to limit their size, so it can be considered an evolutionary design constraint. 
Therefore, the question to be addressed in this study is whether such adaptations can occur 
synchronously with an increase in muscle fibre size. 
Myostatin regulates skeletal muscle metabolism, since its genetic ablation, or epigenetic 
interfering with its function, leads to a predominance of glycolytic fibres as a result of a 
marked depress in muscle oxidative capacity (Matsakas et al., 2010, Relizani et al., 2014). 
Similar bias toward the glycolytic myofibres phenotype has also been identified in cattle with 
muscle hypertrophy that is associated with mutation in Myostatin gene (Wegner et al., 
2000). Further work has revealed the role of activin-receptor IIB that is activated by 
Myostatin to regulate SDH activity (Matsakas et al., 2012a). In addition to the low oxidative 
capacity, the hypertrophic-glycolytic phenotype that develops in the absence of Myostatin 
was associated with a decrease in force generation and exercise capacity. Previous work has 
reported that the exercise failure could be attributed to the reduction in mitochondrial 
density as a consequence of Myostatin deletion (Amthor et al., 2007). Therefore, an 
important point addressed here is whether inducing mitochondrial number will be 
efficacious to restore exercise capacity via promoting energy production, thereby enhancing 
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muscle physiological activity. A study by Desplanches et al. demonstrated that the ability of 
mitochondria to produce ATP depends on oxygen supply via tissue blood perfusion 
(Desplanches et al., 1996). As we mentioned above such process requires a high density of 
blood vessels to deliver oxygen to muscle fibre, as well as the proper distribution of 
mitochondria. In agreement with data shown in chapter four of this study, previous work 
has identified a decreased in capillary density of a muscle lacking Myostatin (Rehfeldt et al., 
2005, Amthor et al., 2007), which might attribute to the direct effect of Myostatin on 
regulating of muscle capillary density via controlling endothelial cells proliferation (Hayot et 
al., 2011). Moreover, an aforementioned study has reported a decrease in Vegf-α 
expression following treatment of C2C12 myotubes with sActRIIB, providing additional 
evidence of the indirect negative impact of Myostatin inhibition on capillary formation 
(Relizani et al., 2014). In fact, the unfavourable combination of decreased muscle 
vascularization and metabolic changes after Myostatin ablation or inhibition would likely 
result in insufficient mitochondrial ATP synthesis during exhaustive exercise, which might 
explain rapid fatigability of these animals (Robergs et al., 2004).  
The decreased oxidative capacity, mitochondrial number and capillary density of Mtn-/- 
muscles, was associated with an increase in the proportion of the fast MHCIIB that is known 
to be related to the increase in muscle fatigability (Girgenrath et al., 2005). It was well 
established that muscle fibres have the ability to modify MHC type in response to changes in 
the internal or external environment (Pette and Staron, 2001). Myostatin plays a vital role in 
the determination of adult muscle fibre type. Notably, its absence inhibits proliferation or 
differentiation of primary myoblasts that results in a decline in slow muscle fibre number. 
Conversely, increases the proliferation or differentiation of secondary myoblasts leading to 
a high number of fast-twitch phenotypes. Accordingly, increased type IIB fibres would cause 
the muscle to be predominantly glycolytic (Girgenrath et al., 2005, Langley et al., 2002). 
Significantly, the predominance of fast glycolytic fibres may well explain the increase in 
contraction speed, and shortening in relaxation time in Mtn-/- muscles. However, there is no 
benefit of these muscles in term of the high tetanic generation to be expected of glycolytic 
fibres (Wegner et al., 2000, McPherron et al., 1997).  
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Alternatively, low level of connective tissue in Mtn-/- muscles (shown in chapter seven) may 
act as an additional contributor that promote further rapid twitch kinetics (Amthor et al., 
2007).  
Nevertheless the similarity in muscle fibre size and muscle mass of Mtn-/- and Mtn-/-/ErrγTg/+, 
the later muscle fibres showed high oxidative capacity indicated by the high proportion of 
SDH+ fibres. Such combination could challenge the constraint between muscle fibre aerobic 
metabolism and its size. A number of studies have reported that Errγ directly or indirectly 
regulates the expression of numerous target genes that are related to different metabolic 
pathways, specifically mitochondrial biogenesis and respiration in response to cellular stress 
(Narkar et al., 2011, Badin et al., 2016). Therefore, superimposition of Errγ onto Mtn-/- or WT 
muscles may be a powerful strategy to overcome the metabolic disorders following 
Myostatin deletion or inhibition of its function at the post-natal stage. Previous studies have 
revealed a robust increase in SDH activity following Errγ overexpression, and the oxidative 
phenotype stimulated even with the absence of ligands (including PGC-1α) (Rangwala et al., 
2010, Greschik et al., 2002). Further work has demonstrated that the overexpression of Errγ 
leads to an increase in oxidative metabolism and heat generation (Dixen et al., 2013). These 
outcomes which are in agreement with findings of the current study may well explain the 
high level of Errγ during physical exercise as a part of an adaptive metabolic response 
(Narkar et al., 2011, Badin et al., 2016). By understanding the phenotype of Myostatin null 
mice, our work provides key mechanisms that need to be induced in order to promote 
fatigue resistance. Therefore, we suggest that the ability of Mtn-/-/ErrγTg/+ mice to run longer 
than other genotypic groups, is possibly attributed to the increased mitochondrial density 
that associated with high ATP production, and improved oxidative capacity which evidences 
Errγ potential to control the metabolic response of skeletal muscle during exercise.  
The increased exercise capacity of Mtn-/-/ErrγTg/+ mice raises interest in the understanding of 
Errγ role in regulating other pathways that might contribute to the improvement muscle 
physiological function, that might need to be raised in order to meet the energy demands. 
We showed previously that the coupling between muscle fibre size and capillary density has 
been altered in Mtn-/- muscle fibres that reflected negatively on muscle energy status and 
thereby reduced muscle physiological performance. On the other hand, numerous studies 
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have reported that transgenic expression of Errγ in anaerobic fast muscle fibre promotes 
aerobic transformation, angiogenic programming and mitochondrial biogenesis in absence 
of exercise (Narkar et al., 2011, Matsakas et al., 2012b). In support of this view, previous 
work has revealed an essential role of Errγ to transcribe all Vegf-α isoforms mediating by 
stimulating of this biomarker gene’s promoter that contains Errγ binding sites (Arany et al., 
2008a). It is worth noting that Errγ effect on angiogenesis may not only be due to Vegf-α 
induction, but in addition to its role in activation of Fgf1, Errγ also regulates endothelial cell 
proliferation and migration (Zheng et al., 2007, Partridge et al., 2000). Most importantly, the 
angiogenesis programme established by introducing of Errγ in the either Mtn-/- or WT 
muscles is responsive to the increase in muscle fibres size resulted from Myostatin deletion 
or sActRIIB administration. Collectively, these findings indicate a direct transcriptional 
activation of angiogenesis genes by Errγ, as well as evidence its positive impacts on 
endothelial cells proliferation, thereby increases muscle capillary density, to provide a 
suitable microenvironment that matches the increased muscle fibres size and oxidative 
capacity requirements.  
Although Errγ overexpression induces mitochondrial density and blood supply in 
hypertrophic myofibres, high rate of oxygen diffusion from capillary to mitochondria is 
required to sustain high energy level, and hence support a long time of exercise. 
Interestingly, important modifications take place in Mtn-/-/ErrγTg/+ muscles are, firstly, the 
hyper-oxidative hypertrophic myofibres displayed a high mitochondria subpopulation at 
subsarcolemmal than the intrafibrillar ones. Secondly, introducing of Errγ in the Mtn-/- 
muscles significantly induced myoglobin transcription and this protein would facilitate 
oxygen diffusion and storage into mitochondria in the developed hypertrophic myofibres 
(Hoofd and Egginton, 1997). Indeed, mitochondria were brought to attention here due to its 
central role in producing ATP to meet cellular requirements, and sustain high metabolic rate 
and physical performance, which are characteristics of oxidative fibres. The mitochondrial 
density is dynamically regulated in response to oxygen availability, that supporting 
mitochondrial biogenesis (Levett et al., 2012). Although the precise mechanism through 
which Errγ promote mitochondrial biogenesis is uncertain, there is ample evidence that it 
enhances oxygen diffusion. Previous work has shown that mitochondrial biogenesis is 
regulated by signalling given by nitric oxide (NO) and hydrogen peroxide H2O2 diffusion from 
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mitochondria to cytosol, the process that is controlled by membrane potential, and reliant 
on the mitochondrial metabolic state (Nisoli et al., 2004). Moreover, the mitochondrial nitric 
oxide synthase (mtNOS) activity is also regulated by membrane potential, and it works as a 
regulatory enzyme that is in turn regulates mitochondrial O2 uptake, thereby promotes 
oxidative phosphorylation to repeat the biogenesis cycle (Navarro et al., 2005). It seems that 
the increased capillary density, mitochondrial number at the appropriate area of muscle 
fibre, accompanied with a high level of myoglobin are contributing to the preventing of a 
decline in maximum steady state power when oxidative fibre get larger (Heard et al., 2000). 
Taken together, these data would challenge the inverse relationship between muscle fibre 
size and oxidative capacity by taking into account the capability of hypertrophic hyper-
oxidative myofibres from Mtn-/-/ErrγTg/+ muscles to produce angiogenic factors, and 
promote mitochondrial biogenesis. Ultimately, it permits the formation of new blood 
vessels, and improves oxygen diffusion rate to mitochondria that is associated with high 
level of ATP production, which are positively affected animals' behavioural performance and 
physical exercise.  
An interesting feature highlighted by our work is the high proportion of SDH+ fibres in Mtn-/-
/ErrγTg/+ muscles was accompanied with a partial normalisation of the MHC fibre profile; 
indicated by a decrease in the proportion of MHCIIB, and increase in MHCIIA and MHCIIX 
fibre numbers. However, the conversion does not lead to the formation of MHC type I. It 
was well established that Errγ is highly expressed in oxidative (type I) slow-twitch muscle 
fibres, and it works coordinately with AMPK to initiate formation of this myofibre type 
possibly via activation of miRNA-208b and miRNA-499 (Gan et al., 2013). However, the 
protocol of overexpression of Errγ in the Mtn-/- muscles we established in this study was 
unable to influence this process. In fact, a number of studies have reported that MHC 
isoforms clearly correlate with the kinetics of stretch activation that induces delayed force 
increase (Galler et al., 1994, Hilber et al., 1999). Such correlation indicates that different 
MHC isoforms are generating different speeds of force. Further work reported that the 
kinetics of stretch activation is proportional to the ratio between MHC-IIX and MHC-IIB 
(Andruchov et al., 2004), which possibly explain the transition between these two types of 
muscle fibres. Alternatively, the post-translational modifications of MHC could be another 
crucial reason behind the protein variations with altered functions (Maggs et al., 2000, 
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Ramamurthy et al., 2001). Furthermore, presence of other myofibrillar proteins such as 
myosin light chain (MLC), and thin filament proteins also could influence muscle fibres 
kinetic, thereby induce the transition in muscle fibre phenotypes (Bottinelli et al., 1994a, 
D'Antona et al., 2002). These data provide ample evidence that MHCII fibres are more 
plastic and adaptable phenotypes, but it is not the case with MHC type I (Sutherland et al., 
1998). Moreover, changes in MHC profiling following either Myostatin deletion or Errγ 
overexpression anticipated as an adaptive step to preserve the contractile function.  
A number of studies have shown that ECM in skeletal muscle is critical for force transmission 
from muscle fibres to tendons (Purslow, 2002, Kjaer, 2004), thus precise regulation of ECM is 
necessary to ensure optimal muscle functions. Interestingly, our findings show that the 
restored ECM and DGC proteins due to remodelling of Mtn-/- muscles through muscle-
specific expression of Errγ distributed regularly on between muscle fibre types, slow fibres 
contain high ECM than the fast ones. Notably, restoration and distribution of ECM and DGC 
compartments in Mtn-/-/ErrγTg/+ muscles were positively correlated to the increased capillary 
density, oxidative capacity, force generation and exercise tolerance of these mice. 
Collectively, these findings provide evidence that the oxidative metabolic program 
established by Errγ expression is not only influence muscle fibres, but also their associated 
ECM and DGC components that positively affected muscle physiological performance.   
An important aspect to be elucidated here is the potential involvement of metabolic genes 
in the improvement of physiological activity. Interestingly, the features of metabolic profile 
of Mtn-/-/ErrγTg/+ muscles were mirrored at the transcriptional level. The increased oxidative 
capacity, energy production and capillary density accompanied by a marked upregulation of 
genes known to regulate oxidative and energy metabolism, glucose metabolism and 
transport, angiogenesis, and fatty acid metabolism, uptake and transport. These 
observations strongly supported by previous studies that revealed a central role of Errγ in 
regulating multiple genes that linked to mitochondrial function and biogenesis, fatty acid 
oxidation and metabolism, and glucose metabolism (Zhang et al., 2006, Dufour et al., 2007).   
In this study, the observed large myofibres CSA in Mtn-/- muscles was attributed to the high 
level of protein synthesis that driven by upregulating of Akt that subsequently 
phosphorylates and inactivates of FoxO3, a key regulator of protein degradation pathways, 
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autophagy and proteasome. These results support data of others showing that autophagy is 
reduced in Mtn-/- muscles (Amthor et al., 2007). Further work has unveiled a marked 
reduction in autophagy level and exercise tolerance due to post-natal inhibition of 
Myostatin by sActRIIB administration (Mizushima et al., 2010). Alternative factor that might 
contribute to the low autophagy flux in the Mtn-/- muscles is the marked reduction of ECM 
content (Grumati et al., 2010). It has been demonstrated that autophagy is a conserved 
homeostatic process that is responsible for removing damaged organelles and other 
unwanted cytoplasmic components to support cell survival (Sandri, 2013, Mizushima et al., 
2010). Thus, we believe that the reduced autophagy rate may well explain the unfavourable 
accumulation of damaged organelles, and hence the appearance of ultrastructural 
abnormalities (misaligned and disrupted Z-lines, large intra-sarcomeric space, and altered 
mitochondrial size and distribution) in Mtn-/- muscles as shown in chapter three, which 
possibly hamper muscle contractile functions and reduced exercise capacity. Furthermore, 
the proteolytic enzymes that degrade the modified proteins (Grune et al., 2003), were lower 
in Mtn-/- muscles which imply less efficient removal and thereby an accumulation of 
unwanted organelles. Moreover, the high level of ROS production was found in Mtn-/- and 
WT.sActRIIB muscles may consider another important reason for the reduced force 
generation and exercise capacity, as it induces mitochondrial dysfunction, and because of 
mitochondria are sites of ROS production, so they become a potential target of damage. The 
observed loss of specific force in Mtn-/- muscles in the current study might also attribute to 
the impairment in muscle excitation-contraction (EC) coupling, a Ca2+ dependent process. It 
has been documented that during muscle contraction, the Ca2+ channels in the transverse 
tubules are activated due to membrane depolarization, which in turn trigger activation of 
sarcoplasmic reticulum (SR) Ca2+ release channels named ryanodine receptor 1 (RyR1). 
Subsequently, increased cytoplasmic Ca2+ level, which is essential for actin-myosin cross-
bridging, sarcomeric shortening, and muscle contraction (Allen et al., 2008, Andersson and 
Marks, 2010). There is an evidence that skeletal muscle RyR1 function and Ca2+ signalling are 
negatively affected by the oxidative stress resulted from high production of ROS in aged 
muscles (Aracena-Parks et al., 2006, Jang et al., 2010). In the same line of thought, Durham 
et al. reported that mice with a malignant hypothermia mutation (Y522S) in RyR1 displayed 
SR Ca2+ leakage and high ROS production, which induces mitochondrial dysfunction and 
General discussion 
332 
S. S. Omairi, PhD 2018 
 
oxidative stress, ultimately mediated changes of the RyR1 (Durham et al., 2008). Moreover, 
the increased level of ROS production in the aged muscles is associated with alteration of 
cellular Ca2+ handling (Durham et al., 2008). Taken together these data suggest that RyR1 
mediated SR Ca2+ leak may exacerbate mitochondrial dysfunction by causing mitochondrial 
Ca2+ overload, which in turn leads to increase ROS production, that further induces RyR1 SR 
Ca2+  leak via oxidising the channels. Given our observations show that muscles developed in 
the absence of Myostatin were associated with high level of ROS and ultrastructural 
abnormalities, we suggest that Myostatin null phenotypes likely share a common 
mechanism that contributes to impaired force generation and exercise capacity.        
Interestingly, the ultrastructural abnormalities were largely eliminated following Errγ 
overexpression possibly by inducing and normalising FoxO3 level. Additionally, ROS 
production was significantly reduced in Mtn-/-/ErrγTg/+ and ErrγTg/+. sActRIIB muscles. A key 
aspect of our work is that unwanted organelles clearance programmes are being mediated 
by FoxO3, are not anabolic, but are essential for maintaining muscle homeostasis. Therefore, 
removal of dysfunctional sarcomeres and mitochondria in Errγ transgenic muscles robustly 
attributed to the efficient autophagy and proteasome systems. Alternatively, energy sensor 
AMPK that known to be induced by Errγ, has been shown to have a critical role in regulating 
autophagy (Hoyer-Hansen and Jaattela, 2007). The additional modification that takes place 
in Mtn-/-/ErrγTg/+ muscles is the high level of antioxidants (anserine and catalase), that play a 
positive role as scavenger agents for byproducts arising from elevated oxidative activity in 
these muscles. Consistently, it was well established that aged mice received antioxidants 
exhibited better performance in behavioural tests, as these compounds induced 
mitochondrial oxygen uptake and oxidative phosphorylation, thereby less ROS emission, and 
more ATP production that robustly supporting physiological functions (Navarro et al., 2005). 
Furthermore, Errγ regulates expression level of genes that control ETC pathway in 
mitochondria, which is the main sources of ROS production (Alaynick et al., 2007). In the 
same line of thought, numerous studies have unveiled the Errγ potential to regulate 
expression of genes that control calcium handling pathways (Stein and McDonnell, 2006, 
Rangwala et al., 2010). Together, Errγ transgenic potentially promotes autophagy and 
proteasome pathways, increases antioxidants level and hence reduces ROS production, and 
prevent Ca2+ overload on mitochondria by regulating its signalling pathway. Importantly, 
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these modifications positively correlate with improvement in physiological performance, 
force generation capacity and exercise tolerance.   
Experiments looking at myonuclei distribution within individual muscle fibres show that 
myonuclei are not scattered randomly. This view is confirmed by Bruusgaard et al. who 
revealed evenly and orderly distribution of myonuclei throughout cytosol (Bruusgaard et al., 
2003). Moreover, it has been shown that proper nuclei spacing is a prerequisite for normal 
muscle function (Metzger et al., 2012). Substantially, nuclear disorganization is a hallmark of 
aged skeletal muscle, and is detected in models of muscular dystrophy (Bruusgaard et al., 
2006, Meinke et al., 2014). Further work has reported that myonuclear domain size is mainly 
defined by mitochondrial protein systems (Liu et al., 2009). Although the number of 
myonuclei increased significantly following Errγ overexpression in the Mtn-/- muscles, they 
were disorganised. We mentioned above that in addition to the high number of myonuclei, 
Mtn-/-/ErrγTg/+ muscles showed a high density of functional mitochondria. Possible 
explanation that the increased myonuclei and mitochondrial numbers are beneficial to 
compensate the alteration in myonuclei distribution, hence offers appropriate 
transcriptional level for protein synthesis in order to meet the increased cytoplasmic volume 
demand, ultimately restores muscle physical activity.  
Although the muscle’s active contractile properties take a major focusing of skeletal muscle 
research, it is evident that muscle ECM is structurally and functionally important. More 
specifically, skeletal muscle ECM is essential for providing mechanical stability to muscle 
fibres and blood vessels (Kjaer, 2004). Skeletal muscle is a composite structure that consists 
of muscle fibres, blood vessels, and connective tissue. Therefore, in order to generate an 
optimally functional organ, it is important that all these components develop and work in a 
coordinated manner. We demonstrated notable changes in oxidative properties, myofibre 
phenotypes and blood capillary density following the metabolic reprograms underwent in 
this study. Previous work has reported that the contractile properties of muscle fibres are a 
key factor that can modulate surrounding ECM quality and quantity (Kovanen et al., 1980). 
Despite that the majority of functional ECM proteins are producing by fibroblast cells, other 
cell types such as skeletal myoblast have also been shown to contribute to the production of 
this tissue content like collagen (Kuhl et al., 1982, Gatchalian et al., 1989). Thus, we believe 
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it is feasible to understand the relationship between muscle metabolism, myofibre types, 
and extracellular matrix (ECM) components, thereby identify the importance of this 
supporting tissue. In fact, the dearth of knowledge regarding the relationship between 
muscle metabolism and ECM, might be attributed to the absence of techniques that allow 
an accurate measurement required for significant outcomes. Therefore, we have taken 
advantage of the development of semi-quantitative immunofluorescence-based techniques 
that can expand our knowledge regarding these components role in the force transduction 
apparatus in specific muscle fibre types (Ho-Kim and Rogers, 1992, Anthony et al., 2011). 
Our work examining the intensity and thickness of ECM components offers interesting 
insights into the interaction between muscle metabolic status and connective tissue content. 
A number of studies have revealed an inhibition effect of Smad and AKT pathways that are 
driven by Myostatin signalling on myogenesis, while the same pathways induce fibroblast 
proliferation, and promote connective tissue development (Li et al., 2008, Langley et al., 
2002). Therefore, it would be expected that either genetic deletion or post-natal blocking of 
Myostatin, the muscle would develop hypertrophic myofibres that are invested with less 
ECM, which is what we observed in Mtn-/- and WT muscles treated with sActRIIB in the 
current study. Alternatively, Myostatin absence leads to the development a thin connective 
tissue that is suited to the contractile profile of the developed muscle (fast/glycolytic). These 
findings indicate the critical role of muscle fibres type in the determination of ECM content. 
Interestingly, this possible thought was confirmed at the individual muscle fibre level, we 
found that slow-twitch oxidative myofibres content more ECM than the fast-twitch 
glycolytic phenotypes. Indeed, there is an interaction between muscle fibre and connective 
tissue has been recognised during embryonic and adult life. It was well established that 
fibroblast plays a vital role in regulating of muscle fibre type through Tcf-4 signalling 
pathway, suggesting an indirect control on MHC via connective tissue (Mathew et al., 2011). 
Moreover, it has been illustrated that TGF-β, which plays a similar role as Myostatin, as it 
induces fibroblast differentiation and promotes ECM production (Cui et al., 2011). Thus, 
Myostatin deletion or blockage might negatively affect TGF-β receptor sensitivity in ECM 
compartment, which in turn leads to a reduction in fibroblast proliferation thereby less 
connective tissue formation. Interestingly, muscle-specific overexpression of ErrγTg/+ in the 
Mtn-/- background, or in the WT muscles before being treated with sActRIIB overcomes the 
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negative impacts of Myostatin absence or inhibition on ECM and DGC contents. It was 
efficacious to restore almost all proteins constituting ECM and DGC to their normal levels. 
Importantly, the restoration of these compartments was correlated to the improvement of 
animals’ behavioural performance, muscles tension production, and regeneration capacity. 
We suggest that metabolic program of muscle is profoundly affect ECM and DGC 
components. Additionally, Errγ overexpression might stimulate the muscles to secrete 
molecules that either increase fibroblast number, or promote their capacity to proliferate 
and produce more connective tissue. 
 
Using an acute skeletal muscle in vivo model to investigate effect of Errγ overexpression 
on muscle regeneration with low population of satellite cells    
Study of muscle regeneration has been used extensively to understand satellite cells 
functional (Czerwinska et al., 2012). Thus, in this study we offer a new perspective regarding 
the relationship between muscle metabolism, connective tissue content, and satellite cells 
number and their activity during regeneration. In agreement with aforementioned reports, 
work covered in chapter seven showed that the oxidative muscle fibres were invested with 
more ECM compared to the glycolytic phenotypes (Kovanen et al., 1980, Elashry et al., 
2012). In the line of thought, a number of investigators have revealed a high population of 
satellite cells in slow myofibres than the fast ones (Putman et al., 1999, Christov et al., 2007). 
Furthermore, satellite cells maintained their ability to proliferate and differentiate in 
response to the need of myofibre hypertrophy (Schmalbruch and Lewis, 2000). Indeed, 
skeletal muscle metabolism effectively modulates satellite cells function, fate and capability 
to induce recovery from injury (Cerletti et al., 2012). In addition to the effects of muscle 
metabolism on satellite cells activity, previous work has demonstrated regulatory impacts of 
ECM composition changes on satellite cells, thus influencing their quiescent, activation, 
differentiation, and maintaining SCs pool via self-renewal (Calve et al., 2010). Other studies 
have revealed a crucial role of ECM components on mechanical properties of tissue 
microenvironment, accordingly induce the activity of satellite cells (Gilbert et al., 2010, 
Guilak et al., 2009). Moreover, Murphy et al. reported that fibroblast cells are required for 
proper regeneration of skeletal muscle, a process drives by satellite cells (Murphy et al., 
2011). Subsequently, fibroblast depletion resulted in a marked alteration in satellite cells 
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dynamics, that led to the premature differentiation of these cells with poorly regeneration 
capacity indicated by relatively small size regenerated myofibres (Murphy et al., 2011).   
In spite data in chapter three showed a partial transition of myofibres toward the slow-
twitch phenotypes within MHCII subsets following Errγ overexpression on Mtn-/- muscles, 
the number of SCs in these muscles (Mtn-/-/ErrγTg/+) was lower than those in other genotypic 
groups. Taking into account the high number of myonuclei per each muscle fibres of Mtn-/-
/ErrγTg/+, it is possible that Myostatin deletion induces myoblast fusion at the expense of 
satellite cells, and overexpression of Errγ profoundly exacerbates this relationship. Further 
studies have reported that glycolysis negatively regulates Notch pathway, which in turn 
makes myoblast competent to fuse (Saj et al., 2010, Gildor et al., 2012). In fact, satellite cells 
population and activity underpin skeletal muscle regeneration. Therefore, a reduction in 
their number has been reported to be severely hinder muscle regeneration process 
(Schuster-Gossler et al., 2007, Vasyutina et al., 2007). Strikingly, a decrease to less than 50% 
of satellite cells population did not affect the regeneration capacity of Mtn-/-/ErrγTg/+ 
muscles, possibly because they have a vast capacity to generate precursors which in most 
situation is never realized fully (Collins et al., 2005). A study by Carlson and Faulkner has 
unveiled an effective role of the microenvironment on satellite cells activation, proliferation 
and differentiation, thereby whole regeneration process (Carlson and Faulkner, 1989). 
Related to this, a number of studies referred to a positive correlation between oxidative 
metabolism and muscle regeneration capacity (Lowrie et al., 1982, Matsakas et al., 2013). 
Consistently, genetic manipulation that induces oxidative capacity profoundly accelerates 
muscle regeneration (Li et al., 2007b).  
On the other hand, it was well identified that glycolysis genes are essential in embryogenesis 
for muscle precursors to increase their size via fusing with surrounding fusion-competent 
myoblast (Johnson et al., 2003). It seems that glycolysis effectively contributes to cell 
proliferation and growth during muscle regeneration and development. We suggest that 
oxidative metabolism resulted from remodelling of Mtn-/- muscle through overexpression of 
ErrγTg/+ did not overcome entire glycolysis pathway, thus imparts more efficient growth and 
development approach.   
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As mentioned earlier, Mtn-/-/ErrγTg/+ muscle fibres show high capillary density. Work by 
Bencze et al. showed that efficient skeletal muscle angiogenesis is necessary for proper 
regeneration process (Bencze et al., 2012). Data shown in chapter five revealed a high rate 
of clearing process indicated by the low number and small size necrotic fibres, high 
macrophages density, and elevated proportion of committed muscle cells in regenerated 
areas of Mtn-/-/ErrγTg/+ muscles at both time points (day 3 and day 6) after CTX injection. By a 
way of explanation, the high capillary density that robustly enabling an efficient clearing of 
debris and necrotic tissue in the Mtn-/-/ErrγTg/+ muscles, allows the small number of satellite 
cells to expand greatly, thereby leads to rapid muscle regenerate and repair.     
Alternatively, other non-muscle stem cell population named endothelial-associated cells 
may also contribute in the regeneration process. They reside either within the muscles or 
can be recruited via the circulation in response to signals producing from the injured 
muscles (De Angelis et al., 1999). Previous work has reported a vital role of Myostatin in 
regulating of endothelial cells proliferation (Hayot et al., 2011), since its deletion negatively 
affects the activity of these cells, and reduces muscle capillarization. In contrast, Errγ is able 
to induce endothelial cells proliferation and migration (Zheng et al., 2007, Partridge et al., 
2000). Together, these studies provide additional evidence of the importance of surrounding 
environment that induced by introducing of Errγ on the Mtn-/-  to accelerate muscle 
regeneration and repair even with a low number of satellite cells. 
During muscle regeneration, an interaction between satellite cells and ECM of skeletal 
muscle is essential for muscle repair and adaptation (MAURO, 1961). A number of studies 
have shown that the interstitial muscle niche is vital for satellite cells activation in response 
to external stimuli associated with muscle repair (Barberi et al., 2013, Urciuolo et al., 2013). 
Consistently, it was established that satellite cells contribute to their own environment 
through inducing ECM synthesis (Brohl et al., 2012), as its components are required for 
proper SCs activity during muscle regeneration (Calve et al., 2010). Satellite cells are able to 
regulate their surrounding ECM composition via exosome-mediated regulation of fibrogenic 
cell ECM (Fry et al., 2014). Furthermore, work by Engler et al. demonstrated that satellite 
cells differentiation into myoblast requires optimal connective tissue level that can offer an 
ideal tissue elasticity (Engler et al., 2006). It seems that correct regulation of satellite cells 
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activity is crucial for maintaining tissue homeostasis after CTX injury. Given our observations 
in chapter seven showed a restoration of almost all examined ECM and DGC components to 
their normal levels and distribution following Errγ overexpression in the Mtn-/- background 
muscles could have dual function : on one hand it is critical for the regulation of skeletal 
muscle mechanical properties that were related to high exercise and force generation 
capacity, and on the other hand it induces interaction between CT components and SCs, 
that simultaneously enhances satellite cells activity, thereby the regeneration rate. Another 
important molecule within ECM that can induce muscle regeneration after injury is 
Fibromodulin, an extracellular matrix component that was found to be upregulated during 
muscle regeneration (Svensson et al., 1999). As Mtn-/-/ErrγTg/+ muscles show high levels of 
ECM and DGC proteins, so there is more Fibromodulin production that is associated with the 
recruitment of satellite cells into the site of injury (Lee et al., 2016), thereby promotes 
regeneration pace.   
Expanding on this finding, the increased in numbers of myogenic precursor and committed 
cells in regenerated areas of Mtn-/-/ErrγTg/+ muscles did not affect the population of satellite 
cells (Pax7+ / MyoD-), which are essential for future degeneration/regeneration cycle. 
Previous work has demonstrated that ECM components are required for maintaining SCs 
self-renewal and muscle regeneration (Calve et al., 2010). Our findings provide novel 
insights into the relevance of ECM molecules in the regulation of SCs homeostasis. In fact, 
this is again clearly evident the prominence of microenvironment to promote muscle 
regeneration following repetitive injury. This hypothesis supported by our data investigating 
a number of (eMHC) fibres, and size of newly generated myofibres after 14 days of muscle 
injury. 
 
Introducing of Errγ in the Mtn-/- background muscles failed to eliminate all abnormalities  
Although the attractive impacts of oxidative programme imparted by introducing of Errγ in 
the Mtn-/- background muscles, a number of abnormalities were not normalised in Mtn-/-
/ErrγTg/+ muscles.  
The transgenic protocol utilised in this study caused partial conversion of MHC profiling 
toward the slow phenotypes, however it was unable to induce the proportion of MHC type I. 
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This data extends findings of previous work by Matsakas et al. who revealed an absence of 
complete transition from MHCIIA to MHCI following Errγ transgenic (Matsakas et al., 2012b). 
Previous work has demonstrated that there is a large gap between the kinetics of type IIA 
and type I myofibres that possibly disrupt the continuum transition between the two 
phenotypes (Andruchov et al., 2004). A number of investigators have examined whether it is 
possible to get the final step of conversion from MHCIIA to MHCI. Indeed, Chronic low-
frequency stimulation (CLFS) is a profound example to describe MHCI development in a 
number of conditions (Kwong and Vrbova, 1981). However, further investigation to 
determine whether MHCI fibres formed as a consequence of the remodelling of type II 
muscle fibres or through the formation of new fibres, is required. It was well identified that 
the development of muscle fibre type I following extended CLFS can only be induced to 
significant levels when accompanied by robust myofibre regeneration (Maier et al., 1988). 
We deduced from this, Myostatin signalling plays a critical role at the embryonic stage of 
muscle development to form myofibres type I mediating by patterning a subpopulation of 
satellite cells/muscle precursor. In opposition, the protocol applied in this study (Errγ 
introducing onto Mtn-/- muscles) was unable to influence the final step of myofibres 
transition.  
Our work examining the impacts of genetic deletion of Myostatin and muscle-specific 
overexpression of Errγ onto Mtn-/- muscles offers important findings in related to DGC 
composition. Although almost all decreased ECM and DGC proteins in Mtn-/- muscles were 
restored to their normal level following Errγ expression, β and δ-SG show high expression 
levels in Mtn-/- and Mtn-/-/ErrγTg/+ than the WT muscles. It has been reported that DGC 
components have identical roles in this complex (Jung et al., 1996a). Further work has 
demonstrated the importance of a fully assembled of sarcoglycan complex in order to 
support sarcolemma stability and to reduce possible degradation during physiological 
activity (Jung et al., 1996b), which might explain the maintaining of increased β and δ-SG in 
Mtn-/-/ErrγTg/+ muscle that correlated to the increased level of other ECM and DGC proteins, 
as well as muscle physiological activity. On the other hand, we believe that the alteration of 
relative SGs in hypertrophic muscle fibres developed in absence of Myostatin may attribute 
to the unique functional property of each component. In support of this view, previous work 
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demonstrated that different diseases could result from a mutation in each SG complex 
member (Wicklund and Kissel, 2014).   
Investigation at the cellular level in the current study revealed some abnormalities that 
metabolic reprogramming driven by muscle-specific overexpression of Errγ onto Mtn-/- 
muscles was unable to eliminate. Firstly, single myofibres from Mtn-/-/ErrγTg/+ muscles show 
few satellite cells number compared to either WT or Mtn-/- myofibres. Secondly, unlike in 
WT, myonuclei distribution was randomly and irregularly in Mtn-/- and Mtn-/-/ErrγTg/+ 
muscles.  
The predominance glycolysis in muscles due to the absence of Myostatin may promote 
myoblast fusion mediating by downregulating of Notch pathway (Gildor et al., 2012). An 
interpretative view that genetic alteration of Myostatin induces myoblast to fuse to each 
other at the expense of satellite cells population, and notably introducing of Errγ in the Mtn-
/- muscles intensify this phenomenon.  
The results from this work show that the accretion in myonuclei number in Mtn-/-/ErrγTg/+ 
muscle, was coupled with an increase in mitochondrial biogenesis and activity, which were 
positively correlated to the improvement of the animal's physiological performance. 
Previous work by Liu et al. reported a critical role of mitochondrial protein systems to define 
myonuclear domain size in hypertrophic muscle fibres (Liu et al., 2009). We suggest that the 
high density of myonuclei and mitochondria in Mtn-/-/ErrγTg/+ muscle was efficacious to 
compensate the far disorganization in myonuclei positioning, thereby overcoming the 
possible reduction in muscle functions.  
It seems that the oxidative programme established by remodelling of Mtn-/- muscles 
through muscle-specific expression of Errγ was impotent to overcome all the defects of 
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Conclusion  
A number of key conclusions can be drawn from this body of work. Firstly, the lack of 
Myostatin has been utilised as treatment of various muscle wasting disorders. However, we 
and others have demonstrated that, despite the larger muscle mass of Mtn-/- compared to 
age-matched wild type, Myostatin deletion compromises strength production in association 
with a reduction of muscle oxidative properties and connective tissue contents (Amthor et 
al., 2007, Elashry et al., 2012). Consequently, these changes profoundly contribute to the 
decreased level of physical activity and exercise tolerance. Importantly, superimposition of 
Errγ in the Mtn-/- background muscles maintains the increase in muscle mass exhibited by 
Mtn-/- muscles, while promotes muscle force generation capacity and in fact even resulted 
in improvement in animal exercise capacity, ultimately challenges the dogma of an inverse 
relationship between muscle fibre size and oxidative capacity. Such deviation might result 
from the significantly increased capillarization, muscle myoglobin content, ECM components, 
and normalised mitochondrial quality and quantity. Furthermore, although we show that 
Mtn-/-/ErrγTg/+ muscles content few number of satellite cells, their regeneration capacity 
exceeded that of other genotypic groups (WT and Mtn-/-). Most likely the surrounding 
environment, in particular the high oxidative capacity, angiogenesis program and high 
connective tissue abundant that are imparted by Errγ overexpression play a crucial role in 
accelerating muscle regeneration.   
Secondly, Myostatin/ActRIIB signalling is essential for optimizing skeletal muscle oxidative 
metabolism leading to lower muscle fatigability. Despite blocking of this pathway increases 
muscle mass, it results in a reduction of oxidative capacity which can negatively affect 
muscle physiological performance (Hulmi et al., 2013a, Relizani et al., 2014). Consequently, 
the fundamental functions of this signalling should be taken into account in order to 
develop therapies based on its inhibition. Alternatively, a genetic modification that might 
complement this approach should be performed. We showed that muscle-specific 
expression of Errγ in the Mtn-/- background restored the markers of oxidative metabolism 
and autophagy to that level of healthy mice. Indeed, an adequate level of muscle size and 
function has beneficial effects on overall health and life quality (Safdar et al., 2011), since a 
low aerobic fitness and low level of muscle function are associated with various health risks 
(Kujala et al., 1998). We show that combined approaches (blocking of Myostatin signalling in 
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ErrγTg/+ mice) result in an increase in muscle size, and oxidative capacity appear to offer 
more. Such combination might be appropriate for both genetic and acquired muscle 
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Future direction priorities  
This body of work has utilised the transgenic method in order to optimize a therapeutic 
approach that can offer a synchronized development of a large and functional muscle, hence 
improve quality of life. This was attained by taking advantage of the high power of Myostatin 
to negatively regulate skeletal muscle development and growth (McPherron et al., 1997), 
and most importantly the potential of Errγ in regulating metabolic and energy profiles 
mainly in mitochondrial rich and energy-dependent tissues including brain, heart, skeletal 
muscles, and brown adipose tissue (BAT) (Hong et al., 1999).  
Further investigations following on from this study should focus on special areas that were 
uncovered by this work. Thereafter, advancement of this therapeutic agent into a clinical 
investigation, which may provide a new conduit for the treatment of an adult with metabolic 
disorders, and physical limitation of elderly people is required. 
Previous work reported that Myostatin null muscles had elevated levels of both proteolytic 
and autophagy programmes,  as well as shutting down protein synthesis extensively during 
acute starvation compared to age-matched wild type mice (Collins-Hooper et al., 2015). 
Therefore, future investigation of consequences of overexpression of Errγ in the starved 
muscle lacking Myostatin would be feasible in order to verify results shown in chapter 3 of 
this study that provided evidence of Errγ potential to normalise autophagy and proteolytic 
systems activity. Moreover, it would expand our understanding of Errγ roles to attenuate 
hypertrophic myofibres functional lack during starvation.   
It was well established that obesity is mainly caused by excessive accumulation of white 
adipose tissue (WAT), that can eventually lead to type 2 diabetes, and other metabolic 
deteriorations (Gesta et al., 2007). Thus, the transition of WAT to BAT is necessary to burn 
body fat, induce heat production and avoid obesity risk (Cannon and Nedergaard, 2004). It 
has been reported that Errγ markedly induces expression of uncoupling protein 1 (UCP1), 
brown-fat specific gene, and improve fatty acid oxidation in differentiated white pre-
adipocytes and BAT (Dixen et al., 2013). This hypothesis is supported in a part by our 
observations shown in chapter 4 at least at the transcriptional level. Therefore, developing a 
therapeutic intervention that enables efficacious delivery of Errγ actions into human 
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muscles, and hence enhance muscle functions would halt risks of fat deposition; ultimately 
contribute to offer healthy life.    
The world population is ageing, and as society ages, physical performance limitation 
incident will be increased, which in turn raise the possibility of predisposition to a number of 
diseases and premature death as well (Louie and Ward, 2010). Although numerous factors 
contribute to physical disability with age advance, a reduction in muscle performance is the 
major contributor (Janssen et al., 2002). Old age is associated with progressive loss of 
skeletal muscle mass, a process is known sarcopenia, which leads to diminish of muscle 
strength, induce fatigability, and ultimately decrease the quality of life (Cruz-Jentoft et al., 
2010, Faulkner et al., 1990). A number of studies on the effects of ageing on skeletal 
muscles have revealed a considerable reduction in muscle fibres size in the elderly people 
(Larsson, 1978, Verdijk et al., 2007). Notably, muscle fibres type II are more prone to size 
decrease observed in the elderly, however type I muscle fibre appears largely sustained with 
ageing (Larsson, 1978). With regard to muscle energetic, previous work has reported that 
aged muscles show an elevated level of mitochondrial abnormalities (Berger and Doherty, 
2010). Consistently, it was well established that muscle aerobic metabolism is profoundly 
affected by ageing (Fleg et al., 2005), which might be attributed to the impairment of ATP 
synthesis pathways in aged muscle (Russ and Lanza, 2011). We and others have identified 
Errγ potential to promote muscle energy production, and mitochondrial biogenesis and 
activity (Alaynick et al., 2007, Rangwala et al., 2010). Moreover, it has been documented 
that Errγ is exclusively and abundantly expressed in oxidative (type I) slow-twitch fibre 
(Narkar et al., 2011) which may impart capability of this muscle fibre type to resistant the 
age-related ailments.  
Therefore, in order to convert the Errγ biological versatility into the effective therapeutic 
target, identification of synthesized ligands for Errγ that displaying better specificity and are 
able to positively regulate the transcriptional activity of this nuclear receptor is required. 
Work by Wang et al. showed that it is a challenge to identify a small molecule that can 
improve Errγ transcriptional functions, because of the small volume of its ligand binding 
pocket (Wang et al., 2006). In fact, a number of synthetic ligands have been developed, 
DY131 and GSK4716, a phenolic acyl hydrazine compounds, have been described to 
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selectively upregulate the transcriptional functions of Errγ and potently stimulate the 
browning process of white adipose tissue (Zuercher et al., 2005, Kim et al., 2009). 
Furthermore, Bisphenol A is another ligand that can positively regulate the transcriptional 
activity of a human isoform of Errγ (Tohme et al., 2014), however, recent data has linked 
Bisphenol A levels with type 2 diabetes and metabolic dysfunction in human (Lang et al., 
2008).    
The fundamental strategy for delivering Errγ synthesized ligands could potentially 
accomplish by utilising gene therapy vectors that provide a continuous source of exogenous 
ligand. In fact, the main obstacle to the successful application of gene therapy is not a 
paucity of the therapeutic gene, but the deficit of an efficient non-toxic gene delivery 
system. Adeno-associated virus (AAV), a single-stranded of DNA viruses, has attracted 
considerable interest in gene therapy approach due to its lack of pathogenicity, and the 
ability to integrate into host cell genome (Surosky et al., 1997, Miller et al., 2004). Moreover, 
AAVs characterized by low immunogenicity, with low possibility to induce a cytotoxic 
response (Chirmule et al., 1999). Indeed, using different AAV serotypes has been discovered 
in order to improve transduction of specific cell type. AAV-5 able to transduce airway 
epithelial cells in the murine and human model (Rabinowitz et al., 2002), AAV-6 shows very 
efficient uptake into skeletal muscles (Zabner et al., 2000), and AAV-8 has been successfully 
used for post-natal inhibition of Myostatin by delivering Myostatin propeptide (MyoPPT) 
into adult mice via tail vein injection (Yue and Dongsheng, 2002), and same serotype was 
utilised to induce human Survival of Motor Neuron (hSMN) into the CNS of Spinal muscular 
atrophy  (SMA) mouse model (McCarty, 2008). Moreover, AAV9 has been utilised to infect 
different tissues due to its wide tropism, which make it a strong candidate for gene therapy 
in multisystem disorders (Gadalla et al., 2013). Therefore, further investigation of the most 
efficient vector to be used should be carried out in order to ascertain the best way to attain 
the greatest value of Errγ transcriptional activity.  
Discoveries of efficient methods of gene transducing with exciting observations of our work 
may provide valuable knowledge and opportunity to expand the search of more potent and 
selective compounds that may represent unique chemical tools that able to elucidate Errγ 
functions and could be new potential therapeutic value for the treatment of human energy 
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and metabolic disorders during the life, and prevent or attenuate physical performance 
limitation in the elderly.  
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Appendix 1 - Antibodies used 
Antibodies used for Immunostaining  
Primary antibodies  
Antigen  Type  Immuno- 
-globulin 





Monoclonal  IgM Mouse 1:1 DSHB A4.840 
MYHCIIA 
 
Monoclonal IgG Mouse 1:1 DSHB A4.74 
MYHCIIB 
 
Monoclonal IgM Mouse 1:1 DSHB BF.F3 
CD31 Polyclonal IgG Rat 1:40 AbD serotec MCA2388 
Pax7  Monoclonal IgG Mouse 1:1 DSHB 
MyoD Polyclonal IgG Rabbit 1:200 Santa Cruz Biot, # sc-760 
F4/80 Monoclonal IgG Rat  1:100 Bio-RAD, MCA4978 
MYH3 Monoclonal IgG Mouse 1:200 Santa Cruz Biot, sc-53091 
Cleaved 
Caspase-3 




Monoclonal IgG Mouse 1:500 Abcam, 6308 
Collagen 
type IV 
Polyclonal IgG Rabbit 1:500 Abcam, 6586 
Dystrophin  Polyclonal  IgG Rabbit 1:200 Abcam, 15277 
α-DG Monoclonal IgM Mouse 1:50 Millipore, 05-593 
β-DG Monoclonal IgG Mouse 1:10 Leica Biosystems, B-DG-CE 
α-SG Monoclonal IgG Mouse 1:40 Leica Biosystems, A-SARC-L-
CE 
β-SG Monoclonal IgG Mouse 1:50 Leica Biosystems, B-SARC-L-
CE 
-SG Monoclonal IgG Mouse 1:30 Leica Biosystems, G-SARC-CE 
-SG Monoclonal IgG Mouse 1:25 Leica Biosystems, D-SARC-CE 
Laminin 1 Polyclonal IgG Rabbit 1:200 Sigma L9393 
 
Secondary antibodies  
Antibody Species Dilution 
factor 
Supplier 
Alexa fluor 633 anti‐mouse Goat 1:200 Life Technologies # A20146 
Alexa fluor 488 anti‐mouse Goat 1:200 Life Technologies # A11029 
Alexa fluor 488 anti‐rabbit Goat 1:200 Life Technologies # A11034 
Appendices 
349 
S. S. Omairi, PhD 2018 
 
Alexa fluor 594 anti‐rabbit Goat 1:200 Life Technologies # A11037 
Alexa fluor 594 anti‐rat Goat 1:200 Life Technologies # A11007 
 
Antibodies used for western blotting  
Primary antibodies  




Species  Dilution 
factor  
Supplier 

































Dystrophin  Polyclonal  IgG 420 kDa Rabbit 1:200 Abcam 
ab15277 
α-DG Monoclonal IgM 156 kDa Mouse 1:2000 Millipore 
05-593 
β -DG Monoclonal IgG 45 kDa Mouse 1:1000 DSHB 7D11 
β-SG Polyclonal IgG  45 kDa Rabbit 1:200 Abcam 
ab203392 
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Secondary antibodies for western blot 
Antibody Species  Dilution factor Supplier 
HRP-anti rabbit Goat 1:50,000 Jackson ImmunoResearch 111-035-045 
HRP-anti mouse  Goat 1:50,000 Jackson ImmunoResearch 115-035-166 
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Appendix 2 - Materials 
Reagents: 
 
Reagent    Supplier 
100bp DNA Ladder  Promega G2101 
4, 6-diamidino-2-phenylindole (DAPI) 
(2.5µg/ml) 
DakoCytomation DAKO Corp, 
Carpinteria, Calif 
Acid phosphatase  Sigma Aldrich N2250 
Agarose Powder  BIOLINE  BIO-41025  
CaCl2 Fisher Scientific  10161800 
Cardiotoxin  Sigma- Aldrich C9759 
Chloroform  ACROS ORGANIC  
DMEM Gibco 31966-021 
DPX Fisher Scientific D/5319/05 
DHE Sigma-Aldrich 7008 
Eosin  Sigma-Aldrich 318906-500ML 
Epoxy resin  Durcopan, Roth, Germany 
FBS Gibco 10270-106 
Gluteraldehyde Solution 25% Merck, Germany 1042390250 
Glycerol  Sigma-Aldrich G6279-1L 
Haematoxylin  Sigma-Aldrich MHS16-500ML 
HEPES Fisher Scientific BP410-500 
Horse serum Gibco 16050-122 
Hydro mounting media  Agar scientific R1356 
Isopropanol  Fisher Scientific P/7490/17 
KCl  BDH 101984L 
KCN Fisher Scientific 1059938 
KH2PO4 BDH 10203 
Methanol Fisher Scientific M/4056/17 
MgCl2 Sigma-Aldrich M2670-500 
MgSO4 BDH 101514Y 
NaCl   Sigma-Aldrich 71382 
NaHCO3  Sigma S-8875 
NaOH Sigma S-5881 
NBT Sigma Aldrich 74032 
Na Citrate BDH # 30128 
OsO4 Roth, Germany  
PBS Tablets Oxoid BR0014G 
Penicillin-streptomycin Invitrogen 15240-062 
Periodic acid solution Thermo Scientific 88016 
PFA Fisher Scientific P/0840/53 
Phenazin methosulphate Sigma P9625-1G 
Protease Inhibitor Cocktail Set l CALBIOCHEM #539131 
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RevertAid H Minus First Strand cDNA 
Synthesis Kit 
Life Technologies k1631 
RNase-Free DNase Set (50) QIAGEN 79254 
RNeasy Mini Kit (50) QIAGEN 74104 
Schif reagent Thermo Scientific 88017 
SDS Fisher Scientific S/200/53 
Sodium azide Fluka 
Sodium succinate Fisher Scientific  11418852 
Sodium-Cacodylate  TAAB S007 
Sucrose Fisher chemical S/8560/53 
SYBER Safe DNA gel Invitrogen S33102 
SYBR® Green PCR Master Mix  Applied Biosystems 4309155 
Taq 2X Master Mix  New England Biolabs M0270L 
Triton X-100 Fisher Scientific T/3751/08 
TRIzol  Sigma-Aldrich T9424-100ml 
Type 1 collagenase Sigma C0130 
Uranyl acetate  Polysciences, Germany 





Taq 2X Master Mix  
10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, 0.2 mM dNTPs, 5% Glycerol, 0.08% IGEPAL® CA-
630, 0.05% Tween® 20, 25 units/ml Taq DNA Polymerase pH 8.6 at 25°C. The solution was 
stored at -20°C. 
 
TAE buffer 
40 mM Tris base, 5 mM Na Acetate, and 1 mM EDTA, adjusted to pH 7.8. The solution was 
stored at room temperature. 
 
Krebs solution  
124 mM NaCl, 3 mM KCl, 1.25 mM KH2PO4, 36 mM NaHCO3, 1 mM MgSO4,  2 mM CaCl2, , 
and Glucose. The solution was stored at 4°C. 
 
1 x Phosphate Buffer Saline (PBS) 
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4% Paraformaldehyde (PFA)  
20 g of paraformaldehyde powder dissolved in 480 ml 1 x PBS by heating to 65°C. Volume 
was then made to 500 ml with 1 x PBS and stored at room temperature. 
 
Permeabilisation buffer 
0.952 g Hepes, 0.260 g MgCl2, 0.584 g  NaCl, 0.1 g Sodium azide, 20.54 g Sucrose and 1 ml 
Triton X-100 were made up to 200 ml distilled water. The buffer was stored at 4°C. 
 
Wash buffer 
25 ml Foetal bovine serum (FBS), 200 mg Sodium azide and 250 µl Triton X-100 were 
dissolved in 500 ml 1 x PBS and stored at 4°C. 
 
Preparation of type 1 collagenase  
To digest two EDL muscles, 2 mg type 1 collagenase was dissolved in 1 ml serum free DMEM 
GlutamaxTM  (0.2% w/v) under septic conditions.  
 
Single Fibre Culture Medium (SFCM) 
45 ml of DMEM GlutamaxTM was supplemented with 250 µl of chick embryo extract, 5 ml 
of 10% horse serum and 500 µl penicillin-streptomycin. The medium was stored at 4°C. 
 
Chick embryo extract 
Fertilised white leghorn chicken (Gallus gallus) eggs were incubated for a period of 10 days 
at 39°C, 80% humidity. Following incubation the chick embryos were harvested and the eyes 
from the embryos were removed using a pair of sterile forceps. The chick embryos were 
then transferred to 50 ml Falcon tube. An equal volume of sterile 1 x PBS was added. The 
embryos were then finely triturated and the resultant mixture was allowed to stand for 30 
minutes at room temperature. The mixture was then centrifuged at 2000 g for 15 minutes. 
The supernatant was then aspirated and aliquoted into 250 µl aliquots. The aliquots were 
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Antigen retrieval solution  
2.14 g of Sodium Citrate was dissolve in 50 ml of deionised H2O. Then 50 µl of tween was 
added to the mix, the solution’s pH was justified to 6 before being made up to 100 ml with 
distilled water and stored at RT. 
  
Nitro blue tetrazolium (NBT) stock  
Phosphate buffer (100 mM, pH 7.6) was prepared by mixing two solutions; Solution A (1.36 
g KH2PO4 /100 ml) 12 ml, and Solution B (1.42 g Na2HPO4/100 ml) 88 ml. Then 6.5 mg KCN, 
185 mg EDTA, and 100 mg Nitroblue tetrazolium (NBT) were dissolved in 100 ml Phosphate 
buffer. The mixture was stored as aliquots of 2 ml at -20°C. 
 
Sodium succinate stock 
2.7 g Sodium succinate was dissolved in 20 ml distilled water. Then aliquots of 2 ml were 
stored at -20°C. 
 
Formal calcium  
10 g of Sodium chloride was dissolved in 900 ml distilled water, and 100 ml 40% 
Formaldehyde was added to the mixture. The solution was stored at room temperature. 
 
Acid phosphatase incubation medium 
2 ml HPR reagent, 0.1 M acetate buffer pH 5.0, 50 mg/ml naphthol AS-BI phosphate, 
solution was adjusted to pH 5.0 and stored at -20°C. 
 
Preparation of fixative solution for TEM samples  
10 ml Glutaraldehyde 25% was added to 50 ml 0.2 M Na- cacodylate buffer pH 7.4, volume 
was then made to 100 ml with distilled water. The fixative solution was prepared freshly and 
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Appendix 3 – RT-PCR Primer sequences  
R_mERRg.F ACT TGG CTG ACC GAG AGT TG 
R_mERRg.R  GCC AGG GAC AGT GTG GAG AA 
R.MHCIIA F AGTCCCAGGTCAACAAGCTG 
R.MHCIIA R GCATGACCAAAGGTTTCACA 
R.MHCIIX F AGTCCCAGGTCAACAAGCTG 
R.MHCIIX R CACATTTTGCTCATCTCTTTG 
R.MHCIIB F AGTCCCAGGTCAACAAGCTG 
R.MHCIIB R TTTCTCCTGTCACCTCTCAACA 
R_mCYCLO.F TGG AGA GCA CCA AGA CAG ACA 
R_mCYCLO.R TGC CGG AGT CGA CAA TGA T 




R.mPGC1A.F  AAC CAC ACC CAC AGG ATC AGA 
R.mPGC1A.R  TCT TCG CTT TAT TGC TCC ATG A 
R_mPERM1.F  CCTGGTCGTAAGAAGAGGCG 
R_mPERM1.R  CTTGGGCCTGGTAAGCTGT 
R_mGlut1.F  CTCTGTCGGCCTCTTTGTTAAT 
R_mGlut1.R  CCAGTTTGGAGAAGCCCATAAG 
R_mGlut4.F  ACACTGGTCCTAGCTGTATTCT 
R_mGlut4.R  CCAGCCACGTTGCATTGTA 
R_mPDK4.F  AAG CAA AAC ACA AAC ACG AGT A 
R_mPDK4.R  CCC GGG TCA TCC AAC CA 
R_mHAD.F  GCTGGGCCTAACTTTGAGTATG 
R_mHAD.R  CAAAATCAGCGTCATCAGGAGAA 
R_mLPL.F  GCTGGGCCTAACTTTGAGTATG 
R_mLPL.R  CAAAATCAGCGTCATCAGGAGAA 
R_mcycs.F  CCA AAT CTC CAC GGT CTG TTC 
R_mcycs.R  ATC AGG GTA TCC TCT CCC CAG 
R_mCat.F  GGATTATGGCCTCCGAGATCTT 
R_mCat.R  TAAAACGTCCAGGACGGGTAA 
R_mMYOG.F  CTG TTT AAG ACT CAC CCT GAG AC 
R_mMYOG.R  GGT GCA ACC ATG CTT CTT CA 
R_mCD36.F  AGATGACGTGGCAAAGAACAG 
R_mCD36.R  CCTTGGCTAGATAACGAACTCTG 
R_mSlc25a20.F  CAACCACCAAGTTTGTCTGGA 
R_mSlc25a20.R  CCCTCTCTCATAAGAGTCTTCCG 
R_mFATP1.F  AGGTCAATGAGGACACGATGGAG 
R_mFATP1.R  CTGGTACATTGAGTTAGGGTCCAAC 
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R_mFabp3.F  ACCTGGAAGCTAGTGGACAG 
R_mFabp3.R  TGATGGTAGTAGGCTTGGTCAT 
R_mACADL.F  TGCCCTATATTGCGAATTACGG 
R_mACADL.R  CTATGGCACCGATACACTTGC 
R_mACADM.F  CCAGAGAGGAGATTATCCCCG 
R_mACADM.R  TACACCCATACGCCAACTCTT 
R_mVEGFA165.F  TGC AGG CTG CTG TAA CGA TG 
R_mVEGFA165.R  GAA CAA GGC TCA CAG TGA TTT TCT 
R_mVEGFA189.F  TGC AGG CTG CTG TAA CGA TG 
R_mVEGFA189.R  CTC CAG GAT TTA AAC CGG GAT T 
R_mFGF1.F  GAAGCATGCGGAGAAGAACTG 
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Abstract A central tenet of skeletal muscle biology is the existence of an inverse relationship
between the oxidative fibre capacity and its size. However, robustness of this relationship is
unknown. We show that superimposition of Estrogen-related receptor gamma (Errg) on the
myostatin (Mtn) mouse null background (Mtn-/-/ErrgTg/+) results in hypertrophic muscle with a high
oxidative capacity thus violating the inverse relationship between fibre size and oxidative capacity.
We also examined the canonical view that oxidative muscle phenotype positively correlate with
Satellite cell number, the resident stem cells of skeletal muscle. Surprisingly, hypertrophic fibres
from Mtn-/-/ErrgTg/+ mouse showed satellite cell deficit which unexpectedly did not affect muscle
regeneration. These observations 1) challenge the concept of a constraint between fibre size and
oxidative capacity and 2) indicate the important role of the microcirculation in the regenerative
capacity of a muscle even when satellite cell numbers are reduced.
DOI: 10.7554/eLife.16940.001
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Introduction
John Eccles and colleagues first applied the concept of ‘plasticity’ to skeletal muscle to describe the
effect of cross-innervation experiments in cats on the size and fibre characteristics of skeletal muscle
(Buller et al., 1960). Many factors have since been shown to profoundly effect on skeletal muscle
structure and function, including chronic electrical stimulation, exercise, diet and ageing
(Salmons and Vrbova´, 1969; Hickson, 1980; Wade et al., 1990; Mitchell et al., 2012).
In mammalian skeletal muscle, fibres are broadly characterized as slow or fast fibres, where slow
fibres express the myosin heavy chain (MHC) isoform I, whereas fast fibres express MHC IIA, IIX and/
or IIB. Slow fibres generally have a smaller cross sectional area (CSA), contain more mitochondria
which sustain a high oxidative capacity, and a denser microvascular network than fast fibres that rely
predominantly on glycolysis for ATP production. Muscle fibres can change their phenotype, such as
the expression of MHC, mitochondrial content and capillary supply in response to external stimuli
(Pette and Staron, 1997, 2001).
We are beginning to understand some of the cellular, biochemical and molecular processes that
act to concord muscle structure and morphology to the functional demands placed on the muscle.
For instance, it has been shown that the development of the slow muscle fibre phenotype is largely
controlled by Protein Kinase C, Calcineurin/NFAT, AMP Activated Protein kinase (AMPK), peroxi-
some proliferator-activated receptor gamma co-activator 1-alpha (PGC-1a) and Sex determining
region Y-box 6 (Sox6) (Gundersen, 2011; von Hofsten et al., 2008). Recently, we have shown that
the Estrogenrelated receptor gamma (Errg) is robustly expressed in slow muscle and can promote
the formation of oxidative fibres in a PGC-1a independent manner (Narkar et al., 2011). Fast, glyco-
lytic muscle development on the other hand seems to involve the activation of the Akt signalling
pathway through the transcriptional regulation by molecules including Baf60c (also called Smarcd3)
and T-box 15 (Tbx15) (Meng et al., 2013, 2014; Lee et al., 2015). Lifting the inhibition of Akt sig-
nalling mediated by Myostatin is also a potent means of inducing the formation of glycolytic muscle
fibres (Trendelenburg et al., 2009). Additionally, a recent study has shown that the DNA binding
protein Nuclear Factor I X (Nfix) acts to inhibit the slow muscle phenotype (Rossi et al., 2016).
Myostatin (Mtn), a member of the Transforming Growth Factor Beta (TGF-b) family of secreted
proteins, is highly expressed in skeletal muscle (McPherron et al., 1997). It is a potent inhibitor of
skeletal muscle growth and its deletion results in a hypermuscular phenotype called ‘Muscle Dou-
bling’ seen in mice, cattle and even humans (McPherron et al., 1997; McPherron and Lee, 1997;
Schuelke et al., 2004). We and others have shown that the glycolytic muscles that develop in the
absence of Mtn have a mitochondrial deficit and a low specific force (Amthor et al., 2007;
Mendias et al., 2006).
A fundamental concept of skeletal muscle biology is the existence of the inverse relationship
between the oxidative capacity of a fibre and its cross-sectional area (CSA) that applies to muscles
as diverse as the limb, diaphragm and masseter muscle within an animal and even across species
boundaries (van Wessel et al., 2010; Degens, 2012; Van Der Laarse et al., 1997). This relationship,
in theory, ultimately imparts a constraint on the size that mitochondria-rich and therefore high O2 -
dependent oxidative fibres can attain before they become anoxic or adapt to a glycolytic phenotype
less reliant on O2 (Desplanches et al., 1996; Deveci et al., 2001). The metabolic properties of mus-
cle are believed not only to control fibre size but also the number of satellite cells. A number of cor-
relative studies have described the number of SC increases as a muscle becomes progressively
oxidative (Putman et al., 1999; Christov et al., 2007).
Here we investigated whether this suggested constraint between fibre size and oxidative capacity
can be broken and sought to develop large oxidative fibres without compromising function, such as
fatigue resistance. To that end, we developed a novel mouse line by introducing an Errg over-
expression allele driven by a skeletal muscle fibre promoter (Human a -Skeletal Muscle Actin)
(Muscat and Kedes, 1987) that enhances the oxidative capacity (Narkar et al., 2011) into a hyper-
trophic Mtn-/- background. Based on the concept of a constraint between the CSA and oxidative
capacity of a fibre we postulated three possible outcomes of the cross: (1) the Akt pathway that is
de-repressed due to the absence of Mtn would prevail and lead to hypertrophic, but glycolytic
fibres; (2) oxidative features would be imparted by the Errg programme that would follow the inverse
size relationship and lead to mitochondria-rich fibres which could be smaller than wild-type
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(Rangwala et al., 2010); (3) the constraint is broken in this strain and results in the development of
hypertrophic yet oxidative fibres.
The main observations of the study are firstly that the muscles of Mtn-/-/ErrgTg/+ mice have large
fibres with a larger than expected oxidative capacity, breaking the constraint of the inverse size-oxi-
dative capacity relationship. This was attained through the activation of the Akt pathway, increased
myoglobin gene expression, relocation of mitochondria to the sub sarcolemma and hyper-capillarisa-
tion of the muscle. We show that these modifications not only bring about normalization of many
ultrastructural abnormalities in the hypertrophic muscles of Mtn-/- mice, but the Mtn-/-/ErrgTg/+ mice
even outperform wild type mice during an incremental exercise test. Secondly that the hypertrophic
oxidative muscles from the Mtn-/-/ErrgTg/+ mice do not follow the dogma regarding metabolism and
satellite cells number. We actually show that the metabolic reprogramming in this study led to a
decrease in satellite cell number. However, this deficit did not impact at all in terms of the muscle’s
ability to regenerate. We believe this highlights the importance of the microcirculation during regen-
eration and has major clinical implications.
Results
Body and skeletal muscle mass
Introduction of Errg in a skeletal muscle-specific manner into the Mtn-/- background to generate dou-
ble transgenic Mtn-/-/ErrgTg/+ resulted in viable, fertile offspring that were born at the expected
Mendelian ratios. Firstly, we found that the HSA promoter used induced robust over-expression of
Errg in the Mtn-/- background (Figure 1A). The body mass of WT, Mtn-/- and Mtn-/-/ErrgTg/+ animals
was similar at 12 weeks of age (Figure 1B). However, the EDL, gastrocnemius, soleus and TA
muscles were in both Mtn-/- and Mtn-/-/ErrgTg/+ approximately 43%, 44%, 47% and 70% larger than
their WT counterpart, respectively (Figure 1C–F). Importantly, there was no significant difference in
mass for any of the muscles from Mtn-/- and Mtn-/-/ErrgTg/+ mice (Figure 1C–F).
Exercise capacity
Using the running to exhaustion protocol on a treadmill, we found that Mtn-/- mice performed worse
than WT. However the Mtn-/-/ErrgTg/+ ran for approximately 80% longer than the Mtn-/- and 25%
longer than the WT mice (Figure 1G).
Force generating capacity
We found that the maximal isometric tetanic force generated by the EDL of Mtn-/- was not signifi-
cantly different from that of the WT mice, despite the larger muscle mass (Figure 1H). The tetanic
force generated by Mtn-/-/ErrgTg/+ EDL was, however, greater than that of the EDL from both WT
and Mtn-/- mice. We next calculated the Specific Force (sPo), the tetanic force per muscle mass. The
sPo of the EDL of Mtn
-/- mice was lower that of the other groups, with that of the Mtn-/-/ErrgTg/+
mice being significantly greater than Mtn-/- mice, but not normalized to WT levels (Figure 1I). We
also examined the force generating capacity of the soleus. The tetanic force of Mtn-/- soleus muscle
was significantly lower than those of WT. There was no difference in this parameter between the
soleus muscles of WT and Mtn-/-/ErrgTg/+ (Figure 1—figure supplement 1A). The specific force of
the soleus showed the same overall profile as that of the EDL but did not reach statistical signifi-
cance, possibly due to low sample size (Figure 1—figure supplement 1A).
Muscle fibre number, area and MHC profile
The increased muscle mass in Mtn-/- mice are due to both hypertrophy and hyperplasia. We found
that the introduction of Errg into Mtn-/- did not significantly change the number of fibres normally
seen in Mtn-/- EDL (Figure 2A–B) or soleus muscles (Figure 2—figure supplement 1A–B) both of
which were greater than in WT. The fibre sizes were equivalent in the EDL of Mtn-/- and Mtn-/-/
ErrgTg/+ mice. Of particular note was that the MHCIIB fibres in the EDL were approximately 270%
larger in both Mtn-/- and Mtn-/-/ErrgTg/+ compared to WT (Figure 2B). The other notable result was
the smaller size of MHCIIA fibres in Mtn-/-/ErrgTg/+ than Mtn-/-, but they were still larger than those
in the WT (Figure 2B).
Omairi et al. eLife 2016;5:e16940. DOI: 10.7554/eLife.16940 3 of 25
Research article Developmental Biology and Stem Cells
Figure 1. Concomitant skeletal muscle hypertrophy and tissue specific expression of ERRg and resultant fatigue resistant characteristics. (A) ERRg
mRNA levels. (B) Body and (C–F) skeletal muscle mass in wild type (Wt), myostatin null (Mtn) and ERRg transgenic mice on the myostatin null
background (Mtn:Eg). (G) Exercise tolerance test on a mouse treadmill. (H–I) Contractile properties of the EDL muscle. Specific force denotes tetanic
force normalized to wet muscle mass. N = 5 male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s multiple comparison
tests, *p<0.05.
Figure 1 continued on next page
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Introduction of Errg into Mtn-/- caused a partial reversal of MHC profile of Mtn-/- towards the WT
condition in all muscles examined (Figure 2C and Figure 2—figure supplement 1A and C). This
conversion was only detected within the MHCII subtypes but did not extend to normalization of the
proportion of MHCI fibres; in the soleus of Mtn-/-/ErrgTg/+, the proportion of MHCIIB fibres was
lower than that in Mtn-/- while that of MHCIIA fibres was higher. Nevertheless, both Mtn-/- and
Mtn-/-/ErrgTg/+ display a lower proportion of MHCI fibres in the soleus muscle than WT (Figure 2C).
Next, we examined the mechanism underpinning fibre enlargement. We found that the levels of
phosphorylated Akt (an inducer of anabolism) were higher in the muscle of Mtn-/- and Mtn-/-/
ErrgTg/+ compared to WT (Figure 2D). A similar relationship was discovered for its downstream tar-
get 4EBP1 (Figure 2D). Akt not only promotes protein synthesis but also suppresses catabolism
partly by phosphorylating and thereby inactivating FoxO3. We found that deletion of Mtn resulted
in an increased ratio of the inactive:active (phosphorylated:non-phosphorylated) form of FoxO3.
However, in muscles of Mtn-/-/ErrgTg/+ mice the levels of inactive FoxO3 were lower than in that of
the Mtn-/- (Figure 2D).
Oxidative fibre profiling and vascular organisation
In all muscles examined, the intensity of the SDH staining (measure of oxidative activity) of fibres
was lower in muscle from Mtn-/- compared to WT (Figure 3A and Figure 3—figure supplement
1A–B). However, upon over-expression of Errg , the intensity of SDH staining in fibres of
Mtn-/- muscle was restored to that of WT. Indeed, also the number of SDH positive fibres was higher
than that seen in even the WT muscles albeit not significantly so (Figure 3A and Figure 3—figure
supplement 1C). Introduction of Errg into Mtn-/- also caused normalization of the number PAS posi-
tive fibres (Figure 3A and Figure 3—figure supplement 1D). The capillary to fibre ratio (C:F); was
lowest in the muscles of Mtn-/- mice and highest in those of the Mtn-/-ErrgTg/+ mice (Figure 3B).
Metabonomics
The muscle metabolite profile was characterized by 1H NMR spectroscopy. To identify any metabolic
variation driven by the genotypic differences, principal components analysis (PCA) was applied to
these profiles. A clear clustering was observed in the scores plot comparing all three genotypic
groups demonstrating that they had distinctive metabolite profiles (Figure 3C). Comparing the met-
abolic signature of the Mtn-/- muscle to the Mtn-/-/ErrgTg/+ showed clear differences between the
two groups (Figure 3C) characterised by significantly greater levels of muscle lactate in Mtn-/- muscle
compared to that of the Mtn-/-/ErrgTg/+ consistent with a greater glycolytic phenotype. Furthermore
the levels of creatine/phosphocreatine were also more pronounced in the muscle from
Mtn-/- compared to Mtn-/-/ErrgTg/+. Errg modification led to higher taurine and anserine content in
the muscle of these animals.
Therefore, histochemical and NMR muscle profiles of the three genotypic groups provide further
evidence that Errg modification of Mtn-/- results in a remodeling of phenotype to a state that differ-
entiates it not only from Mtn-/- but also WT.
Metabolic gene profile
Key molecular and cellular features that would explain the metabolic profile of Mtn-/-/ErrgTg/+ muscle
were defined. In the first instance, we examined key regulators of energy metabolism. We found
that Errg over-expression induced changes in levels of two key transcriptional regulators of metabo-
lism; Perm1 and Pgc1a in Mtn-/- muscle (Figure 4A).
Next, we examined the expression of key regulators of glucose and fatty acid oxidation (Glut1,
Glut4, Pdk4 and Had, Lpl and Cycs respectively). We found that Glut4 and Pdk4 were lower in
Mtn-/-/ErrgTg/+ compared to Mtn-/-. Moreover, Had and Lpl, was higher in Mtn-/-/ErrgTg/+ than in
Figure 1 continued
DOI: 10.7554/eLife.16940.002
The following figure supplement is available for figure 1:
Figure supplement 1. Contractile properties of the soleus.
DOI: 10.7554/eLife.16940.003
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Figure 2. Musclespecific expression of ERRg maintain the hyperplasia in the myostatin null background and normalizes myosin type II phenotype. (A)
Representative immunohistochemical images for MHC IIA and IIB staining in the EDL muscle. (B) EDL total fibre number and myofibre cross sectional
Figure 2 continued on next page
Omairi et al. eLife 2016;5:e16940. DOI: 10.7554/eLife.16940 6 of 25
Research article Developmental Biology and Stem Cells
Mtn-/-. Of particular note was the finding that the expression of markers of fatty acid metabolism,
Had and Lpl, were not only higher in Mtn-/-/ErrgTg/+ than in Mtn-/- but also than in the WT condition
(Figure 4A).
Oxidative metabolism relies on oxygen that can be stored in muscle by myoglobin. Secondly, oxi-
dative metabolism generates destructive radicals which can be broken down by enzymes including
catalase. We found that expression of myoglobin, which facilitates the diffusion of oxygen, and cata-
lase, an anti-oxidant enzyme, were higher in the muscle of Mtn-/-/ErrgTg/+ than in WT and Mtn-/-
mice (Figure 4A).
Then we investigated genes that control oxidative energetics and examined the expression of
molecules controlling fat metabolism (fatty acid transport and uptake molecules: Cd36, Slc25a20,
Fatp1, Fabp3 and regulators of fatty acid oxidation: Acadl, Acadm). We found that all six genes
were expressed to a higher degree in Mtn-/-/ErrgTg/+ than in Mtn-/- and WT mice (Figure 4A).
We established if the differences in oxidative metabolism between Mtn-/- and Mtn-/-ErrgTg/+ in
muscle were mirrored by factors related to the microvascular supply to the muscle. We found that
the expression of endothelial mitogenic factors (Vegfa165, Vegf189 and Ffg1) was lower in
the muscles of Mtn-/- than WT mice, but similar in those of Mtn-/-ErrgTg/+ and WT mice (Figure 4B).
Therefore, the musclespecific expression of Errg in Mtn-/- mice not only normalizes its metabolic
molecular profile but also results in a better microvascular supply of the muscle.
Ultra-structure
The ultra-structure of muscle in the three cohorts were examined. Using transmission electron
microscopy, we found a number of abnormalities in the structure of muscle from Mtn-/- mice hetero-
geneously sized sarcomeres, misaligned and disrupted Z-Lines, large inter-sarcomeric spaces and
altered mitochondrial distribution and size (Figure 5A). In contrast, the muscle from Mtn-/-/ErrgTg/+
largely lacked these abnormalities (Figure 5A). We found that the density of mitochondria in both
sub-membrane and intrafusal locations was decreased significantly following the deletion of Mtn.
However, the expression of Errg significantly increased the mitochondrial density at both locations
compared to Mtn-/- and at the major site, the sub-membrane region, increased it even compared to
WT. Mitochondrial hypertrophy has been postulated to compensate for decreased mitochondrial
number or function. Hypertrophy is thought to either protect against apoptosis or for functional
mitochondria to fuse with aberrant ones resulting in the maintenance of cell function (Frank et al.,
2001; Ono et al., 2001). Mitochondrial hypertrophy was evident in both compartments in muscle
from Mtn-/- (Figure 5B–E) and was normalized by Errg in the sub-membrane region (Figure 5D).
These results show that the deletion of Mtn leads to numerous ultra-structural abnormalities.
Over-expression of Errg in the Mtn-/- prevents almost all the ultra-structural abnormalities.
Myonuclear organization and satellite cell
We next examined the features of individual muscle fibres to determine the effect of Errg in Mtn-/-
mice. We found, that deletion of Mtn resulted in fewer satellite cells compared to WT and that the
number of satellite cells was even lower in the muscles of the Mtn-/-/ErrgTg/+ mice (Figure 6A,C and
D). Next, we determined proliferation and differentiation characteristics of satellite cells in the three
cohorts. We found that following 48 hr of culture, the number of progeny had increased in all the
genotypes but the proportional relationship found in uncultured fibres persisted (Figure 6E–F). Dur-
ing the 48 hr period of culture, satellite cells not only divide but also form clusters (Figure 6G–H).
We found that the number of clusters were similar in fibres from WT and Mtn-/- (Figure 6G), but
Figure 2 continued
area (CSA, mm2). (C) EDL, soleus and superficial TA muscle fibre type composition (D) Protein expression of key regulators that control anabolism
(pAKT, p4EBP1) and catabolism (pFoxO3) in the gastrocnemius muscle. N = 5 male twelve-week old mice per group; One-way ANOVA followed by
Bonferroni’s multiple comparison tests, *p<0.05, #p<0.01, ¥p<0.001.
DOI: 10.7554/eLife.16940.004
The following figure supplement is available for figure 2:
Figure supplement 1. Reprogramming of the soleus myostatin null muscle by ERRg .
DOI: 10.7554/eLife.16940.005
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Figure 3. Musclespecific expression of ERRg normalizes the metabolic and capillary profile of myostatin null mice. (A) SDH staining and quantification
of EDL and soleus muscles of Wt, Mtn and Mtn:Eg mice. N = 5 male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s
Figure 3 continued on next page
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there were fewer clusters in the Mtn-/-/ErrgTg/+-derived cultures. The number of cells per cluster was
highest in WT and lowest in the Mtn-/- with that of the Mtn-/-/ErrgTg/+ in between the
two (Figure 6H). Finally, we found deletion of Mtn and the introduction of Errg did not impact on
the process of differentiation (Figure 6I).
Myonuclear number and organization were then determined. First, there were significantly more
myonuclei in the fibres of Mtn-/-/ErrgTg/+ compared to WT (Figure 6A–B). Secondly, we examined
the distribution of myonuclei within a fibre. This is thought to be a regulated process since myonuclei
position is important to minimize issues related to macromolecule movement in larger cells. There-
fore the degree of regulation is inversely proportional to random positioning of the nuclei
(Bruusgaard et al., 2003). In order to quantify this, we calculated the distance to the nearest
Figure 3 continued
multiple comparison tests, *p<0.05, #p<0.01, ¥p<0.001. (B) Muscle capillary density as determined by CD31 staining. (C) Pair-wise comparisons of the
metabolic profiles obtained from the gastrocnemius muscle from WT, Mtn and Mtn:Eg mice. Principal components analysis (PCA) scores plots
comparing WT, Mtn and Mtn:Eg; WT and Mtn:Eg; as well as Mtn and Mtn:Eg); (% variance in the parenthesis). Colour loadings plots shown for PC1 of
the model comparing Mtn and Mtn:Eg. Product of PC loadings with standard deviation of the entire data set coloured by the square of the PC loading.
DOI: 10.7554/eLife.16940.006
The following figure supplement is available for figure 3:
Figure supplement 1. Reprogramming of the tibialis anterior muscle of myostatin null mice by ERRg.
DOI: 10.7554/eLife.16940.007
Figure 4. Molecular reprogramming of myostatin null muscle by ERRg and its ability to promote capillary formation by the expression of angiogenic
factors. (A) Gene expression levels of transcriptional regulators, glucose metabolism regulators, oxidative metabolism genes, antioxidant and oxygen
handling genes and fat metabolism genes. (B) Angiogenic gene expression. ‘a’ denotes changed significantly from WT and ‘b’ denotes changes
significantly from Mtn. N = 5 male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s multiple comparison tests, p<0.05.
DOI: 10.7554/eLife.16940.008
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neighbour for the nuclei located at the periphery of single fibres from WT, Mtn-/- and Mtn-/-/ErrgTg/+
mice. Confocal stacks of single fibres labelled with DAPI (Figure 6J) were used to generate the 3D
coordinates of each nucleus in a fibre (Figure 6K) using Imaris software. Using custom made soft-
ware, a simulation of randomly and optimally distributed nuclei was compared to the actual distribu-
tion (see Materials and methods). The WT fibres displayed an improvement from a random
distribution of 20%. However Mtn-/- and Mtn-/-/ErrgTg/+ fibres had distributions that were more ran-
dom, with significantly lower improvements of 10% and 4%, respectively (Figure 6L). These results
show that the expression of Errg in the Mtn-/- does not normalize key features related to either the
satellite cells, myonuclei number of their positioning.
Figure 5. Musclespecific expression of ERRg normalizes ultra-structural abnormalities myostatin null mice. (A) Transmission electron microscopy images
in longitudinal and transverse sections of WT, Mtn and Mtn:Eg muscle, scale 0.5 mm. Note the large spaces (red arrow) disrupted Z-lines (red
arrowhead) and non-uniform sarcomere width (yellow arrows). (B) Quantification of submembrane mitochondrial density. (C) Quantification of Intrafusal
mitochondrial density. (D) Quantification of submembrane mitochondrial size. (E) Quantification of intrafusal mitochondrial size. N = 3 male twelve-week
old mice per group; One-way ANOVA followed by Bonferroni’s multiple comparison tests, *p<0.05.
DOI: 10.7554/eLife.16940.009
Omairi et al. eLife 2016;5:e16940. DOI: 10.7554/eLife.16940 10 of 25
Research article Developmental Biology and Stem Cells
Figure 6. Oxidative muscle developed through ERRg in the muscle of myostatin null mice shows depletion of satellite cells and increased myonuclie
content. (A) Single EDL muscle fibres stained with DAPI to visualize myonuclei. (B) Quantification of myonuclear number in EDL fibres. (C) Quiescent
Figure 6 continued on next page
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Skeletal muscle regeneration
Thus, far all the changes in muscle resulting from the over–expression of Errg in theMtn-/- were bene-
ficial except for a lower number of satellite cells. In this section we determined the consequence of
this deficit on the ability of skeletal muscle to regenerate, a process reliant on satellite cells. To that
end, we induced injury of the TA using cardiotoxin and the progression of regeneration assessed at
three crucial time points; day three (D3) as the process of debris clearance is ongoing and regenera-
tion of fibres begins, day six (D6) when robust fibre regeneration can be quantified and day fourteen
(D14) when debris clearance has been completed.
At D3 the muscle clearance of dying fibres was slowest in Mtn-/- compared to the other two geno-
types (Figure 7A–B). Clearance is mediated in part by macrophages and we found that the density
of macrophages was highest in the muscle of Mtn-/-/ErrgTg/+ compared to either Mtn-/- or WT
(Figure 7C–D). Furthermore, we found that the TA from Mtn-/-/ErrgTg/+ at the early stages of gener-
ation contained the highest number of committed muscle cells (Figure 7E–F).
By D6, there was a greater degree of regeneration (size of newly formed eMHC+ fibres) in Mtn-/-/
ErrgTg/+ compared to either Mtn-/- or WT (Figure 7G–H) and a more advanced removal of dying
fibres in Mtn-/-/ErrgTg/+ than in Mtn-/- (Figure 7I–J). We also found evidence for a lower amount of
cell death in the regenerating areas of Mtn-/-/ErrgTg/+ than Mtn-/- or WT mice (Figure 7K–L). At D6
macrophage activity was still high in the muscle of Mtn-/-/ErrgTg/+ compared to either Mtn-/- or wild
type (Figure 7M–N) as were the number of committed (Myo+/Pax7-) muscle progenitor cells
(Figure 7O–P). Precocious differentiation could lead to an exhaustion of cells which would ultimately
attenuate fibre size. To examine this line of thought we examined damaged muscles at an advanced
stage of regeneration (D14). We found further evidence for accelerated regeneration in the Mtn-/-/
ErrgTg/+ compared to either Mtn-/- or WT gauged by a decrease in the density of fibres still express-
ing eMHC (Figure 7—figure supplement 1A). Importantly, there was no deficit in the size of newly
regenerated fibre in the muscle of Mtn-/-/ErrgTg/+ mice (Figure 7—figure supplement 1B). These
results show that even though the muscles of Mtn-/-/ErrgTg/+ have fewer satellite cells than the
muscles of the WT and Mtn-/- mice, their muscle regenerating capacity exceeds that of both
Mtn-/- and WT mice.
Non-genetic post-natal induction of oxidative skeletal muscle growth
Our newly generated hypermuscular, hyper-oxidative mouse line (Mtn-/-/ErrgTg/+) displays a number
of characteristics that make them attractive both in terms of physiology and regeneration. However,
the muscle phenotype in these models is largely established during embryonic and post-natal devel-
opment. Therefore, we next established if similar phenotypes could be obtained via non-genetic
modifications. To do so, we inhibited Mtn at post-natal stages in ErrgTg/+ mice (which displays an
increased oxidative profile) by weekly injections of soluble activin receptor IIB protein (sActRIIB),
which has been shown to antagonize signalling mediated by myostatin and related-proteins.
Following 8 weeks of weekly injections we found that sActRIIB caused an increase in the body
mass of both WT and ErrgTg/+ mice (Figure 8A). Examination of isolated muscles showed an increase
in muscle mass of approximately 70% in the EDL of WT and 44% in ErrgTg/+ above age-matched
control animals (Figure 8B). Other muscles examined showed a similar increase in muscle mass (Fig-
ure 8—figure supplement 1A). The increase in muscle mass was not due to an increase in fibre
number (data not shown) but due to hypertrophy of all MHC fibre types (Figure 8—figure supple-
ment 1B). There was no change in the MHC fibre type composition following the injection of sAc-
tRIIB in either genotype (Figure 8C and F). However, we found that injection of sActRIIB induced a
decrease in the oxidative capacity of the muscle in WT mice as indicated by a decreased proportion
Figure 6 continued
satellite cells stained for Pax7 on freshly isolated (T = 0 hr) muscle fibres from the EDL (arrowhead). (D) Quantification of satellite cell number on freshly
isolated EDL fibres. (E) Single muscle fibres after 48 hr in cell culture stained for DAPI, Pax7 and MyoD (arrowhead). (F) Quantification of total number of
cells on muscle fibre at 48 hr. (G) Quantification of satellite cell clusters at 48 hr. (H) Cluster size at 48 hr on muscle fibres. (I) Profiling of differentiation
at 48 hr. (J) Confocal stacks of single fibres labelled with DAPI to study myonuclear organization. (K) Virtual reconstruction of single muscle fibres,
colour encondes distance in the z-plane. (L) Improvement in myonuclear organization, where 0% denote a random distribution. Fibres were from 4 male
twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s multiple comparison tests, *p<0.05, #p<0.01, ¥p<0.001.
DOI: 10.7554/eLife.16940.010
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Figure 7. Skeletal muscle regeneration is accelerated by the expression of Errg in myostatin null mice through enhanced macrophage and satellite cell
activity. Skeletal muscle regeneration in response to cardiotoxin injury. (A) Muscle necrotic fibres visualized by IgG staining at Day 3 (arrows). (B)
Figure 7 continued on next page
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of SDH+ fibres (Figure 8D and G). Strikingly, sActRIIB did not cause a reduction in the proportion of
SDH+ fibres in ErrgTg/+ (Figure 8D and G). The increased oxidative capacity of the muscle was
accompanied with a rise in the number of capillaries serving each fibre in the muscle from ErrgTg/+
but not WT mice (Figure 8E and H and Figure 8—figure supplement 1D). These results show that
it is possible to induce substantial muscle enlargement while maintaining oxidative capacity, chal-
lenging the generally accepted dogma that the size and oxidative capacity of a fibre are, because of
diffusion constraints, inversely related.
Discussion
The main observations of this study are firstly that substantial hypertrophy can occur without a con-
comitant reduction in fibre oxidative capacity. This observation challenges the dogma that there is a
trade-off between muscle fibre size and oxidative capacity. Secondly, our results challenge the
notion that slow oxidative muscle has a higher number of satellite cells than those that are fast
glycolytic.
A number of studies have shown that deletion of myostatin leads to the development of hypertro-
phic muscle. Although such enlarged muscles appear essentially normal at the histological level, their
ability to generate tension is impaired, particularly during prolonged periods of work (Amthor et al.,
2007; Mendias et al., 2006; Relizani et al., 2014). The higher than normal fatigability of the muscle
could be attributable to the lower number of mitochondria consequent to deletion of myostatin in
the germline (Amthor et al., 2007).
To alleviate this mitochondrial deficit in Mtn-/- mice, we introduced the expression of Errg into
skeletal muscle. This gene is highly expressed in tissues with a high oxidative capacity, such as
the heart, kidneys, brain and slow oxidative skeletal muscle where it has been demonstrated to trig-
ger mitochondrial biogenesis (Hong et al., 1996; Heard et al., 2000; Gigue`re, 2008; Narkar et al.,
2011). Introduction of Errg overexpression that would increase oxidative capacity on a Mtn-/- back-
ground that is associated with hypertrophy would challenge the trade-off that is thought to exist
between oxidative capacity and fibre size (Van Der Laarse et al., 1997; Degens, 2012).
One of the key features of Mtn-/- muscle is the lower SDH activity, indicative of a low oxidative
status. This combination of a low oxidative capacity and a large fibre size fits nicely with the concept
of the trade-off between fibre size and oxidative capacity. It also is associated with a larger propor-
tion of type IIB fibres than seen in muscles from WT mice. Here we show that even though the mus-
cle mass and fibre sizes did not differ between Mtn-/- and Mtn-/-/ErrgTg/+ mice, the latter had a
higher SDH activity.
The higher SDH activity in Mtn-/-/ErrgTg/+ than Mtn-/- mice was associated with a partial normalisa-
tion of the MHC fibre profile; a decrease in the proportion of IIB fibres in all muscles examined.
What was conspicuous, however, was the absence of normalization of the proportion of MHC I
fibres. We believe that this is significant and reveals a key feature of the influence of a metabolic
programme on muscle physiology. We suggest that the oxidative programme, here driven by Errg ,
readily converts IIB to IIA fibres but is that it is unable to induce the transition to type I MHC
Figure 7 continued
Quantification of dying fibre size at Day 3. (C) Macrophage infiltration in the TA muscle using an F4.80 antibody at Day 3 (arrows). (D) Quantification of
macrophage density in damaged muscle. (E) Myogenic progenitors at Day 3. Pax-7 detection in green, MyoD expressing cells in red (arrows). (F)
Quantification of uncommitted muscle cells (Pax-7+/MyoD-), precursor (Pax-7+/MyoD+) and committed (Pax-7-/MyoD+) muscle cells at Day 3. (G)
Expression of embryonic myosin heavy chain on Day 6 (arrows). (H) Quantification of regenerating muscle fibres at Day 6. (I) Necrotic fibres at Day 6
detected via infiltrated fibre IgG profiling (arrows). (J) Quantification of dying muscle fibres at Day 6. (K) Cleaved caspase 3 staining at Day 6 as a
marker of apoptosis (arrows). (L) Quantification of apoptotic density at Day 6. (M) Macrophage infiltration in the TA on Day 6 (arrows). (N) Quantification
of macrophage infiltration at Day 6. (O) Myogenic progenitors on Day 6. Pax-7 detection in green, MyoD expressing cells in red (arrows). (P)
Quantification of uncommitted muscle cells (Pax-7+/MyoD-), precursor (Pax-7+/MyoD+) and committed (Pax-7-/MyoD+) muscle cells at Day 6. N = 4/5
male twelve-week old mice per group; One-way ANOVA followed by Bonferroni’s multiple comparison tests, *p<0.05, #p<0.01, ¥p<0.001.
DOI: 10.7554/eLife.16940.011
The following figure supplement is available for figure 7:
Figure supplement 1. Characterisation of regenerating tibialis anterior muscle at day 14.
DOI: 10.7554/eLife.16940.012
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Figure 8. Post-natal inhibition of myostatin in the muscle-specific ERRg mice leads to hypertrophic muscle with enhanced oxidative and vascular
features. (A) Body mass in 12-week-old mice after an 8 week treatment regime. (B) EDL muscle mass after sACtRIIB treatment. (C) Muscle fibre type
Figure 8 continued on next page
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isoforms. Energy status (ATP/ADP or phosphocreatine) has been implicated as a determinant of
the MHC fibre type with high levels inducing ever more fast forms in keeping with their myofibrillar
ATPase activity (Conjard et al., 1998; Bottinelli et al., 1994). We show here from our NMR profiling
that indeed the muscle of Mtn-/- has high levels of phosphocreatine, which would be in keeping with
the high ATPase activity of Type IIB fibres found in its muscle. Furthermore, we show Errg over-
expression in the muscle of Mtn-/- normalizes this feature yet does not lead to the formation of I
fibres. This observation adds to a growing body of evidence that the type II programme is plastic
and adaptable whereas the Type I fibres are more resistant to change (Sutherland et al., 1998) and
may not be part of the IIB !IIX !IIA continuum. Indeed a number of studies have questioned
whether the ‘final step’ (conversion of Type IIA to I) is even possible. Development of type I fibres
has been described in a number of conditions, for example following Chronic low-frequency stimula-
tion (CLFS) (Peuker et al., 1999; Kwong and Vrbova´, 1981). However, these studies never exam-
ined whether Type I were formed as a consequence of the remodeling of Type II fibres or through
the formation of new fibres, a process that would require satellite cells. Indeed the development of
Type I fibres following extended CLFS can only be induced to significant levels when accompanied
by robust myofibre regeneration (Pette et al., 2002; Maier et al., 1988). Taken together, these
studies imply that myostatin signalling acts at an embryonic/foetal stage of muscle development to
pattern a subpopulation of satellite cells/muscle precursors in a muscle specific manner to form Type
I fibres. The protocol of over-expressing Errg used in this study is unable to influence this process.
One of the intriguing aspects of the Mtn-/- phenotype is the concurrence of a larger muscle mass
and a low oxidative capacity, as also reflected by a low mitochondrial content (Amthor et al., 2007).
As mentioned above, this association corresponds with the prediction of the concept of a trade-off
between muscle fibre size and oxidative capacity. There could, however, also be another function
for the high glycolytic capacity. For instance, the Warburg Effect is the observation that most cancer
cells rely on glycolysis even in the presence of oxygen (Warburg et al., 1927) for the production of
a intermediates essential for the building blocks of any cell including nucleic acids, lipids and pro-
teins (Deberardinis et al., 2008). In a similar way, glycolysis in the muscles of Mtn-/- mice may sup-
port the high levels of protein synthesis required for the initial muscle hypertrophy and maintenance
of the large muscle mass. An interesting point is that such cells are not only dependent on glycolysis
but also often have decreased oxidative phosphorylation capacity (Petros et al., 2005). Where the
similarities between the Warburg Effect in cancer cells and findings from this study differ is the out-
come following an intervention that promotes oxidative metabolism. In cancer cells such an interven-
tion reduces cell growth (Wang and Moraes, 2011) while we have shown with Errg overexpression
on a Mtn-/- background not only re-establishes the oxidative capacity but also maintains the hyper-
trophic state. Consistent with the oxidative metabolic phenotype of the Mtn-/-/ErrgTg/+ mice are the
higher levels of taurine and anserine observed in the NMR metabonomic analysis, since taurine is
positively correlated with the oxidative capacity of muscle tissues (Dunnett et al., 1997). Anserine is
b-alanine and histidine related dipeptide with antioxidant properties commonly found in skeletal
muscle of many animals (Kohen et al., 1988). Thus, it may act as a scavenging agent of the byprod-
ucts arising from elevated oxidative activity in the muscle of Mtn-/-/ErrgTg/+ mice.
A number of studies have suggested that fibres that rely on oxidative phosphorylation limit their
size in order that oxygen from the capillaries diffuses efficiently into the cells and to the mitochon-
dria for ATP production (Kinsey et al., 2007; Van Der Laarse et al., 1997; van Wessel et al.,
2010). The large fibres with a low oxidative capacity in Mtn-/- mice conform to this concept and have
a low capillary supply per fibre. During compensatory hypertrophy the time course of angiogenesis
Figure 8 continued
profiling with MHCIIA (green) and MHCIIB (red) antibodies. (D) Oxidative enzyme profiling using SDH histochemistry. (E) Muscle capillary density
profiling with CD31 antibody. Quantification of (F) MHC EDL fibre type, (G) SDH positive fibres, (H) capillary density. Intrafibre staining in the Errg
muscle in (D) is artefact and was ignored in all quantification procedures; One-way ANOVA followed by Bonferroni’s multiple comparison tests,
*p<0.05.
DOI: 10.7554/eLife.16940.013
The following figure supplement is available for figure 8:
Figure supplement 1. Muscle characterisation after post-natal inhibition of myostatin in the muscle specific ERRg mice.
DOI: 10.7554/eLife.16940.014
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and fibre hypertrophy are similar (Egginton et al., 1998; Plyley et al., 1998) and the capillary supply
to a fibre is related to the size of the fibre (Ahmed et al., 1997; Degens et al., 1994). Such a cou-
pling between the fibre size and capillary supply seems to be altered in the Mtn-/- mice in such a
way that they have fewer capillaries than expected for the size of the fibre. However, over-expres-
sion of Errg in either WT or Mtn-/- drives a robust angiogenic gene programme, increases the num-
ber of capillaries per fibre and ultimately muscle blood flow as shown previously (See Figure 3B and
(Narkar et al., 2011; Matsakas et al., 2012b). An important finding here is that the angiogenesis
programme promoted by muscle expression of Errg is responsive to change in fibre size so that
when a fibre grows, it stimulates the formation of blood vessels presumably to ensure optimal perfu-
sion (Figure 8H). Two additional modifications take place, an increase in myoglobin transcription
and increasing the density of mitochondria at the sarcolemma that would sustain large oxidative
fibres developed as a consequence of Errg in the Mtn-/- background. These outcomes have been
postulated to prevent a decline in maximum steady state power as an oxidative fibre increases size
(Hickson, 1980; Heard et al., 2000).
In this study, we show that the muscle hypertrophy that develops following germline deletion of
Mtn has many ultrastructural abnormalities including splitting of sarcomeres, misaligned Z-lines and
alteration in mitochondrial distribution and morphology. The maintenance of muscle structure is
largely mediated by mechanisms that remove unwanted proteins and organelles through either the
proteasome or autophagic pathways (Sandri, 2013; Bonaldo and Sandri, 2013). Furthermore,
deregulated proteasome activity or autophagy leads to muscle wasting in a number of diseased con-
ditions (Sandri et al., 2004; Carmignac et al., 2011). As these pathways are involved in anabolic
processes, it seems intuitive that they should be tuned down in order to support muscle growth.
Indeed, we show that the activity of a key regulator of these processes, FoxO3 is suppressed in the
absence of Mtn. However, we show that Errg expression in muscle leads to a substantial normaliza-
tion of the ultrastructure Mtn-/- skeletal muscle as well an improvement in the specific force. Most
importantly, we show that a more physiological measure of muscle function- fatigability, is not only
normalized but exceeds the value of WT mice. Our data demonstrate that the suppression of FoxO3
activity is alleviated by Errg. We suggest that the molecular and organelle clearance programmes
being mediated by FoxO3 are generally not anabolic but are rather there to maintain cellular
homeostasis. However, when its activity is attenuated, it leads to an accumulation of structural
abnormalities that compromises muscle function. Nevertheless, not all features of the Mtn-/- muscle
were normalised by Errg expression; Myonuclei in Mtn-/- and Mtn-/-/ErrgTg/+ were more disorganized
than those in WT fibres. Proper nuclear positioning is probably required for normal muscle function,
possibly due to irregular size and spacing of myonuclear domains (Metzger et al., 2012) and myo-
nuclear disorganization is observed both in ageing skeletal muscle and in models of muscular dystro-
phies (Bruusgaard et al., 2006; Meinke et al., 2014). Additionally, accretion of myonuclei is a
prerequisite for maintaining specific force during hypertrophy and mitochondrial protein systems
have been suggested to play a role in defining myonuclear domain size in rodents (Liu et al., 2009).
The increased number of myonuclei and increased synthesis of mitochondria in the Mtn-/-/ErrgTg/+
mice might compensate for the observed disorganized myonuclei, restoring specific force and
ultrastructure.
Finally, our study gives a new perspective on the relationship between metabolism, satellite cell
numbers and their activity during regeneration. A number of studies have implied that slow muscles
contain more satellite cells than fast (Putman et al., 1999; Christov et al., 2007). In this study, we
show that at least in the EDL as the fibres transitioned from Type IIB to Type IIA, the number of asso-
ciated satellite cells was significantly reduced. One possible explanation for this finding is by taking
into account the concomitant increase in the number of nuclei in the myofibre. Here, the relationship
is opposite to satellite cell fibre number. We postulate that the absence of myostatin promotes myo-
blast fusion at the expense of satellite cell. Furthermore, that over-expression of Errg exacerbates
this relationship. Severe depletion of satellite cell numbers has been reported to severely retard the
process of muscle regeneration (Schuster-Gossler et al., 2007; Vasyutina et al., 2007). Here, we
show that the depletion of satellite cells to less than 50% of their normal levels does not impact on
skeletal muscle regeneration since they have a vast capacity to generate precursors which in most
situations are never realized fully (Collins et al., 2005). Instead, we suggest that oxidative environ-
ment established by Errg is the key determinant in accelerating regeneration. Our work supports
previous work showing that oxidative metabolism supports muscle regeneration (Lowrie et al.,
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1982; Matsakas et al., 2012b, 2013) and are in agreement with a number of studies showing that
genetic manipulations leading to a greater oxidative capacity accelerate muscle regeneration
(Li et al., 2007; Hussain et al., 2013). One possible explanation for our results is our finding that
Errg promotes hyper-vascularization. Angiogenesis is a key determinant in the muscle regeneration
process. We suggest that the reduction of satellite cell is off-set by the ability to promote vasculari-
zation and clearance of the necrotic tissues, allowing the small number of satellite cells to expand
greatly to enact rapid repair. This hypothesis is supported by our data investigating both macro-
phage density and the generation of myoblast in the Mtn-/-/ErrgTg/+ mice. Many studies have found
that programmes of muscle repair are often at the expense of satellite cells which are not available
for future cycles of degeneration/regeneration (Castets et al., 2011). We will investigate this avenue
of research in the future by conducting a second round tissue damage in the three genetic lines
described here. Encouragingly, our data show that although there was an increase in the number of
myogenic precursors (Pax7+/MyoD+) as well as committed cells (Pax7-/MyoD+) in the Mtn-/-/
ErrgTg/+ compared to WT at D6, this was not at the expense of cells with satellite cell character
(Pax7+/MyoD-).
In summary, our work challenges the dogma of an inverse relationship between muscle fibre size
and oxidative capacity. The deviation from this relationship may be realized by the increased capil-
larisation and myoglobin content of the muscle and redistribution of mitochondria to a subsarcolem-
mal location. These adaptations were not associated with the loss of muscle force generating
capacity and in fact even resulted in improved exercise capacity. It is likely that the increased micro-
vascular network plays a crucial role in muscle regeneration as the Mtn-/-/ErrgTg/+ mice had even
lower satellite cell numbers than Mtn-/- mice, yet a regenerative capacity that even exceeded that of
WT mice. In future we will determine whether it confers other advantages in particular the ability to
confer resistance to obesity and sarcopenia.
Materials and methods
Ethical approval
The experiments were performed under a project license from the United Kingdom Home Office in
agreement with the Animals (Scientific Procedures) Act 1986. The University of Reading Animal Care
and Ethical Review Committee approved all procedures. Animals were humanely sacrificed via
Schedule 1 killing between 8:00–13:00.
Animal maintenance
Healthy C57Bl/6 (WT), Mtn-/-, Mtn-/-/ErrgTg/+ and ErrgTg/+ mice were bred and maintained in accor-
dance to the Animals (Scientific Procedures) Act 1986 (UK) and approved by the University of Read-
ing in the Biological Resource Unit of Reading University. Mice were housed under standard
environmental conditions (20–22˚C, 12–12 hr light–dark cycle) and provided food and water ad libi-
tum. We used male mice that were 4–5 months old at the start of the study. Each experimental
group consisted of 3–12 mice. Mtn-/- and ErrgTg/+ mice were a gift of Se-Jin Lee (John’s Hopkins
USA) and Ronald Evans respectively (Salk Institute for Biological Studies, La Jolla, USA). Post-natal
muscle growth was induced in one month-old males WT and ErrgTg/+ mice that were injected twice
weekly intraperitoneally with 10 mg/kg of the soluble activin receptor IIB (sActRIIB-Fc) for a period
of two months. Each experimental group consisted of 5–6 mice.
Exercise fatigue test
Mice were acclimatised to running on a treadmill in three sessions (10 mmin 1 for 15 min followed
by a 1 mmin 1 increase per minute to a maximum of 12 mmin 1) (Columbus Instruments Model
Exer 3/6 Treadmill, Serial S/N 120416). Exhaustion was determined by exercising the mice at
12 mmin 1 for 5 min, followed by 1 mmin 1 increases to a maximum of 20 mmin 1until the mouse
was unable to run.
Muscle tension measurements
Dissection of the hind limb was carried out under oxygenated Krebs solution (95% O2 and 5% CO2).
Under circulating oxygenated Krebs solution one end of a silk suture was attached to the distal
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tendon of the extensor digitorum longus (EDL) and the other to a Grass Telefactor force transducer
(FT03). The proximal tendon remained attached to the tibial bone. The leg was pinned to a Sylgard-
coated experimental chamber. Two silver electrodes were positioned longitudinally on either side of
the EDL. A constant voltage stimulator (S48, Grass Telefactor) was used to directly stimulate the EDL
which was stretched to attain the optimal muscle length to produce maximum twitch tension (Pt).
Tetanic contractions were provoked by stimulus trains of 500 ms duration at, 10, 20, 50, 100 and
200 Hz. The maximum tetanic tension (Po) was determined from the plateau of the frequency-tension
curve. Specific force was estimated by normalising tetanic force to EDL muscle mass (g).
Histological analysis and immunohistochemistry
Following dissection, the muscle was immediately frozen in liquid nitrogen-cooled isopentane and
mounted in Tissue Tech freezing medium (Jung) cooled by dry ice/ethanol. Immunohistochemistry
was performed on 10 mm cryosections that were dried for 30 min before the application of block
wash buffer (PBS with 5% foetal calf serum (v/v), 0.05% Triton X-100). Antibodies were diluted in
wash buffer 30 min before use. Details of primary and secondary antibodies are given in
Supplementary file 1. F4/80 was detected using the Vector Laboratories ImmPRESS Excel Staining
Kit. Morphometric analysis of fibre size was performed as previously described (Matsakas et al.,
2012a).
Succinate dehydrogenase (SDH) staining
Transverse EDL muscle sections were incubated for 3 min at room temperature in a sodium phos-
phate buffer containing 75 mM sodium succinate (Sigma), 1.1 mM Nitroblue Tetrazolium (Sigma)
and 1.03 mM Phenazine Methosulphate (Sigma). Samples were then fixed in 10% formal-calcium and
cleared in xylene prior to mounting with DPX mounting medium (Fisher). Densitometry of the sam-
ples was performed on a Zeiss Axioskop2 microscope mounted with an Axiocam HRc camera. Axio-
vision Rel. 4.8 software was used to capture the images.
Transmission electron microscopy
To identify the distribution of the mitochondria in the muscle fibres, biceps and extensor carpi radia-
lis muscle were removed cut in pieces of 1 mm3 and immerse fixed in 4% PFA and 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer pH 7.4 (4˚C, 48 hr). Tissue blocks were contrasted using 0.5% OsO4
(Roth, Germany; RT, 1.5 hr) and 1% uranyl acetate (Polysciences, Germany) in 70% ethanol (RT, 1 hr).
After dehydration tissue blocks were embedded in epoxy resin (Durcopan, Roth, Germany) and
ultrathin sections of 40 nm thickness were cut using a Leica UC6 ultramicrotome (Leica, Wetzlar, Ger-
many). Sections were imaged using a Zeiss 906 TEM (Zeiss, Oberkochen, Germany) and analysed
using ITEM software (Olympus, Germany).
1H NMR spectroscopy-based metabonomic analysis
Polar metabolites were extracted from the gastrocnemius muscle using previously described proto-
cols (Beckonert et al., 2007). Briefly, 40–50 mg of muscle tissue was snap frozen in liquid nitrogen
and finely ground in 300 mL of chloroform: methanol (2:1) using a tissue lyzer. The homogenate was
combined with 300 mL of water, vortexed and spun (13,000 g for 10 min) to separate the aqueous
(upper) and organic (lower) phases. A vacuum concentrator (SpeedVac) was used to remove the
water and methanol from the aqueous phase before reconstitution in 550 mL of phosphate buffer
(pH 7.4) in 100% D2O containing 1 mM of the internal standard, 3-(trimethylsilyl)-[2,2,3,3,
 2H4]-pro-
pionic acid (TSP). For each sample, a standard one-dimensional NMR spectrum was acquired with
water peak suppression using a standard pulse sequence (recycle delay (RD)-90˚-t1-90˚-tm-90˚-
acquire free induction decay (FID)). RD was set as 2 s, the 90˚ pulse length was 16.98 ms, and the
mixing time (tm) was 10 ms. For each spectrum, 8 dummy scans were followed by 128 scans with an
acquisition time per scan of 3.8 s and collected in 64 K data points with a spectral width of 12.001
ppm. 1H nuclear magnetic resonance (NMR) spectra were manually corrected for phase and baseline
distortions and referenced to the TSP singlet at d 0.0. Spectra were digitized using an in-house MAT-
LAB (version R2009b, The Mathworks, Inc.; Natwick, MA) script. To minimize baseline distortions
arising from imperfect water saturation, the region containing the water resonance was excised from
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the spectra. Principal components analysis (PCA) was performed with Pareto scaling in MATLAB
using scripts provided by Korrigan Sciences Ltd, UK.
Protein expression by western blotting
Frozen muscles were powdered and lysed in a buffer containing 50 mM Tris, pH7.5, 150 mM NaCl,
5 mM MgCl2, 1 mM DTT, 10% glycerol, 1%SDS, 1%Triton X-100, 1XRoche Complete Protease Inhibi-
tor Cocktail, 1X Sigma-Aldrich Phosphatase Inhibitor Cocktail 1 and 3. Then, the samples were
immunoblotted and visualized with SuperSignal West Pico Chemiluminescent substrate (Pierce).
Blots were stripped using Restore Western Blotting Stripping Buffer (Pierce) according to the manu-
facturer’s instructions and were reprobed if necessary. Details of antibodies are given in
Supplementary file 1.
Quantitative PCR
Tissue samples were solubilised in TRIzol (Fisher) using a tissue homogeniser. Total RNA was pre-
pared from skeletal muscles using the RNeasy Mini Kit (Quigen, Manchester, UK ). Total RNA (5 mg)
was reverse-transcribed to cDNA with SuperScript II Reverse Transcriptse (Invitrogen) and analyzed
by quantitative real-time RT-PCR on a StepOne Plus cycler, using the Applied Biosystems SYBR-
Green PCR Master Mix. Primers were designed using the software Primer Express 3.0 (Applied Bio-
systems). Relative expression was calculated using the DDCt method with normalization to the
housekeeping genes cyclophilin-B, hypoxanthine-guanine phosphoribosyltransferase (hprt) and glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH). Specific primer sequences are given in
Supplementary file 1.
Myonuclear organisation
For visualizing myonuclei, fibres were mounted with ProLong Diamons Antifade Mountant with DAPI
(Molecular Probes, P36962), and a confocal microscope (Olympus FluoView 1000, BX61W1, Olym-
pus, Japan) was used to observe single muscle fibres. Pictures were taken in confocal planes, sepa-
rated by z-axis steps varying between 0.4 and 2 mm according to the optical thickness and the
desired Nyquist sampling frequency. Confocal microscope images used for mapping of Euclidean
positions of myonuclei were processed and analysed using Imaris (Bitplane) and ImageJ (NIH,
Bethesda, MD, USA).
For each muscle fibre, an idealized circular cylinder segment with constant radius was con-
structed, and the distance from each nucleus to its nearest neighbour was calculated.
In order to measure how ordered the nuclei distribution for a particular fibre is, the mean nearest
neighbour distance was calculated for the experimental data, as well as for the random and optimal
distribution using parameters from the experiment. We denote the experimental, random and opti-




Further details and availability of custom made software, please contact j.c.bruusgaard@ibv.uio.no.
Satellite cell culture
Single fibres from EDL were isolated using 0.2% collagenase I in DMEM medium and either fixed or
cultured for 48 and 72 hr as previously described (Otto et al., 2008).
Skeletal muscle regeneration
Skeletal muscle damage was induced by injecting 30 ml of 50 mM cardiotoxin in the tibialis anterior
(TA) muscle of one limb while the contralateral TA of the other limb was injected with 30 mL PBS to
serve as an internal control. The degree of muscle regeneration was assessed on day 3 and day 6
post-injury.
Statistical analysis
Data are presented as mean ± SE. Significant differences between two groups were performed by
Student’s t-test for independent variables. The normality of the data for two samples was checked
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with a Kolmogorov–Smirnov test (a = 10%). Differences among groups were analysed by one-way or
two-way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison tests as appro-
priate. In the case of non-homogeneous variances (Lavene’s test; p<0.05) for a variable, ANOVA was
performed using the square root of the observations. Statistical analysis was performed on SPSS
18.0 (Chicago, IL). Differences were considered statistically significant at p<0.05.
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Original ArticleLink between MHC Fiber Type and Restoration
of Dystrophin Expression and Key Components of
theDAPCby Tricyclo-DNA-Mediated ExonSkipping
Saleh Omairi,1 Kwan-Leong Hau,2 Henry Collin-Hooper,1 Federica Montanaro,2 Aurelie Goyenvalle,3 Luis Garcia,3
and Ketan Patel1
1School of Biological Sciences, University of Reading, Reading, UK; 2UCL Great Ormond Street Institute of Child Health, Developmental Neurosciences Programme,
London, UK; 3Universite de Versailles St. Quentin, INSERM U1179, Montigny-le-Bretonneux, FranceExon skipping mediated by tricyclo-DNA (tc-DNA) antisense
oligonucleotides has been shown to induce signiﬁcant levels
of dystrophin restoration in mdx, a mouse model of Duchenne
muscular dystrophy. This translates into signiﬁcant improve-
ment in key disease indicators in muscle, cardio-respiratory
function, heart, and the CNS. Here we examine the relationship
between muscle ﬁber type, based on myosin heavy chain
(MHC) proﬁle, and the ability of tc-DNA to restore not only
dystrophin but also other members of the dystrophin-associ-
ated glycoprotein complex (DAPC). We ﬁrst proﬁled this rela-
tionship in untreated mdx muscle, and we found that all ﬁber
types support reversion events to a dystrophin-positive state,
in an unbiased manner. Importantly, we show that only a small
fraction of revertant ﬁbers expressed other members of the
DAPC. Immunoblot analysis of protein levels, however, re-
vealed robust expression of these components, which failed to
correctly localize to the sarcolemma. We then show that
tc-DNA treatment leads to nearly all ﬁbers expressing not
only dystrophin but also other key components of the DAPC.
Of signiﬁcance, our work shows that MHC ﬁber type does
not bias the expression of any of these important proteins.
This work also highlights that the improved muscle physiology
following tc-DNA treatment reported previously results from
the complete restoration of the dystrophin complex in all
MHCII ﬁbers with equal efﬁciencies.Received 20 July 2017; accepted 21 October 2017;
https://doi.org/10.1016/j.omtn.2017.10.014.
Correspondence: Ketan Patel, School of Biological Sciences, University of Reading,
Whiteknights, Reading RG6 6UB, UK.
E-mail: ketan.patel@reading.acc.ukINTRODUCTION
Duchenne muscular dystrophy (DMD) affects 1:5,000 male births,
and it is the most common fatal childhood muscular disease.1,2 Mu-
tations in the DMD gene affect expression of dystrophin, a protein
normally localized to the inner surface of the sarcolemma in muscle
ﬁbers.3,4 Dystrophin together with a number of other proteins that
constitute the dystrophin-associated glycoprotein complex (DAPC)
acts to link the muscle ﬁber cytoskeleton, the sarcolemma, and the
extracellular matrix (ECM) into a functional unit that maintains mus-
cle integrity.5,6 The DAPC is composed of three sub-complexes: (1)
the sarcoglycans (a, b, g, and d); (2) syntrophin, nNOS, and dystro-
brevin; and (3) a and b dystroglycan. The absence of dystrophin re-
sults in a drastic reduction of all components of the DAPC at theMolecular Ther
This is an open access article under tsarcolemma, and it renders muscle cells prone to stretch-induced
muscle damage.7
A number of drug-based or surgical procedures have been developed,
including the use of corticosteroids or addressing scoliosis, that
greatly improve the quality of life for DMD patients or delay disease
onset.8,9 However, none has completely halted progression of the dis-
ease. Gene-based approaches that aim to restore dystrophin in muscle
hold great promise. One attractive approach is to take advantage of
the molecular structure of the dystrophin gene and to use antisense
oligonucleotides (AONs) to promote exon skipping to bypass
mutated stretches of DNA and restore the open reading frame.10
The aim of the current study is to establish expression of a functional,
albeit internally deleted, dystrophin protein. Restoration of dystro-
phin expression by exon skipping has been proven to be efﬁcacious
in vitro, in animal models and in DMD patients.11–13 Several classes
of chemical modiﬁcations have been developed for AON-mediated
exon skipping, among which are 20O-methylribooligonucleoside-
phosphorothioate (20OMe), phosphorodiamidate morpholino oligo-
mers (PMOs), and tricyclo-DNA (tc-DNA). The latter has a number
of properties that make it an attractive chemistry to exploit for ther-
apeutic uses, including high RNA afﬁnity, resistance to nuclease activ-
ity, and the ability to form nanoparticles that may facilitate uptake
into cells.14–16 We have recently shown, using mdx mice as a rodent
model for DMD, that tc-DNA mediates unprecedented levels of exon
skipping after systemic delivery not only in skeletal muscle but also in
the heart and brain.16 This translated into normalization of speciﬁc
force in the tibialis anterior muscle as well as improved cardiovascular
function and the correction of behavioral characteristics.16
A number of studies using AONs in both mdx mice and DMD pa-
tients have shown restoration of dystrophin in a subset of muscle ﬁ-
bers.13,17,18 Most skeletal muscles are composed of a heterogeneousapy: Nucleic Acids Vol. 9 December 2017 ª 2017 The Authors. 409
he CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Myosin Heavy Chain Profile of the Tibialis
Anterior Muscle
(A) Immunohistochemical images of TA muscle from 20-
to 22-week-old male wild-type,mdx, and tc-DNA-treated
mdx mice. Green fibers signify the expression of MHCIIA
with MHCIIB appearing as red. Non-green and red fibers
represent MHCIIX. (B) MHC profile in the three cohorts.
Results show that WT, mdx, and tc-DNA-treated mdx
mice have the same proportion of each MHC subtype
(n = 4 for each cohort). Statistical analysis was performed
by one-way ANOVA followed by Bonferroni correction for
multiple comparison.
Molecular Therapy: Nucleic Acidspopulation of muscle ﬁbers that differ in their metabolic properties as
well as contractile speeds, a feature impacted by the type of myosin
heavy chain (MHC) being expressed. Muscle of adult mice is
composed of MHCI, MHCIIA, MHCIIX, and MHCIIB ﬁbers.
MHCI has the slowest contraction rate and is highly reliant on oxida-
tive phosphorylation for energy production. MHCIIB is at the other
end of the spectrum, displaying the fastest contraction rates and high-
ly dependent on glycolytic metabolism. Slow ﬁbers are invested with a
higher capillary density as well as thicker ECM compared to fast ﬁ-
bers.19,20 Fast-contracting ﬁber with its decreased ability to store en-
ergy in the ECM is hypothesized to facilitate a greater proportion of
force transfer to the skeletal elements.21 A number of studies have
shown that slow muscle, based on MHC expression proﬁling as
well as physical measures, expresses more dystrophin than fast mus-
cle22 and that fast muscle ﬁbers are preferentially affected in DMD.23
Here we examined whether the efﬁcacy of dystrophin exon skipping
is inﬂuenced by MHC ﬁber type, possibly due to ﬁber type differ-
ences in ECM thickness impacting on the rate of AON diffusion
into the muscle ﬁber. We ﬁrst proﬁled revertant ﬁbers in mdx
mice with a view of establishing whether their appearance was
related to MHC ﬁber type. We then investigated the relationship be-
tween the restoration of dystrophin and of members of the three
DAPC sub-complexes by treatment with tc-DNA and by MHC ﬁber
type. Our results demonstrate that revertant ﬁbers caused by
splicing events in untreated mdx mice develop in a manner inde-
pendent of MHC ﬁber type. Importantly, we show that only a frac-
tion of revertant ﬁbers also express DAPC members. Treatment
with tc-DNA results in over 90% of all ﬁbers expressing all proteins
examined, with no observed bias toward any one MHC ﬁber type.
These data demonstrate that tc-DNA treatment is able to induce
exon skipping in all MHCII ﬁbers.410 Molecular Therapy: Nucleic Acids Vol. 9 December 2017RESULTS
We ﬁrst established the MHC landscape of the
tibialis anterior (TA) muscle and the effect
wrought upon it ﬁrst by the mdx mutation
and second after treatment with AONs con-
sisting of tc-DNA. Previous work has reported
that the mdx mutation affects the MHC ﬁber
proﬁle in a muscle-speciﬁc manner, with the
extensor digitorum longus (EDL) and soleusunchanged by the mutation24 whereas the diaphragm contains
slower isoforms compared to control.25 Analysis of the TA muscle
of wild-type (WT) mice at its maximum circumference revealed
an approximate ratio of 1:3:6 with respect to MHCIIA, MHCIIX,
and MHCIIB ﬁbers (Figures 1A and 1B). The same ratios were
found in the TA muscles of mdx mice and tc-DNA-treated mdx
mice (Figures 1A and 1B). Statistical analysis failed to reveal signif-
icant differences in the proportions of a particular MHC isoform
among the three cohorts. Therefore, the MHCII proﬁle of TA mus-
cle was not affected by the absence of dystrophin or by treatment
with tc-DNA.
We next examined the relationship between revertant ﬁbers
(dystrophin+), co-expression of one member of each of the three
DAPC sub-complexes, and MHCII class in untreated mdx mice.
There were approximately 60 dystrophin+ ﬁbers in the TA muscle
of 20- to 22-week-old mice. The ratio of dystrophin+ in relation
to MHC ﬁber type (IIA:IIX:IIB) was approximately 1:3:6, respec-
tively. Therefore, the segregation of dystrophin+ ﬁbers within
MHC subtypes followed the distribution of each isoform. Hence,
there was no bias toward any one MHC isoform with regard to
reversion to a dystrophin-positive state (Figure 2A). Proﬁling the
expression of b-sarcoglycan, nNOS, and a-dystroglycan revealed a
number of interesting features. First, they were found in all three
MHC ﬁber isoforms, and, similar to dystrophin, there was no bias
toward any one MHCII type (Figure 2A). b-sarcoglycan-, nNOS-,
and a-dystroglycan-expressing ﬁbers were a subset of those that ex-
pressed dystrophin. However, the number of ﬁbers that expressed
these three molecules was always lower than the number expressing
dystrophin (Figure 2B). Indeed, nNOS-positive ﬁbers, although be-
ing the most frequent of the three, only represented about half of
dystrophin-positive ﬁbers.
Figure 2. Expression of Dystrophin, b-Sacroglycan, nNOS, and a-Dystroglycan in the TA Muscle of 20- to 22-Week-Old Male mdx Mice
(A) Each row shows the entire TAmuscle stained for one of the four molecules together with amagnified detailed image. All positive fibers were correlated to the expression of
an MHC isoform, and their distribution is given as the total number as well as proportion to the frequency of the MHC isoform. (B) Graph showing the proportion of TA fibers
expressing the four investigated molecules (n = 4 for each cohort). *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical analysis was performed by one-way ANOVA followed by
Bonferroni correction for multiple comparison.
www.moleculartherapy.orgThese results show that revertant ﬁbers do not express the full com-
plement of DAPC components.
Thereafter, we examined the expression of dystrophin, b-sarcogly-
can, nNOS, and a-dystroglycan in relation to MHC ﬁber type inthe TA muscle of tc-DNA-treated mdx mice. Immunostaining re-
vealed that the majority of ﬁbers were positive for dystrophin after
tc-DNA treatment, which is in agreement with previous ﬁndings
of Goyenvalle and colleagues16 (Figure 3A). Robust expression of
dystrophin was found in all MHC ﬁber types, and analysis ofMolecular Therapy: Nucleic Acids Vol. 9 December 2017 411
Figure 3. Expression of Dystrophin, b-Sarcoglycan, nNOS, and a-Dystroglycan in the TA Muscle of 20- to 22-Week-Old Male tc-DNA-Treated mdx Mice
(A) Each row shows the entire TA muscle immunostained for dystrophin, b-sarcoglycan, nNOS, and a-dystroglycan together with a magnified detailed image. All positive
fibers were correlated to the expression of an MHC isoform, and their distribution is given as the total number as well as proportion to the frequency of the MHC isoform.
(B) Graph showing the proportion of TA fibers from tc-DNA-treated mdx mice expressing the four investigated molecules (n = 4 for each cohort). *p < 0.05, **p < 0.01, and
***p < 0.001. Statistical analysis was performed by one-way ANOVA followed by Bonferroni correction for multiple comparison.
Molecular Therapy: Nucleic Acidsfrequency with respect to ﬁber proportion revealed that there was
no bias to any one ﬁber type. Immunostaining for b-sacroglycan,
nNOS, and a-dystroglycan revealed the same features as dystro-
phin; the vast majority of ﬁbers expressed the three proteins, and
their presence in a particular MHC ﬁber type was proportional412 Molecular Therapy: Nucleic Acids Vol. 9 December 2017to the frequency of that form (Figure 3A). We then compared
the relative frequency of ﬁbers expressing each of the four proteins.
We found there were signiﬁcantly more ﬁbers that expressed dys-
trophin than the other three components of the DAPC assessed
(Figure 3B).
Figure 4. Semiquantitative Analysis of DAPC Restoration following tc-DNA Treatment of 20- to 22-Week-Old Male mdx Mice
Untreated and tc-DNA-treatedmuscle shows high levels of individual proteins inMHCIIA fibers (white arrows) compared toMHCIIB fibers (yellow arrows). Intensities from over
30 regions for each fiber type were taken from revertant untreatedmdx and set to a reference value of one. Similar numbers of intensity readings were plotted for each fiber
(legend continued on next page)
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Figure 5. Western Blot Analysis of DAPC Proteins in
20- to 22-Week-Old Male Mice
(A) Western blot image of DAPC proteins in the TA
muscle. (B) Quantification of DAPC proteins relative to
GAPDH. Note the robust expression of b-sarcoglycan,
nNOS, and a-dystroglycan in untreated mdx muscle
(n = 3 for each cohort). **p < 0.01. Statistical analysis was
performed using two-tailed t test.
Molecular Therapy: Nucleic AcidsThese results show that tc-DNA treatment ofmdxmice results in the
restoration of dystrophin in the majority of muscle ﬁbers. This is also
the case for a-dystroglycan, b-sarcoglycan, and nNOS. However, the
number of ﬁbers expressing b-sarcoglycan, nNOS, and a-dystrogly-
can was signiﬁcantly lower compared to dystrophin.
Previous work has shown that contractile properties of a muscle ﬁber
impact both qualitatively and quantitatively on its surrounding
ECM.19,20 Here we examined the relationship between MHC ﬁber
type and expression of components of the DAPC as well as an ECM
component, collagen IV, using semiquantitative techniques. Fluores-
cence intensity was used as previously described to gain an indication
of the amount of protein at the sarcolemma.18We ﬁrst determined the
signal intensity for the ﬁve proteins in question in relation to MHC ﬁ-
ber type in the revertant ﬁbers from the mdx mouse. For each ﬁber
type, the signal intensity was set to a reference value of 1. Thereafter
the same procedure was repeated for the tc-DNA-treated muscle,
and intensity was compared to that of the untreated TA muscle. The
outcome of the process showed that tc-DNA treatment resulted in
an increase in the amount of each protein of interest in all ﬁber types
compared to untreated revertant mdx ﬁbers (Figure 4). We also
measured the thickness of the expression domain for each of the ﬁve
marker proteins, revealing that each expression domain was thicker
in MHCIIA ﬁbers compared to MHCIIB ﬁbers (Figure 4). This rela-
tionship persisted following tc-DNA treatment. Second, we found
that there was an increase in the expression domain following tc-DNA
treatment for all ﬁber types (Figure 4).
These results show that the amount of each component of the DAPC
and collagen IV at the sarcolemmawere elevated above those found in
revertant ﬁbers.
Last, we examined the effect of tc-DNA treatment on the total level of
expression of the DAPC components under investigation here. Totype from tc-DNA-treated mdxmuscle. In all cases there was a significant increase in intensity compared to untre
expression domain was measured and plotted for each MHC isoform originating from revertant untreated mdx an
expression domains compared toMHCIIB. Thickness for expression domains irrespective of MHC fiber type was in
bar applicable to all images represents 50 mm. *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical analysis was p
414 Molecular Therapy: Nucleic Acids Vol. 9 December 2017that end we carried out quantitation of western
blots. Our results showed that there was a
14-fold increase in the amount of dystrophin
following tc-DNA treatment (Figures 5A and
5B). Interestingly, we found robust expressionof b-sarcoglycan, nNOS, and a-dystroglycan in untreated mdx mus-
cle and that their levels were not changed signiﬁcantly by tc-DNA
treatment. In summary, components of the DAPC are translated in
the absence of dystrophin, but they fail to localize to the sarcolemma.
DISCUSSION
Tc-DNA chemistry is an exciting development in the area of molec-
ular medicine. We have previously shown that, in the context of a
mouse model of DMD, tc-DNA treatment was more efﬁcacious in
restoring muscle function than many other approaches.16 Of partic-
ular note was the ﬁnding that tc-DNA AONs spontaneously form
nanoparticles, which are believed to promote entry into the cell and
may be the reason why these were able to penetrate the heart and
the brain.16 In this study, we investigated the relationship between
muscle compositions in terms of MHC ﬁber type and dystrophin
restoration by tc-DNA AON with a view to developing an under-
standing of its speciﬁcity of action.
We commenced the study by comparing the MHC proﬁle of the TA
muscle in the three cohorts under investigation: WT, mdx, and
tc-DNA-treated mdx mice. We found that all three shared the same
MHC proﬁle. Previous studies have shown that the MHC proﬁle of
the diaphragm underwent a signiﬁcant change in its MHC composi-
tions, with a decrease in the proportion of MHCIIB+ ﬁbers and a
concomitant increase in the number of MHCI+ ﬁbers.25 The change
in MHC proﬁle was proposed to be an adaptive step to preserve con-
tractile function and ﬁber integrity by lowering energy requirements.
In contrast, the EDL and soleus muscles of themdx were shown to be
identical to those from WT in terms of MHC proﬁle.24 Our results
here now add the TA muscle to the list of muscles that show normal
MHC proﬁle in the mdx mouse. Nevertheless, all mdx muscles have
reduced speciﬁc force. We propose that, if a change toward a slower
MHC proﬁle is an adaptive change to the absence of dystrophin, it
must be a secondary step that is dependent on other upstream factors,ated revertant fibers of the same MHC type. Thickness of
d tc-DNA-treated mdx muscle. MHCIIA fibers had thicker
creased by tc-DNA treatment (n = 4 for each cohort). Scale
erformed using two-tailed t test.
www.moleculartherapy.orgone of which could be contractile activity, which would explain the
change in constantly used muscles like the diaphragm and not in
limb muscles. A number of studies have proposed mechanisms to
explain the reduced speciﬁc force in mdx, including nitrosylation of
the contractile machinery, which, if it occurred, would lead to long-
term damage due to low turnover rate of MHC.26,27 However, recent
work has shown that theMHC frommdx functions normally in terms
of cross-bridging, which argues against long-term effect of altered
muscle function.28 This suggestion is indirectly corroborated by the
efﬁcacy of tc-DNA treatment being able to normalize speciﬁc force
in the TA muscle of mdx mice.16
Our work examining the distribution of the DAPC protein in un-
treated mdx muscle offers interesting insights into the formation of
the functional unit. First, we show that there was no bias in terms
to MHC ﬁber type and the appearance of dystrophin. Therefore, if
metabolic activity were to generate differential cellular stress based
on ﬁber contraction rate, then this metric does not impact on the
splicing events that restore dystrophin expression in mdx muscle.
Furthermore, when serendipitous events lead to the restoration of
dystrophin, they bring back the protein in a relatively normal manner
with respect to MHC ﬁber type, with higher expression in slow ﬁbers
compared to faster ones.22 Additionally, there was no bias in terms of
MHC ﬁber type and any of the other components of the DAPC exam-
ined here.
An interesting feature highlighted by our work in this section was the
ﬁnding that revertant ﬁbers (dystrophin+) are heterogeneous in terms
of their DAPC composition as follows: dystrophin+ > nNOS+ >
a-dystroglycan (aDG)+ > b-sarcoglycan (ßSG)+. Our quantiﬁcations
of DAPC expression in revertant ﬁbers extends previous ﬁndings of
Lu et al.29 who showed co-expression of DAPC proteins in clusters
of revertant ﬁbers. Interestingly, our western blotting data agree
with prior reports showing an abundance of nNOS, aDG, and ßSG
total protein inmdxmuscle.30 It follows, therefore, that a mechanism
must be active that prevents the translocation of DAPC proteins to
the sarcolemma of some revertant ﬁbers. One possibility is that
they may not have had sufﬁcient time to correctly translocate. This
is, however, unlikely since revertant ﬁbers form from events that
occur in muscle precursors.31 Another possibility is linked to the
poor diffusion of dystrophin within the myoﬁber sarcolemma,
limiting membrane expression to spatially conﬁned nuclear domains.
Moving out of this dystrophin domain during serial sectioning would
affect detection of other components of the DAPC. While this phe-
nomenon can contribute to a decreased co-detection of dystrophin
and DAPC proteins, it should be noted that dystrophin expression
in revertant ﬁbers has been reported to span membrane segments
of 654 ± 409 mm.32 It is unlikely that exiting a nuclear domain during
collection of serial sections over a length of muscle not exceeding
160 mm (16 serial sections) could on its own account for over half
of the revertant ﬁbers lacking expression of other DAPC proteins
(Figure 3B). It is therefore possible that a signiﬁcant proportion of
internally deleted dystrophins generated by revertant ﬁbers is not
able to assemble a functional DAPC but can be correctly localizedto the membrane. This hypothesis would be consistent with reports
of truncated or internally deleted dystrophins that lack the
cysteine-rich domain required for interaction with the DAPC but
can still be correctly localized to the sarcolemma.33 Overall our results
highlight two interesting ﬁndings: ﬁrst, the majority of revertant ﬁ-
bers produce internally deleted forms of dystrophin that cannot func-
tionally contribute to force transduction, since they are uncoupled
from the dystroglycan and sarcoglycan complexes; and, second,
mdx muscle has a rich pool of DAPC proteins available for recruit-
ment to the sarcolemma upon expression of a functional dystrophin
protein.
Restoration of dystrophin expression following tc-DNA treatment re-
sulted in near total coverage of TA ﬁbers, consistent with our previous
work.16 We do not believe that the variation in the afﬁnities of anti-
bodies for their epitopes is a decisive factor in showing a variation
in DAPC proﬁle betweenmdx and tc-mdxmice. We base this conclu-
sion on the fact that have we have compared the same strain (indeed
littermates) with or without tc-DNA treatment. Therefore, the
differing afﬁnities between antibodies for their particular epitope
would remain a constant factor. Hence, the appearance of a molecule
at the sarcolemma in tc-mdx mice compared to mdx must be due to
changes in the expression levels of the protein. The results of this
study demonstrate that there is no bias with regard to dystrophin
expression induction following tc-DNA treatment and ﬁber type.
This is, we believe, highly relevant and important for prospective
translation into therapies.
Previous work carried out in humans revealed restoration of dystro-
phin in a subset of muscle ﬁbers, a differential restoration that may
have been inﬂuenced by the structural properties of the muscle.13,17
Indeed, it is well established that slow muscle ﬁbers have a thicker
ECM in comparison to fast ﬁbers.19,20 It would, therefore, be reason-
able to postulate that slow ﬁbers are more resistant to inﬁltration by
tc-DNAAON.However, our work shows that, at least in terms of type
II ﬁber sub-types, there is no preference to exon skipping. This bodes
well for the use of this chemistry in a spectrum of muscles with
differing ﬁber composition, as it seems they are all in principle able
to take up the tc-DNA AON. In addition, we show that MHC ﬁber
type does not inﬂuence the restoration of the other components
examined here. Also, tc-DNA treatment leads to more of each
component at the sarcolemma compared to revertant mdx ﬁbers.
Nevertheless, it is worth noting that not all the ﬁbers that expressed
dystrophin contained the other three components of the DAPC
examine here (dystrophin+ > nNOS+ > ßSG+ > aDG+). This again
highlights the point that the presence of the DAPC proteins does
not necessarily translate into them being assembled into a functional
complex.
There is a dearth of knowledge regarding mechanisms that regulate
the formation of the DAPC, a gap in our understanding that requires
urgent attention. One potential consequence of this gap in our un-
derstanding is that it is possible that we will develop the means
of inducing protein dystrophin expression but that it may notMolecular Therapy: Nucleic Acids Vol. 9 December 2017 415
Molecular Therapy: Nucleic Acidstranslocate to the correct sub-cellular region and, therefore, reduce
therapeutic beneﬁt. Insights into this process could be gained by
examining revertant ﬁbers. Nevertheless, tc-DNA treatment resulted
in over 90% of the ﬁbers having all four of the DAPC components at
the sarcoplasm. We believe that this high level of DAPC restoration
explains the normalization of speciﬁc force following tc-DNA treat-
ment, and, again, it bodes well for translation into the clinic since
previous studies have demonstrated that restoration of dystrophin
protein levels to 10%–20% of WT results in improved health.34
In summary, we show that reversion of ﬁbers to a dystrophin-positive
state in mdx mice is a stochastic process with regard to MHC ﬁber
type. However, expression of dystrophin in mdx revertant ﬁbers
only translates into a minority (>25%) of ﬁbers expressing members
of the three sub-complexes. Tc-DNA treatment results in over 90% of
ﬁbers’ expression of dystrophin as well as members of the three sub-
complexes in the TA muscle. Importantly, there is no bias in terms of
expression of any component with regard to MHC ﬁber type. This
work shows that, in principle, tc-DNA treatment is equally efﬁcacious
across all type II ﬁbers.
MATERIALS AND METHODS
Animals
Animal procedures were performed in accordance with national and
European legislation, approved by the French government (Ministère
de l’enseignement supérieur et de la recherche, Autorisation APAFiS
6518). Mdx (C57BL/10ScSc-Dmdmdx/J) and C57BL/10 mice were
bred in our speciﬁc opportunistic pathogen-free (SOPF) animal facil-
ity at the Plateform 2Care, UFR des Sciences de la santé, Université de
Versailles Saint Quentin, and they were maintained in a standard
12-hour light/dark cycle with free access to deionized water and stan-
dard laboratory chow (M20, Dietex) ad libitum. Mice were weaned at
postnatal weeks 4–5 and 2–5 individuals were housed per cage. Mice
were randomly allocated to treatment and control groups, ensuring
equal numbers of control and treated mice within the same litters.
The tc-DNA-AON PS M23D (50-AACCTCGGCTTACCT-30) target-
ing the donor splice site of exon 23 of the mouse dystrophin pre-
mRNA used in this study was synthesized by SYNTHENA (Bern,
Switzerland). The 6- to 8-week-old male mdx mice were injected
intravenously in the retro-orbital sinus, under general anesthesia us-
ing 1.5%–2% isoﬂurane, once a week with 200 mg/kg/week of the
M23D-tc-DNA for a period of 12 weeks. Treated mice were sacriﬁced
2 weeks after the last injection, and muscles and tissues were har-
vested and snap-frozen in liquid nitrogen-cooled isopentane and
stored at 80C before further analysis.
Immunohistochemistry
Dissected and frozen muscles were mounted in Tissue Tech freezing
medium (Jung) cooled by dry ice/ethanol. Immunohistochemistry
staining was performed on 10-mm cryosections that were dried for
30 min at room temperature (RT) prior to three washes in 1 PBS.
Muscle sections were incubated in permeabilization buffer solution
(0.952 g HEPES, 0.260 g MgCl2, 0.584 g NaCl, 0.1 g Sodium azide,416 Molecular Therapy: Nucleic Acids Vol. 9 December 201720.54 g Sucrose, and 1 mL Triton X-100) for 15 min at room temper-
ature, before the application of block wash buffer (PBS with 5% fetal
calf serum [v/v] and 0.05% Triton X-100) for 30 min at room
temperature.
Primary antibodies were pre-blocked in wash buffer for 30 min prior
to incubation onto muscle sections overnight at 4C. Pre-blocked-in
wash buffer was performed for all secondary antibodies (in dark) for a
minimum of 30 min prior to their addition onto the slides. Sections
were then incubated for 1 hr in the dark at room temperature. Finally,
slides were mounted in ﬂuorescent mounting medium, and myonu-
clei were visualized using 2.5mg/mLDAPI. Details of primary and sec-
ondary antibodies are given in Supplemental Materials and Methods.
Western Blotting
TA proteins from 20- to 22-week-old male mice (20 mg/lane) were
separated on 4%–12% gradient SDS-PAGE gels (Invitrogen), trans-
ferred to nitrocellulose membranes (Whatman), and blocked with
5% skim milk in 0.1% Tween 20/Tris-buffered saline. Membranes
were cut at appropriate molecular weights in order to allow for
simultaneous probing of the exact same samples for dystrophin and
multiple DAPC proteins. Membrane strips were then incubated
with appropriate primary antibodies overnight at 4C, followed by
a 1-hr incubation at room temperature with the appropriate horse-
radish peroxidase-conjugated secondary antibodies (Jackson Im-
munoResearch Laboratories). Protein bands were visualized using
enhanced chemiluminescence reagents (Pierce). Signal was detected
on X-ray ﬁlm (RPI) at multiple exposures. For densitometric analysis,
protein band intensities from multiple non-saturated ﬁlm exposures
were quantiﬁed using ImageJ (NIH). Values in the linear range of
pixel intensities were selected for quantiﬁcations. Signal intensities
were normalized to GAPDH, used as an internal loading control,
and probed on the samemembrane. Details of primary and secondary
antibodies are given in Supplemental Materials and Methods.
Semiquantitative Measures of Sarcolemma Protein Expression
Intensity of signals of protein of interest was measured as previously
described.18 Brieﬂy, membrane signal intensities of approximately
30 muscle ﬁbers of each MHC phenotype (IIA, IIX, and IIB) in
each TA muscle section from mdx mice and mdx mice treated with
tc-DNA were measured. Fiji software was used to measure signal
from area of interest after images had been corrected for background
to avoid regions of signal saturation. To calculate relative signal inten-
sity levels, individual measurements from treated and control ﬁbers
were taken as a percentage of mean of control samples.
Sarcolemma Thickness Measurement
Connective tissue thickness between approximately 30 ﬁbers of the
same MHC phenotypes (IIA-IIA, IIX-IIX, and IIB-IIB) of TA muscle
sections was measured using Fiji software. One measurement on the
constant connective tissue thickness and multiple measurements on
the ﬂuctuating connective tissue thickness areas between each two
myoﬁbers that expressed the same MHC isoform were taken on all
muscle sections of mdx mice and mdx mice treated with tc-DNA.
www.moleculartherapy.orgImaging and Analysis
A ﬂuorescence microscope (Zeiss AxioImegar A1) was used to
examine immunoﬂuorescently stained sections, and images were
captured using an Axiocam digital camera with Zeiss Axiovision
computer software version 4.8.
Statistical Analysis
Data are presented as mean ± SE. Signiﬁcant differences between two
groups were performed by two-tailed Student’s t test for independent
variables. Differences among groups were analyzed by one-way
ANOVA followed by Bonferroni multiple comparison tests as
appropriate. Statistical analysis was performed on GraphPad Prism
software. Differences were considered statistically signiﬁcant at
*p < 0.05, **p < 0.01, or ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Materials and
Methods and can be found with this article online at https://doi.
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mouse models that allow for testing of such therapies in the context of the
human DMD sequence in vivo. Therefore, we have created a novel mouse model
whereby we have used the hDMDmouse (containing the full human DMD gene
integrated into chromosome 5) and mutated it to be out-of-frame by deleting
exon 45 using CRISPR/Cas9 in hDMD zygotes. We have crossed these hDMD
del45 mice to mdx and mdx D2 backgrounds, both of which lack mouse
dystrophin, to create a fully dystrophic model containing the human DMD gene.
We have utilized this model to demonstrate proof of principle that our CRISPR/
Cas9 platform, which targets deletion of human DMD exons 45–55, can be
directly applied in vivo to restore dystrophin expression. These studies
demonstrate that the hDMD del45 mdxD2 mouse is a useful model for pre-
clinical testing of genetic therapies that act on the DMD gene and provide




Development of a CRISPR-based gene therapy approach targeting the
large exon 45-exon 55 mutation hotspot in DMD gene
J. Bellec-Dyèvre, W. Lostal, E. Bernard, J. Cosette, I. Richard
Généthon, Inserm U951, INTEGRARE, Evry, France
Gene replacement and exon skipping therapies for Duchenne muscular
dystrophy (DMD) showed successful improvements in preclinical studies.
However, results obtained in recent clinical trials called for the development of
new therapeutic strategies that would restore a full-length or nearly full-length
dystrophin expression, provide long-term correction and answer challenges
regarding body-wide targeting. Dmd gene editing approaches hold great
promise and indeed have been shown to successfully excise exon 23 and exons
52–53 in vivo, leading to histopathological improvement. Targeting the larger
exon 45-exon 55 (Ex45-Ex55) mutation hotspot would account for about 60%
of the DMD patients. A proof-of-concept study validated this approach in iPS
cells. We are developing a CRISPR-based gene therapy approach targeting the
Dmd Ex45-Ex55 region to restore reading-frame and protein expression in vivo.
Both Streptococcus pyogenes (sp) and Staphylococcus aureus (sa) Cas9
endonucleases are used to edit Dmd gene followingAAV transfer. First, gRNAs
were designed and validated in vitro. Selected gRNAs have been injected
either in mouse models with muscle-specific Cas9 expression or in wild-type
mice with spCas9 or saCas9 as single or dual AAV vectors. Cas9 expression
was confirmed at the RNA and protein levels. Nuclear localization and
transduction efficiency was checked by immuno-histo-fluorescence (IHF).
Endonuclease activity at the targeted loci and Ex45-Ex55 inversion or deletion




A single neonatal injection of anAAV9.U7snRNA virus mediating skipping
of dmd exon 2 allows dystrophin expression preventing apparition of
pathologic features in the Dup2 mouse one year post injection
N. Wein 1, T. Simmons 1, F. Gumienny 1, N. Huang 1, K. Heller 1, J. Yurkoski 1,
L. Rodino-Klapac 1, F. Muntoni 2, K. Flanigan 3
1 Nationwide Childrens Hospital, Columbus, USA; 2 UCL Institute of Child
Health, London, UK; 3 The Research Institute at Nationwide Children’s
Hospital, Columbus, USA
Mutations that truncate the reading frame 5’ of exon 5 of the DMD gene
result in use of an internal ribosome entry site (IRES). This element allows
alternate translational initiation beginning within exon 6 that results in
expression of an N-truncated isoform. Despite lacking half of the actin binding
domain 1, this isoform is highly functional. We developed an AAV9.U7snRNA
vector directed against exon 2 which induces skipping of this exon, thus
resulting in a truncation of the reading frame therefore forcing expression of the
highly functional N-truncated protein. Injection of this vector have shown that
in a Duchenne muscular dystrophy (DMD) mouse model carrying a duplication
of exon 2 (the Dup2 mouse), postnatal intramuscular (IM) or late or early
intravascular (IV) treatment results in functional and pathologic improvement
in skeletal muscle. Importantly, early delivery of the vector results in almost
complete protection of the muscle 6months post injection which is highly
relevant to efforts to identify and treat DMD patients at an earlier age. Here we
are presenting a follow up study one year post injection. In the Dup2 mouse,
efficient skipping and abundant dystrophin expression were still present at one
year following the single AAV injection. Dystrophic pathology was absent at
all-time points; at one year, less than 1 % of fibers showed central nucleation,
in comparison to ~70% in untreated Dup2 mice. Assessment of strength, and
evaluation of sarcolemma stability were also performed. Both tests
demonstrated a significant protection of the treated animals. Finally, to model
the applicability of this approach beyond exon 2 duplication patients, the same
vector was used to treat 6 human patient fibroblast-derived transdifferentiated
myoblasts harboring various mutations within exons 1 to 4. In all FibroMyoD
cultures, abundant exon 2 skipping and dystrophin expression were detected
after treatment. These results suggest that this exon-skipping vector offers a
therapeutic approach not only to patients with exon 2 duplications but with all
mutations within the first four DMD exons (~6% of patients), an area of the
gene largely ignored by the current therapeutic approaches. This work strongly
supports the idea that early treatment of these patients will have longstanding
and significant benefit resulting in a better outcome.
http://dx.doi.org/10.1016/j.nmd.2017.06.339
P.300
Correction of the exon 2 duplication in DMD myoblasts by a single
CRISPR/Cas9 system
A. Lattanzi 1, S. Duguez 2, A. Moiani 3, A. Izmiryan 3, E. Barbon 4, S. Martin 1,
K. Mamchaoui 2, V. Mouly 2, F. Bernardi 4, F. Mavilio 1, M. Bovolenta 4
1 Genethon, Evry, France; 2 Institut de Myologie, UMRS 974, Paris, France;
3 Genethon, Paris, France; 4 University of Ferrara, Ferrara, Italy
Exonic duplications account for 10–15% of all mutations in Duchenne
muscular dystrophy (DMD), a severe hereditary neuromuscular disorder. We
report a novel CRISPR (Clustered Regularly Interspaced Short Palindromic
Repeat)/Cas9-based strategy to correct the most frequent (exon 2) duplication
in the DMD gene by targeted deletion, and tested the efficacy of such an
approach in patient-derived myogenic cells. We demonstrate restoration of
wild-type dystrophin expression at transcriptional and protein level in myotubes
derived from genome-edited myoblasts in the absence of selection. Removal of
the duplicated exon was achieved by the use of only one gRNA directed against
an intronic region, thereby increasing editing efficiency and reducing the risk of
off-target effects. This study opens a novel therapeutic perspective for patients




The relationship between dystrophin restoration through tricyclo
DNA-AON treatment to myosin fast fibre phenotype and other members of
the DAG complex
S. Omairi 1, A. Goyenvalle 2, H. Amthor 2, L. Garcia 2, K. Patel 1
1 University of Reading, Reading, UK; 2 University de Versailles St-Quentin,
Paris, France
Restoration of Dystrophin expression is a potential means of treating
Duchenne muscular dystrophy. One exciting approach to achieve this endpoint
through antisense oligonucleotide (AON) mediate exon skipping. Recently we
described a novel class of AON made of tricyclo-DNA (tc) which due to their
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unprecedented tissue uptake promoted a high degree of dystrophin expression.
Here we examined whether muscle fibre characteristics influenced the efficacy
of tcDNA-AON to restore dystrophin expression. We first examined untreated
mdx muscle for dystrophin expression in revertant fibres and it relation to the
expression of myosin heavy chain isoforms. We show that revertant fibres (less
than 2% of all fibres) showed no bias for MHCII expression. Interestingly only
about a quarter of revertant fibres expressed other components of the
Dystrophin-Associated Glycoprotein (DAG) complex. As expected treatment
with tcDNA-AON resulted in a dystrophin restoration, with 10% of fibres in the
tibialis anterior muscle showing positivity. Importantly this restoration was
equal between MHCIIB and non-IIB fibres. However two key components of
the DAG only featured in 2–4% of all fibres again without any MHCIIB fibre
type bias. Finally we show that amount of not only dystrophin but also of b-SG,
a DG and collagen IV were increased in muscle fibres following TC-AON.
These results show that dystrophin restoration does not necessitate the
restoration of other members of the DAG. However the levels of each
component when reinstated were higher than in revertant fibres. The importance
of our work is that it demonstrates that a relatively small proportion of fibres




In vivo analysis of dystrophin (re-) expression in DmdEGFP and
DmdEGFP-mdx reporter mice
M. Petkova 1, C. Laplace-Builhé 2, A. Goyenvalle 1, L. Garcia 1, M. Schuelke 3,
H. Amthor 1
1 University of Versailles St-Quentin, Montigny-le-Bretonneux, France;
2 Institut Gustave Roussy, Villejuif, France; 3 Charité – Universitätsmedizin
Berlin, Berlin, Germany
Duchenne muscular dystrophy (DMD), the most frequently inherited
muscle disease in childhood, is caused by mutations in the gene encoding
dystrophin. The modification of dystrophin mRNA splicing, called exon-
skipping, is a promising therapeutic strategy. This approach uses small
molecules, anti-sense oligonucleotides, that “repair” the open reading frame of
the Dmd gene through skipping of exons, which flank the original mutation and
lead to the production of truncated dystrophin. Animal models play an
indispensable role in the development and optimization of therapeutic
approaches for DMD as well as in understanding the role dystrophin in the
muscle. Our group recently generated the first dystrophin reporter mice on the
wildtype (DmdEGFP) and mdx (DmdEGFP-mdx) genetic background. These models
express an endogenous dystrophin-EGFP fusion protein permitting the
visualization of dystrophin expression using native fluorescence. We currently
study the expression of dystrophin in vivo using intravital two photon
microscopy in skeletal muscle from DmdEGFP mice. We analyze the dynamics
of dystrophin during the course of an acute injury and reconstitute the
regenerating muscle in 3D using the dystrophin-EGFP re-expression in
myofibers. We use DmdEGFP-mdx and study in vivo the restoration of dystrophin
following of exon skipping for direct visualization, quantification and precising
the dynamics of dystrophin restoration. Data of these ongoing experiments will




SGT-001 Micro-dystrophin gene therapy for Duchenne muscular
dystrophy
J. Schneider, J. Gonzalez, K. Brown, D. Golebiowski, V. Ricotti, J. Quiroz,
C. Morris
Solid Biosciences, Cambridge, USA
Duchenne muscular dystrophy (DMD) is a severe muscle disorder caused
by loss-of-function mutations in the DMD gene, which lead to the absence of
the dystrophin protein. Without dystrophin, the structural link between the
actin cytoskeleton and extracellular matrix is broken, and muscles are highly
susceptible to contraction-induced damage. Direct dystrophin replacement has
thus far been unsuccessful due to large size of the DMD gene. As a wide
variety of mutations can be responsible for the disease, therapeutic strategies
aimed at specific mutations only have the potential to benefit subsets of patients.
SGT-001 is an AAV micro-dystrophin gene therapy being developed to enter
clinical trials for DMD. This represents a unique strategy to benefit DMD
patients regardless of dystrophin mutation. The program is based on extensive
research on the dystrophin protein, to develop shorter yet functional
micro-dystrophin variants, and to deliver genes to muscle. Significant preclinical
work has been conducted to fully characterize SGT-001. Solid has performed
studies in dystrophic mouse and dog models to evaluate biodistribution and
micro-dystrophin protein expression following systemic administration of SGT-001.
Preclinical data show that a single dose of SGT-001 leads to widespread
biodistribution and long-term micro-dystrophin expression in skeletal and cardiac
muscle. Quantification of protein expression using immunofluorescence, Western
blotting and mass spectrometry identified a dose-response increase in percent
positive muscle and overall protein levels. Further, in vivo and in vitro functional
assessments have demonstrated improved muscle function in a similar
dose-dependent manner. The goal of the SGT-001 program is to develop a
clinical candidate that will generate tolerated and efficacious levels of
micro-dystrophin protein in all affected muscles in DMD. Solid is planning to




Dose finding study in the DMDmdx rat model to determine the efficacious
dose of a rAAV9 vector encoding a human mini-dystrophin after IV
administration
C. Le Guiner 1, M. McIntyre 2, T. Larcher 1, O. Adjali 1, A. Lafoux 1,
G. Toumaniantz 1, L. Wood 3, X. Xiao 4, P. Moullier 1, R. Samulski 2
1 University of Nantes, Nantes, France; 2 Bamboo Therapeutics, Pfizer, Chapel
Hill, USA; 3 Pfizer, Cambridge, USA; 4 University of North Carolina, Chapel
Hill, USA
We determined the pharmacologically effective dose range of rAAV9-
dys3978, a recombinant AAV serotype 9 vector expressing a human mini-
dystrophin gene under the control of a muscle-specific promoter, administered
intravenously in 2-month old DMDmdx rat. Animals were followed for 3 and 6
months after vector administration. Primary measures of efficacy included the
percentage of dystrophin-expressing myofibers in skeletal, cardiac and
diaphragm muscle, dystrophic muscle pathology, strength and fatigue as
measured by grip force test, and cardiac function as measured by 2D
echocardiography. In-life clinical observations, clinical biochemistry measures
and immuno-monitoring were included in the study design to provide dose-
related information about the safety of the test article in an animal model of
disease. The complete data will be presented.
http://dx.doi.org/10.1016/j.nmd.2017.06.344
P.305
Molecular therapy in a novel translational large animal model for
Duchenne muscular dystrophy
S. Krause 1, S. Reichert 1, T. Donandt 1, C. Kalbe 2, M. Schmuck 1,
N. Klymiuk 3, B. Kessler 3, A. Blutke 4, E. Wolf 3, B. Schoser 1, M. Walter 1
1 Friedrich Baur Institute, Munich, Germany; 2 Leibniz Institute for Farm
Animal Biology, Dummerstorf, Germany; 3 Molecular Animal Breeding and
Biotechnology and Laboratory for Functional Genome Analysis (LAFUGA),
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Muscular dystrophies are characterized by weakness and wasting of skeletal
muscle tissues and treating wasting muscle is one of the biggest issues in the
neuromuscular field. Several drugs targeting the myostatin pathway have been
used in clinical trials to increase muscle mass and function but so far, most drugs
had no or limited effects in improving function in neuromuscular patients. In our
study, the expression levels of different actors of the myostatin network were
analysed at mRNA and protein levels in neuromuscular patients’ sera and skeletal
muscle specimens. In muscle wasting or atrophying diseases, a strong down-
regulation of the whole myostatin pathway was observed with a decrease of
myostatin and activin receptor, and an increase of the myostatin antagonist,
follistatin. We also provide in vivo evidence in the congenital myopathy mtm1
mouse model that a down-regulated myostatin pathway can be reactivated by
correcting the underlying gene defect using AAV-mediated gene therapy.
Importantly, we show that the MTM1 restoration effect on muscle mass can be
further enhanced by anti-myostatin therapy. Our data may explain the poor
clinical efficacy of anti-myostatin approaches in clinical studies and the apparent
contradictory results in mice regarding the efficacy of anti-myostatin approaches
and may profoundly affect patient selection and stratification for future trials.
http://dx.doi.org/10.1016/j.nmd.2017.06.026
EC.O.5
The multi-systemic protection against age-related tissue function decline in
progeric mice through the attenuation of myostatin/activin signalling
K. Patel 1, K. Alyodawi 1, S. Omairi 1, W. Vermeij 2, O. Kretz 3, F. Salagna 3,
T. Huber 3
1 University of Reading, Reading, UK; 2 Erasmus, Rotterdam, Netherlands;
3 University of Freiburg, Freiburg, Germany
A dominant principle underpinning our understanding of the ageing process
is that DNA damage induces a stress response that shifts cellular resources from
growth towards maintenance. A contrasting and seemingly irreconcilable view
is that prompting growth of, for example skeletal muscle, results in systemic
benefit. To investigate the robustness of these axioms, we induced muscle
growth in a murine progeric model. Here we show that the muscle of Ercc1Δ/-
progeric mice undergoes an extremely severe form of wasting which can be
protected through an intervention that attenuates myostatin/activin signalling.
Significantly we found that treated progeric mice not only maintained muscle
activity but also kidney function, protected against the development of liver
abnormalities and osteoporosis. This study fundamentally challenges the notion
that tissue growth and the maintaining tissue function during ageing are
incompatible mechanisms. As importantly, it highlights the potential of
therapies based on myostatin/activin blockade to promote healthy ageing.
http://dx.doi.org/10.1016/j.nmd.2017.06.027
EC.O.6
Abolition of the NLRP3 inflammasome improves the dystrophic phenotype
in a murine model of Duchenne muscular dystrophy
R. Boursereau, M. Abou-Samra, S. Lecompte, L. Noel, S. Brichard
Catholic University of Louvain (UCL), Brussels, Belgium
Assembly of the NLRP3 inflammasome leads to caspase-1 activation and
mediates the cleaving and release of several inflammatory cytokines. The NLRP3
inflammasome can amplify inflammatory responses and thus worsen several
diseases. Duchenne muscular dystrophy (DMD) is one of the most devastating
muscle disease and it is known to harbour a severe inflammation.We have recently
shown that NLRP3 was more expressed in skeletal muscle fibers of mdx mice (a
murine model of DMD) than in Wild-Type (WT) mice. Adiponectine (ApN) is a
hormone known to possess powerful anti-inflammatory effects on skeletalmuscle.
Interestingly, transgenic mdx mice that overexpress ApN exhibited lower muscle
inflammation/damage as well as higher globular muscle force/endurance when
compared to regular mdx mice. These beneficial effects of ApN were associated
with a reduction in NLRP3 expression in skeletal muscle. In this study, we
investigated the effects of the absence of NLRP3 on the dystrophic phenotype by
crossingmdxmicewith NLRP3-knockout (NLRP3-KO)mice. First, functional in
vivo studies (grip test,wire test and treadmill exercise)were performedon4groups
ofmice:WT,NLRP3-KO,mdxandNLRP3-KO-mdx.Compared toWT,mdxmice
presented a strong decrease of global force and endurance that was partially
restored in NLRP3-KO-mdx mice. In addition, NLRP3-KO-mdx mice also
exhibited a significant decrease in muscle damage, oxidative stress and
inflammation as well as a reduction in caspase-1 activation, when compared to
regular mdx mice. Furthermore, satellite cells obtained from control and DMD
subjects were cultured and differentiated into myotubes. We found that NLRP3
basal expression was 3.5-fold higher in DMDmyotubes than in control myotubes.
This expressionwas then reduced afterApN treatment.These novel data show that
NLRP3 is implicated in DMD where it plays a key pathogenic role, thus opening
new therapeutic perspectives to control muscle inflammation and damage.
http://dx.doi.org/10.1016/j.nmd.2017.06.028
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Necroptosis, a programmed form of necrosis, participates in muscle
degeneration in Duchenne muscular dystrophy
M. Bencze, J. Meng, V. Pini, F. Conti, F. Muntoni, J. Morgan
UCL, London, UK
Efforts to treat Duchenne muscular dystrophy (DMD) mainly focus on
strategies aimed at increasing dystrophin expression, or enhancing muscle
regeneration/growth. However, the process of cell death in muscle wasting
disorders has been largely overlooked. In DMD, fibres die with a necrotic
morphology, making myonecrosis a central process in its pathogenesis.
Inflammation and oxidative stress play a significant part in muscle loss, but how
inflammation induces myonecrosis is still unknown. Lately, there has been a
conceptual revolution in the cell death field, with the discovery of regulated
forms of necrosis. In particular, necroptosis, a RIPK3-dependent programmed
cell death, plays a major role in cell death following inflammation-induced
injuries in several tissues and is commonly initiated by ligands to the TNF
Receptor superfamily members. As a programmed cell death mode, necroptosis
can be pharmacologically prevented. Its involvement in skeletal muscle
degeneration has not yet been reported. We are currently investigating the
involvement of necroptosis in inflammatory-induced myonecrosis, and more
specifically in the pathogenesis of DMD. In vitro, we found that TNFα can
trigger necroptosis in C2C12 cell line, suggesting that muscle cells can undergo
necroptosis upon inflammatory challenge. In vivo, we found evidence of
necroptosis in human and mouse dystrophin-deficient muscles. By depleting
RIPK3 in mdx mice, we significantly decreased myonecrosis. Together, our data
demonstrate that the necroptotic machinery is involved in DMD pathogenesis
and that its prevention could represent a new therapeutic target.
http://dx.doi.org/10.1016/j.nmd.2017.06.029
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Epigenetic regulation of a mitochondrial apoptosis mediator, harakiri in
maintaining muscle membrane stability in autoimmune myositis
K. Nagaraju 1, J. Boehler 2, A. Horn 2, J. Novak 2, S. Ghimbovschi 2,
I. Lundberg 3, J. Jaiswal 2
1 Binghamton University-SUNY, Binghamton, USA; 2 Children’s national
medical center, Washington, DC, USA; 3 Karolinska Institute, Stockholm,
Sweden
Currently, the cause of myositis is unknown, but disease onset sometime has
been associated with exposure to environmental agents such as viral infections.
Although attempts to identify viruses in myositis skeletal muscle have failed,
several studies have shown that a viral signature (e.g., Type 1 interferon) is
present in myositis muscle. To investigate this, we hypothesized that certain
virus alters DNA methylation in the promoter regions of genes, leading to their
aberrant expression in target tissues and disease phenotype in susceptible
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